data_4hck_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 4hck _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.442 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.976 0.417 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.425 ' CD1' ' CG1' ' A' ' 106' ' ' VAL . 5.8 mm -96.54 132.86 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.009 -1.057 . . . . 0.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.52 168.12 13.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.571 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.16 133.66 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -78.85 121.02 24.3 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.854 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 3.7 mt -94.23 3.33 55.39 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.452 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 80.6 m-85 -153.16 152.86 31.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -69.97 142.59 52.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.37 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 68.6 t80 -151.72 131.87 13.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.427 -0.795 . . . . 0.0 110.137 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -101.9 141.01 35.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.725 . . . . 0.0 111.036 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.131 0 O-C-N 121.623 -0.673 . . . . 0.0 111.283 -179.724 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 44.7 p30 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.8 tp -154.89 124.64 6.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.0 111.102 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -95.14 113.48 25.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.746 -0.596 . . . . 0.0 110.148 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 16.8 p90 -109.83 -173.28 2.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.965 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 179.52 4.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.188 0.994 . . . . 0.0 111.996 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.1 ttmt -61.05 -20.93 63.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.4 41.2 1.31 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.99 164.29 14.03 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.16 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.33 135.22 55.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 75.7 mtm -140.27 151.96 45.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.32 0.581 . . . . 0.0 109.647 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.425 ' CG1' ' CD1' ' A' ' 82' ' ' ILE . 43.2 t -101.43 147.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 90.8 t -95.12 139.89 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.019 -1.051 . . . . 0.0 110.113 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.9 mp -97.05 -27.5 14.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -156.07 161.33 40.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.674 -0.641 . . . . 0.0 109.853 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -107.58 143.44 36.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.436 -0.79 . . . . 0.0 109.816 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -153.05 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.831 . . . . 0.0 110.388 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.09 -113.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -94.99 -16.69 22.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.668 -0.901 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -100.62 101.09 11.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.604 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.409 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 52.8 m0 -97.53 148.96 22.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.436 -0.79 . . . . 0.0 110.204 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -98.14 111.37 23.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.422 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.08 169.26 13.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.186 -0.946 . . . . 0.0 112.302 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -113.03 118.57 35.17 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 121.69 -0.631 . . . . 0.0 109.757 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.9 t -72.45 115.4 11.67 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.88 -27.65 66.86 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.124 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.4 61.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 0.0 110.389 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p -137.7 10.67 2.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.456 -0.777 . . . . 0.0 110.78 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 53.1 26.76 5.16 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.083 -1.011 . . . . 0.0 110.567 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -102.12 176.67 5.12 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.58 143.0 19.46 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.29 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.38 -152.26 7.55 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 47.1 m-85 -93.76 158.46 15.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 -179.474 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.53 115.39 2.27 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.843 -0.535 . . . . 0.0 109.778 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.76 104.32 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 122.945 0.971 . . . . 0.0 110.993 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.409 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 2.4 m -63.49 -12.37 31.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.613 -0.679 . . . . 0.0 111.426 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -68.03 -8.92 41.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.075 -1.016 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -132.68 35.94 3.57 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.1 t -139.84 173.16 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.925 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.01 129.26 35.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.419 -0.801 . . . . 0.0 111.969 -179.389 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.457 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.595 0.236 . . . . 0.0 110.998 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 56.0 mt -97.02 139.45 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.072 -1.018 . . . . 0.0 109.115 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.433 ' HB ' HG23 ' A' ' 133' ' ' VAL . 25.5 m -128.78 179.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.295 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.3 p -131.59 126.73 58.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.496 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -68.96 119.78 13.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.419 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 42.8 mt -94.01 1.34 56.26 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.071 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.457 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 60.0 m-85 -152.63 152.17 31.47 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.94 148.98 50.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.492 -0.755 . . . . 0.0 110.487 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.421 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 77.1 t80 -155.15 127.44 7.78 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.47 -0.769 . . . . 0.0 111.13 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.84 132.73 43.18 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.568 -0.708 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.122 0 O-C-N 121.456 -0.777 . . . . 0.0 111.018 179.741 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tt -112.33 143.17 43.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.436 -0.79 . . . . 0.0 111.102 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -96.4 122.36 39.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.728 -0.607 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 13.7 p90 -114.03 -171.29 1.88 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.654 -0.654 . . . . 0.0 109.6 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 179.56 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.133 0.968 . . . . 0.0 111.9 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -60.76 -22.55 64.16 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.38 41.94 1.28 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.91 165.99 13.29 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.805 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.18 128.68 51.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.529 -0.732 . . . . 0.0 109.132 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.418 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 1.6 mpp? -136.96 150.47 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.767 -0.583 . . . . 0.0 109.613 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 23.3 t -101.27 151.01 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.457 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 99.4 t -94.58 141.46 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.022 -1.048 . . . . 0.0 110.077 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -96.78 -30.93 12.9 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.645 0.736 . . . . 0.0 109.029 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -156.36 162.2 40.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.773 -0.579 . . . . 0.0 109.729 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.72 154.26 19.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.453 -0.78 . . . . 0.0 109.896 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.8 t -147.65 -75.65 0.18 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.403 -0.811 . . . . 0.0 110.433 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.86 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 114' ' ' TRP . 2.4 tt0 -92.93 -16.04 25.63 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.94 . . . . 0.0 110.832 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 113' ' ' GLU . 85.8 m95 -132.25 107.63 8.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.452 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 31.3 m0 -100.88 155.58 17.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.292 -0.88 . . . . 0.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -97.16 111.73 23.83 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.28 168.32 14.92 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.082 0.944 . . . . 0.0 112.609 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.7 ttt180 -112.61 121.9 46.12 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.628 -0.67 . . . . 0.0 109.647 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t -74.87 110.02 8.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.912 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.28 -21.72 66.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.827 -0.546 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.88 -24.92 67.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.4 p -140.71 15.08 2.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.232 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 50.91 27.21 3.04 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.695 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 18.8 mttt -97.13 179.9 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 109.319 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -155.9 149.01 24.44 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.945 0.879 . . . . 0.0 111.791 179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -176.88 -153.98 11.41 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -93.49 165.03 12.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.628 -0.925 . . . . 0.0 109.391 179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.2 pt -155.41 116.48 2.33 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 109.901 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -48.0 104.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.138 1.073 . . . . 0.0 111.847 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.1 m -60.12 -16.53 33.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.944 -0.473 . . . . 0.0 111.276 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.469 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 3.3 p-10 -83.91 12.11 6.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.102 -0.999 . . . . 0.0 112.06 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.469 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 3.8 m-85 -146.93 39.74 1.04 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.433 HG23 ' HB ' ' A' ' 83' ' ' VAL . 3.8 p -146.82 168.86 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.16 134.04 55.21 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.277 0.561 . . . . 0.0 110.189 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 112.177 -178.813 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.431 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.445 0.164 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.5 mt -99.2 150.12 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.964 -1.085 . . . . 0.0 108.87 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.13 171.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.287 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.49 124.14 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -66.52 118.42 10.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 95.0 mt -94.25 1.86 55.94 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.102 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.457 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 56.0 m-85 -151.54 150.83 30.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.218 -0.927 . . . . 0.0 108.726 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -70.55 144.23 51.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.527 -0.733 . . . . 0.0 110.319 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 72.5 t80 -155.54 131.89 10.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.253 -0.905 . . . . 0.0 111.531 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.9 146.23 25.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.617 . . . . 0.0 110.364 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.451 -0.781 . . . . 0.0 110.676 -179.841 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 46.8 p30 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 120.766 0.317 . . . . 0.0 110.344 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -150.63 126.32 10.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.459 -0.775 . . . . 0.0 111.264 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -94.68 117.82 30.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 110.171 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 16.1 p90 -114.57 -169.87 1.62 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.725 -0.61 . . . . 0.0 110.266 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.94 179.78 4.88 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.284 1.04 . . . . 0.0 112.422 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.6 ttmt -61.18 -22.1 64.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.54 41.32 1.29 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 171.6 9.15 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.915 -0.756 . . . . 0.0 112.026 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.5 130.26 51.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.429 -0.794 . . . . 0.0 109.52 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.29 153.39 50.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.639 . . . . 0.0 109.747 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.95 149.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 58.9 t -95.57 138.02 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.164 -0.96 . . . . 0.0 109.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -96.57 -29.0 14.11 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.447 0.641 . . . . 0.0 109.469 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -155.63 149.41 25.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.777 -0.577 . . . . 0.0 109.786 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -96.19 144.59 26.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.718 . . . . 0.0 109.292 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 t -134.88 -66.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.7 -64.18 0.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -112.34 -29.86 7.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.601 -0.941 . . . . 0.0 110.047 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -125.25 103.36 7.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.709 -0.62 . . . . 0.0 109.876 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.423 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 42.6 m0 -97.31 153.78 17.84 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 0.0 110.598 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.97 117.29 31.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.19 167.66 15.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.189 -0.945 . . . . 0.0 112.485 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.1 ttt180 -114.96 126.33 54.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.657 -0.652 . . . . 0.0 109.416 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 123' ' ' ARG . 3.8 t -79.42 118.81 21.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.83 -25.21 64.54 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.565 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p -128.05 7.11 6.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.672 -0.642 . . . . 0.0 110.897 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 119' ' ' SER . 0.3 OUTLIER 52.91 32.22 12.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.066 -1.021 . . . . 0.0 110.305 -179.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.8 mttm -100.78 178.86 4.57 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -154.89 137.13 14.84 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.008 0.908 . . . . 0.0 111.6 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.39 -147.95 5.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 76.7 m-85 -94.18 164.15 13.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.622 -0.928 . . . . 0.0 110.787 -179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -153.83 104.5 2.49 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.56 106.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.931 0.964 . . . . 0.0 111.774 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 14.3 m -59.46 -18.49 40.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.947 -0.47 . . . . 0.0 111.097 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -73.4 -1.26 17.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.366 -0.834 . . . . 0.0 112.596 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -142.65 46.7 1.58 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.09 169.72 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.607 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -120.21 122.55 41.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.815 0.817 . . . . 0.0 112.625 -178.299 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 107' ' ' VAL . 3.6 tp . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 77.4 mt -115.11 165.61 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 135' ' ' ARG . 12.0 m -143.64 171.1 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.78 129.37 58.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -71.9 119.8 16.59 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.689 -0.804 . . . . 0.0 108.898 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 61.7 mt -94.12 0.05 55.6 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.895 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.478 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.9 m-85 -151.97 152.39 32.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -68.83 145.05 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.432 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 79.4 t80 -152.39 125.32 8.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.409 -0.807 . . . . 0.0 110.576 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -94.76 134.11 37.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 110.003 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.401 -0.812 . . . . 0.0 110.719 -179.691 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.0 139.78 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 0.0 111.532 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -95.29 118.63 32.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.617 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 12.2 p90 -112.95 -171.7 1.91 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.0 110.048 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.93 -178.54 4.09 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.187 0.994 . . . . 0.0 112.379 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.1 ttmt -61.12 -23.06 65.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.27 41.71 1.23 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.84 167.51 12.4 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.738 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -121.04 128.27 52.5 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.469 -0.769 . . . . 0.0 109.702 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -136.97 150.39 48.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 11.3 t -95.26 152.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 81' ' ' ILE . 38.4 t -94.02 134.49 31.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -94.68 -27.3 15.92 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -156.56 -169.5 3.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.69 -0.631 . . . . 0.0 110.314 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -150.98 115.06 5.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.497 -0.752 . . . . 0.0 109.961 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -127.4 -68.4 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.47 142.74 3.47 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 65.44 -69.18 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.632 -0.922 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -109.47 117.24 33.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 110.256 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.432 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 53.8 m0 -107.02 154.19 21.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.25 118.77 32.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.437 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -133.39 159.12 41.26 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.138 -0.976 . . . . 0.0 112.285 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -111.52 126.72 55.28 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.469 -0.769 . . . . 0.0 110.166 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 t -81.25 112.06 18.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 109.532 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 mt -65.89 -20.86 66.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.889 -0.507 . . . . 0.0 110.913 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.67 73.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.9 p -129.4 11.39 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.753 -0.592 . . . . 0.0 110.658 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.69 30.14 8.37 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -102.16 178.27 4.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.62 -0.675 . . . . 0.0 109.385 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.76 149.11 24.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.745 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.59 -150.42 7.52 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 68.8 m-85 -93.27 162.22 14.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.745 -0.856 . . . . 0.0 109.931 179.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.0 108.75 2.66 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.733 -0.604 . . . . 0.0 109.382 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.51 108.11 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.027 1.014 . . . . 0.0 111.735 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 12.1 m -57.36 -15.33 6.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.776 -0.578 . . . . 0.0 111.804 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -76.7 5.54 7.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.131 -0.98 . . . . 0.0 112.808 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -151.17 38.72 0.65 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.89 -1.131 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.3 p -146.79 168.51 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.81 141.46 46.41 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.43 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.4 ' HA ' ' CG1' ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.701 0.762 . . . . 0.0 110.577 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.4 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 66.6 mt -96.93 157.43 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.869 -1.144 . . . . 0.0 109.558 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 133' ' ' VAL . 33.8 m -139.94 172.2 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.24 120.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -62.56 118.42 7.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.792 . . . . 0.0 109.222 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 69.2 mt -94.46 2.46 55.74 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.2 m-85 -153.67 152.87 31.32 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.14 -0.975 . . . . 0.0 108.831 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.35 144.29 53.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.391 -0.818 . . . . 0.0 110.447 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 48.2 t80 -155.4 127.95 7.89 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.396 -0.815 . . . . 0.0 110.793 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.87 149.35 21.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.422 -0.799 . . . . 0.0 110.771 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.998 0 O-C-N 121.467 -0.77 . . . . 0.0 109.929 179.444 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.6 p30 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 120.766 0.317 . . . . 0.0 110.425 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.9 tt -155.07 128.67 8.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.321 -0.862 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -94.79 117.02 29.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.404 -0.81 . . . . 0.0 110.494 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 19.0 p90 -115.94 -170.03 1.71 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.724 -0.61 . . . . 0.0 110.501 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 179.4 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.343 1.068 . . . . 0.0 112.525 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.464 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.9 ttmt -61.08 -20.72 62.94 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 41.16 1.33 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.409 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 1.9 m-20 -91.02 170.51 9.98 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.746 -0.855 . . . . 0.0 111.693 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.87 129.28 47.92 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.513 -0.742 . . . . 0.0 109.49 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.402 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 3.1 mpp? -137.48 152.94 50.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.738 -0.601 . . . . 0.0 109.444 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 25.4 t -101.08 152.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.4 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 88.3 t -95.39 141.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.031 -1.043 . . . . 0.0 110.527 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -156.04 159.44 39.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.877 -0.515 . . . . 0.0 110.117 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -102.2 152.08 21.44 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.511 -0.743 . . . . 0.0 109.581 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -146.25 -66.95 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.142 -0.973 . . . . 0.0 111.019 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.13 -84.34 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -98.48 -20.89 16.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.591 -0.947 . . . . 0.0 110.777 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.85 107.51 9.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 109.506 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.44 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 41.6 m0 -101.26 155.06 18.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.39 -0.818 . . . . 0.0 110.886 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -100.6 111.96 24.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.09 169.71 13.11 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.241 1.02 . . . . 0.0 112.717 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.5 ttt180 -113.0 124.73 53.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.844 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.0 t -78.08 115.08 17.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.95 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.43 -23.77 66.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.847 -0.533 . . . . 0.0 110.114 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.26 -30.51 66.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.806 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.4 p -136.35 12.26 3.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.834 -0.541 . . . . 0.0 110.952 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.89 30.95 7.72 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.062 -1.024 . . . . 0.0 110.461 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.9 mttt -100.18 -179.88 4.27 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.22 137.25 14.63 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.035 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.26 6.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 70.7 m-85 -94.24 162.85 13.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.578 -0.954 . . . . 0.0 111.317 -179.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -155.31 111.03 2.25 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.998 -0.439 . . . . 0.0 110.166 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -45.36 101.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.04 1.021 . . . . 0.0 112.0 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.44 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.2 m -51.89 -28.87 17.65 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -81.57 11.62 4.49 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.298 -0.876 . . . . 0.0 112.569 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -136.79 30.87 2.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.061 -1.025 . . . . 0.0 108.589 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -147.98 170.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -119.32 129.27 54.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.408 ' HD3' ' CZ3' ' A' ' 115' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.236 0 O-C-N 121.522 -0.736 . . . . 0.0 112.924 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 80.7 mt -111.66 166.95 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.728 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.4 HG12 ' CG2' ' A' ' 107' ' ' VAL . 13.4 m -143.53 169.04 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.722 -0.611 . . . . 0.0 109.678 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -131.95 126.53 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.778 . . . . 0.0 108.948 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -66.97 118.24 10.16 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.84 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.42 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 86.9 mt -94.18 1.26 56.08 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.874 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.471 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 55.9 m-85 -152.99 151.1 29.9 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.197 -0.939 . . . . 0.0 108.652 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.05 145.99 55.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.587 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 69.1 t80 -150.31 163.84 37.29 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.502 -0.749 . . . . 0.0 110.611 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.76 125.59 22.53 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.61 -0.682 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 121.456 -0.778 . . . . 0.0 111.268 179.638 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t0 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.1 tp -107.57 129.19 55.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.76 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -94.5 176.8 6.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.699 -0.625 . . . . 0.0 109.953 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 11.6 p90 -172.98 -167.48 0.42 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.494 -0.754 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -176.88 3.64 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.125 0.964 . . . . 0.0 111.539 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.471 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.0 ttmt -61.08 -22.73 64.89 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.38 44.7 1.0 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.405 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 3.0 m-20 -90.78 166.51 13.07 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.797 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.13 116.96 25.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.45 -0.781 . . . . 0.0 110.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.5 mtm -129.78 146.36 51.53 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -98.54 156.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.545 -1.262 . . . . 0.0 108.71 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 81' ' ' ILE . 43.3 t -93.62 139.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.01 0.909 . . . . 0.0 109.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.462 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -94.54 -30.76 14.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -156.23 161.2 40.29 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.71 144.68 31.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 0.0 109.975 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -139.03 -77.93 0.34 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.392 -0.817 . . . . 0.0 110.318 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.28 -85.29 0.07 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -94.27 -13.2 26.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.896 . . . . 0.0 110.596 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -133.47 96.66 3.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.775 . . . . 0.0 110.163 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.421 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 31.7 m0 -94.91 146.04 24.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.243 -0.911 . . . . 0.0 109.787 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.21 117.06 29.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -129.57 165.77 21.05 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.039 0.923 . . . . 0.0 112.419 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.9 ttm180 -115.01 124.54 51.9 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.593 -0.692 . . . . 0.0 109.961 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 t -83.92 118.77 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.68 -0.638 . . . . 0.0 109.932 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.25 -20.8 62.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.398 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.24 -26.93 66.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.0 109.864 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p -137.62 10.99 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.766 -0.584 . . . . 0.0 110.606 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 53.64 30.81 11.53 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.147 -0.971 . . . . 0.0 110.755 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -104.79 174.0 6.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.526 -0.734 . . . . 0.0 109.27 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.83 146.66 22.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.694 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -176.27 -147.19 6.33 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.2 m-85 -93.44 160.59 14.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.648 -0.913 . . . . 0.0 110.061 -179.808 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -152.14 117.57 3.05 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 89' ' ' TYR . 35.0 Cg_exo -41.33 103.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.323 1.349 . . . . 0.0 112.843 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.421 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 74.2 m -62.36 -15.1 46.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.865 -0.522 . . . . 0.0 111.008 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -86.13 13.87 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 111.522 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -152.23 40.2 0.61 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.252 -0.905 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 134' ' ' ALA . 6.2 p -149.09 168.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.421 -0.799 . . . . 0.0 110.831 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.402 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -127.82 127.81 44.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.975 -0.453 . . . . 0.0 109.93 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.454 -178.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.9 tp . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 119.858 -0.115 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 7.0 mt -110.31 167.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 108.436 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 133' ' ' VAL . 3.8 m -146.17 167.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.669 . . . . 0.0 110.617 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.51 124.16 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -66.9 117.57 9.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 79.8 mt -94.39 5.53 51.5 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.257 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.444 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 38.9 m-85 -152.44 151.74 31.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -70.17 141.99 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 109.536 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 65.4 t80 -155.53 126.95 7.25 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.349 -0.844 . . . . 0.0 111.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -100.1 122.02 42.32 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.506 0.67 . . . . 0.0 109.895 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.508 0.671 . . . . 0.0 111.903 -179.153 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 . . . . . 0 N--CA 1.501 2.125 0 CA-C-O 121.049 0.452 . . . . 0.0 111.505 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 tt -137.54 134.34 35.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.415 -0.803 . . . . 0.0 110.47 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -94.44 166.94 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 110.001 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 24.0 p90 -164.76 -170.78 2.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.291 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -124.37 179.88 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.328 1.061 . . . . 0.0 112.69 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 16.6 ttmt -60.95 -19.32 60.75 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.34 41.22 1.31 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.9 166.06 13.26 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.686 -0.89 . . . . 0.0 111.527 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.05 111.31 15.82 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.561 -0.712 . . . . 0.0 110.112 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.9 mtm -126.01 147.41 49.55 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.1 m -95.02 157.33 3.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.073 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.9 t -93.98 135.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.201 1.001 . . . . 0.0 110.329 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -94.98 -27.62 15.56 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.632 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -155.61 177.45 11.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.75 -0.594 . . . . 0.0 109.844 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.81 94.52 3.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -97.29 -152.87 0.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.678 -0.639 . . . . 0.0 110.084 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.33 -114.66 0.07 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -86.54 -6.87 58.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.948 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -119.0 102.81 9.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 109.669 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -98.72 157.11 16.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.421 -0.799 . . . . 0.0 110.645 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -97.51 121.72 39.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -131.24 161.32 32.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.351 -0.843 . . . . 0.0 111.83 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.8 ttm180 -114.97 122.35 45.98 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.545 -0.722 . . . . 0.0 109.83 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.5 t -84.48 127.33 33.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.645 -0.659 . . . . 0.0 110.456 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.88 -26.59 60.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.114 -0.366 . . . . 0.0 110.715 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.76 66.15 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.42 -0.8 . . . . 0.0 110.671 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p -128.31 9.4 6.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.688 . . . . 0.0 110.566 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.48 33.78 19.56 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -107.82 176.98 4.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.562 -0.711 . . . . 0.0 109.087 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pm0 -155.26 137.99 15.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.39 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -162.41 -149.71 5.76 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -94.52 161.35 14.25 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 122.032 -0.687 . . . . 0.0 110.69 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -155.4 117.59 2.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -48.62 109.38 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.036 1.019 . . . . 0.0 111.73 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 m -56.96 -18.2 12.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.765 -0.584 . . . . 0.0 111.719 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 18.7 4.27 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.096 -1.003 . . . . 0.0 111.631 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -145.74 36.66 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.462 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 8.9 p -154.86 169.21 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.784 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.65 132.54 39.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.062 0.458 . . . . 0.0 110.301 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.413 ' HA ' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.882 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.43 HG13 ' HB ' ' A' ' 107' ' ' VAL . 1.4 tp . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 88.0 mt -123.16 159.18 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 133' ' ' VAL . 17.2 m -137.83 169.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.01 123.96 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.26 120.67 14.18 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.045 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.3 mt -94.26 1.12 56.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.95 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.6 m-85 -152.48 152.53 32.06 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.49 146.23 54.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.452 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 36.7 t80 -155.15 127.68 7.91 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.35 -0.844 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -98.03 144.4 27.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.427 -0.796 . . . . 0.0 111.551 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.665 -0.647 . . . . 0.0 111.585 -179.764 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.3 p30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.204 0.526 . . . . 0.0 111.498 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.35 121.89 5.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 110.106 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -94.52 112.0 23.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 110.55 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 14.4 p90 -114.83 -169.24 1.51 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.806 -0.559 . . . . 0.0 109.959 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -178.15 4.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.062 0.934 . . . . 0.0 111.72 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -60.95 -20.56 62.43 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.01 42.51 1.13 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.05 169.21 11.06 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.947 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.33 125.65 43.81 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.495 0.664 . . . . 0.0 109.547 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -134.4 153.95 51.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.6 t -94.41 152.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.43 ' HB ' HG13 ' A' ' 81' ' ' ILE . 33.6 t -95.57 134.93 31.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.902 0.858 . . . . 0.0 110.142 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -95.64 -27.83 15.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.54 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -156.05 -168.92 2.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.596 0.712 . . . . 0.0 111.128 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -143.62 99.22 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.64 -0.662 . . . . 0.0 109.562 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 t -94.42 -71.47 0.66 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 110.697 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.88 -77.21 0.07 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -94.04 -22.7 18.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.488 -1.007 . . . . 0.0 110.298 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -133.83 108.27 8.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.539 -0.726 . . . . 0.0 110.217 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.416 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 34.0 m0 -98.98 158.9 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -100.27 126.65 46.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.416 -0.802 . . . . 0.0 109.094 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.426 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -135.73 162.6 32.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 112.164 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.3 ttt180 -111.35 120.54 42.53 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.391 -0.818 . . . . 0.0 109.829 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.1 t -72.41 110.71 7.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.485 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.96 -26.0 68.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 -29.95 70.88 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.632 -0.668 . . . . 0.0 110.097 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.0 p -129.53 8.61 5.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 110.883 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 53.66 29.25 9.07 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.135 -0.978 . . . . 0.0 109.86 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -97.48 176.24 5.94 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.74 140.59 17.18 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.765 0.793 . . . . 0.0 111.464 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.24 -150.01 6.83 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 52.8 m-85 -93.92 165.28 12.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.905 -0.762 . . . . 0.0 110.805 -179.215 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.29 112.56 2.27 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 34.3 Cg_exo -42.67 102.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.109 1.206 . . . . 0.0 112.078 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.416 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 71.6 m -54.9 -20.6 9.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.906 -0.496 . . . . 0.0 111.513 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -90.26 25.32 2.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.214 -0.928 . . . . 0.0 111.63 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -154.99 32.02 0.4 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 109.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.411 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 7.6 p -149.02 169.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.579 -0.7 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.79 123.88 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.916 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 . . . . . 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 112.455 -178.69 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.916 0.389 . . . . 0.0 110.641 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.41 ' CD1' ' CG1' ' A' ' 106' ' ' VAL . 4.9 mm -96.65 140.1 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.064 -1.022 . . . . 0.0 108.882 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 133' ' ' VAL . 32.2 m -126.33 174.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.428 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.66 123.66 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.655 -0.653 . . . . 0.0 109.365 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -66.36 119.41 11.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 64.5 mt -94.3 4.2 54.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.561 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.47 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.1 m-85 -152.63 151.5 30.68 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.031 -1.043 . . . . 0.0 109.117 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -69.13 143.14 54.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.352 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.437 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 58.9 t80 -155.12 131.15 10.15 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.181 -0.949 . . . . 0.0 111.019 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -97.4 142.19 29.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.7 -0.625 . . . . 0.0 110.723 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.123 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 179.701 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.4 tp -151.9 129.33 11.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.312 -0.868 . . . . 0.0 111.14 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.76 116.65 28.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.686 -0.634 . . . . 0.0 110.295 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 17.3 p90 -113.62 -170.92 1.79 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.579 -0.7 . . . . 0.0 109.958 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.71 -179.77 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.032 0.92 . . . . 0.0 111.831 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.47 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.14 -23.36 65.47 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.7 40.9 1.37 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.96 171.08 9.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.049 -0.677 . . . . 0.0 111.543 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 139.55 53.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.484 -0.76 . . . . 0.0 109.781 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 71.8 mtm -142.95 154.01 43.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.79 -0.569 . . . . 0.0 110.178 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.41 ' CG1' ' CD1' ' A' ' 82' ' ' ILE . 22.4 t -100.77 147.89 7.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 95.4 t -94.92 138.93 19.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.881 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.14 -25.69 14.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.04 155.33 32.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.749 -0.595 . . . . 0.0 110.05 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -108.7 133.16 53.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 109.916 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.8 t -132.6 -85.38 0.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.279 -0.888 . . . . 0.0 110.658 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.96 -91.76 0.08 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.88 -16.83 30.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.585 -0.95 . . . . 0.0 110.807 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -127.59 104.9 8.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.371 -0.831 . . . . 0.0 110.468 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 44.5 m0 -101.95 153.56 19.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.249 -0.907 . . . . 0.0 109.984 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -102.78 113.21 26.44 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -128.02 167.93 16.01 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.127 -0.983 . . . . 0.0 112.675 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.1 ttt180 -115.76 124.01 49.71 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.65 -0.656 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 24.2 t -78.98 120.82 24.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.624 -0.673 . . . . 0.0 109.741 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mt -71.75 -21.81 61.7 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.17 73.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.4 -0.812 . . . . 0.0 109.656 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 p -130.56 9.54 5.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.726 -0.609 . . . . 0.0 110.735 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.23 31.3 13.87 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.042 -1.036 . . . . 0.0 110.641 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.5 mtpt -104.51 173.3 6.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.6 OUTLIER -154.6 140.35 18.08 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.644 179.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.03 -146.04 4.71 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 72.7 m-85 -94.15 157.81 15.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 122.056 -0.673 . . . . 0.0 110.6 -179.232 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -154.0 113.59 2.53 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.794 -0.566 . . . . 0.0 109.796 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.62 97.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.277 1.146 . . . . 0.0 112.062 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 66.9 m -49.56 -24.6 2.21 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.684 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -85.71 16.4 4.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.403 -0.811 . . . . 0.0 111.755 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.71 29.15 1.93 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.2 -0.938 . . . . 0.0 109.147 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.464 HG23 ' HB ' ' A' ' 83' ' ' VAL . 6.3 p -146.69 169.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.669 0.747 . . . . 0.0 110.901 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.7 135.71 54.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.867 -0.52 . . . . 0.0 110.072 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.39 -0.818 . . . . 0.0 111.696 -179.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.0 mt -107.88 157.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.902 -1.124 . . . . 0.0 109.055 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.447 ' HB ' ' CG2' ' A' ' 133' ' ' VAL . 28.9 m -139.86 173.12 11.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.815 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -133.09 121.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -64.42 118.94 9.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.707 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.5 mt -94.15 0.75 55.99 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.253 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.448 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 41.0 m-85 -150.13 149.72 30.66 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.257 -0.902 . . . . 0.0 108.834 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -66.24 151.31 47.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -153.94 167.78 28.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.374 -0.829 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 94.06 2.17 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.169 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.587 -0.696 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 91' ' ' ALA . 20.2 p-10 . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 120.989 0.423 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.43 134.66 43.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 m -94.7 170.2 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.594 -0.691 . . . . 0.0 109.976 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 18.4 p90 -161.02 -169.14 2.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.623 -0.673 . . . . 0.0 110.638 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.98 179.22 4.73 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.259 1.028 . . . . 0.0 112.523 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -61.12 -23.02 65.21 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.36 43.62 1.08 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 2.3 m-20 -90.53 167.85 12.27 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.894 -0.768 . . . . 0.0 111.396 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.47 128.61 50.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.589 -0.694 . . . . 0.0 109.717 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.407 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 2.1 mpp? -137.45 148.1 45.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.08 155.16 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 81' ' ' ILE . 49.4 t -95.13 140.51 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.159 -0.963 . . . . 0.0 110.634 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -97.59 -27.63 14.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -156.14 173.23 17.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.776 -0.578 . . . . 0.0 110.122 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -139.98 89.17 2.28 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.459 -0.775 . . . . 0.0 110.0 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.6 t -99.32 -68.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 110.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.86 154.59 7.27 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 65.14 -72.64 0.07 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.562 -0.963 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.424 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 39.4 m95 -108.86 126.4 53.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.94 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CE2' ' OG ' ' A' ' 130' ' ' SER . 51.6 m0 -106.39 141.62 37.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.521 -0.737 . . . . 0.0 110.213 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.6 114.02 25.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.406 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -130.31 164.89 23.65 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.841 0.829 . . . . 0.0 111.987 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.0 ttt180 -112.34 124.53 52.67 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.625 -0.672 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -78.88 114.39 17.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.578 . . . . 0.0 109.664 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.16 -27.7 68.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.51 . . . . 0.0 109.992 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.97 38.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.094 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -139.49 10.6 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.676 -0.64 . . . . 0.0 110.717 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 52.24 30.51 7.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.959 -1.088 . . . . 0.0 110.707 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 28.2 mttt -103.26 -178.75 3.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.4 OUTLIER -155.38 147.41 23.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.52 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -155.73 11.15 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.424 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 79.0 m-85 -94.18 157.75 15.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 122.045 -0.68 . . . . 0.0 110.348 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.8 pt -155.0 125.58 3.41 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.641 -0.662 . . . . 0.0 110.793 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.01 117.34 4.18 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 122.967 0.983 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.404 ' OG ' ' CE2' ' A' ' 115' ' ' TRP . 5.2 m -53.95 -34.43 59.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.789 -0.57 . . . . 0.0 111.989 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -71.33 -6.52 40.6 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.907 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -109.72 25.36 11.88 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.098 -1.001 . . . . 0.0 109.466 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 7.3 p -156.71 170.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.965 0.888 . . . . 0.0 112.175 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -124.65 127.1 46.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 . . . . . 0 N--CA 1.487 1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 112.58 -178.172 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.465 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -119.34 164.48 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.938 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 135' ' ' ARG . 15.4 m -142.12 169.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -129.9 126.71 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.455 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -70.56 120.58 16.41 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 95.0 mt -94.33 3.2 55.52 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.187 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.448 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 44.9 m-85 -153.0 150.58 29.35 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 108.872 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.48 141.06 58.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 109.941 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 44.2 t80 -155.38 119.99 4.73 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.361 -0.837 . . . . 0.0 111.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.52 124.23 50.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.133 0 O-C-N 121.25 -0.906 . . . . 0.0 110.433 179.738 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.0 t0 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.4 tp -98.23 133.54 42.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.912 . . . . 0.0 111.734 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -94.56 162.42 13.81 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 13.6 p90 -171.53 -165.66 0.4 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.491 -0.756 . . . . 0.0 110.115 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 178.37 5.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.242 1.02 . . . . 0.0 112.247 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 16.7 ttmt -61.08 -21.49 63.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.74 40.57 1.44 Allowed Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.0 169.55 10.79 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.852 -0.793 . . . . 0.0 112.131 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 122.04 36.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.561 -0.712 . . . . 0.0 110.116 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.7 mtm -127.69 152.85 47.19 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.5 154.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.465 ' HB ' HG13 ' A' ' 81' ' ' ILE . 5.7 t -94.78 136.25 26.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.949 0.88 . . . . 0.0 109.699 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -96.89 -27.03 14.86 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.546 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -155.99 -174.42 4.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.706 -0.621 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -137.88 98.78 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.405 -0.809 . . . . 0.0 109.751 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 t -94.69 -77.98 0.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.51 -80.23 0.08 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -93.55 -8.66 40.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.945 . . . . 0.0 110.729 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -143.44 96.94 2.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.893 . . . . 0.0 110.076 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -95.65 157.87 15.71 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.098 -1.002 . . . . 0.0 110.781 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -102.17 122.47 44.22 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -132.16 159.96 37.46 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 112.37 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.0 ttt180 -113.0 124.41 52.57 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.496 -0.753 . . . . 0.0 109.937 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.1 t -81.51 119.21 23.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.622 . . . . 0.0 109.362 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 mt -71.15 -24.79 62.33 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.767 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.33 59.57 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.35 -0.844 . . . . 0.0 109.587 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 p -137.34 9.4 2.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.436 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.19 27.63 6.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.01 -1.056 . . . . 0.0 110.67 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -95.51 171.47 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.5 151.83 28.17 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.854 0.835 . . . . 0.0 111.849 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.07 -152.89 12.67 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.92 153.36 18.83 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.865 . . . . 0.0 109.705 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.55 132.31 14.18 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.803 -0.561 . . . . 0.0 110.404 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 39.0 Cg_exo -47.87 96.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.121 1.064 . . . . 0.0 111.677 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 m -55.87 -20.5 15.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.721 -0.612 . . . . 0.0 111.379 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.65 18.36 5.56 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.327 -0.858 . . . . 0.0 111.351 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -146.75 33.33 0.93 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.13 168.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.936 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.21 120.09 22.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.413 ' HA ' ' CG1' ' A' ' 83' ' ' VAL . 14.6 ttp180 . . . . . 0 N--CA 1.484 1.242 0 O-C-N 121.229 -0.92 . . . . 0.0 112.029 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.43 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.14 164.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.873 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.4 m -142.22 173.49 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 p -131.49 128.07 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.012 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HA ' HG11 ' A' ' 133' ' ' VAL . . . -70.46 116.1 10.41 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.2 mt -94.33 3.05 55.72 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.261 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.6 m-85 -149.71 150.32 31.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.198 -0.939 . . . . 0.0 108.906 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -71.75 145.02 49.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.166 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 19.6 t80 -155.5 121.95 5.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.465 -0.772 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -97.15 124.42 41.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.354 -0.841 . . . . 0.0 110.752 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.575 -0.703 . . . . 0.0 111.323 -179.773 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 p30 . . . . . 0 N--CA 1.509 2.519 0 CA-C-O 120.948 0.404 . . . . 0.0 111.239 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tt -109.28 146.19 34.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.513 -0.742 . . . . 0.0 111.024 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -97.29 119.97 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.821 -0.549 . . . . 0.0 109.777 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 20.2 p90 -114.99 -170.92 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.587 -0.696 . . . . 0.0 110.742 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.73 177.28 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.295 1.045 . . . . 0.0 112.159 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.443 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.7 ttmt -61.32 -20.29 62.78 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.68 1.32 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.88 170.14 10.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.902 -0.763 . . . . 0.0 111.724 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.33 123.52 41.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 110.181 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.423 ' HE3' ' CD2' ' A' ' 99' ' ' PHE . 77.4 mtm -129.58 150.43 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.0 t -96.2 153.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.43 ' HB ' HG13 ' A' ' 81' ' ' ILE . 24.8 t -95.2 134.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.84 0.829 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -95.03 -26.36 16.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.208 0.528 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -155.43 -177.37 6.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.067 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -145.17 95.19 2.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 t -104.88 -53.99 2.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.524 -0.735 . . . . 0.0 111.003 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.81 141.99 3.8 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 64.58 -72.41 0.06 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.646 -0.914 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -106.07 117.86 35.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 0.0 110.208 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.4 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 45.1 m0 -106.78 152.38 23.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.643 . . . . 0.0 110.207 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.69 117.2 31.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.541 -0.724 . . . . 0.0 109.187 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -130.21 162.5 28.79 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.623 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 4.6 ttt180 -114.88 124.51 51.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.7 -0.625 . . . . 0.0 109.889 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 3.1 t -78.23 117.06 19.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.482 -0.761 . . . . 0.0 109.654 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.35 -26.3 66.42 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.313 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.46 66.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -136.58 9.89 3.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.588 -0.695 . . . . 0.0 110.714 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.65 27.84 4.32 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.979 -1.075 . . . . 0.0 110.414 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 47.6 mttt -101.84 179.71 4.25 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.24 151.36 28.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.412 -0.805 . . . . 0.0 111.48 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.1 -157.58 15.22 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 88.4 m-85 -94.03 151.35 19.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 122.311 -0.523 . . . . 0.0 109.703 -179.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.04 130.12 5.45 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.58 -0.7 . . . . 0.0 110.575 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.69 107.51 0.75 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 109.347 -1.059 . . . . 0.0 109.347 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.4 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 1.3 m -55.34 -26.01 38.29 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.384 -0.822 . . . . 0.0 110.857 -179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' ND2' ' CD1' ' A' ' 132' ' ' TYR . 16.8 p-10 -71.28 -12.44 61.45 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.414 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.436 ' CD1' ' ND2' ' A' ' 131' ' ' ASN . 3.0 m-85 -100.54 9.23 42.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 85' ' ' ALA . 35.2 m -138.5 -177.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 111.929 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.06 114.77 14.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 O-C-N 121.308 -0.87 . . . . 0.0 111.066 -178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.782 0.325 . . . . 0.0 110.725 . . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 73.7 mt -98.47 144.73 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.746 -1.221 . . . . 0.0 109.889 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 135' ' ' ARG . 28.0 m -127.45 174.62 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 110.785 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -130.38 126.22 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -69.63 121.17 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 64.5 mt -94.43 1.83 55.78 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.738 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.6 m-85 -152.52 151.01 30.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.257 -0.902 . . . . 0.0 108.899 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -67.12 147.88 52.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.531 -0.731 . . . . 0.0 109.927 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CZ ' ' HG3' ' A' ' 129' ' ' PRO . 54.4 t80 -153.89 146.35 24.02 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.354 -0.841 . . . . 0.0 111.768 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 114.88 23.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.538 0.685 . . . . 0.0 110.921 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.297 0 O-C-N 121.387 -0.821 . . . . 0.0 112.09 -179.776 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.9 tp -138.84 125.62 20.91 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.592 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -93.98 159.74 15.03 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.289 0.566 . . . . 0.0 109.587 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.429 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 17.5 p90 -163.36 -170.42 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.637 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -178.17 3.93 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.164 0.983 . . . . 0.0 112.162 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -61.07 -21.32 63.55 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.98 43.3 1.04 Allowed Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -90.76 171.68 9.17 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.989 -0.712 . . . . 0.0 111.877 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.87 136.03 53.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.665 -0.647 . . . . 0.0 109.764 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 76.4 mtm -143.44 154.52 43.77 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 40.8 t -101.65 150.94 5.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 61.9 t -95.5 138.21 21.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 O-C-N 121.241 -0.912 . . . . 0.0 110.542 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.87 -25.84 14.49 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.39 147.72 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.648 -0.658 . . . . 0.0 110.192 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.09 145.39 28.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.297 -0.877 . . . . 0.0 109.237 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -142.29 -71.5 0.33 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.51 -77.61 0.14 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.27 -10.22 30.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -1.014 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -147.71 107.15 3.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.272 -0.893 . . . . 0.0 110.585 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -104.21 155.61 18.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -105.17 116.74 32.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.05 169.41 14.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.897 . . . . 0.0 112.54 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.6 ttt180 -115.3 121.67 43.59 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 121.775 -0.578 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.3 t -77.6 116.11 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.676 -0.64 . . . . 0.0 109.765 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.63 -22.41 65.33 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.052 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.93 66.78 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.676 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.7 p -138.63 9.02 2.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.892 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 53.68 29.01 8.73 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.981 -1.074 . . . . 0.0 110.597 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 52.5 mttt -103.09 174.73 5.74 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -155.22 142.57 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.931 0.872 . . . . 0.0 111.406 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.22 -146.31 4.98 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 56.5 m-85 -93.49 161.39 14.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 122.058 -0.672 . . . . 0.0 109.827 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 pt -151.52 118.87 3.28 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.736 -0.603 . . . . 0.0 109.83 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.462 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 68.5 Cg_exo -40.76 99.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.37 1.38 . . . . 0.0 112.436 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -61.02 -19.68 61.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.905 -0.497 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 24.8 p30 -87.82 17.89 4.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.32 -0.862 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.428 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 4.5 m-85 -152.06 44.49 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.052 -1.03 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.18 168.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 111.023 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -123.41 138.98 54.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.882 -0.511 . . . . 0.0 110.37 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.412 ' HA ' ' CG1' ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 O-C-N 121.397 -0.815 . . . . 0.0 112.088 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.424 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.838 0.351 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 27.3 mt -97.55 124.91 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.056 -1.027 . . . . 0.0 109.206 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' A' ' 133' ' ' VAL . 32.8 m -111.23 171.94 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.364 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -128.32 127.6 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.66 117.84 10.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.5 mt -94.54 4.26 54.08 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.297 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.43 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 27.6 m-85 -151.94 150.42 30.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -68.26 146.15 53.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 109.725 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.422 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 65.3 t80 -153.48 145.04 23.28 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.255 -0.903 . . . . 0.0 111.15 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -118.32 103.48 9.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.916 -0.49 . . . . 0.0 110.165 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.414 ' HB2' ' OD2' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.103 0 O-C-N 121.46 -0.775 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 91' ' ' ALA . 19.2 p-10 . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 121.092 0.472 . . . . 0.0 112.132 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -148.45 130.91 15.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.699 -0.625 . . . . 0.0 110.227 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -94.8 151.57 19.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.612 -0.68 . . . . 0.0 110.157 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 16.5 p90 -142.43 -167.96 2.62 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.455 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -125.39 179.93 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.173 0.987 . . . . 0.0 112.119 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.0 ttmt -61.24 -20.07 62.4 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.54 41.49 1.32 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.06 165.04 13.73 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.744 -0.856 . . . . 0.0 112.408 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.69 54.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.421 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 2.0 mpp? -138.75 153.14 48.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 20.9 t -100.83 152.61 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 94.5 t -95.36 139.7 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.109 -0.995 . . . . 0.0 109.789 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -98.6 -27.18 14.13 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -156.23 159.46 38.93 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.88 105.34 13.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.216 -0.927 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 -151.96 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.4 -0.813 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.53 -107.22 0.61 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.91 -4.42 59.16 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.543 -0.975 . . . . 0.0 111.575 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.445 ' CH2' ' HG3' ' A' ' 129' ' ' PRO . 30.7 m95 -127.77 106.21 8.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.421 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 50.1 m0 -100.67 153.03 19.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 109.767 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -100.62 114.26 27.79 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.61 164.03 22.92 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.712 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -113.33 120.61 41.73 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.724 -0.61 . . . . 0.0 109.6 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.1 t -78.38 122.67 26.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.655 -0.653 . . . . 0.0 109.35 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.84 -27.88 63.19 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.934 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.45 31.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.443 -0.785 . . . . 0.0 109.85 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.8 p -137.81 10.33 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.613 . . . . 0.0 110.528 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 50.61 27.48 2.95 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.993 -1.067 . . . . 0.0 110.574 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 4.2 mttt -100.45 179.78 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.24 147.18 23.46 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.77 0.795 . . . . 0.0 111.183 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -147.03 5.52 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.436 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 75.8 m-85 -94.42 157.39 16.04 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.091 -0.652 . . . . 0.0 110.606 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.15 109.59 2.83 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.652 -0.655 . . . . 0.0 109.735 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HG3' ' CH2' ' A' ' 114' ' ' TRP . 51.3 Cg_exo -50.66 110.07 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 122.958 0.978 . . . . 0.0 111.56 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.421 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 24.0 m -59.88 -17.23 35.43 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.935 -0.478 . . . . 0.0 111.249 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -84.77 12.93 6.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.276 -0.89 . . . . 0.0 111.719 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -147.02 44.27 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 0.0 108.802 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 83' ' ' VAL . 7.4 p -156.25 168.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.792 0.806 . . . . 0.0 111.317 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.426 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -128.61 127.6 42.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 112.474 -178.782 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -104.29 155.91 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.915 -1.116 . . . . 0.0 109.448 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.01 176.5 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.28 122.69 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.549 -0.72 . . . . 0.0 109.414 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.42 120.36 13.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.84 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.415 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 79.5 mt -94.09 1.47 56.15 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.49 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.8 m-85 -152.49 151.0 30.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.152 -0.967 . . . . 0.0 108.393 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -66.61 148.46 51.87 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.501 -0.75 . . . . 0.0 110.339 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.44 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 46.2 t80 -155.3 131.05 9.91 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.317 -0.865 . . . . 0.0 111.31 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -100.09 137.73 38.14 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.403 -0.811 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.506 2.349 0 O-C-N 121.606 -0.684 . . . . 0.0 111.721 179.901 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 p30 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.2 tp -155.01 124.78 6.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.488 -0.758 . . . . 0.0 111.232 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.75 114.93 26.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.27 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 14.3 p90 -113.14 -168.86 1.38 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.63 -0.669 . . . . 0.0 110.057 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -125.69 -178.33 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.352 1.073 . . . . 0.0 112.799 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.2 -23.9 65.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.95 42.42 1.19 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.52 166.84 13.0 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.649 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.17 128.75 50.47 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.691 -0.631 . . . . 0.0 109.377 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -135.78 148.47 48.78 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.6 t -98.65 152.59 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.05 138.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.16 -31.65 13.43 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -156.32 163.4 39.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.917 -0.49 . . . . 0.0 109.857 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.87 153.72 21.0 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.9 t -147.87 -68.62 0.24 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.03 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -99.57 -20.74 16.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.652 -0.91 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -121.43 102.33 8.19 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.422 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 50.2 m0 -99.19 150.78 21.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.932 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -94.75 112.73 24.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.425 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -128.56 166.59 18.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.257 -0.902 . . . . 0.0 112.246 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -112.75 124.93 53.69 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.2 t -77.85 115.1 17.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 mt -68.8 -24.93 64.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 110.625 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.69 67.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.802 . . . . 0.0 109.965 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p -135.99 9.29 3.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.605 -0.685 . . . . 0.0 110.798 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.36 30.63 12.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.045 -1.034 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 mmmm -99.68 177.73 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.262 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.44 139.0 15.96 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.83 0.824 . . . . 0.0 111.388 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.31 -150.71 6.74 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -93.89 162.73 13.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.718 -0.872 . . . . 0.0 110.663 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pt -155.45 111.7 2.23 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.713 -0.617 . . . . 0.0 109.866 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 O-C-N 123.038 1.02 . . . . 0.0 112.079 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 16.4 m -61.27 -17.11 51.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -76.79 1.48 17.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.208 -0.932 . . . . 0.0 112.316 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -141.84 46.82 1.66 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.1 p -154.83 168.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -120.98 129.07 53.27 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.416 -0.803 . . . . 0.0 112.871 -178.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.454 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 122.181 0.991 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.0 mt -128.75 150.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.89 175.1 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.5 p -132.74 118.12 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -63.33 116.18 5.26 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.2 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.45 1.68 55.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.126 -0.359 . . . . 0.0 111.77 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 51.3 m-85 -151.25 151.75 32.28 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.98 144.54 54.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 109.685 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.438 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 33.6 t80 -152.28 131.78 13.0 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.125 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -99.79 139.73 35.03 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.277 0.56 . . . . 0.0 111.202 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.505 2.276 0 O-C-N 121.567 -0.708 . . . . 0.0 111.24 179.426 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.9 p30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.3 tt -145.92 127.77 15.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 111.037 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -94.7 116.5 28.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.566 -0.709 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 12.1 p90 -114.35 -167.75 1.26 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -126.11 177.43 6.38 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.194 0.997 . . . . 0.0 111.942 -178.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.475 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 1.3 ttmt -60.92 -18.78 58.72 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.75 38.19 1.3 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.03 171.77 9.03 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.802 -0.822 . . . . 0.0 111.871 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.72 136.75 54.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 69.6 mtm -140.33 155.64 46.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 t -98.68 152.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.454 ' HB ' HG13 ' A' ' 81' ' ' ILE . 84.8 t -94.41 133.42 35.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.934 0.873 . . . . 0.0 109.704 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -96.25 -26.99 15.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -156.4 179.63 9.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 0.0 109.291 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.57 86.26 2.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.173 -0.954 . . . . 0.0 110.389 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.0 t -96.2 -164.7 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.685 -0.634 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.11 139.79 15.06 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 66.43 -64.16 0.23 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.593 -0.946 . . . . 0.0 111.095 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -105.88 115.39 30.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.423 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 54.4 m0 -101.96 149.0 24.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.417 -0.802 . . . . 0.0 109.231 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -95.38 113.97 25.69 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.613 -0.68 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -129.58 164.91 22.81 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.952 0.882 . . . . 0.0 112.34 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -114.03 124.32 51.85 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.473 -0.767 . . . . 0.0 110.364 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 t -80.09 123.08 27.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.338 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.67 -25.96 60.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.696 -0.627 . . . . 0.0 110.94 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.16 68.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.314 -0.867 . . . . 0.0 110.031 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p -127.79 7.68 6.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.832 -0.542 . . . . 0.0 110.36 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.55 31.98 13.42 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.991 -1.068 . . . . 0.0 110.128 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -102.17 175.41 5.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -155.62 143.24 19.61 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.669 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.21 -150.01 6.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 66.5 m-85 -93.91 167.93 11.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.956 . . . . 0.0 109.994 179.985 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.98 116.49 2.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -52.23 105.49 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 122.849 0.921 . . . . 0.0 111.594 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 20.4 m -55.19 -19.33 7.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.715 -0.616 . . . . 0.0 111.241 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -83.88 20.08 1.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.249 -0.907 . . . . 0.0 111.746 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -154.29 39.69 0.46 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.021 -1.05 . . . . 0.0 109.288 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.0 170.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 111.112 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -129.36 120.57 25.8 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 113.148 -177.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.464 HG13 ' HB ' ' A' ' 107' ' ' VAL . 2.4 tp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 110.867 -0.049 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 82' ' ' ILE . 82.3 mt -115.6 164.71 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.419 HG13 ' HA ' ' A' ' 135' ' ' ARG . 18.5 m -143.18 175.72 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.428 0.632 . . . . 0.0 110.087 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -137.14 122.33 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -63.76 119.96 10.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 109.345 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.3 mt -94.26 3.06 55.75 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.352 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.468 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 39.3 m-85 -150.67 148.99 29.26 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 0.0 108.885 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -66.29 143.97 56.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 18.2 t80 -155.39 122.67 5.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.272 -0.892 . . . . 0.0 111.466 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.69 113.35 26.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 110.238 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 1.978 0 O-C-N 121.328 -0.857 . . . . 0.0 111.092 -179.947 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 p30 . . . . . 0 N--CA 1.503 2.175 0 CA-C-O 121.16 0.505 . . . . 0.0 110.808 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.7 149.51 27.21 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.746 0.784 . . . . 0.0 111.619 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.0 m -94.88 147.36 23.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.84 -0.537 . . . . 0.0 109.903 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 17.3 p90 -148.1 -165.04 2.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.447 -0.783 . . . . 0.0 110.496 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -129.41 176.47 7.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.449 1.119 . . . . 0.0 112.889 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 17.7 ttmt -60.95 -21.06 63.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.18 41.15 1.28 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.86 167.2 12.62 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.782 -0.834 . . . . 0.0 111.63 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.46 124.77 46.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.416 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 72.0 mtm -134.82 151.52 51.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 21.3 t -94.73 154.07 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.464 ' HB ' HG13 ' A' ' 81' ' ' ILE . 38.1 t -94.36 141.16 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 0.0 108.996 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.8 mp -101.68 -26.46 13.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -155.95 -171.33 3.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 110.692 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -147.44 105.19 3.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.475 -0.766 . . . . 0.0 110.579 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.4 t -104.76 -53.83 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.01 -70.73 0.3 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -83.24 -57.29 3.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.634 -0.921 . . . . 0.0 110.064 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . 0.434 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 40.8 m95 -105.55 121.63 44.36 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.626 . . . . 0.0 110.576 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 130' ' ' SER . 50.9 m0 -107.04 146.39 31.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.474 -0.767 . . . . 0.0 109.751 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -96.94 120.86 38.06 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -132.96 160.69 36.36 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.187 -0.946 . . . . 0.0 112.323 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.0 ttt180 -111.74 121.46 45.17 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.586 -0.696 . . . . 0.0 109.933 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 5.1 t -75.11 115.77 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.641 -0.662 . . . . 0.0 109.427 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.38 -24.95 64.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.909 -0.495 . . . . 0.0 110.209 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.74 -23.77 65.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p -138.93 10.71 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.713 . . . . 0.0 111.002 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.32 30.62 6.14 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.928 -1.108 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 7.8 mtmt -105.19 -177.05 3.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.61 156.5 35.15 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.279 -0.888 . . . . 0.0 111.776 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.81 -159.44 21.08 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . 0.434 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 89.3 m-85 -94.25 158.33 15.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.059 -0.671 . . . . 0.0 110.33 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.65 123.9 3.14 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.36 121.14 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.787 0.888 . . . . 0.0 109.973 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 1.5 m -51.59 -35.86 43.16 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.459 -0.775 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -75.1 -9.23 58.35 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.924 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 87' ' ' TYR . 3.0 m-85 -104.69 23.72 12.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.333 -0.854 . . . . 0.0 109.42 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 9.8 p -159.43 170.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.848 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.95 135.47 36.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.419 ' HA ' HG13 ' A' ' 83' ' ' VAL . 1.7 tmm_? . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.115 -0.99 . . . . 0.0 112.265 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.401 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 65.0 mt -101.17 151.78 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.869 -1.144 . . . . 0.0 109.263 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 133' ' ' VAL . 29.6 m -135.22 177.56 6.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.096 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.57 121.79 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.47 118.84 11.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.413 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 18.8 mt -94.11 1.35 56.15 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.489 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.7 m-85 -151.9 151.14 30.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.392 -0.817 . . . . 0.0 108.846 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -67.5 145.35 55.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.135 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 67.4 t80 -151.75 126.99 9.87 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.364 -0.835 . . . . 0.0 110.779 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -94.71 135.56 36.05 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.63 0.729 . . . . 0.0 111.963 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.759 -0.588 . . . . 0.0 110.824 179.423 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 t0 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.1 tp -112.89 136.01 53.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.474 -0.766 . . . . 0.0 110.861 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 120.76 35.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.806 . . . . 0.0 110.232 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.461 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 17.9 p90 -115.45 -169.51 1.59 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.963 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.0 179.83 5.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.134 0.969 . . . . 0.0 112.062 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.5 ttmt -60.66 -22.04 63.44 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.84 41.3 1.23 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.4 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 1.1 m-20 -90.63 171.53 9.32 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.557 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.14 132.48 50.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -139.1 150.71 46.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.2 t -95.85 151.22 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.401 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 68.6 t -94.98 137.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.117 -0.99 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.02 -30.96 13.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.742 0.782 . . . . 0.0 108.936 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -156.36 163.98 38.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.58 119.87 40.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.633 . . . . 0.0 109.514 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -109.63 -76.44 0.61 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.126 -0.984 . . . . 0.0 110.858 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.05 -85.89 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.45 -20.56 18.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -127.47 103.76 7.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 108.982 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.416 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 46.1 m0 -95.75 155.76 16.61 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.098 -1.001 . . . . 0.0 110.851 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -95.67 112.51 24.21 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -126.85 165.84 18.59 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.143 0.973 . . . . 0.0 112.798 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.3 ttt180 -112.68 130.52 56.02 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 123' ' ' ARG . 29.3 t -82.96 115.29 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.183 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.5 mt -67.24 -26.35 66.53 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.24 0.543 . . . . 0.0 110.368 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.68 -29.74 66.84 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.462 -0.774 . . . . 0.0 109.813 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.7 p -133.62 10.53 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.762 -0.586 . . . . 0.0 110.476 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 119' ' ' SER . 7.8 mmm-85 51.68 28.3 4.7 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.986 -1.071 . . . . 0.0 110.898 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 10.9 mtmt -99.8 177.91 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.425 -0.797 . . . . 0.0 109.376 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -153.56 151.77 30.15 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.947 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -177.99 -150.72 8.79 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -93.58 164.76 13.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.666 -0.902 . . . . 0.0 110.207 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pt -155.09 110.71 2.29 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.668 -0.645 . . . . 0.0 109.981 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -45.19 99.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 O-C-N 123.008 1.004 . . . . 0.0 111.838 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.416 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 53.2 m -57.03 -20.68 25.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.825 -0.547 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 5.0 p-10 -74.42 -1.84 22.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.535 -0.728 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 4.8 m-85 -137.23 44.92 2.25 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.908 -1.12 . . . . 0.0 110.186 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 130' ' ' SER . 7.7 p -147.7 170.85 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.32 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -125.12 117.41 23.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.746 -0.596 . . . . 0.0 109.509 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.858 0.837 . . . . 0.0 112.648 -178.106 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.005 0.431 . . . . 0.0 110.405 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.9 mt -97.43 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.46 172.55 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.748 -0.595 . . . . 0.0 109.414 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -127.63 124.41 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.148 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -64.68 116.12 5.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.418 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 93.9 mt -93.85 3.53 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.837 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.45 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 70.5 m-85 -153.57 150.29 28.52 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -66.64 150.91 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.455 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.456 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 66.0 t80 -154.38 119.78 5.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.254 -0.904 . . . . 0.0 110.896 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.38 128.75 39.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.35 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.611 -0.681 . . . . 0.0 110.704 179.611 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t0 . . . . . 0 N--CA 1.513 2.711 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.11 137.45 46.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.975 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -94.44 122.22 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.684 -0.635 . . . . 0.0 109.599 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 8.6 p90 -117.36 -167.13 1.27 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.788 -0.57 . . . . 0.0 110.029 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 179.42 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.324 1.059 . . . . 0.0 112.695 -177.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.7 ttmt -61.14 -23.35 65.47 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.94 40.05 1.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.427 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 2.3 m-20 -91.27 163.91 14.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.688 -0.89 . . . . 0.0 112.065 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.22 134.95 55.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.428 ' HE3' ' CD2' ' A' ' 99' ' ' PHE . 76.2 mtm -142.45 149.3 39.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.839 -0.538 . . . . 0.0 109.6 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.01 150.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 81' ' ' ILE . 79.3 t -94.79 139.57 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.131 -0.981 . . . . 0.0 110.192 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.7 mp -95.72 -27.11 15.43 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 144.15 20.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -103.02 137.73 40.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -128.34 -70.73 0.67 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 157.15 -40.51 0.55 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.48 -30.37 4.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.355 -1.086 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -137.11 102.88 4.96 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.0 109.24 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -98.22 151.14 20.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.401 -0.812 . . . . 0.0 111.099 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -101.06 124.59 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -132.73 166.12 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.896 . . . . 0.0 111.883 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.4 ttt180 -114.0 126.59 55.3 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.652 -0.655 . . . . 0.0 109.985 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -77.92 114.9 17.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.698 -0.626 . . . . 0.0 109.387 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 mt -67.56 -28.74 68.04 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.083 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.97 60.71 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -135.04 12.02 3.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.738 -0.601 . . . . 0.0 110.767 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.9 30.93 4.24 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.175 -0.953 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -100.47 177.37 5.05 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -152.2 149.48 28.79 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.966 0.889 . . . . 0.0 111.913 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.88 -152.98 9.06 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -94.07 164.09 13.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 122.201 -0.588 . . . . 0.0 109.47 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -151.06 106.96 3.01 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -47.32 107.4 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.04 1.021 . . . . 0.0 111.719 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.0 m -60.76 -15.95 35.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.944 -0.472 . . . . 0.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 39.5 p30 -80.74 3.19 23.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.21 -0.931 . . . . 0.0 112.063 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 8.9 m-85 -144.92 46.96 1.34 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.142 -0.974 . . . . 0.0 109.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.4 p -153.91 170.83 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.424 -0.797 . . . . 0.0 110.594 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -125.57 124.14 40.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.75 -0.594 . . . . 0.0 109.905 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 112.498 -178.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.415 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.4 mt -101.39 157.87 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 109.554 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 133' ' ' VAL . 31.6 m -139.83 165.67 21.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -123.61 122.02 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 109.095 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.458 ' CB ' ' CD1' ' A' ' 99' ' ' PHE . . . -64.24 116.85 6.41 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.926 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.418 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 96.6 mt -94.5 7.95 43.84 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.158 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.448 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.7 m-85 -154.81 151.16 28.31 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.226 -0.921 . . . . 0.0 108.851 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.93 141.03 56.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 39.5 t80 -155.34 125.14 6.5 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.222 -0.924 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.17 130.94 54.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 110.682 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.451 -0.781 . . . . 0.0 110.217 179.699 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.524 3.236 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -98.31 133.77 42.25 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.565 0.698 . . . . 0.0 111.481 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -94.75 142.82 27.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 20.3 p90 -152.99 -164.71 2.0 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.261 -0.899 . . . . 0.0 111.017 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.24 179.25 5.35 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.118 0.961 . . . . 0.0 111.742 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 10.3 ttmt -61.36 -18.94 61.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.69 41.22 1.38 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.93 172.01 8.89 Favored 'General case' 0 N--CA 1.505 2.325 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.815 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.63 129.5 45.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.646 -0.659 . . . . 0.0 110.199 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.9 mtm -132.52 156.19 47.25 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.9 t -106.5 152.37 8.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 94.9 t -95.06 139.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.557 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp -94.84 -30.83 14.0 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.64 152.93 27.76 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -95.97 151.32 19.54 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.6 t -147.27 -83.09 0.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.394 -0.816 . . . . 0.0 110.715 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.03 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -91.32 -5.61 54.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.429 -1.042 . . . . 0.0 110.825 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -143.97 96.96 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 109.886 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.422 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 9.6 m0 -94.95 149.05 21.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.73 117.34 29.97 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -131.3 164.54 25.4 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.239 -0.913 . . . . 0.0 112.607 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.1 ttt180 -118.03 131.82 56.43 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.633 -0.667 . . . . 0.0 109.914 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -87.46 118.36 26.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.577 -0.702 . . . . 0.0 109.859 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.36 -23.02 65.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.827 -0.545 . . . . 0.0 110.579 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.86 -31.11 68.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.353 -0.842 . . . . 0.0 110.171 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 p -137.57 14.0 2.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.725 -0.609 . . . . 0.0 110.437 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 50.52 35.18 10.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.103 -0.998 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 45.6 mttt -102.93 173.75 6.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.7 156.51 35.03 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.737 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 174.59 -154.91 19.99 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -93.64 118.77 31.81 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.974 -0.721 . . . . 0.0 109.701 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -99.14 134.83 21.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.108 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . 0.408 ' HD2' ' CZ ' ' A' ' 99' ' ' PHE . 36.1 Cg_exo -57.96 95.89 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.978 0.989 . . . . 0.0 111.058 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 73.4 m -57.89 -18.74 24.81 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.663 -0.648 . . . . 0.0 111.412 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 14.2 p-10 -90.03 19.16 5.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.153 -0.967 . . . . 0.0 111.934 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 20.6 m-85 -155.19 52.26 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -160.52 170.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.421 -0.799 . . . . 0.0 111.396 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.424 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -120.72 126.07 49.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.243 -0.911 . . . . 0.0 112.809 -177.716 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.436 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 . . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 59.6 mt -96.23 137.42 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.778 -1.201 . . . . 0.0 108.717 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -125.34 170.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -124.59 122.93 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.6 -0.688 . . . . 0.0 109.625 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.86 123.53 20.82 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 84.2 mt -94.32 -2.4 52.26 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.703 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.484 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 62.2 m-85 -151.67 151.14 31.07 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.135 -0.978 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -62.71 147.09 50.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.61 -0.681 . . . . 0.0 110.236 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.445 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 53.3 t80 -154.56 134.05 12.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.559 -0.713 . . . . 0.0 110.916 179.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -98.4 136.62 38.29 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.585 -0.697 . . . . 0.0 111.713 -179.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 121.442 -0.786 . . . . 0.0 111.22 179.477 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.6 p30 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.911 0.386 . . . . 0.0 110.268 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 49.7 tp -153.25 132.34 12.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 110.831 -179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.0 116.26 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.916 -0.49 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 15.6 p90 -108.65 -176.27 3.0 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.324 178.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -176.63 3.31 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.278 1.037 . . . . 0.0 112.104 -178.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.484 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.3 ttmt -60.48 -27.07 67.28 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.14 43.67 1.15 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -178.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.04 165.32 13.59 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.233 -179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.2 131.99 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.434 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 2.2 mpp? -138.77 152.22 47.74 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 11.8 t -102.1 147.84 8.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 71.5 t -94.94 139.22 19.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.025 -1.047 . . . . 0.0 109.976 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.41 -30.27 13.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -156.51 159.57 38.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.74 -0.6 . . . . 0.0 110.332 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.0 147.97 27.23 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.4 t -135.99 -75.07 0.44 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 170.9 -44.74 0.19 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -127.61 -40.27 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.621 -0.929 . . . . 0.0 110.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -116.7 107.97 15.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.106 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 35.5 m0 -98.29 151.88 20.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.819 . . . . 0.0 110.002 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -97.57 118.1 33.32 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -131.41 168.23 17.95 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.1 ttt180 -116.73 121.55 41.95 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.608 -0.683 . . . . 0.0 109.634 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.2 t -73.81 121.3 20.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.827 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.98 -29.35 65.31 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.14 62.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.436 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -136.87 9.39 3.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 110.795 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 51.92 30.31 7.07 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.045 -1.035 . . . . 0.0 110.706 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 14.9 mttt -101.85 176.76 5.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 2.4 pm0 -155.66 143.78 19.97 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.154 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.62 -149.83 6.36 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -95.22 162.42 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.755 -0.85 . . . . 0.0 110.72 -179.586 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.0 pt -155.5 113.67 2.24 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.613 -0.679 . . . . 0.0 110.182 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -53.29 110.06 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.154 1.081 . . . . 0.0 111.541 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 8.8 m -59.03 -18.48 35.01 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.897 -0.502 . . . . 0.0 110.917 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -71.96 -0.79 12.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.421 -0.799 . . . . 0.0 113.094 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.53 40.61 1.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.912 -1.117 . . . . 0.0 109.863 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.402 ' CG1' ' HA ' ' A' ' 130' ' ' SER . 7.3 p -150.06 169.65 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.729 . . . . 0.0 111.315 -178.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -122.54 137.25 54.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.217 0.532 . . . . 0.0 110.325 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 111.518 -178.821 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.615 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 90.2 mt -98.3 155.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.299 -0.96 . . . . 0.0 108.619 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.41 174.6 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.367 -0.833 . . . . 0.0 110.2 179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -133.89 128.15 53.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -70.79 120.28 16.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.497 -0.752 . . . . 0.0 109.145 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 77.2 mt -94.28 0.39 55.59 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.284 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.448 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.3 m-85 -152.21 151.13 30.61 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.57 150.58 48.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.406 -0.809 . . . . 0.0 110.05 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 42.5 t80 -153.65 136.55 15.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.339 -0.851 . . . . 0.0 111.094 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 3.7 tt0 -101.06 142.36 32.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.794 -0.566 . . . . 0.0 111.163 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.502 2.15 0 O-C-N 121.393 -0.817 . . . . 0.0 110.535 179.808 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.0 p30 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 tp -151.82 128.75 10.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.423 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.2 m -95.2 105.36 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.463 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 16.9 p90 -103.01 -168.1 1.47 Allowed 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.774 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.32 178.87 5.36 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.408 1.099 . . . . 0.0 112.859 -177.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.0 ttmt -60.92 -19.41 60.58 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 42.37 1.13 Allowed Glycine 0 C--N 1.281 -2.512 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.47 164.14 14.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.525 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.94 110.78 15.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.637 -0.664 . . . . 0.0 109.853 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.0 mtm -124.84 143.45 50.82 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -96.53 160.21 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.396 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -94.02 138.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.982 -1.074 . . . . 0.0 110.613 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.19 -29.25 14.63 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -156.0 163.62 39.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.838 -0.539 . . . . 0.0 109.649 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -121.23 121.11 37.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.503 -0.748 . . . . 0.0 110.75 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.7 t -123.23 -60.96 1.46 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 150.19 129.54 1.68 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 65.97 -68.01 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.549 -0.971 . . . . 0.0 110.505 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -98.77 109.64 22.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.275 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.409 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 46.3 m0 -108.13 147.94 30.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.147 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.42 162.82 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.338 -0.851 . . . . 0.0 112.205 -178.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.5 tmm_? -111.1 125.48 53.81 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.495 -0.753 . . . . 0.0 109.374 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 31.8 t -88.14 122.81 32.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.06 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.96 -26.17 63.05 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.503 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.49 -32.87 42.27 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.438 -0.788 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 p -134.5 10.19 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.617 -0.677 . . . . 0.0 110.334 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.04 31.9 14.56 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.081 -1.012 . . . . 0.0 110.545 -179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -104.37 -178.04 3.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.04 139.71 17.04 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.889 0.852 . . . . 0.0 111.349 179.14 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.44 -156.59 10.94 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 53.0 m-85 -93.47 157.85 16.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.891 . . . . 0.0 110.693 -178.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.61 110.93 2.19 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.9 102.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 122.802 0.896 . . . . 0.0 110.805 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 1.1 m -62.01 -15.32 43.38 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.706 -0.621 . . . . 0.0 111.313 -178.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -64.66 -11.33 34.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.161 -0.962 . . . . 0.0 111.478 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -130.03 43.41 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 134' ' ' ALA . 61.5 t -145.76 170.81 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 -177.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.427 ' N ' HG13 ' A' ' 133' ' ' VAL . . . -124.09 125.63 44.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.529 -0.732 . . . . 0.0 109.341 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.423 -0.798 . . . . 0.0 112.522 -178.501 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 48.3 mt -95.11 139.31 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.78 -1.2 . . . . 0.0 108.504 178.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.93 166.95 22.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.444 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 5.2 p -121.16 128.35 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.219 178.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.513 ' O ' ' HA2' ' A' ' 102' ' ' GLY . . . -68.78 145.76 53.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 9.6 mt -106.74 -15.84 14.64 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.851 0.751 . . . . 0.0 110.972 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 87.8 m-85 -149.01 153.99 38.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.293 -0.88 . . . . 0.0 109.559 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -56.43 149.45 16.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.703 -0.623 . . . . 0.0 111.625 -178.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -155.42 126.89 7.3 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.731 -0.605 . . . . 0.0 110.353 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -100.5 130.59 46.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 121.32 -0.863 . . . . 0.0 111.442 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 91' ' ' ALA . 2.8 t0 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.47 127.21 50.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.314 -0.866 . . . . 0.0 111.107 -178.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.35 93.33 6.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.625 -0.672 . . . . 0.0 109.251 178.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 85' ' ' ALA . 31.5 p90 -97.56 -173.97 2.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.082 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -118.4 -164.89 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.67 0.747 . . . . 0.0 111.368 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 2.0 ttmt -53.9 -90.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 85' ' ' ALA . . . -93.45 65.49 1.82 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 1.4 m-20 -91.64 167.58 12.1 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.967 -0.725 . . . . 0.0 111.549 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.66 120.26 32.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 110.181 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -128.69 156.73 43.0 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 24.5 t -103.07 151.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 84.0 t -95.64 139.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.133 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -97.18 -30.55 12.94 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.66 0.743 . . . . 0.0 109.522 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -156.39 158.07 36.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.94 -0.475 . . . . 0.0 109.925 -178.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -99.6 152.07 20.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.384 -0.822 . . . . 0.0 109.588 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -146.95 -75.71 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.91 -92.72 0.08 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.85 -27.08 14.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.935 . . . . 0.0 109.611 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -110.39 107.29 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 0.0 109.401 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -100.1 148.02 25.03 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.303 -0.873 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -96.35 111.6 23.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -126.84 169.47 13.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.871 0.843 . . . . 0.0 111.856 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.5 ttt180 -114.14 123.7 50.25 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.628 -0.67 . . . . 0.0 109.693 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.1 t -78.29 111.98 14.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.741 -0.599 . . . . 0.0 109.537 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.4 mt -65.48 -24.41 67.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.856 -0.527 . . . . 0.0 110.351 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.44 -31.24 69.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 p -133.93 16.29 3.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.566 . . . . 0.0 110.459 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.51 29.91 2.24 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.266 -0.896 . . . . 0.0 110.857 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.8 mttt -96.82 177.18 5.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.66 134.93 12.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.086 0.946 . . . . 0.0 112.023 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.37 -156.7 9.69 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.0 m-85 -93.03 160.69 14.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.746 -0.855 . . . . 0.0 109.637 -179.846 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.98 107.66 2.66 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.835 -0.54 . . . . 0.0 109.99 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.45 100.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.263 1.138 . . . . 0.0 111.572 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.2 m -60.62 -13.69 15.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.666 -0.646 . . . . 0.0 112.288 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -65.0 -11.0 33.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.123 -0.986 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.1 45.22 2.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.897 . . . . 0.0 108.877 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.7 t -145.07 171.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.774 -0.578 . . . . 0.0 109.719 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -133.46 124.58 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.539 -0.725 . . . . 0.0 109.87 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 111.728 -178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.403 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.834 0.349 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 61.2 mt -98.71 152.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . 0.456 ' HB ' HG23 ' A' ' 133' ' ' VAL . 27.6 m -138.41 179.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.541 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.61 121.29 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 99' ' ' PHE . . . -60.7 115.37 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.434 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 62.2 mt -94.54 10.78 33.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.447 -178.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CG ' ' C ' ' A' ' 86' ' ' LEU . 33.4 m-85 -154.35 151.42 29.03 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.019 -1.051 . . . . 0.0 109.686 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.69 146.6 48.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.312 -0.867 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 52.4 t80 -153.57 169.48 23.14 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.006 -1.059 . . . . 0.0 110.988 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -151.56 99.17 2.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.694 . . . . 0.0 110.517 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.4 -0.813 . . . . 0.0 110.515 179.675 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.2 p30 . . . . . 0 N--CA 1.506 2.365 0 CA-C-O 120.822 0.344 . . . . 0.0 111.746 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . 0.414 ' N ' ' HA3' ' A' ' 126' ' ' GLY . 1.4 tp -135.76 146.99 48.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.248 -0.907 . . . . 0.0 112.035 -177.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.0 m -96.92 167.26 11.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.808 -0.558 . . . . 0.0 110.074 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CD1' ' HB3' ' A' ' 85' ' ' ALA . 20.8 p90 -165.32 -167.46 1.17 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.405 -0.809 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -126.19 176.55 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.042 0.925 . . . . 0.0 111.506 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 15.3 ttmt -61.25 -19.18 61.4 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -177.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.72 41.48 1.41 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 85' ' ' ALA . 2.5 m-20 -90.94 166.43 13.04 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.704 -0.88 . . . . 0.0 111.508 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.41 131.17 54.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.605 -0.684 . . . . 0.0 109.461 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 60.7 mtm -140.53 148.67 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 41.6 t -95.67 155.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 69.3 t -95.73 142.5 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.159 -0.963 . . . . 0.0 110.464 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.66 -31.1 13.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -156.24 -177.45 6.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.742 -0.599 . . . . 0.0 110.472 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.45 94.8 3.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.504 -0.748 . . . . 0.0 110.306 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -94.66 -75.13 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.434 -0.791 . . . . 0.0 110.304 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.82 -98.88 0.11 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.486 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.41 -50.1 68.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.403 -1.057 . . . . 0.0 110.814 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.67 140.97 41.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.613 -0.679 . . . . 0.0 109.469 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.71 121.95 36.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.386 -0.821 . . . . 0.0 108.997 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.98 32.75 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.978 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.5 ttt180 -114.57 125.89 54.29 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.555 -0.715 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' SER . . . . . 0.429 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 15.3 t -78.16 121.4 24.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.52 -26.91 63.8 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.51 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.18 63.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.599 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -138.1 12.49 2.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.513 -0.742 . . . . 0.0 111.089 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 52.18 30.21 7.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.009 -1.057 . . . . 0.0 110.738 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 6.0 mttp -103.14 176.32 5.19 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -155.87 150.08 25.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.416 -0.803 . . . . 0.0 111.356 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 97' ' ' LEU . . . -166.58 -140.04 2.8 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.815 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -113.34 154.24 27.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 122.03 -0.688 . . . . 0.0 110.746 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 pt -153.49 134.98 8.67 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.822 -0.549 . . . . 0.0 110.161 178.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -69.01 124.74 11.7 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 O-C-N 123.085 1.045 . . . . 0.0 109.918 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.9 m -51.94 -35.31 45.41 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.519 -0.738 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -75.34 -6.91 52.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.49 -0.756 . . . . 0.0 111.701 -178.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . 0.422 ' HA ' ' CD2' ' A' ' 87' ' ' TYR . 3.3 m-85 -104.78 24.02 12.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.157 -0.964 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . 0.456 HG23 ' HB ' ' A' ' 83' ' ' VAL . 5.7 p -161.26 169.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.531 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . 0.419 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -118.58 135.29 54.51 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.718 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.404 ' HA ' HG11 ' A' ' 83' ' ' VAL . 3.4 tpp180 . . . . . 0 N--CA 1.485 1.29 0 O-C-N 121.297 -0.877 . . . . 0.0 112.779 -178.436 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' ILE . . . . . 0.407 HG13 ' HB ' ' A' ' 107' ' ' VAL . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 86.9 mt -109.17 161.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.894 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.95 167.63 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.714 0.768 . . . . 0.0 110.637 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' A' ' 104' ' ' GLN . 6.4 p -130.2 123.42 55.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -68.9 121.57 16.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.454 -0.899 . . . . 0.0 109.361 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . 0.427 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 19.7 mt -94.04 0.03 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 65.3 m-85 -151.14 151.18 31.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.242 -0.911 . . . . 0.0 109.041 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.68 145.9 54.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.517 -0.74 . . . . 0.0 110.178 -179.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 40.5 t80 -153.54 132.92 12.8 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.201 -0.937 . . . . 0.0 111.025 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -100.95 133.4 45.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.776 -0.577 . . . . 0.0 111.675 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.501 2.11 0 O-C-N 121.48 -0.762 . . . . 0.0 110.363 179.29 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.4 p30 . . . . . 0 N--CA 1.505 2.318 0 CA-C-O 121.085 0.469 . . . . 0.0 111.902 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.07 153.61 48.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.436 -0.79 . . . . 0.0 111.493 -178.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m -98.93 116.38 31.03 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.418 0.628 . . . . 0.0 109.767 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PHE . . . . . 0.462 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 16.2 p90 -104.62 -172.29 2.07 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.839 -0.538 . . . . 0.0 110.016 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.1 -178.83 4.32 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.389 1.09 . . . . 0.0 112.439 -178.048 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -60.75 -22.72 64.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.28 43.15 1.08 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.54 165.14 13.94 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.311 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' A' ' 84' ' ' VAL . 1.9 mt-30 -122.05 109.76 14.96 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.573 -0.705 . . . . 0.0 109.718 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' MET . . . . . 0.422 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 1.5 mpp? -126.7 147.21 49.97 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 4.5 m -99.02 158.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.27 -178.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 81' ' ' ILE . 39.6 t -94.09 143.06 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . 0.417 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -98.06 -28.26 13.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.501 0.667 . . . . 0.0 109.512 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -156.32 168.26 27.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.734 -0.604 . . . . 0.0 109.591 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -115.48 109.54 17.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.453 -0.78 . . . . 0.0 109.261 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -96.95 -66.68 0.89 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.284 -0.885 . . . . 0.0 110.76 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 -56.49 0.24 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -119.33 -31.28 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.944 . . . . 0.0 109.752 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -121.67 101.97 7.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' TRP . . . . . 0.414 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 52.0 m0 -94.8 154.15 17.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.406 -0.808 . . . . 0.0 109.846 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -94.48 135.67 35.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -143.7 159.61 42.18 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.217 -177.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.5 ttm180 -112.82 122.51 47.86 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.743 0.783 . . . . 0.0 110.174 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -84.23 129.53 34.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.829 -0.544 . . . . 0.0 110.675 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.1 -26.56 53.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.925 -0.484 . . . . 0.0 110.561 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.9 65.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 109.745 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -129.48 4.89 5.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.843 -0.535 . . . . 0.0 110.662 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.45 28.32 9.44 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.996 -1.065 . . . . 0.0 109.678 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 124' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 64.9 mttt -109.18 -173.89 2.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.603 -0.685 . . . . 0.0 109.919 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -154.87 153.88 31.83 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.337 -0.852 . . . . 0.0 111.034 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.56 -124.16 0.7 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -127.82 157.4 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.73 -0.865 . . . . 0.0 109.732 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 128' ' ' ILE . . . . . 0.429 HG21 ' CE2' ' A' ' 99' ' ' PHE . 2.3 pt -153.08 106.24 2.63 Favored Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.429 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -47.31 113.08 0.63 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.013 1.142 . . . . 0.0 111.731 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 130' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 11.0 m -59.86 -15.4 20.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.709 -0.62 . . . . 0.0 111.849 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -75.67 1.5 14.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.91 -1.119 . . . . 0.0 111.951 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -144.97 45.09 1.35 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.926 -1.109 . . . . 0.0 110.711 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.28 168.84 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 110.874 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -124.28 116.44 22.65 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 . . . . . 0 C--N 1.311 -1.094 0 O-C-N 121.24 -0.912 . . . . 0.0 112.069 -178.654 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -72.75 -177.65 2.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.089 179.887 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -139.18 -152.74 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.442 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -127.41 43.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.425 ' CD1' ' CG1' ' A' ' 106' ' ' VAL . 5.8 mm -96.54 132.86 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.009 -1.057 . . . . 0.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.9 m -120.52 168.12 13.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.571 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -125.16 133.66 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.19 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.434 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -78.85 121.02 24.3 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.854 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.405 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 3.7 mt -94.23 3.33 55.39 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.452 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 80.6 m-85 -153.16 152.86 31.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -69.97 142.59 52.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.37 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.444 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 68.6 t80 -151.72 131.87 13.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.427 -0.795 . . . . 0.0 110.137 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -101.9 141.01 35.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.725 . . . . 0.0 111.036 -179.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.67 177.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.623 -0.673 . . . . 0.0 111.283 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 tt -174.26 35.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.702 . . . . 0.0 110.362 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.47 -164.73 0.61 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -73.29 -74.4 0.18 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 14.2 tp10 -86.02 54.58 3.19 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 44.7 p30 -93.46 175.73 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 62.8 tp -154.89 124.64 6.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.0 111.102 -179.212 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -95.14 113.48 25.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.746 -0.596 . . . . 0.0 110.148 179.341 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.444 ' CE1' ' HB3' ' A' ' 89' ' ' TYR . 16.8 p90 -109.83 -173.28 2.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.965 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 179.52 4.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.188 0.994 . . . . 0.0 111.996 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.452 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.1 ttmt -61.05 -20.93 63.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.4 41.2 1.31 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -90.99 164.29 14.03 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.16 -179.375 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.33 135.22 55.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 75.7 mtm -140.27 151.96 45.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.32 0.581 . . . . 0.0 109.647 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.425 ' CG1' ' CD1' ' A' ' 82' ' ' ILE . 43.2 t -101.43 147.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.442 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 90.8 t -95.12 139.89 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.019 -1.051 . . . . 0.0 110.113 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.422 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.9 mp -97.05 -27.5 14.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -156.07 161.33 40.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.674 -0.641 . . . . 0.0 109.853 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -107.58 143.44 36.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.436 -0.79 . . . . 0.0 109.816 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -153.05 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.831 . . . . 0.0 110.388 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.09 -113.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -94.99 -16.69 22.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.668 -0.901 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -100.62 101.09 11.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.604 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.409 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 52.8 m0 -97.53 148.96 22.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.436 -0.79 . . . . 0.0 110.204 -179.733 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -98.14 111.37 23.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.422 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.08 169.26 13.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.186 -0.946 . . . . 0.0 112.302 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.514 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -113.03 118.57 35.17 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 121.69 -0.631 . . . . 0.0 109.757 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 14.9 t -72.45 115.4 11.67 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.108 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.88 -27.65 66.86 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.124 -179.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.4 61.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 0.0 110.389 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p -137.7 10.67 2.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.456 -0.777 . . . . 0.0 110.78 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 53.1 26.76 5.16 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.083 -1.011 . . . . 0.0 110.567 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 16.6 mtmt -102.12 176.67 5.12 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.218 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.514 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.58 143.0 19.46 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.29 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.38 -152.26 7.55 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.431 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 47.1 m-85 -93.76 158.46 15.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -155.53 115.39 2.27 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.843 -0.535 . . . . 0.0 109.778 179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.76 104.32 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 122.945 0.971 . . . . 0.0 110.993 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.409 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 2.4 m -63.49 -12.37 31.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.613 -0.679 . . . . 0.0 111.426 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -68.03 -8.92 41.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.075 -1.016 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -132.68 35.94 3.57 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 90.1 t -139.84 173.16 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.925 -178.521 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.01 129.26 35.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 179.909 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -85.12 137.06 33.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.419 -0.801 . . . . 0.0 111.969 -179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.4 m -151.48 170.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.5 p30 -94.39 24.07 4.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.855 . . . . 0.0 110.581 -179.994 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 1.8 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 -179.874 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.168 0.508 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 12.4 mt-10 -75.16 153.4 38.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.45 -0.781 . . . . 0.0 110.079 179.917 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -134.86 -159.66 0.98 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.427 -0.796 . . . . 0.0 109.385 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.457 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -125.02 41.58 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.998 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.469 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 56.0 mt -97.02 139.45 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.072 -1.018 . . . . 0.0 109.115 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.433 ' HB ' HG23 ' A' ' 133' ' ' VAL . 25.5 m -128.78 179.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.295 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.3 p -131.59 126.73 58.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.496 179.086 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -68.96 119.78 13.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.419 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 42.8 mt -94.01 1.34 56.26 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.071 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.457 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 60.0 m-85 -152.63 152.17 31.47 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.94 148.98 50.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.492 -0.755 . . . . 0.0 110.487 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.421 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 77.1 t80 -155.15 127.44 7.78 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.47 -0.769 . . . . 0.0 111.13 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.84 132.73 43.18 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.568 -0.708 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.76 155.3 4.35 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.456 -0.777 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 pt -154.56 43.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.79 -0.569 . . . . 0.0 109.566 179.427 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -178.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.457 -0.777 . . . . 0.0 109.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -58.24 -73.82 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.443 -0.786 . . . . 0.0 111.048 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.438 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 4.6 tp10 -89.13 45.59 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.319 -0.863 . . . . 0.0 110.437 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -102.4 128.49 48.97 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.429 -0.794 . . . . 0.0 109.421 179.391 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tt -112.33 143.17 43.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.436 -0.79 . . . . 0.0 111.102 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -96.4 122.36 39.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.728 -0.607 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 13.7 p90 -114.03 -171.29 1.88 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.654 -0.654 . . . . 0.0 109.6 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 179.56 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.133 0.968 . . . . 0.0 111.9 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -60.76 -22.55 64.16 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.38 41.94 1.28 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -90.91 165.99 13.29 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.805 -179.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.18 128.68 51.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.529 -0.732 . . . . 0.0 109.132 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.418 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 1.6 mpp? -136.96 150.47 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.767 -0.583 . . . . 0.0 109.613 -179.669 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.469 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 23.3 t -101.27 151.01 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.457 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 99.4 t -94.58 141.46 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.022 -1.048 . . . . 0.0 110.077 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.441 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -96.78 -30.93 12.9 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.645 0.736 . . . . 0.0 109.029 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -156.36 162.2 40.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.773 -0.579 . . . . 0.0 109.729 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.72 154.26 19.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.453 -0.78 . . . . 0.0 109.896 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.8 t -147.65 -75.65 0.18 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.403 -0.811 . . . . 0.0 110.433 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.86 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . 0.421 ' HB3' ' CD1' ' A' ' 114' ' ' TRP . 2.4 tt0 -92.93 -16.04 25.63 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.94 . . . . 0.0 110.832 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.421 ' CD1' ' HB3' ' A' ' 113' ' ' GLU . 85.8 m95 -132.25 107.63 8.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.452 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 31.3 m0 -100.88 155.58 17.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.292 -0.88 . . . . 0.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -97.16 111.73 23.83 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.441 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.28 168.32 14.92 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.082 0.944 . . . . 0.0 112.609 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.534 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.7 ttt180 -112.61 121.9 46.12 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.628 -0.67 . . . . 0.0 109.647 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t -74.87 110.02 8.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.912 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.28 -21.72 66.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.827 -0.546 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.88 -24.92 67.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.4 p -140.71 15.08 2.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.232 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 50.91 27.21 3.04 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.695 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 18.8 mttt -97.13 179.9 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 109.319 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.534 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -155.9 149.01 24.44 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.945 0.879 . . . . 0.0 111.791 179.347 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -176.88 -153.98 11.41 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.438 ' CE2' ' HB3' ' A' ' 95' ' ' GLU . 53.2 m-85 -93.49 165.03 12.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.628 -0.925 . . . . 0.0 109.391 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.2 pt -155.41 116.48 2.33 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 109.901 -179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -48.0 104.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.138 1.073 . . . . 0.0 111.847 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.1 m -60.12 -16.53 33.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.944 -0.473 . . . . 0.0 111.276 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.469 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 3.3 p-10 -83.91 12.11 6.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.102 -0.999 . . . . 0.0 112.06 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.469 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 3.8 m-85 -146.93 39.74 1.04 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.433 HG23 ' HB ' ' A' ' 83' ' ' VAL . 3.8 p -146.82 168.86 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -121.16 134.04 55.21 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.277 0.561 . . . . 0.0 110.189 179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 tpt180 -90.91 127.74 36.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 112.177 -178.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.06 167.09 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.44 0.638 . . . . 0.0 110.34 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -94.39 -159.18 0.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.223 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.159 0.504 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -85.16 117.72 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.553 -0.717 . . . . 0.0 109.945 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -123.66 -158.71 0.82 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.774 . . . . 0.0 109.791 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.431 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -129.22 51.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.42 -0.8 . . . . 0.0 111.224 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 63.5 mt -99.2 150.12 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.964 -1.085 . . . . 0.0 108.87 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.5 m -137.13 171.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.287 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -124.49 124.14 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.555 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.435 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -66.52 118.42 10.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 95.0 mt -94.25 1.86 55.94 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.102 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.457 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 56.0 m-85 -151.54 150.83 30.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.218 -0.927 . . . . 0.0 108.726 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -70.55 144.23 51.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.527 -0.733 . . . . 0.0 110.319 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.439 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 72.5 t80 -155.54 131.89 10.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.253 -0.905 . . . . 0.0 111.531 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -96.9 146.23 25.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.617 . . . . 0.0 110.364 179.456 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.26 178.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.451 -0.781 . . . . 0.0 110.676 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 tt -172.88 36.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.41 -166.09 0.31 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.893 -1.129 . . . . 0.0 110.305 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -70.8 -74.8 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.326 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 3.6 tp10 -83.62 57.32 4.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.887 . . . . 0.0 109.205 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -99.66 168.6 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.732 -0.605 . . . . 0.0 110.344 -179.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.5 tp -150.63 126.32 10.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.459 -0.775 . . . . 0.0 111.264 -179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.2 m -94.68 117.82 30.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 110.171 179.183 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.439 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 16.1 p90 -114.57 -169.87 1.62 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.725 -0.61 . . . . 0.0 110.266 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.94 179.78 4.88 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.284 1.04 . . . . 0.0 112.422 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.457 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.6 ttmt -61.18 -22.1 64.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.54 41.32 1.29 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 171.6 9.15 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.915 -0.756 . . . . 0.0 112.026 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.5 130.26 51.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.429 -0.794 . . . . 0.0 109.52 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.29 153.39 50.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.639 . . . . 0.0 109.747 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.5 t -103.95 149.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.431 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 58.9 t -95.57 138.02 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.164 -0.96 . . . . 0.0 109.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -96.57 -29.0 14.11 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.447 0.641 . . . . 0.0 109.469 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -155.63 149.41 25.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.777 -0.577 . . . . 0.0 109.786 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -96.19 144.59 26.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.718 . . . . 0.0 109.292 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 t -134.88 -66.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.7 -64.18 0.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -112.34 -29.86 7.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.601 -0.941 . . . . 0.0 110.047 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -125.25 103.36 7.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.709 -0.62 . . . . 0.0 109.876 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.423 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 42.6 m0 -97.31 153.78 17.84 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 0.0 110.598 -179.576 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.97 117.29 31.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.468 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.19 167.66 15.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.189 -0.945 . . . . 0.0 112.485 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.488 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.1 ttt180 -114.96 126.33 54.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.657 -0.652 . . . . 0.0 109.416 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.405 ' O ' ' N ' ' A' ' 123' ' ' ARG . 3.8 t -79.42 118.81 21.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.83 -25.21 64.54 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.565 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p -128.05 7.11 6.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.672 -0.642 . . . . 0.0 110.897 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 119' ' ' SER . 0.3 OUTLIER 52.91 32.22 12.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.066 -1.021 . . . . 0.0 110.305 -179.122 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.449 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.8 mttm -100.78 178.86 4.57 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.488 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -154.89 137.13 14.84 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.008 0.908 . . . . 0.0 111.6 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.39 -147.95 5.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.436 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 76.7 m-85 -94.18 164.15 13.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.622 -0.928 . . . . 0.0 110.787 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -153.83 104.5 2.49 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.913 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.56 106.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.931 0.964 . . . . 0.0 111.774 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 14.3 m -59.46 -18.49 40.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.947 -0.47 . . . . 0.0 111.097 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -73.4 -1.26 17.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.366 -0.834 . . . . 0.0 112.596 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -142.65 46.7 1.58 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 6.6 p -150.09 169.72 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.607 -179.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -120.21 122.55 41.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.6 tmm_? -85.11 136.97 33.32 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.815 0.817 . . . . 0.0 112.625 -178.299 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.3 m -139.82 132.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.422 0.629 . . . . 0.0 109.421 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.98 -24.68 11.92 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.553 -0.717 . . . . 0.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.114 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.106 0.479 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.43 119.27 30.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.466 -0.771 . . . . 0.0 110.46 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.9 m-20 -99.28 -152.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.457 -0.777 . . . . 0.0 109.955 179.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' O ' ' HB ' ' A' ' 107' ' ' VAL . 3.6 tp -112.22 45.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 77.4 mt -115.11 165.61 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.4 ' CG1' ' HA ' ' A' ' 135' ' ' ARG . 12.0 m -143.64 171.1 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.78 129.37 58.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.463 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -71.9 119.8 16.59 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.689 -0.804 . . . . 0.0 108.898 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 61.7 mt -94.12 0.05 55.6 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.895 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.478 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.9 m-85 -151.97 152.39 32.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -68.83 145.05 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.432 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 79.4 t80 -152.39 125.32 8.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.409 -0.807 . . . . 0.0 110.576 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.9 tp10 -94.76 134.11 37.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 110.003 179.404 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -54.13 165.9 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.401 -0.812 . . . . 0.0 110.719 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 tt -163.16 41.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.714 -0.616 . . . . 0.0 109.995 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -174.91 -175.97 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.239 -0.913 . . . . 0.0 110.138 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -63.87 -69.57 0.27 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.562 -0.712 . . . . 0.0 110.448 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 20.9 tt0 -88.98 46.81 1.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.587 -0.696 . . . . 0.0 109.812 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -108.96 126.4 53.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 179.675 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.0 139.78 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 0.0 111.532 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -95.29 118.63 32.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.617 179.699 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.463 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 12.2 p90 -112.95 -171.7 1.91 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.0 110.048 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.93 -178.54 4.09 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.187 0.994 . . . . 0.0 112.379 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.1 ttmt -61.12 -23.06 65.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.27 41.71 1.23 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.84 167.51 12.4 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.738 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -121.04 128.27 52.5 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.469 -0.769 . . . . 0.0 109.702 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -136.97 150.39 48.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 11.3 t -95.26 152.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.408 ' HB ' ' O ' ' A' ' 81' ' ' ILE . 38.4 t -94.02 134.49 31.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.437 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -94.68 -27.3 15.92 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -156.56 -169.5 3.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.69 -0.631 . . . . 0.0 110.314 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -150.98 115.06 5.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.497 -0.752 . . . . 0.0 109.961 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -127.4 -68.4 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.47 142.74 3.47 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 65.44 -69.18 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.632 -0.922 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -109.47 117.24 33.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 110.256 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.432 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 53.8 m0 -107.02 154.19 21.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.25 118.77 32.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.437 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -133.39 159.12 41.26 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.138 -0.976 . . . . 0.0 112.285 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.495 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -111.52 126.72 55.28 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.469 -0.769 . . . . 0.0 110.166 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 t -81.25 112.06 18.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 109.532 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 mt -65.89 -20.86 66.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.889 -0.507 . . . . 0.0 110.913 -179.432 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.67 73.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.9 p -129.4 11.39 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.753 -0.592 . . . . 0.0 110.658 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.69 30.14 8.37 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 27.6 mtpt -102.16 178.27 4.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.62 -0.675 . . . . 0.0 109.385 179.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.76 149.11 24.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.745 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -173.59 -150.42 7.52 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 68.8 m-85 -93.27 162.22 14.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.745 -0.856 . . . . 0.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -153.0 108.75 2.66 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.733 -0.604 . . . . 0.0 109.382 179.36 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.51 108.11 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.027 1.014 . . . . 0.0 111.735 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.432 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 12.1 m -57.36 -15.33 6.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.776 -0.578 . . . . 0.0 111.804 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -76.7 5.54 7.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.131 -0.98 . . . . 0.0 112.808 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -151.17 38.72 0.65 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.89 -1.131 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 3.3 p -146.79 168.51 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 -179.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.81 141.46 46.41 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.43 179.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.4 ' HA ' ' CG1' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -85.08 122.53 29.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.701 0.762 . . . . 0.0 110.577 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.01 167.92 12.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 22.0 p-10 -94.56 -153.77 0.39 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.538 -0.726 . . . . 0.0 110.345 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.482 -178.891 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.955 0.407 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.95 137.41 38.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -158.41 -163.26 1.25 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.502 -179.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.4 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -114.31 54.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.58 178.73 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 66.6 mt -96.93 157.43 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.869 -1.144 . . . . 0.0 109.558 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.4 ' HB ' HG23 ' A' ' 133' ' ' VAL . 33.8 m -139.94 172.2 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -130.24 120.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.503 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.478 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -62.56 118.42 7.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.792 . . . . 0.0 109.222 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 69.2 mt -94.46 2.46 55.74 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.464 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.2 m-85 -153.67 152.87 31.32 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.14 -0.975 . . . . 0.0 108.831 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.35 144.29 53.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.391 -0.818 . . . . 0.0 110.447 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.466 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 48.2 t80 -155.4 127.95 7.89 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.396 -0.815 . . . . 0.0 110.793 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.87 149.35 21.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.422 -0.799 . . . . 0.0 110.771 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.57 170.02 1.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.467 -0.77 . . . . 0.0 109.929 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 tt -171.41 38.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 109.817 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -171.46 -168.34 0.6 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.246 -0.909 . . . . 0.0 109.851 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -74.09 -70.82 0.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.482 -0.761 . . . . 0.0 110.124 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 8.6 tp10 -86.53 54.44 3.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.885 . . . . 0.0 108.93 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.6 p30 -98.79 173.52 6.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.678 -0.638 . . . . 0.0 110.425 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.9 tt -155.07 128.67 8.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.321 -0.862 . . . . 0.0 110.917 -179.951 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -94.79 117.02 29.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.404 -0.81 . . . . 0.0 110.494 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.478 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 19.0 p90 -115.94 -170.03 1.71 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.724 -0.61 . . . . 0.0 110.501 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 179.4 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.343 1.068 . . . . 0.0 112.525 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.464 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.9 ttmt -61.08 -20.72 62.94 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 41.16 1.33 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.409 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 1.9 m-20 -91.02 170.51 9.98 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.746 -0.855 . . . . 0.0 111.693 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.87 129.28 47.92 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.513 -0.742 . . . . 0.0 109.49 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.402 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 3.1 mpp? -137.48 152.94 50.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.738 -0.601 . . . . 0.0 109.444 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.441 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 25.4 t -101.08 152.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.4 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 88.3 t -95.39 141.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.031 -1.043 . . . . 0.0 110.527 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.405 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -156.04 159.44 39.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.877 -0.515 . . . . 0.0 110.117 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -102.2 152.08 21.44 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.511 -0.743 . . . . 0.0 109.581 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -146.25 -66.95 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.142 -0.973 . . . . 0.0 111.019 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.13 -84.34 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -98.48 -20.89 16.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.591 -0.947 . . . . 0.0 110.777 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.85 107.51 9.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 109.506 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.44 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 41.6 m0 -101.26 155.06 18.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.39 -0.818 . . . . 0.0 110.886 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -100.6 111.96 24.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.405 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.09 169.71 13.11 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.241 1.02 . . . . 0.0 112.717 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.518 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.5 ttt180 -113.0 124.73 53.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.844 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 20.0 t -78.08 115.08 17.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.95 179.598 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.43 -23.77 66.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.847 -0.533 . . . . 0.0 110.114 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.26 -30.51 66.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.806 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.4 p -136.35 12.26 3.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.834 -0.541 . . . . 0.0 110.952 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.89 30.95 7.72 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.062 -1.024 . . . . 0.0 110.461 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.443 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.9 mttt -100.18 -179.88 4.27 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.518 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.22 137.25 14.63 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.035 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.26 6.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.441 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 70.7 m-85 -94.24 162.85 13.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.578 -0.954 . . . . 0.0 111.317 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.6 pt -155.31 111.03 2.25 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.998 -0.439 . . . . 0.0 110.166 179.238 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -45.36 101.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.04 1.021 . . . . 0.0 112.0 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.44 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.2 m -51.89 -28.87 17.65 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -81.57 11.62 4.49 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.298 -0.876 . . . . 0.0 112.569 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -136.79 30.87 2.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.061 -1.025 . . . . 0.0 108.589 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.412 HG23 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -147.98 170.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.412 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -119.32 129.27 54.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.408 ' HD3' ' CZ3' ' A' ' 115' ' ' TRP . 0.0 OUTLIER -93.16 114.17 26.59 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.522 -0.736 . . . . 0.0 112.924 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 28.4 m -103.19 146.37 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.3 p30 -154.28 40.2 0.47 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.303 -0.873 . . . . 0.0 109.582 -178.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.926 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.048 0.451 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.41 46.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -150.91 -157.59 0.83 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.541 -0.725 . . . . 0.0 110.543 -179.44 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.8 OUTLIER -97.18 52.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.134 -0.979 . . . . 0.0 109.69 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.524 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 80.7 mt -111.66 166.95 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.728 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.4 HG12 ' CG2' ' A' ' 107' ' ' VAL . 13.4 m -143.53 169.04 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.722 -0.611 . . . . 0.0 109.678 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -131.95 126.53 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.778 . . . . 0.0 108.948 178.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -66.97 118.24 10.16 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.84 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.42 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 86.9 mt -94.18 1.26 56.08 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.874 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.471 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 55.9 m-85 -152.99 151.1 29.9 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.197 -0.939 . . . . 0.0 108.652 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.05 145.99 55.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.587 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.433 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 69.1 t80 -150.31 163.84 37.29 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.502 -0.749 . . . . 0.0 110.611 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.76 125.59 22.53 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.61 -0.682 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.95 168.42 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.456 -0.778 . . . . 0.0 111.268 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 tt -167.14 39.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.636 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -169.52 -164.99 0.47 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.731 -0.606 . . . . 0.0 109.67 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -69.38 -74.7 0.12 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 110.914 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 5.2 tp10 -89.98 50.89 1.95 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.2 t0 -100.46 128.04 46.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.485 -0.759 . . . . 0.0 109.598 179.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.1 tp -107.57 129.19 55.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.76 -178.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -94.5 176.8 6.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.699 -0.625 . . . . 0.0 109.953 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 11.6 p90 -172.98 -167.48 0.42 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.494 -0.754 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -176.88 3.64 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.125 0.964 . . . . 0.0 111.539 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.471 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.0 ttmt -61.08 -22.73 64.89 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.38 44.7 1.0 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.405 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 3.0 m-20 -90.78 166.51 13.07 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.797 179.932 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.13 116.96 25.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.45 -0.781 . . . . 0.0 110.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 68.5 mtm -129.78 146.36 51.53 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.78 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.524 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -98.54 156.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.545 -1.262 . . . . 0.0 108.71 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 81' ' ' ILE . 43.3 t -93.62 139.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.01 0.909 . . . . 0.0 109.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.462 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -94.54 -30.76 14.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -156.23 161.2 40.29 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.71 144.68 31.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 0.0 109.975 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -139.03 -77.93 0.34 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.392 -0.817 . . . . 0.0 110.318 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.28 -85.29 0.07 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -94.27 -13.2 26.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.896 . . . . 0.0 110.596 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -133.47 96.66 3.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.775 . . . . 0.0 110.163 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.421 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 31.7 m0 -94.91 146.04 24.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.243 -0.911 . . . . 0.0 109.787 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.21 117.06 29.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.462 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -129.57 165.77 21.05 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.039 0.923 . . . . 0.0 112.419 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.9 ttm180 -115.01 124.54 51.9 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.593 -0.692 . . . . 0.0 109.961 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 4.8 t -83.92 118.77 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.68 -0.638 . . . . 0.0 109.932 179.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.25 -20.8 62.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.398 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.24 -26.93 66.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.0 109.864 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p -137.62 10.99 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.766 -0.584 . . . . 0.0 110.606 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 53.64 30.81 11.53 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.147 -0.971 . . . . 0.0 110.755 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -104.79 174.0 6.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.526 -0.734 . . . . 0.0 109.27 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.83 146.66 22.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.694 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -176.27 -147.19 6.33 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.603 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 36.2 m-85 -93.44 160.59 14.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.648 -0.913 . . . . 0.0 110.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.2 pt -152.14 117.57 3.05 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.332 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HG2' ' CD1' ' A' ' 89' ' ' TYR . 35.0 Cg_exo -41.33 103.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.323 1.349 . . . . 0.0 112.843 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.421 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 74.2 m -62.36 -15.1 46.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.865 -0.522 . . . . 0.0 111.008 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -86.13 13.87 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 111.522 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -152.23 40.2 0.61 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.252 -0.905 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.402 HG23 ' N ' ' A' ' 134' ' ' ALA . 6.2 p -149.09 168.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.421 -0.799 . . . . 0.0 110.831 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.402 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -127.82 127.81 44.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.975 -0.453 . . . . 0.0 109.93 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -95.15 129.43 42.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.454 -178.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 10.9 m -102.96 129.29 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -155.65 -165.96 2.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.988 -0.445 . . . . 0.0 109.838 -179.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.917 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.057 0.456 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -88.87 125.67 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.615 -0.678 . . . . 0.0 110.534 -179.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.413 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 59.6 m-20 -100.61 -150.57 0.39 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.407 -0.808 . . . . 0.0 109.625 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 4.9 tp -120.51 41.66 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.169 -0.957 . . . . 0.0 111.082 -179.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.539 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 7.0 mt -110.31 167.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 108.436 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.462 ' HB ' ' CG2' ' A' ' 133' ' ' VAL . 3.8 m -146.17 167.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.669 . . . . 0.0 110.617 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.6 p -128.51 124.16 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.47 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -66.9 117.57 9.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 79.8 mt -94.39 5.53 51.5 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.257 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.444 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 38.9 m-85 -152.44 151.74 31.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -70.17 141.99 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 109.536 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.477 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 65.4 t80 -155.53 126.95 7.25 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.349 -0.844 . . . . 0.0 111.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -100.1 122.02 42.32 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.506 0.67 . . . . 0.0 109.895 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.91 161.98 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.508 0.671 . . . . 0.0 111.903 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.07 64.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.634 -0.666 . . . . 0.0 109.571 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.2 -157.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.94 -72.12 0.59 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.432 -0.792 . . . . 0.0 110.693 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 19.8 tp10 -74.04 -8.08 54.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.082 -1.011 . . . . 0.0 110.176 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 20.1 p-10 -48.23 156.96 0.35 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.348 -0.845 . . . . 0.0 111.505 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.9 tt -137.54 134.34 35.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.415 -0.803 . . . . 0.0 110.47 -179.877 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -94.44 166.94 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 110.001 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.477 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 24.0 p90 -164.76 -170.78 2.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.291 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -124.37 179.88 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.328 1.061 . . . . 0.0 112.69 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.444 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 16.6 ttmt -60.95 -19.32 60.75 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.34 41.22 1.31 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -90.9 166.06 13.26 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.686 -0.89 . . . . 0.0 111.527 -179.811 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.05 111.31 15.82 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.561 -0.712 . . . . 0.0 110.112 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.9 mtm -126.01 147.41 49.55 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.539 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.1 m -95.02 157.33 3.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.073 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 73.9 t -93.98 135.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.201 1.001 . . . . 0.0 110.329 -178.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.446 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -94.98 -27.62 15.56 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.632 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -155.61 177.45 11.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.75 -0.594 . . . . 0.0 109.844 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.81 94.52 3.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -97.29 -152.87 0.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.678 -0.639 . . . . 0.0 110.084 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.33 -114.66 0.07 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -86.54 -6.87 58.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.948 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -119.0 102.81 9.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 109.669 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -98.72 157.11 16.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.421 -0.799 . . . . 0.0 110.645 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.9 mttt -97.51 121.72 39.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.446 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -131.24 161.32 32.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.351 -0.843 . . . . 0.0 111.83 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.505 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.8 ttm180 -114.97 122.35 45.98 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.545 -0.722 . . . . 0.0 109.83 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.5 t -84.48 127.33 33.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.645 -0.659 . . . . 0.0 110.456 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.88 -26.59 60.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.114 -0.366 . . . . 0.0 110.715 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.76 66.15 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.42 -0.8 . . . . 0.0 110.671 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p -128.31 9.4 6.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.688 . . . . 0.0 110.566 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.48 33.78 19.56 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -107.82 176.98 4.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.562 -0.711 . . . . 0.0 109.087 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.505 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pm0 -155.26 137.99 15.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.39 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -162.41 -149.71 5.76 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 75.9 m-85 -94.52 161.35 14.25 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 122.032 -0.687 . . . . 0.0 110.69 -179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -155.4 117.59 2.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -48.62 109.38 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.036 1.019 . . . . 0.0 111.73 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 m -56.96 -18.2 12.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.765 -0.584 . . . . 0.0 111.719 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 18.7 4.27 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.096 -1.003 . . . . 0.0 111.631 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -145.74 36.66 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.462 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 8.9 p -154.86 169.21 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.784 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -134.65 132.54 39.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.062 0.458 . . . . 0.0 110.301 179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.413 ' HA ' HG13 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -75.2 119.36 19.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.882 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.08 151.96 14.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.413 ' HA ' ' HB2' ' A' ' 80' ' ' ASP . 31.0 p-10 -96.89 38.07 1.26 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.745 -0.597 . . . . 0.0 110.098 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.279 -179.477 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.3 t . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 121.336 0.588 . . . . 0.0 110.34 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 18.6 mt-10 57.13 -152.49 0.39 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.474 -0.766 . . . . 0.0 110.188 179.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.43 ' N ' ' HA ' ' A' ' 137' ' ' ASP . 1.6 m-20 61.63 -103.03 0.13 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.401 -0.812 . . . . 0.0 110.586 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.43 HG13 ' HB ' ' A' ' 107' ' ' VAL . 1.4 tp -112.8 56.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.881 -1.137 . . . . 0.0 109.575 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 88.0 mt -123.16 159.18 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.411 ' HB ' ' CG2' ' A' ' 133' ' ' VAL . 17.2 m -137.83 169.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 p -130.01 123.96 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.469 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.26 120.67 14.18 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.045 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 85.3 mt -94.26 1.12 56.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.95 -179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.6 m-85 -152.48 152.53 32.06 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.49 146.23 54.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.452 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 36.7 t80 -155.15 127.68 7.91 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.35 -0.844 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -98.03 144.4 27.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.427 -0.796 . . . . 0.0 111.551 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -56.78 147.23 23.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.665 -0.647 . . . . 0.0 111.585 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.61 -67.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.586 -0.696 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -59.92 -167.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.198 -0.939 . . . . 0.0 110.734 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -81.12 -48.8 11.66 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.429 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 12.6 tp10 -95.76 52.99 1.38 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 40.3 p30 -92.28 -179.11 5.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.204 0.526 . . . . 0.0 111.498 -178.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -154.35 121.89 5.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 110.106 -179.241 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.1 m -94.52 112.0 23.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 110.55 179.621 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 14.4 p90 -114.83 -169.24 1.51 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.806 -0.559 . . . . 0.0 109.959 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -178.15 4.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.062 0.934 . . . . 0.0 111.72 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -60.95 -20.56 62.43 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.01 42.51 1.13 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -91.05 169.21 11.06 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.947 -179.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.33 125.65 43.81 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.495 0.664 . . . . 0.0 109.547 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 3.2 mpp? -134.4 153.95 51.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 36.6 t -94.41 152.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.33 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.43 ' HB ' HG13 ' A' ' 81' ' ' ILE . 33.6 t -95.57 134.93 31.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.902 0.858 . . . . 0.0 110.142 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.426 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -95.64 -27.83 15.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.54 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -156.05 -168.92 2.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.596 0.712 . . . . 0.0 111.128 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -143.62 99.22 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.64 -0.662 . . . . 0.0 109.562 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 t -94.42 -71.47 0.66 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 110.697 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.88 -77.21 0.07 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -94.04 -22.7 18.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.488 -1.007 . . . . 0.0 110.298 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 84.0 m95 -133.83 108.27 8.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.539 -0.726 . . . . 0.0 110.217 -179.553 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.416 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 34.0 m0 -98.98 158.9 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -100.27 126.65 46.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.416 -0.802 . . . . 0.0 109.094 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.426 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -135.73 162.6 32.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 112.164 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.3 ttt180 -111.35 120.54 42.53 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.391 -0.818 . . . . 0.0 109.829 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.1 t -72.41 110.71 7.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.485 179.208 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.3 mt -64.96 -26.0 68.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 -179.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 -29.95 70.88 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.632 -0.668 . . . . 0.0 110.097 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.0 p -129.53 8.61 5.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 110.883 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 53.66 29.25 9.07 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.135 -0.978 . . . . 0.0 109.86 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.419 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -97.48 176.24 5.94 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.74 140.59 17.18 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.765 0.793 . . . . 0.0 111.464 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.24 -150.01 6.83 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.429 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 52.8 m-85 -93.92 165.28 12.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.905 -0.762 . . . . 0.0 110.805 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -155.29 112.56 2.27 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.424 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 34.3 Cg_exo -42.67 102.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.109 1.206 . . . . 0.0 112.078 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.416 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 71.6 m -54.9 -20.6 9.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.906 -0.496 . . . . 0.0 111.513 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -90.26 25.32 2.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.214 -0.928 . . . . 0.0 111.63 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -154.99 32.02 0.4 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 109.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.411 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 7.6 p -149.02 169.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.579 -0.7 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.79 123.88 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.916 179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 18.6 ttp180 -91.76 126.53 36.88 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 112.455 -178.69 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.9 m -94.58 140.81 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.012 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.43 ' HA ' ' N ' ' A' ' 80' ' ' ASP . 2.9 p30 -141.51 -157.21 0.75 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.955 -0.466 . . . . 0.0 109.967 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.153 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.99 165.04 7.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.625 -0.672 . . . . 0.0 110.502 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -138.22 -162.55 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.567 -0.708 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.422 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -121.86 46.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.641 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.41 ' CD1' ' CG1' ' A' ' 106' ' ' VAL . 4.9 mm -96.65 140.1 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.064 -1.022 . . . . 0.0 108.882 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.464 ' HB ' HG23 ' A' ' 133' ' ' VAL . 32.2 m -126.33 174.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.428 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 7.1 p -127.66 123.66 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.655 -0.653 . . . . 0.0 109.365 178.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.443 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -66.36 119.41 11.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.417 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 64.5 mt -94.3 4.2 54.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.561 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.47 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.1 m-85 -152.63 151.5 30.68 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.031 -1.043 . . . . 0.0 109.117 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.6 m-20 -69.13 143.14 54.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.352 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.437 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 58.9 t80 -155.12 131.15 10.15 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.181 -0.949 . . . . 0.0 111.019 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -97.4 142.19 29.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.7 -0.625 . . . . 0.0 110.723 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.93 175.21 0.1 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.0 tt -172.23 39.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.533 -0.729 . . . . 0.0 110.278 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -173.29 -168.3 0.45 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.288 -0.882 . . . . 0.0 110.217 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -72.44 -74.25 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.398 -0.814 . . . . 0.0 109.828 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 10.7 tp10 -83.36 55.59 3.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.356 -0.84 . . . . 0.0 109.15 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 53.2 p-10 -101.36 170.97 7.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.606 . . . . 0.0 109.809 -179.722 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 55.4 tp -151.9 129.33 11.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.312 -0.868 . . . . 0.0 111.14 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.76 116.65 28.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.686 -0.634 . . . . 0.0 110.295 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.443 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 17.3 p90 -113.62 -170.92 1.79 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.579 -0.7 . . . . 0.0 109.958 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -125.71 -179.77 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.032 0.92 . . . . 0.0 111.831 -178.596 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.47 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.14 -23.36 65.47 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.7 40.9 1.37 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.96 171.08 9.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.049 -0.677 . . . . 0.0 111.543 -179.415 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 139.55 53.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.484 -0.76 . . . . 0.0 109.781 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.411 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 71.8 mtm -142.95 154.01 43.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.79 -0.569 . . . . 0.0 110.178 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.41 ' CG1' ' CD1' ' A' ' 82' ' ' ILE . 22.4 t -100.77 147.89 7.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.422 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 95.4 t -94.92 138.93 19.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.881 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.402 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.14 -25.69 14.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.04 155.33 32.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.749 -0.595 . . . . 0.0 110.05 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -108.7 133.16 53.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 109.916 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.8 t -132.6 -85.38 0.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.279 -0.888 . . . . 0.0 110.658 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.96 -91.76 0.08 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.88 -16.83 30.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.585 -0.95 . . . . 0.0 110.807 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -127.59 104.9 8.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.371 -0.831 . . . . 0.0 110.468 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 44.5 m0 -101.95 153.56 19.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.249 -0.907 . . . . 0.0 109.984 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -102.78 113.21 26.44 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.402 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -128.02 167.93 16.01 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.127 -0.983 . . . . 0.0 112.675 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.1 ttt180 -115.76 124.01 49.71 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.65 -0.656 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.411 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 24.2 t -78.98 120.82 24.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.624 -0.673 . . . . 0.0 109.741 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mt -71.75 -21.81 61.7 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.17 73.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.4 -0.812 . . . . 0.0 109.656 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 p -130.56 9.54 5.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.726 -0.609 . . . . 0.0 110.735 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.23 31.3 13.87 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.042 -1.036 . . . . 0.0 110.641 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.4 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.5 mtpt -104.51 173.3 6.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.6 OUTLIER -154.6 140.35 18.08 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.644 179.632 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.03 -146.04 4.71 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.423 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 72.7 m-85 -94.15 157.81 15.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 122.056 -0.673 . . . . 0.0 110.6 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.7 pt -154.0 113.59 2.53 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.794 -0.566 . . . . 0.0 109.796 179.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.62 97.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.277 1.146 . . . . 0.0 112.062 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 66.9 m -49.56 -24.6 2.21 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.684 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -85.71 16.4 4.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.403 -0.811 . . . . 0.0 111.755 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.71 29.15 1.93 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.2 -0.938 . . . . 0.0 109.147 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.464 HG23 ' HB ' ' A' ' 83' ' ' VAL . 6.3 p -146.69 169.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.669 0.747 . . . . 0.0 110.901 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -119.7 135.71 54.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.867 -0.52 . . . . 0.0 110.072 179.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.95 128.1 40.08 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.39 -0.818 . . . . 0.0 111.696 -179.065 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.7 m -146.39 179.9 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.63 . . . . 0.0 109.985 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -94.18 -158.08 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.751 . . . . 0.0 109.852 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.286 -179.713 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.202 0.525 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.8 84.02 0.91 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.532 -0.73 . . . . 0.0 110.295 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 3.5 m-20 -161.03 -167.06 1.72 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.495 -0.753 . . . . 0.0 109.975 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.41 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -94.8 58.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.801 -1.187 . . . . 0.0 109.566 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.0 mt -107.88 157.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.902 -1.124 . . . . 0.0 109.055 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.447 ' HB ' ' CG2' ' A' ' 133' ' ' VAL . 28.9 m -139.86 173.12 11.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.815 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -133.09 121.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.446 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -64.42 118.94 9.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.707 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 90.5 mt -94.15 0.75 55.99 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.253 -179.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.448 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 41.0 m-85 -150.13 149.72 30.66 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.257 -0.902 . . . . 0.0 108.834 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -66.24 151.31 47.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -153.94 167.78 28.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.374 -0.829 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 94.06 2.17 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.169 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.402 ' CB ' ' HB2' ' A' ' 96' ' ' ASP . . . -60.13 161.91 6.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.587 -0.696 . . . . 0.0 111.013 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.1 mt -130.85 -31.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.312 -0.867 . . . . 0.0 111.693 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -157.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.033 -1.042 . . . . 0.0 111.065 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -91.26 -70.72 0.67 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.354 -0.842 . . . . 0.0 111.161 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -66.12 -17.53 64.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.402 ' HB2' ' CB ' ' A' ' 91' ' ' ALA . 20.2 p-10 -42.08 146.8 0.27 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.766 -0.584 . . . . 0.0 112.074 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 2.3 tt -133.43 134.66 43.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 110.431 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 m -94.7 170.2 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.594 -0.691 . . . . 0.0 109.976 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.446 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 18.4 p90 -161.02 -169.14 2.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.623 -0.673 . . . . 0.0 110.638 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.98 179.22 4.73 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.259 1.028 . . . . 0.0 112.523 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -61.12 -23.02 65.21 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.36 43.62 1.08 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.404 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 2.3 m-20 -90.53 167.85 12.27 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.894 -0.768 . . . . 0.0 111.396 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.47 128.61 50.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.589 -0.694 . . . . 0.0 109.717 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.407 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 2.1 mpp? -137.45 148.1 45.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.4 t -95.08 155.16 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 81' ' ' ILE . 49.4 t -95.13 140.51 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.159 -0.963 . . . . 0.0 110.634 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.406 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -97.59 -27.63 14.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -156.14 173.23 17.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.776 -0.578 . . . . 0.0 110.122 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -139.98 89.17 2.28 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.459 -0.775 . . . . 0.0 110.0 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.6 t -99.32 -68.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 110.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.86 154.59 7.27 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 65.14 -72.64 0.07 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.562 -0.963 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.424 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 39.4 m95 -108.86 126.4 53.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.94 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CE2' ' OG ' ' A' ' 130' ' ' SER . 51.6 m0 -106.39 141.62 37.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.521 -0.737 . . . . 0.0 110.213 -179.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.6 114.02 25.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.406 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -130.31 164.89 23.65 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.841 0.829 . . . . 0.0 111.987 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.0 ttt180 -112.34 124.53 52.67 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.625 -0.672 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.8 t -78.88 114.39 17.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.578 . . . . 0.0 109.664 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.16 -27.7 68.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.51 . . . . 0.0 109.992 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.97 38.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.094 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -139.49 10.6 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.676 -0.64 . . . . 0.0 110.717 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 52.24 30.51 7.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.959 -1.088 . . . . 0.0 110.707 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 28.2 mttt -103.26 -178.75 3.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.4 OUTLIER -155.38 147.41 23.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.52 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -155.73 11.15 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.424 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 79.0 m-85 -94.18 157.75 15.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 122.045 -0.68 . . . . 0.0 110.348 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.8 pt -155.0 125.58 3.41 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.641 -0.662 . . . . 0.0 110.793 -179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.01 117.34 4.18 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 122.967 0.983 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.404 ' OG ' ' CE2' ' A' ' 115' ' ' TRP . 5.2 m -53.95 -34.43 59.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.789 -0.57 . . . . 0.0 111.989 -179.629 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -71.33 -6.52 40.6 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.907 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -109.72 25.36 11.88 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.098 -1.001 . . . . 0.0 109.466 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.447 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 7.3 p -156.71 170.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.965 0.888 . . . . 0.0 112.175 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -124.65 127.1 46.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.8 ttp180 -91.59 118.13 30.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 112.58 -178.172 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.0 m -102.68 137.27 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.471 0.653 . . . . 0.0 109.532 178.01 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.472 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 37.2 t70 -155.8 30.52 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.865 -0.522 . . . . 0.0 110.114 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 -179.822 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.146 0.498 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 52.27 93.55 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.374 -0.829 . . . . 0.0 111.054 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -154.96 -162.56 1.39 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.54 -0.725 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.465 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.7 OUTLIER -95.33 58.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.4 mt -119.34 164.48 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.938 -179.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.413 ' CG1' ' HA ' ' A' ' 135' ' ' ARG . 15.4 m -142.12 169.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.3 p -129.9 126.71 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.455 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -70.56 120.58 16.41 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.424 ' HB2' ' CE2' ' A' ' 87' ' ' TYR . 95.0 mt -94.33 3.2 55.52 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.187 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.448 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 44.9 m-85 -153.0 150.58 29.35 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 108.872 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.48 141.06 58.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 109.941 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.456 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 44.2 t80 -155.38 119.99 4.73 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.361 -0.837 . . . . 0.0 111.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.52 124.23 50.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.55 148.02 25.18 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.25 -0.906 . . . . 0.0 110.433 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.4 mt -103.0 -24.24 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.613 -0.68 . . . . 0.0 109.295 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -178.46 -169.96 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.563 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.56 -170.3 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.446 -0.783 . . . . 0.0 111.825 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 8.6 tp10 -81.88 55.99 2.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 24.0 t0 -95.66 137.2 35.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 37.4 tp -98.23 133.54 42.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.912 . . . . 0.0 111.734 -178.312 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -94.56 162.42 13.81 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.456 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 13.6 p90 -171.53 -165.66 0.4 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.491 -0.756 . . . . 0.0 110.115 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 178.37 5.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.242 1.02 . . . . 0.0 112.247 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 16.7 ttmt -61.08 -21.49 63.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.74 40.57 1.44 Allowed Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -91.0 169.55 10.79 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.852 -0.793 . . . . 0.0 112.131 -179.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 122.04 36.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.561 -0.712 . . . . 0.0 110.116 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.7 mtm -127.69 152.85 47.19 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 41.3 t -95.5 154.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.422 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.465 ' HB ' HG13 ' A' ' 81' ' ' ILE . 5.7 t -94.78 136.25 26.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.949 0.88 . . . . 0.0 109.699 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -96.89 -27.03 14.86 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.546 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -155.99 -174.42 4.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.706 -0.621 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -137.88 98.78 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.405 -0.809 . . . . 0.0 109.751 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 t -94.69 -77.98 0.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.51 -80.23 0.08 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -93.55 -8.66 40.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.945 . . . . 0.0 110.729 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -143.44 96.94 2.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.893 . . . . 0.0 110.076 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -95.65 157.87 15.71 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.098 -1.002 . . . . 0.0 110.781 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 tttt -102.17 122.47 44.22 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.437 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -132.16 159.96 37.46 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 112.37 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.471 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.0 ttt180 -113.0 124.41 52.57 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.496 -0.753 . . . . 0.0 109.937 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.1 t -81.51 119.21 23.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.622 . . . . 0.0 109.362 178.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 3.2 mt -71.15 -24.79 62.33 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.767 -179.405 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.33 59.57 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.35 -0.844 . . . . 0.0 109.587 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 p -137.34 9.4 2.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.436 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.19 27.63 6.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.01 -1.056 . . . . 0.0 110.67 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 38.4 mttt -95.51 171.47 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.772 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.471 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.5 151.83 28.17 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.854 0.835 . . . . 0.0 111.849 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 177.07 -152.89 12.67 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.551 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 4.5 m-85 -92.92 153.36 18.83 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.865 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.55 132.31 14.18 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.803 -0.561 . . . . 0.0 110.404 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.408 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 39.0 Cg_exo -47.87 96.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.121 1.064 . . . . 0.0 111.677 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 m -55.87 -20.5 15.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.721 -0.612 . . . . 0.0 111.379 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.65 18.36 5.56 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.327 -0.858 . . . . 0.0 111.351 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -146.75 33.33 0.93 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.6 p -146.13 168.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.936 -179.017 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -131.21 120.09 22.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.413 ' HA ' ' CG1' ' A' ' 83' ' ' VAL . 14.6 ttp180 -88.31 129.43 35.38 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.229 -0.92 . . . . 0.0 112.029 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.9 m -98.88 130.43 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.101 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -155.54 -41.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.849 -0.532 . . . . 0.0 111.001 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.235 -179.756 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.957 0.408 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -166.36 71.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.489 -0.757 . . . . 0.0 110.486 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.458 ' N ' ' HA ' ' A' ' 137' ' ' ASP . 13.8 m-20 -149.24 -152.87 0.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.655 -0.653 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.43 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.4 OUTLIER -98.23 54.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.849 -1.157 . . . . 0.0 109.397 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 74.8 mt -118.14 164.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.873 -179.247 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 22.4 m -142.22 173.49 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.9 p -131.49 128.07 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.012 177.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.409 ' HA ' HG11 ' A' ' 133' ' ' VAL . . . -70.46 116.1 10.41 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 77.2 mt -94.33 3.05 55.72 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.261 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.443 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.6 m-85 -149.71 150.32 31.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.198 -0.939 . . . . 0.0 108.906 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -71.75 145.02 49.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.166 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 19.6 t80 -155.5 121.95 5.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.465 -0.772 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.3 mt-10 -97.15 124.42 41.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.354 -0.841 . . . . 0.0 110.752 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.67 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.575 -0.703 . . . . 0.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.1 mm -135.69 -70.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.225 -0.922 . . . . 0.0 110.679 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -175.1 53.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.084 -1.01 . . . . 0.0 110.396 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -167.32 -153.12 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.261 -0.9 . . . . 0.0 109.45 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.403 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 2.7 tp10 -54.81 -29.27 54.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.206 -0.934 . . . . 0.0 109.171 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -43.35 125.95 4.03 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 120.948 0.404 . . . . 0.0 111.239 179.021 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tt -109.28 146.19 34.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.513 -0.742 . . . . 0.0 111.024 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.8 m -97.29 119.97 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.821 -0.549 . . . . 0.0 109.777 179.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 20.2 p90 -114.99 -170.92 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.587 -0.696 . . . . 0.0 110.742 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.73 177.28 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.295 1.045 . . . . 0.0 112.159 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.443 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.7 ttmt -61.32 -20.29 62.78 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.68 1.32 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.88 170.14 10.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.902 -0.763 . . . . 0.0 111.724 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.33 123.52 41.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 110.181 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.423 ' HE3' ' CD2' ' A' ' 99' ' ' PHE . 77.4 mtm -129.58 150.43 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.0 t -96.2 153.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.43 ' HB ' HG13 ' A' ' 81' ' ' ILE . 24.8 t -95.2 134.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.84 0.829 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.432 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -95.03 -26.36 16.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.208 0.528 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -155.43 -177.37 6.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.067 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -145.17 95.19 2.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 t -104.88 -53.99 2.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.524 -0.735 . . . . 0.0 111.003 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.81 141.99 3.8 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 64.58 -72.41 0.06 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.646 -0.914 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -106.07 117.86 35.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 0.0 110.208 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.4 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 45.1 m0 -106.78 152.38 23.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.643 . . . . 0.0 110.207 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.69 117.2 31.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.541 -0.724 . . . . 0.0 109.187 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.432 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -130.21 162.5 28.79 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.623 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 4.6 ttt180 -114.88 124.51 51.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.7 -0.625 . . . . 0.0 109.889 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.423 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 3.1 t -78.23 117.06 19.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.482 -0.761 . . . . 0.0 109.654 179.198 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 13.2 mt -67.35 -26.3 66.42 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.313 -179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.46 66.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -136.58 9.89 3.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.588 -0.695 . . . . 0.0 110.714 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.65 27.84 4.32 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.979 -1.075 . . . . 0.0 110.414 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.416 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 47.6 mttt -101.84 179.71 4.25 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.24 151.36 28.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.412 -0.805 . . . . 0.0 111.48 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -173.1 -157.58 15.22 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.403 ' CE2' ' HB3' ' A' ' 95' ' ' GLU . 88.4 m-85 -94.03 151.35 19.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 122.311 -0.523 . . . . 0.0 109.703 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.04 130.12 5.45 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.58 -0.7 . . . . 0.0 110.575 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.69 107.51 0.75 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 109.347 -1.059 . . . . 0.0 109.347 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.4 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 1.3 m -55.34 -26.01 38.29 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.384 -0.822 . . . . 0.0 110.857 -179.051 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' ND2' ' CD1' ' A' ' 132' ' ' TYR . 16.8 p-10 -71.28 -12.44 61.45 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.414 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.436 ' CD1' ' ND2' ' A' ' 131' ' ' ASN . 3.0 m-85 -100.54 9.23 42.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.409 HG11 ' HA ' ' A' ' 85' ' ' ALA . 35.2 m -138.5 -177.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 111.929 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -132.06 114.77 14.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -82.34 123.17 28.85 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.308 -0.87 . . . . 0.0 111.066 -178.197 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.3 m -97.48 126.53 50.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.458 ' HA ' ' N ' ' A' ' 80' ' ' ASP . 7.1 p-10 -155.38 -42.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.942 -0.474 . . . . 0.0 110.677 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.239 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 54.01 98.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 110.754 -179.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -143.93 -164.01 1.79 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.416 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -121.13 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.905 . . . . 0.0 110.725 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 73.7 mt -98.47 144.73 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.746 -1.221 . . . . 0.0 109.889 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.412 ' CG1' ' HA ' ' A' ' 135' ' ' ARG . 28.0 m -127.45 174.62 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 110.785 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.6 p -130.38 126.22 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 178.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -69.63 121.17 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.414 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 64.5 mt -94.43 1.83 55.78 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.738 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.469 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.6 m-85 -152.52 151.01 30.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.257 -0.902 . . . . 0.0 108.899 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -67.12 147.88 52.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.531 -0.731 . . . . 0.0 109.927 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CZ ' ' HG3' ' A' ' 129' ' ' PRO . 54.4 t80 -153.89 146.35 24.02 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.354 -0.841 . . . . 0.0 111.768 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 114.88 23.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.538 0.685 . . . . 0.0 110.921 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -48.51 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.387 -0.821 . . . . 0.0 112.09 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -146.19 -58.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.617 -0.677 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.39 -173.48 0.1 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.241 -0.912 . . . . 0.0 111.929 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -64.5 -80.89 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 110.119 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 15.1 tp10 -74.62 63.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 55.4 p-10 -101.44 161.68 13.45 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 40.9 tp -138.84 125.62 20.91 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.592 -179.108 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -93.98 159.74 15.03 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.289 0.566 . . . . 0.0 109.587 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.429 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 17.5 p90 -163.36 -170.42 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.637 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -178.17 3.93 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.164 0.983 . . . . 0.0 112.162 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -61.07 -21.32 63.55 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.98 43.3 1.04 Allowed Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -90.76 171.68 9.17 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.989 -0.712 . . . . 0.0 111.877 -179.488 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.87 136.03 53.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.665 -0.647 . . . . 0.0 109.764 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 76.4 mtm -143.44 154.52 43.77 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.442 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 40.8 t -101.65 150.94 5.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.416 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 61.9 t -95.5 138.21 21.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 O-C-N 121.241 -0.912 . . . . 0.0 110.542 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 4.3 mp -98.87 -25.84 14.49 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.39 147.72 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.648 -0.658 . . . . 0.0 110.192 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.09 145.39 28.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.297 -0.877 . . . . 0.0 109.237 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -142.29 -71.5 0.33 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.51 -77.61 0.14 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.27 -10.22 30.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -1.014 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -147.71 107.15 3.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.272 -0.893 . . . . 0.0 110.585 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -104.21 155.61 18.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.7 tttt -105.17 116.74 32.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.555 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -128.05 169.41 14.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.897 . . . . 0.0 112.54 -178.502 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.473 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.6 ttt180 -115.3 121.67 43.59 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 121.775 -0.578 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.3 t -77.6 116.11 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.676 -0.64 . . . . 0.0 109.765 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.63 -22.41 65.33 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.052 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.93 66.78 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.676 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.7 p -138.63 9.02 2.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.892 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 53.68 29.01 8.73 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.981 -1.074 . . . . 0.0 110.597 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.448 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 52.5 mttt -103.09 174.73 5.74 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.473 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -155.22 142.57 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.931 0.872 . . . . 0.0 111.406 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.22 -146.31 4.98 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.416 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 56.5 m-85 -93.49 161.39 14.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 122.058 -0.672 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.4 pt -151.52 118.87 3.28 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.736 -0.603 . . . . 0.0 109.83 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.462 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 68.5 Cg_exo -40.76 99.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.37 1.38 . . . . 0.0 112.436 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -61.02 -19.68 61.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.905 -0.497 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 24.8 p30 -87.82 17.89 4.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.32 -0.862 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.428 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 4.5 m-85 -152.06 44.49 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.052 -1.03 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.3 p -154.18 168.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 111.023 -179.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -123.41 138.98 54.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.882 -0.511 . . . . 0.0 110.37 179.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.412 ' HA ' ' CG1' ' A' ' 83' ' ' VAL . 0.0 OUTLIER -101.66 120.29 40.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.397 -0.815 . . . . 0.0 112.088 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -121.88 144.41 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.1 p30 -106.61 47.49 0.88 Allowed 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.271 -0.893 . . . . 0.0 109.96 -179.404 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.287 179.864 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.325 0.583 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.22 172.99 3.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.701 -0.624 . . . . 0.0 109.722 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -114.6 -161.58 0.78 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.424 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -115.2 42.76 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.715 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 27.3 mt -97.55 124.91 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.056 -1.027 . . . . 0.0 109.206 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.434 ' HB ' HG23 ' A' ' 133' ' ' VAL . 32.8 m -111.23 171.94 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.364 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.7 p -128.32 127.6 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.441 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.66 117.84 10.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 80.5 mt -94.54 4.26 54.08 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.297 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.43 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 27.6 m-85 -151.94 150.42 30.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -68.26 146.15 53.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 109.725 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.422 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 65.3 t80 -153.48 145.04 23.28 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.255 -0.903 . . . . 0.0 111.15 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -118.32 103.48 9.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.916 -0.49 . . . . 0.0 110.165 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.414 ' HB2' ' OD2' ' A' ' 96' ' ' ASP . . . -56.51 155.13 7.61 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.46 -0.775 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.48 74.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.497 -0.752 . . . . 0.0 109.941 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -175.69 -155.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 -71.28 0.69 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.176 -0.952 . . . . 0.0 110.522 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 5.4 tp10 -65.0 -19.54 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -0.922 . . . . 0.0 109.453 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.414 ' OD2' ' HB2' ' A' ' 91' ' ' ALA . 19.2 p-10 -42.04 161.8 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.826 -0.546 . . . . 0.0 112.132 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.4 tt -148.45 130.91 15.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.699 -0.625 . . . . 0.0 110.227 -179.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -94.8 151.57 19.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.612 -0.68 . . . . 0.0 110.157 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.441 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 16.5 p90 -142.43 -167.96 2.62 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.455 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -125.39 179.93 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.173 0.987 . . . . 0.0 112.119 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.43 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.0 ttmt -61.24 -20.07 62.4 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.54 41.49 1.32 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -91.06 165.04 13.73 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.744 -0.856 . . . . 0.0 112.408 -179.57 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.69 54.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.421 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 2.0 mpp? -138.75 153.14 48.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 20.9 t -100.83 152.61 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.424 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 94.5 t -95.36 139.7 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.109 -0.995 . . . . 0.0 109.789 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.412 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -98.6 -27.18 14.13 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -156.23 159.46 38.93 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.88 105.34 13.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.216 -0.927 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 -151.96 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.4 -0.813 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.53 -107.22 0.61 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.91 -4.42 59.16 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.543 -0.975 . . . . 0.0 111.575 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.445 ' CH2' ' HG3' ' A' ' 129' ' ' PRO . 30.7 m95 -127.77 106.21 8.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.421 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 50.1 m0 -100.67 153.03 19.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 109.767 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -100.62 114.26 27.79 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.412 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.61 164.03 22.92 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.712 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -113.33 120.61 41.73 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.724 -0.61 . . . . 0.0 109.6 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 6.1 t -78.38 122.67 26.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.655 -0.653 . . . . 0.0 109.35 179.244 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.84 -27.88 63.19 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.934 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.45 31.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.443 -0.785 . . . . 0.0 109.85 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.8 p -137.81 10.33 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.613 . . . . 0.0 110.528 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 50.61 27.48 2.95 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.993 -1.067 . . . . 0.0 110.574 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.428 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 4.2 mttt -100.45 179.78 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.24 147.18 23.46 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.77 0.795 . . . . 0.0 111.183 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -171.57 -147.03 5.52 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.436 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 75.8 m-85 -94.42 157.39 16.04 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.091 -0.652 . . . . 0.0 110.606 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.9 pt -152.15 109.59 2.83 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.652 -0.655 . . . . 0.0 109.735 179.431 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.445 ' HG3' ' CH2' ' A' ' 114' ' ' TRP . 51.3 Cg_exo -50.66 110.07 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 122.958 0.978 . . . . 0.0 111.56 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.421 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 24.0 m -59.88 -17.23 35.43 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.935 -0.478 . . . . 0.0 111.249 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -84.77 12.93 6.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.276 -0.89 . . . . 0.0 111.719 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -147.02 44.27 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 0.0 108.802 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.434 HG23 ' HB ' ' A' ' 83' ' ' VAL . 7.4 p -156.25 168.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.792 0.806 . . . . 0.0 111.317 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.426 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -128.61 127.6 42.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.2 tmm_? -88.23 140.03 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 112.474 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 15.9 m -156.54 -168.66 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -105.09 -24.05 12.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.811 178.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.169 -179.679 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.119 0.485 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.11 81.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.41 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 7.5 m-20 -161.06 -165.05 1.27 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.022 -179.88 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -95.42 55.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 0.0 109.446 179.038 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 47.7 mt -104.29 155.91 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.915 -1.116 . . . . 0.0 109.448 179.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.6 m -139.01 176.5 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.272 -179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 3.9 p -134.28 122.69 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.549 -0.72 . . . . 0.0 109.414 178.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.452 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.42 120.36 13.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.84 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.415 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 79.5 mt -94.09 1.47 56.15 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.49 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.8 m-85 -152.49 151.0 30.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.152 -0.967 . . . . 0.0 108.393 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 67.4 m-20 -66.61 148.46 51.87 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.501 -0.75 . . . . 0.0 110.339 -178.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.44 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 46.2 t80 -155.3 131.05 9.91 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.317 -0.865 . . . . 0.0 111.31 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -100.09 137.73 38.14 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.403 -0.811 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -47.7 161.5 0.09 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.606 -0.684 . . . . 0.0 111.721 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . 0.509 HG22 HD11 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -155.23 31.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.627 -0.671 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -173.05 -165.56 0.3 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.171 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -70.8 0.31 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.411 -0.806 . . . . 0.0 110.065 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 1.8 tt0 -86.24 50.67 2.03 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 0.0 109.4 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 50.3 p30 -93.94 176.27 6.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.779 -0.576 . . . . 0.0 110.09 -179.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 61.2 tp -155.01 124.78 6.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.488 -0.758 . . . . 0.0 111.232 -179.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.75 114.93 26.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.27 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.452 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 14.3 p90 -113.14 -168.86 1.38 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.63 -0.669 . . . . 0.0 110.057 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.8 tt0 -125.69 -178.33 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.352 1.073 . . . . 0.0 112.799 -178.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.2 -23.9 65.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.95 42.42 1.19 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.52 166.84 13.0 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.649 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.17 128.75 50.47 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.691 -0.631 . . . . 0.0 109.377 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -135.78 148.47 48.78 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 33.6 t -98.65 152.59 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.45 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 58.2 t -95.05 138.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.549 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.425 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.16 -31.65 13.43 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -156.32 163.4 39.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.917 -0.49 . . . . 0.0 109.857 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.87 153.72 21.0 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.9 t -147.87 -68.62 0.24 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.03 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -99.57 -20.74 16.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.652 -0.91 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -121.43 102.33 8.19 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.422 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 50.2 m0 -99.19 150.78 21.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.932 -179.096 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.4 tttt -94.75 112.73 24.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.118 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.425 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -128.56 166.59 18.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.257 -0.902 . . . . 0.0 112.246 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -112.75 124.93 53.69 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 42.2 t -77.85 115.1 17.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.909 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.5 mt -68.8 -24.93 64.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 110.625 -179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.69 67.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.802 . . . . 0.0 109.965 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p -135.99 9.29 3.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.605 -0.685 . . . . 0.0 110.798 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.36 30.63 12.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.045 -1.034 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.434 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 mmmm -99.68 177.73 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.262 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.44 139.0 15.96 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.83 0.824 . . . . 0.0 111.388 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.31 -150.71 6.74 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.425 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 59.8 m-85 -93.89 162.73 13.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.718 -0.872 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pt -155.45 111.7 2.23 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.713 -0.617 . . . . 0.0 109.866 179.373 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 O-C-N 123.038 1.02 . . . . 0.0 112.079 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 16.4 m -61.27 -17.11 51.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -76.79 1.48 17.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.208 -0.932 . . . . 0.0 112.316 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -141.84 46.82 1.66 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 4.1 p -154.83 168.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 -178.816 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -120.98 129.07 53.27 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -97.17 119.99 36.7 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.416 -0.803 . . . . 0.0 112.871 -178.072 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 20.5 m -99.12 136.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.243 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.41 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 7.6 p30 -155.59 29.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 -179.052 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.161 -179.815 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.06 49.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.5 -0.75 . . . . 0.0 109.992 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.438 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 7.4 m-20 -163.6 -171.11 2.42 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.731 -0.605 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.454 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -94.36 79.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.503 179.228 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 69.0 mt -128.75 150.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 28.4 m -128.89 175.1 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.5 p -132.74 118.12 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.948 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.468 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -63.33 116.18 5.26 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.2 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 95.6 mt -94.45 1.68 55.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.126 -0.359 . . . . 0.0 111.77 -178.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.475 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 51.3 m-85 -151.25 151.75 32.28 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.98 144.54 54.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 109.685 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.438 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 33.6 t80 -152.28 131.78 13.0 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.125 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -99.79 139.73 35.03 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.277 0.56 . . . . 0.0 111.202 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -49.34 152.75 1.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.567 -0.708 . . . . 0.0 111.24 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.35 38.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.444 -0.785 . . . . 0.0 110.255 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.3 -167.76 0.35 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.21 -0.931 . . . . 0.0 110.765 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -69.0 -75.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.649 -0.657 . . . . 0.0 109.926 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 17.9 tp10 -88.33 54.39 3.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.437 -0.789 . . . . 0.0 109.473 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.9 p30 -94.09 169.21 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.3 tt -145.92 127.77 15.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 111.037 -179.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -94.7 116.5 28.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.566 -0.709 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.468 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 12.1 p90 -114.35 -167.75 1.26 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . 0.433 ' O ' ' HB2' ' A' ' 85' ' ' ALA . 0.4 OUTLIER -126.11 177.43 6.38 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.194 0.997 . . . . 0.0 111.942 -178.127 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.475 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 1.3 ttmt -60.92 -18.78 58.72 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.75 38.19 1.3 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -91.03 171.77 9.03 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.802 -0.822 . . . . 0.0 111.871 -179.377 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.72 136.75 54.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 69.6 mtm -140.33 155.64 46.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 t -98.68 152.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.454 ' HB ' HG13 ' A' ' 81' ' ' ILE . 84.8 t -94.41 133.42 35.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.934 0.873 . . . . 0.0 109.704 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -96.25 -26.99 15.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -156.4 179.63 9.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 0.0 109.291 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.57 86.26 2.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.173 -0.954 . . . . 0.0 110.389 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.0 t -96.2 -164.7 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.685 -0.634 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.11 139.79 15.06 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 66.43 -64.16 0.23 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.593 -0.946 . . . . 0.0 111.095 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -105.88 115.39 30.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.423 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 54.4 m0 -101.96 149.0 24.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.417 -0.802 . . . . 0.0 109.231 178.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 15.4 tttt -95.38 113.97 25.69 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.613 -0.68 . . . . 0.0 110.172 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -129.58 164.91 22.81 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.952 0.882 . . . . 0.0 112.34 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.486 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -114.03 124.32 51.85 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.473 -0.767 . . . . 0.0 110.364 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 2.4 t -80.09 123.08 27.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.338 178.854 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.67 -25.96 60.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.696 -0.627 . . . . 0.0 110.94 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.16 68.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.314 -0.867 . . . . 0.0 110.031 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p -127.79 7.68 6.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.832 -0.542 . . . . 0.0 110.36 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.55 31.98 13.42 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.991 -1.068 . . . . 0.0 110.128 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 35.6 mtpt -102.17 175.41 5.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.193 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.486 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -155.62 143.24 19.61 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.669 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.21 -150.01 6.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 66.5 m-85 -93.91 167.93 11.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.956 . . . . 0.0 109.994 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.5 pt -154.98 116.49 2.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -52.23 105.49 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 122.849 0.921 . . . . 0.0 111.594 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 20.4 m -55.19 -19.33 7.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.715 -0.616 . . . . 0.0 111.241 179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -83.88 20.08 1.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.249 -0.907 . . . . 0.0 111.746 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -154.29 39.69 0.46 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.021 -1.05 . . . . 0.0 109.288 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.2 p -154.0 170.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 111.112 -178.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -129.36 120.57 25.8 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.291 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.5 ttm180 -89.12 129.76 35.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 113.148 -177.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.9 m -103.41 142.84 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.438 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 2.4 t0 -155.79 -154.6 0.5 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.894 -0.504 . . . . 0.0 109.652 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.026 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.149 0.499 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 48.64 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.521 -0.737 . . . . 0.0 111.331 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -116.49 -157.68 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.695 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.464 HG13 ' HB ' ' A' ' 107' ' ' VAL . 2.4 tp -115.28 50.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 110.867 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.487 HD11 HG22 ' A' ' 82' ' ' ILE . 82.3 mt -115.6 164.71 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.419 HG13 ' HA ' ' A' ' 135' ' ' ARG . 18.5 m -143.18 175.72 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.428 0.632 . . . . 0.0 110.087 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 8.8 p -137.14 122.33 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.801 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.466 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -63.76 119.96 10.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 109.345 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 32.3 mt -94.26 3.06 55.75 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.352 -179.603 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.468 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 39.3 m-85 -150.67 148.99 29.26 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 0.0 108.885 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 65.7 m-20 -66.29 143.97 56.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 18.2 t80 -155.39 122.67 5.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.272 -0.892 . . . . 0.0 111.466 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.69 113.35 26.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 110.238 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.24 -161.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.328 -0.857 . . . . 0.0 111.092 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.2 mt -117.47 -57.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.915 -0.491 . . . . 0.0 110.125 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -175.83 -37.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.948 -1.095 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -154.61 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.987 -1.071 . . . . 0.0 111.182 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 4.2 tp10 -55.04 -26.22 35.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.357 -0.839 . . . . 0.0 109.7 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -45.26 121.27 2.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.798 -0.564 . . . . 0.0 110.808 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.7 149.51 27.21 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.746 0.784 . . . . 0.0 111.619 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.0 m -94.88 147.36 23.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.84 -0.537 . . . . 0.0 109.903 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.466 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 17.3 p90 -148.1 -165.04 2.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.447 -0.783 . . . . 0.0 110.496 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 -129.41 176.47 7.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.449 1.119 . . . . 0.0 112.889 -177.74 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 17.7 ttmt -60.95 -21.06 63.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.18 41.15 1.28 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.86 167.2 12.62 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.782 -0.834 . . . . 0.0 111.63 -179.537 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.46 124.77 46.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.416 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 72.0 mtm -134.82 151.52 51.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.402 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 21.3 t -94.73 154.07 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.464 ' HB ' HG13 ' A' ' 81' ' ' ILE . 38.1 t -94.36 141.16 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 0.0 108.996 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.436 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.8 mp -101.68 -26.46 13.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -155.95 -171.33 3.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 110.692 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -147.44 105.19 3.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.475 -0.766 . . . . 0.0 110.579 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.4 t -104.76 -53.83 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.01 -70.73 0.3 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -83.24 -57.29 3.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.634 -0.921 . . . . 0.0 110.064 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . 0.434 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 40.8 m95 -105.55 121.63 44.36 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.626 . . . . 0.0 110.576 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.449 ' CZ2' ' HB3' ' A' ' 130' ' ' SER . 50.9 m0 -107.04 146.39 31.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.474 -0.767 . . . . 0.0 109.751 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -96.94 120.86 38.06 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -132.96 160.69 36.36 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.187 -0.946 . . . . 0.0 112.323 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.0 ttt180 -111.74 121.46 45.17 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.586 -0.696 . . . . 0.0 109.933 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.416 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 5.1 t -75.11 115.77 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.641 -0.662 . . . . 0.0 109.427 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.9 mt -68.38 -24.95 64.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.909 -0.495 . . . . 0.0 110.209 -179.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.74 -23.77 65.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p -138.93 10.71 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.713 . . . . 0.0 111.002 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.32 30.62 6.14 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.928 -1.108 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.424 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 7.8 mtmt -105.19 -177.05 3.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.515 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.61 156.5 35.15 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.279 -0.888 . . . . 0.0 111.776 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -174.81 -159.44 21.08 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.434 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 89.3 m-85 -94.25 158.33 15.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.059 -0.671 . . . . 0.0 110.33 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -154.65 123.9 3.14 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.36 121.14 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.787 0.888 . . . . 0.0 109.973 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.449 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 1.5 m -51.59 -35.86 43.16 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.459 -0.775 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -75.1 -9.23 58.35 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.924 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.458 ' HA ' ' CD1' ' A' ' 87' ' ' TYR . 3.0 m-85 -104.69 23.72 12.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.333 -0.854 . . . . 0.0 109.42 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.4 ' CG2' ' HB ' ' A' ' 83' ' ' VAL . 9.8 p -159.43 170.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.848 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -137.95 135.47 36.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.419 ' HA ' HG13 ' A' ' 83' ' ' VAL . 1.7 tmm_? -81.8 138.6 35.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.115 -0.99 . . . . 0.0 112.265 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 162.06 33.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.336 0.589 . . . . 0.0 109.456 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -96.56 28.85 3.17 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 179.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.206 -179.878 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.174 0.512 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.92 68.43 0.81 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.414 -0.804 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -138.9 -165.07 1.76 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.401 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -124.15 54.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.792 . . . . 0.0 110.168 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 65.0 mt -101.17 151.78 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.869 -1.144 . . . . 0.0 109.263 179.444 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.405 ' HB ' HG23 ' A' ' 133' ' ' VAL . 29.6 m -135.22 177.56 6.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.096 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -128.57 121.79 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.427 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.47 118.84 11.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.413 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 18.8 mt -94.11 1.35 56.15 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.489 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.7 m-85 -151.9 151.14 30.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.392 -0.817 . . . . 0.0 108.846 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -67.5 145.35 55.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.135 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 67.4 t80 -151.75 126.99 9.87 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.364 -0.835 . . . . 0.0 110.779 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -94.71 135.56 36.05 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.63 0.729 . . . . 0.0 111.963 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.48 142.15 55.56 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.759 -0.588 . . . . 0.0 110.824 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.64 -54.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.666 -0.646 . . . . 0.0 109.837 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -67.51 177.3 2.0 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.57 -0.706 . . . . 0.0 111.961 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -57.81 -63.18 1.34 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.839 -0.538 . . . . 0.0 110.236 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 10.4 tp10 -92.22 47.9 1.36 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.403 -0.811 . . . . 0.0 109.708 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 1.8 t0 -99.87 137.49 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 32.1 tp -112.89 136.01 53.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.474 -0.766 . . . . 0.0 110.861 -179.045 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 120.76 35.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.806 . . . . 0.0 110.232 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.461 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 17.9 p90 -115.45 -169.51 1.59 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.963 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.0 179.83 5.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.134 0.969 . . . . 0.0 112.062 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.5 ttmt -60.66 -22.04 63.44 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.84 41.3 1.23 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.4 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 1.1 m-20 -90.63 171.53 9.32 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.557 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.14 132.48 50.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.8 mpp? -139.1 150.71 46.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 38.2 t -95.85 151.22 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.401 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 68.6 t -94.98 137.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.117 -0.99 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.435 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.02 -30.96 13.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.742 0.782 . . . . 0.0 108.936 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -156.36 163.98 38.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.58 119.87 40.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.633 . . . . 0.0 109.514 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -109.63 -76.44 0.61 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.126 -0.984 . . . . 0.0 110.858 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.05 -85.89 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.45 -20.56 18.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -127.47 103.76 7.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 108.982 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.416 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 46.1 m0 -95.75 155.76 16.61 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.098 -1.001 . . . . 0.0 110.851 -179.02 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 24.3 tttt -95.67 112.51 24.21 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.435 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -126.85 165.84 18.59 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.143 0.973 . . . . 0.0 112.798 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.525 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.3 ttt180 -112.68 130.52 56.02 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.431 ' O ' ' N ' ' A' ' 123' ' ' ARG . 29.3 t -82.96 115.29 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.183 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.5 mt -67.24 -26.35 66.53 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.24 0.543 . . . . 0.0 110.368 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.68 -29.74 66.84 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.462 -0.774 . . . . 0.0 109.813 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.7 p -133.62 10.53 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.762 -0.586 . . . . 0.0 110.476 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 119' ' ' SER . 7.8 mmm-85 51.68 28.3 4.7 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.986 -1.071 . . . . 0.0 110.898 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.437 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 10.9 mtmt -99.8 177.91 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.425 -0.797 . . . . 0.0 109.376 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.525 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -153.56 151.77 30.15 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.947 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -177.99 -150.72 8.79 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 48.0 m-85 -93.58 164.76 13.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.666 -0.902 . . . . 0.0 110.207 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.3 pt -155.09 110.71 2.29 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.668 -0.645 . . . . 0.0 109.981 -179.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -45.19 99.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 O-C-N 123.008 1.004 . . . . 0.0 111.838 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.416 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 53.2 m -57.03 -20.68 25.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.825 -0.547 . . . . 0.0 110.986 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 5.0 p-10 -74.42 -1.84 22.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.535 -0.728 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 4.8 m-85 -137.23 44.92 2.25 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.908 -1.12 . . . . 0.0 110.186 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.406 HG13 ' HA ' ' A' ' 130' ' ' SER . 7.7 p -147.7 170.85 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.32 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -125.12 117.41 23.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.746 -0.596 . . . . 0.0 109.509 179.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.2 tmm_? -80.07 133.98 36.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.858 0.837 . . . . 0.0 112.648 -178.106 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.79 146.11 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.75 43.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.119 -0.988 . . . . 0.0 109.622 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 13.3 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.684 -179.281 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.987 0.423 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -142.23 76.2 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.58 -164.66 1.24 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 109.564 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.408 ' O ' ' CG2' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -129.47 47.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.79 . . . . 0.0 110.405 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.9 mt -97.43 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.4 m -136.46 172.55 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.748 -0.595 . . . . 0.0 109.414 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.2 p -127.63 124.41 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.148 178.875 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.486 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -64.68 116.12 5.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.418 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 93.9 mt -93.85 3.53 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.837 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.45 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 70.5 m-85 -153.57 150.29 28.52 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 47.9 m-20 -66.64 150.91 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.455 -179.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.456 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 66.0 t80 -154.38 119.78 5.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.254 -0.904 . . . . 0.0 110.896 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.38 128.75 39.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.35 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.611 -0.681 . . . . 0.0 110.704 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mm -127.45 -71.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.378 -0.826 . . . . 0.0 110.11 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.06 53.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -169.31 -153.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.362 -0.836 . . . . 0.0 108.89 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.1 tp10 -59.28 -18.21 35.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.198 -0.939 . . . . 0.0 110.404 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -44.51 130.0 6.7 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.342 -0.849 . . . . 0.0 111.263 179.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -109.11 137.45 46.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.975 -178.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -94.44 122.22 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.684 -0.635 . . . . 0.0 109.599 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.486 ' CD1' ' HB2' ' A' ' 85' ' ' ALA . 8.6 p90 -117.36 -167.13 1.27 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.788 -0.57 . . . . 0.0 110.029 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.08 179.42 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.324 1.059 . . . . 0.0 112.695 -177.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.45 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.7 ttmt -61.14 -23.35 65.47 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.94 40.05 1.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.427 ' HB2' ' HB1' ' A' ' 85' ' ' ALA . 2.3 m-20 -91.27 163.91 14.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.688 -0.89 . . . . 0.0 112.065 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.22 134.95 55.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.428 ' HE3' ' CD2' ' A' ' 99' ' ' PHE . 76.2 mtm -142.45 149.3 39.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.839 -0.538 . . . . 0.0 109.6 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 21.3 t -97.01 150.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.408 ' CG2' ' O ' ' A' ' 81' ' ' ILE . 79.3 t -94.79 139.57 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.131 -0.981 . . . . 0.0 110.192 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.438 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.7 mp -95.72 -27.11 15.43 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 144.15 20.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -103.02 137.73 40.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -128.34 -70.73 0.67 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 157.15 -40.51 0.55 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.48 -30.37 4.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.355 -1.086 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -137.11 102.88 4.96 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.0 109.24 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -98.22 151.14 20.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.401 -0.812 . . . . 0.0 111.099 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -101.06 124.59 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.438 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -132.73 166.12 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.896 . . . . 0.0 111.883 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.4 ttt180 -114.0 126.59 55.3 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.652 -0.655 . . . . 0.0 109.985 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -77.92 114.9 17.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.698 -0.626 . . . . 0.0 109.387 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 mt -67.56 -28.74 68.04 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.083 -179.775 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.97 60.71 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -135.04 12.02 3.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.738 -0.601 . . . . 0.0 110.767 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.9 30.93 4.24 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.175 -0.953 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 36.8 mtmt -100.47 177.37 5.05 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.294 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -152.2 149.48 28.79 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.966 0.889 . . . . 0.0 111.913 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.88 -152.98 9.06 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 96.6 m-85 -94.07 164.09 13.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 122.201 -0.588 . . . . 0.0 109.47 179.373 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.2 pt -151.06 106.96 3.01 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -47.32 107.4 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.04 1.021 . . . . 0.0 111.719 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 24.0 m -60.76 -15.95 35.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.944 -0.472 . . . . 0.0 111.017 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 39.5 p30 -80.74 3.19 23.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.21 -0.931 . . . . 0.0 112.063 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 8.9 m-85 -144.92 46.96 1.34 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.142 -0.974 . . . . 0.0 109.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 5.4 p -153.91 170.83 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.424 -0.797 . . . . 0.0 110.594 -178.847 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -125.57 124.14 40.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.75 -0.594 . . . . 0.0 109.905 179.739 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -83.93 137.82 33.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 112.498 -178.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 25.6 m -140.85 139.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.67 33.84 2.41 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.263 -0.898 . . . . 0.0 110.557 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.951 179.656 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.042 0.448 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -71.83 88.03 1.01 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.597 -0.689 . . . . 0.0 109.998 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.467 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 4.5 m-20 -164.39 -163.6 0.76 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.806 -0.559 . . . . 0.0 109.666 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.415 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -96.7 52.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.689 -1.257 . . . . 0.0 108.914 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 89.4 mt -101.39 157.87 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 109.554 -179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.409 ' HB ' HG23 ' A' ' 133' ' ' VAL . 31.6 m -139.83 165.67 21.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.0 p -123.61 122.02 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 109.095 178.643 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.458 ' CB ' ' CD1' ' A' ' 99' ' ' PHE . . . -64.24 116.85 6.41 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.926 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.418 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 96.6 mt -94.5 7.95 43.84 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.158 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.448 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.7 m-85 -154.81 151.16 28.31 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.226 -0.921 . . . . 0.0 108.851 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.93 141.03 56.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.473 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 39.5 t80 -155.34 125.14 6.5 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.222 -0.924 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.17 130.94 54.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 110.682 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -58.92 -167.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.451 -0.781 . . . . 0.0 110.217 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.03 -38.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.494 -0.754 . . . . 0.0 110.75 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -177.14 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.107 -0.995 . . . . 0.0 110.485 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -58.04 -168.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 110.579 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.433 ' O ' ' C ' ' A' ' 96' ' ' ASP . 3.4 tp10 -51.56 -30.36 20.46 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.295 -0.878 . . . . 0.0 110.416 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.433 ' C ' ' O ' ' A' ' 95' ' ' GLU . 1.0 OUTLIER -14.7 124.54 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.236 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -98.31 133.77 42.25 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.565 0.698 . . . . 0.0 111.481 -177.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.5 m -94.75 142.82 27.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.25 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.473 ' CZ ' ' HB3' ' A' ' 89' ' ' TYR . 20.3 p90 -152.99 -164.71 2.0 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.261 -0.899 . . . . 0.0 111.017 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.24 179.25 5.35 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.118 0.961 . . . . 0.0 111.742 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 10.3 ttmt -61.36 -18.94 61.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.69 41.22 1.38 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.93 172.01 8.89 Favored 'General case' 0 N--CA 1.505 2.325 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.815 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.63 129.5 45.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.646 -0.659 . . . . 0.0 110.199 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 20.9 mtm -132.52 156.19 47.25 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.153 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 24.9 t -106.5 152.37 8.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.415 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 94.9 t -95.06 139.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.557 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.464 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp -94.84 -30.83 14.0 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.64 152.93 27.76 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -95.97 151.32 19.54 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.6 t -147.27 -83.09 0.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.394 -0.816 . . . . 0.0 110.715 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.03 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -91.32 -5.61 54.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.429 -1.042 . . . . 0.0 110.825 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -143.97 96.96 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 109.886 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.422 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 9.6 m0 -94.95 149.05 21.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.774 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.73 117.34 29.97 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.464 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -131.3 164.54 25.4 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.239 -0.913 . . . . 0.0 112.607 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.1 ttt180 -118.03 131.82 56.43 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.633 -0.667 . . . . 0.0 109.914 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -87.46 118.36 26.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.577 -0.702 . . . . 0.0 109.859 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 mt -67.36 -23.02 65.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.827 -0.545 . . . . 0.0 110.579 -179.98 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.86 -31.11 68.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.353 -0.842 . . . . 0.0 110.171 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 p -137.57 14.0 2.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.725 -0.609 . . . . 0.0 110.437 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 50.52 35.18 10.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.103 -0.998 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 45.6 mttt -102.93 173.75 6.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.7 156.51 35.03 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.737 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.41 ' HA3' ' O ' ' A' ' 95' ' ' GLU . . . 174.59 -154.91 19.99 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -93.64 118.77 31.81 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.974 -0.721 . . . . 0.0 109.701 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 4.3 pt -99.14 134.83 21.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.108 179.432 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . 0.408 ' HD2' ' CZ ' ' A' ' 99' ' ' PHE . 36.1 Cg_exo -57.96 95.89 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.978 0.989 . . . . 0.0 111.058 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.422 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 73.4 m -57.89 -18.74 24.81 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.663 -0.648 . . . . 0.0 111.412 179.838 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 14.2 p-10 -90.03 19.16 5.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.153 -0.967 . . . . 0.0 111.934 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 20.6 m-85 -155.19 52.26 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.424 HG23 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -160.52 170.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.421 -0.799 . . . . 0.0 111.396 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.424 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -120.72 126.07 49.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -94.79 120.96 35.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.243 -0.911 . . . . 0.0 112.809 -177.716 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 136' ' ' VAL . 28.8 m -100.24 131.19 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.467 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 26.5 t70 -155.97 -42.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.591 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.112 0.482 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.6 96.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.514 -0.742 . . . . 0.0 110.705 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -133.18 -158.2 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.733 . . . . 0.0 109.171 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.436 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -126.89 43.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.846 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.408 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 59.6 mt -96.23 137.42 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.778 -1.201 . . . . 0.0 108.717 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.8 m -125.34 170.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.025 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.4 p -124.59 122.93 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.6 -0.688 . . . . 0.0 109.625 179.178 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.424 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -67.86 123.53 20.82 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.406 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 84.2 mt -94.32 -2.4 52.26 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.703 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.484 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 62.2 m-85 -151.67 151.14 31.07 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.135 -0.978 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -62.71 147.09 50.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.61 -0.681 . . . . 0.0 110.236 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.445 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 53.3 t80 -154.56 134.05 12.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.559 -0.713 . . . . 0.0 110.916 179.362 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -98.4 136.62 38.29 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.585 -0.697 . . . . 0.0 111.713 -179.204 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.58 154.46 21.06 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.442 -0.786 . . . . 0.0 111.22 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 11.0 tt -171.67 58.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 110.369 179.183 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -175.57 60.9 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 51.16 -95.74 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 O-C-N 120.78 -1.2 . . . . 0.0 110.5 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 10.1 tp10 -77.35 58.06 1.6 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.54 -1.35 . . . . 0.0 108.964 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 32.6 p30 -100.84 174.24 6.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 110.268 -179.422 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 49.7 tp -153.25 132.34 12.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 110.831 -179.671 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.0 116.26 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.916 -0.49 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.445 ' CE1' ' CB ' ' A' ' 89' ' ' TYR . 15.6 p90 -108.65 -176.27 3.0 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.324 178.299 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -176.63 3.31 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.278 1.037 . . . . 0.0 112.104 -178.221 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.484 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.3 ttmt -60.48 -27.07 67.28 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.352 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.14 43.67 1.15 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -178.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.04 165.32 13.59 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.233 -179.085 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.2 131.99 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.434 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 2.2 mpp? -138.77 152.22 47.74 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.408 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 11.8 t -102.1 147.84 8.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.436 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 71.5 t -94.94 139.22 19.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.025 -1.047 . . . . 0.0 109.976 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.447 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.41 -30.27 13.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -156.51 159.57 38.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.74 -0.6 . . . . 0.0 110.332 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.0 147.97 27.23 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.4 t -135.99 -75.07 0.44 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 170.9 -44.74 0.19 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -127.61 -40.27 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.621 -0.929 . . . . 0.0 110.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -116.7 107.97 15.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.106 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 35.5 m0 -98.29 151.88 20.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.819 . . . . 0.0 110.002 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -97.57 118.1 33.32 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.447 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -131.41 168.23 17.95 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.533 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.1 ttt180 -116.73 121.55 41.95 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.608 -0.683 . . . . 0.0 109.634 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 46.2 t -73.81 121.3 20.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.827 179.526 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.98 -29.35 65.31 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.14 62.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.436 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -136.87 9.39 3.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 110.795 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 51.92 30.31 7.07 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.045 -1.035 . . . . 0.0 110.706 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 14.9 mttt -101.85 176.76 5.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.533 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 2.4 pm0 -155.66 143.78 19.97 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.154 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.62 -149.83 6.36 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.426 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 76.2 m-85 -95.22 162.42 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.755 -0.85 . . . . 0.0 110.72 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 3.0 pt -155.5 113.67 2.24 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.613 -0.679 . . . . 0.0 110.182 178.939 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -53.29 110.06 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.154 1.081 . . . . 0.0 111.541 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 8.8 m -59.03 -18.48 35.01 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.897 -0.502 . . . . 0.0 110.917 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -71.96 -0.79 12.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.421 -0.799 . . . . 0.0 113.094 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.53 40.61 1.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.912 -1.117 . . . . 0.0 109.863 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.402 ' CG1' ' HA ' ' A' ' 130' ' ' SER . 7.3 p -150.06 169.65 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.729 . . . . 0.0 111.315 -178.404 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -122.54 137.25 54.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.217 0.532 . . . . 0.0 110.325 179.587 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -96.49 130.85 43.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 111.518 -178.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 27.5 m -144.08 173.24 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.775 -0.578 . . . . 0.0 110.024 179.205 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.33 -159.68 0.72 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.974 179.353 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.271 -179.955 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.962 0.41 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 2.1 tt0 56.95 20.06 5.05 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.362 -0.836 . . . . 0.0 110.988 179.664 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . 0.44 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 6.4 m-20 -165.57 -162.34 0.58 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.437 -0.79 . . . . 0.0 110.105 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -97.23 53.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.783 -1.198 . . . . 0.0 109.073 178.539 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.615 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 90.2 mt -98.3 155.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.299 -0.96 . . . . 0.0 108.619 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.7 m -138.41 174.6 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.367 -0.833 . . . . 0.0 110.2 179.634 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.3 p -133.89 128.15 53.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.629 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.456 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -70.79 120.28 16.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.497 -0.752 . . . . 0.0 109.145 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.421 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 77.2 mt -94.28 0.39 55.59 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.284 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.448 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.3 m-85 -152.21 151.13 30.61 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.57 150.58 48.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.406 -0.809 . . . . 0.0 110.05 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 42.5 t80 -153.65 136.55 15.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.339 -0.851 . . . . 0.0 111.094 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . 0.423 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 3.7 tt0 -101.06 142.36 32.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.794 -0.566 . . . . 0.0 111.163 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -55.54 171.08 0.21 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.393 -0.817 . . . . 0.0 110.535 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 tt -173.85 42.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 109.938 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.72 -166.52 0.13 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.055 -1.028 . . . . 0.0 110.164 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -73.32 -73.78 0.2 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 6.6 tp10 -85.06 52.45 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 54.0 p30 -94.47 171.56 8.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.603 -0.686 . . . . 0.0 109.843 -179.453 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 16.7 tp -151.82 128.75 10.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 0.0 111.149 -179.996 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.423 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.2 m -95.2 105.36 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.204 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.463 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 16.9 p90 -103.01 -168.1 1.47 Allowed 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.774 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.32 178.87 5.36 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.408 1.099 . . . . 0.0 112.859 -177.888 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.448 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.0 ttmt -60.92 -19.41 60.58 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.595 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 42.37 1.13 Allowed Glycine 0 C--N 1.281 -2.512 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.47 164.14 14.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.525 -179.538 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.94 110.78 15.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.637 -0.664 . . . . 0.0 109.853 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.0 mtm -124.84 143.45 50.82 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.615 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -96.53 160.21 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.396 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . . . . . . . . . 60.9 t -94.02 138.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.982 -1.074 . . . . 0.0 110.613 -179.354 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.458 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.19 -29.25 14.63 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -156.0 163.62 39.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.838 -0.539 . . . . 0.0 109.649 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -121.23 121.11 37.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.503 -0.748 . . . . 0.0 110.75 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.7 t -123.23 -60.96 1.46 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 150.19 129.54 1.68 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 65.97 -68.01 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.549 -0.971 . . . . 0.0 110.505 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.9 m95 -98.77 109.64 22.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.275 -179.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.409 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 46.3 m0 -108.13 147.94 30.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.147 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.458 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -127.42 162.82 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.338 -0.851 . . . . 0.0 112.205 -178.121 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.453 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.5 tmm_? -111.1 125.48 53.81 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.495 -0.753 . . . . 0.0 109.374 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 31.8 t -88.14 122.81 32.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.06 -179.872 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.96 -26.17 63.05 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.503 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.49 -32.87 42.27 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.438 -0.788 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 p -134.5 10.19 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.617 -0.677 . . . . 0.0 110.334 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.04 31.9 14.56 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.081 -1.012 . . . . 0.0 110.545 -179.248 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 53.8 mttt -104.37 -178.04 3.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.843 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.453 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.04 139.71 17.04 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.889 0.852 . . . . 0.0 111.349 179.14 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.44 -156.59 10.94 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.439 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 53.0 m-85 -93.47 157.85 16.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.891 . . . . 0.0 110.693 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.3 pt -155.61 110.93 2.19 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.03 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.9 102.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 122.802 0.896 . . . . 0.0 110.805 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.409 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 1.1 m -62.01 -15.32 43.38 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.706 -0.621 . . . . 0.0 111.313 -178.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -64.66 -11.33 34.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.161 -0.962 . . . . 0.0 111.478 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 10.7 m-85 -130.03 43.41 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.517 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.427 HG13 ' N ' ' A' ' 134' ' ' ALA . 61.5 t -145.76 170.81 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 -177.643 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.427 ' N ' HG13 ' A' ' 133' ' ' VAL . . . -124.09 125.63 44.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.529 -0.732 . . . . 0.0 109.341 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 9.4 ttt180 -95.72 121.58 37.58 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.423 -0.798 . . . . 0.0 112.522 -178.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 30.6 m -100.46 133.69 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.289 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . 0.44 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 24.8 t0 -155.64 -55.32 0.09 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.697 -0.627 . . . . 0.0 109.81 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.009 -179.896 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.99 0.424 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.42 -173.83 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 110.885 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -139.68 -159.92 1.01 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.659 -0.651 . . . . 0.0 109.375 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.471 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -121.57 41.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.052 -1.03 . . . . 0.0 112.12 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.411 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 48.3 mt -95.11 139.31 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.78 -1.2 . . . . 0.0 108.504 178.098 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 34.6 m -126.93 166.95 22.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.444 -178.971 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.4 ' HA ' ' O ' ' A' ' 103' ' ' ASP . 5.2 p -121.16 128.35 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.219 178.438 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.513 ' O ' ' HA2' ' A' ' 102' ' ' GLY . . . -68.78 145.76 53.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.054 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.422 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 9.6 mt -106.74 -15.84 14.64 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.851 0.751 . . . . 0.0 110.972 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 87.8 m-85 -149.01 153.99 38.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.293 -0.88 . . . . 0.0 109.559 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -56.43 149.45 16.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.703 -0.623 . . . . 0.0 111.625 -178.604 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -155.42 126.89 7.3 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.731 -0.605 . . . . 0.0 110.353 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -100.5 130.59 46.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . 0.401 ' CB ' ' HB3' ' A' ' 96' ' ' ASP . . . -51.23 162.09 0.36 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.32 -0.863 . . . . 0.0 111.442 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.8 pt -153.22 32.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.789 -0.569 . . . . 0.0 109.965 179.078 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.81 -170.55 1.6 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.431 -0.793 . . . . 0.0 110.613 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -62.1 -78.15 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.769 -0.582 . . . . 0.0 111.195 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 4.2 tp10 -88.27 49.27 1.77 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.222 -0.924 . . . . 0.0 110.861 -179.336 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . 0.401 ' HB3' ' CB ' ' A' ' 91' ' ' ALA . 2.8 t0 -95.32 158.91 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 108.815 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -121.47 127.21 50.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.314 -0.866 . . . . 0.0 111.107 -178.543 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -97.35 93.33 6.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.625 -0.672 . . . . 0.0 109.251 178.479 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.491 ' CD1' ' HB3' ' A' ' 85' ' ' ALA . 31.5 p90 -97.56 -173.97 2.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.082 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -118.4 -164.89 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.67 0.747 . . . . 0.0 111.368 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 2.0 ttmt -53.9 -90.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.581 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . 0.513 ' HA2' ' O ' ' A' ' 85' ' ' ALA . . . -93.45 65.49 1.82 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.4 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 1.4 m-20 -91.64 167.58 12.1 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.967 -0.725 . . . . 0.0 111.549 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.66 120.26 32.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 110.181 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.5 mpp? -128.69 156.73 43.0 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.411 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 24.5 t -103.07 151.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.471 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 84.0 t -95.64 139.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.133 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.424 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -97.18 -30.55 12.94 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.66 0.743 . . . . 0.0 109.522 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -156.39 158.07 36.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.94 -0.475 . . . . 0.0 109.925 -178.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -99.6 152.07 20.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.384 -0.822 . . . . 0.0 109.588 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -146.95 -75.71 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.91 -92.72 0.08 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.85 -27.08 14.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.935 . . . . 0.0 109.611 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -110.39 107.29 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 0.0 109.401 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -100.1 148.02 25.03 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.303 -0.873 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.5 tttt -96.35 111.6 23.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.681 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.424 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -126.84 169.47 13.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.871 0.843 . . . . 0.0 111.856 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.454 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.5 ttt180 -114.14 123.7 50.25 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.628 -0.67 . . . . 0.0 109.693 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.1 t -78.29 111.98 14.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.741 -0.599 . . . . 0.0 109.537 179.336 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.4 mt -65.48 -24.41 67.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.856 -0.527 . . . . 0.0 110.351 -179.65 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.44 -31.24 69.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 p -133.93 16.29 3.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.566 . . . . 0.0 110.459 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.51 29.91 2.24 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.266 -0.896 . . . . 0.0 110.857 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.429 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.8 mttt -96.82 177.18 5.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.454 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.66 134.93 12.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.086 0.946 . . . . 0.0 112.023 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -166.37 -156.7 9.69 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.071 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . 0.414 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 32.0 m-85 -93.03 160.69 14.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.746 -0.855 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 2.5 pt -152.98 107.66 2.66 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.835 -0.54 . . . . 0.0 109.99 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.45 100.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.263 1.138 . . . . 0.0 111.572 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.2 m -60.62 -13.69 15.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.666 -0.646 . . . . 0.0 112.288 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -65.0 -11.0 33.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.123 -0.986 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.1 45.22 2.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.897 . . . . 0.0 108.877 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 98.7 t -145.07 171.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.774 -0.578 . . . . 0.0 109.719 -178.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -133.46 124.58 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.539 -0.725 . . . . 0.0 109.87 179.552 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -79.26 136.85 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 111.728 -178.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 23.0 m -153.32 172.24 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.14 0.495 . . . . 0.0 110.069 179.308 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.34 -162.36 0.94 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.384 -0.823 . . . . 0.0 110.772 -179.624 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.4 t . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.228 -179.635 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.997 0.427 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -91.48 133.87 35.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.764 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -142.52 -165.01 1.94 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.403 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -121.35 52.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 110.75 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.417 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 61.2 mt -98.71 152.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . 0.456 ' HB ' HG23 ' A' ' 133' ' ' VAL . 27.6 m -138.41 179.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.541 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 5.9 p -134.61 121.29 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.327 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.469 ' HB3' ' CD1' ' A' ' 99' ' ' PHE . . . -60.7 115.37 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.434 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 62.2 mt -94.54 10.78 33.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.447 -178.953 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.434 ' CG ' ' C ' ' A' ' 86' ' ' LEU . 33.4 m-85 -154.35 151.42 29.03 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.019 -1.051 . . . . 0.0 109.686 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.69 146.6 48.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.312 -0.867 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 52.4 t80 -153.57 169.48 23.14 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.006 -1.059 . . . . 0.0 110.988 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -151.56 99.17 2.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.694 . . . . 0.0 110.517 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.27 -179.09 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.4 -0.813 . . . . 0.0 110.515 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.8 mt -143.91 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.239 -0.913 . . . . 0.0 110.795 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -167.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.199 -0.938 . . . . 0.0 111.079 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -80.17 168.98 18.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.573 -0.704 . . . . 0.0 110.631 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 65.95 -59.89 0.3 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.697 -0.627 . . . . 0.0 111.352 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 22.2 p30 -41.87 154.04 0.05 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.565 -0.709 . . . . 0.0 111.746 -179.056 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . 0.414 ' N ' ' HA3' ' A' ' 126' ' ' GLY . 1.4 tp -135.76 146.99 48.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.248 -0.907 . . . . 0.0 112.035 -177.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.0 m -96.92 167.26 11.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.808 -0.558 . . . . 0.0 110.074 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.469 ' CD1' ' HB3' ' A' ' 85' ' ' ALA . 20.8 p90 -165.32 -167.46 1.17 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.405 -0.809 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -126.19 176.55 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.042 0.925 . . . . 0.0 111.506 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 15.3 ttmt -61.25 -19.18 61.4 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -177.332 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.72 41.48 1.41 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . 0.408 ' HB2' ' HB2' ' A' ' 85' ' ' ALA . 2.5 m-20 -90.94 166.43 13.04 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.704 -0.88 . . . . 0.0 111.508 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.41 131.17 54.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.605 -0.684 . . . . 0.0 109.461 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.429 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 60.7 mtm -140.53 148.67 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.417 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 41.6 t -95.67 155.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.403 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 69.3 t -95.73 142.5 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.159 -0.963 . . . . 0.0 110.464 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.66 -31.1 13.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.323 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -156.24 -177.45 6.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.742 -0.599 . . . . 0.0 110.472 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.45 94.8 3.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.504 -0.748 . . . . 0.0 110.306 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -94.66 -75.13 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.434 -0.791 . . . . 0.0 110.304 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.82 -98.88 0.11 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.486 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.41 -50.1 68.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.403 -1.057 . . . . 0.0 110.814 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.67 140.97 41.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.613 -0.679 . . . . 0.0 109.469 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.71 121.95 36.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.386 -0.821 . . . . 0.0 108.997 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . . . . . . . . . . . -138.07 162.98 32.75 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.978 -179.066 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.531 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.5 ttt180 -114.57 125.89 54.29 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.555 -0.715 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' SER . . . . . 0.429 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 15.3 t -78.16 121.4 24.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.3 mt -70.52 -26.91 63.8 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.51 -179.859 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.18 63.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.599 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -138.1 12.49 2.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.513 -0.742 . . . . 0.0 111.089 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 52.18 30.21 7.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.009 -1.057 . . . . 0.0 110.738 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.414 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 6.0 mttp -103.14 176.32 5.19 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.95 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.531 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -155.87 150.08 25.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.416 -0.803 . . . . 0.0 111.356 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . 0.414 ' HA3' ' N ' ' A' ' 97' ' ' LEU . . . -166.58 -140.04 2.8 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.815 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 68.9 m-85 -113.34 154.24 27.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 122.03 -0.688 . . . . 0.0 110.746 -178.649 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 19.4 pt -153.49 134.98 8.67 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.822 -0.549 . . . . 0.0 110.161 178.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 6.4 Cg_exo -69.01 124.74 11.7 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 O-C-N 123.085 1.045 . . . . 0.0 109.918 179.911 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.9 m -51.94 -35.31 45.41 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.519 -0.738 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -75.34 -6.91 52.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.49 -0.756 . . . . 0.0 111.701 -178.989 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . 0.422 ' HA ' ' CD2' ' A' ' 87' ' ' TYR . 3.3 m-85 -104.78 24.02 12.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.157 -0.964 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . 0.456 HG23 ' HB ' ' A' ' 83' ' ' VAL . 5.7 p -161.26 169.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.531 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . 0.419 ' N ' HG23 ' A' ' 133' ' ' VAL . . . -118.58 135.29 54.51 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.718 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.404 ' HA ' HG11 ' A' ' 83' ' ' VAL . 3.4 tpp180 -91.99 122.36 34.43 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.297 -0.877 . . . . 0.0 112.779 -178.436 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.06 145.46 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.596 -0.69 . . . . 0.0 110.023 178.218 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -116.59 73.05 0.84 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 121.382 -0.824 . . . . 0.0 109.674 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.383 -179.94 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.988 0.423 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -75.19 125.7 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.923 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -94.11 -169.59 2.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' ILE . . . . . 0.407 HG13 ' HB ' ' A' ' 107' ' ' VAL . 1.7 tp -137.58 44.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ILE . . . . . 0.525 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 86.9 mt -109.17 161.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.894 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 16.3 m -138.95 167.63 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.714 0.768 . . . . 0.0 110.637 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.408 HG22 ' HG2' ' A' ' 104' ' ' GLN . 6.4 p -130.2 123.42 55.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.007 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' ALA . . . . . 0.426 ' HB2' ' CD1' ' A' ' 99' ' ' PHE . . . -68.9 121.57 16.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.454 -0.899 . . . . 0.0 109.361 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . 0.427 ' C ' ' CG ' ' A' ' 87' ' ' TYR . 19.7 mt -94.04 0.03 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 65.3 m-85 -151.14 151.18 31.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.242 -0.911 . . . . 0.0 109.041 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.68 145.9 54.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.517 -0.74 . . . . 0.0 110.178 -179.465 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 40.5 t80 -153.54 132.92 12.8 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.201 -0.937 . . . . 0.0 111.025 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -100.95 133.4 45.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.776 -0.577 . . . . 0.0 111.675 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -57.2 -173.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.48 -0.762 . . . . 0.0 110.363 179.29 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.6 tt -167.27 26.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.407 -0.808 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.89 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.896 -1.127 . . . . 0.0 109.962 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -82.76 159.61 22.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.35 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 65.38 -57.47 0.3 Allowed 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.611 -0.681 . . . . 0.0 111.677 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' ASP . . . . . . . . . . . . . 7.4 p30 -44.19 148.45 0.43 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.134 -0.979 . . . . 0.0 111.902 -179.125 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -130.07 153.61 48.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.436 -0.79 . . . . 0.0 111.493 -178.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m -98.93 116.38 31.03 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.418 0.628 . . . . 0.0 109.767 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PHE . . . . . 0.462 ' CZ ' ' CB ' ' A' ' 89' ' ' TYR . 16.2 p90 -104.62 -172.29 2.07 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.839 -0.538 . . . . 0.0 110.016 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.1 -178.83 4.32 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.389 1.09 . . . . 0.0 112.439 -178.048 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -60.75 -22.72 64.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.28 43.15 1.08 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.54 165.14 13.94 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.311 -179.311 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLN . . . . . 0.408 ' HG2' HG22 ' A' ' 84' ' ' VAL . 1.9 mt-30 -122.05 109.76 14.96 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.573 -0.705 . . . . 0.0 109.718 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' MET . . . . . 0.422 ' HE2' ' CG ' ' A' ' 99' ' ' PHE . 1.5 mpp? -126.7 147.21 49.97 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' VAL . . . . . 0.525 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 4.5 m -99.02 158.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.27 -178.945 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' VAL . . . . . 0.407 ' HB ' HG13 ' A' ' 81' ' ' ILE . 39.6 t -94.09 143.06 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.395 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . 0.417 ' CD1' ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -98.06 -28.26 13.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.501 0.667 . . . . 0.0 109.512 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -156.32 168.26 27.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.734 -0.604 . . . . 0.0 109.591 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -115.48 109.54 17.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.453 -0.78 . . . . 0.0 109.261 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -96.95 -66.68 0.89 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.284 -0.885 . . . . 0.0 110.76 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 -56.49 0.24 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -119.33 -31.28 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.944 . . . . 0.0 109.752 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -121.67 101.97 7.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' TRP . . . . . 0.414 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 52.0 m0 -94.8 154.15 17.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.406 -0.808 . . . . 0.0 109.846 -179.29 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -94.48 135.67 35.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' ALA . . . . . 0.417 ' HA ' ' CD1' ' A' ' 108' ' ' LEU . . . -143.7 159.61 42.18 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.217 -177.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.5 ttm180 -112.82 122.51 47.86 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.743 0.783 . . . . 0.0 110.174 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -84.23 129.53 34.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.829 -0.544 . . . . 0.0 110.675 -179.798 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.1 -26.56 53.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.925 -0.484 . . . . 0.0 110.561 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.9 65.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 109.745 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -129.48 4.89 5.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.843 -0.535 . . . . 0.0 110.662 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.45 28.32 9.44 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.996 -1.065 . . . . 0.0 109.678 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' LYS . . . . . 0.406 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 64.9 mttt -109.18 -173.89 2.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.603 -0.685 . . . . 0.0 109.919 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -154.87 153.88 31.83 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.337 -0.852 . . . . 0.0 111.034 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.56 -124.16 0.7 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -127.82 157.4 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.73 -0.865 . . . . 0.0 109.732 -179.235 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' ILE . . . . . 0.429 HG21 ' CE2' ' A' ' 99' ' ' PHE . 2.3 pt -153.08 106.24 2.63 Favored Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.429 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -47.31 113.08 0.63 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.013 1.142 . . . . 0.0 111.731 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' SER . . . . . 0.414 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 11.0 m -59.86 -15.4 20.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.709 -0.62 . . . . 0.0 111.849 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -75.67 1.5 14.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.91 -1.119 . . . . 0.0 111.951 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -144.97 45.09 1.35 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.926 -1.109 . . . . 0.0 110.711 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' VAL . . . . . . . . . . . . . 7.5 p -153.28 168.84 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 110.874 -179.634 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' ALA . . . . . . . . . . . . . . . -124.28 116.44 22.65 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.407 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 10.9 ttp180 -94.79 120.8 35.59 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.24 -0.912 . . . . 0.0 112.069 -178.654 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 34.2 m -89.69 136.55 23.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.335 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -154.6 47.66 0.57 Allowed 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.723 -0.61 . . . . 0.0 109.36 -178.394 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.012 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.976 0.417 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.968 ' CD1' HG13 ' A' ' 106' ' ' VAL . 5.8 mm -96.54 132.86 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.009 -1.057 . . . . 0.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.9 m -120.52 168.12 13.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.571 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -125.16 133.66 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -78.85 121.02 24.3 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.854 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 134' ' ' ALA . 3.7 mt -94.23 3.33 55.39 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.433 ' N ' ' HA ' ' A' ' 101' ' ' LYS . 80.6 m-85 -153.16 152.86 31.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -69.97 142.59 52.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.37 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 68.6 t80 -151.72 131.87 13.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.427 -0.795 . . . . 0.0 110.137 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 9.6 tp10 -101.9 141.01 35.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.725 . . . . 0.0 111.036 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.86 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.502 2.131 0 O-C-N 121.623 -0.673 . . . . 0.0 111.283 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.86 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 44.7 p30 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 119' ' ' SER . 62.8 tp -154.89 124.64 6.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.0 111.102 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.3 m -95.14 113.48 25.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.746 -0.596 . . . . 0.0 110.148 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.616 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.8 p90 -109.83 -173.28 2.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.965 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 179.52 4.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.188 0.994 . . . . 0.0 111.996 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' LEU . 12.1 ttmt -61.05 -20.93 63.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.4 41.2 1.31 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.3 m-20 -90.99 164.29 14.03 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.16 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.33 135.22 55.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 75.7 mtm -140.27 151.96 45.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.32 0.581 . . . . 0.0 109.647 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.968 HG13 ' CD1' ' A' ' 82' ' ' ILE . 43.2 t -101.43 147.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' ILE . 90.8 t -95.12 139.89 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.019 -1.051 . . . . 0.0 110.113 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.9 mp -97.05 -27.5 14.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -156.07 161.33 40.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.674 -0.641 . . . . 0.0 109.853 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -107.58 143.44 36.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.436 -0.79 . . . . 0.0 109.816 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -153.05 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.831 . . . . 0.0 110.388 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.09 -113.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -94.99 -16.69 22.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.668 -0.901 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -100.62 101.09 11.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.604 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.8 m0 -97.53 148.96 22.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.436 -0.79 . . . . 0.0 110.204 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -98.14 111.37 23.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.71 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.08 169.26 13.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.186 -0.946 . . . . 0.0 112.302 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -113.03 118.57 35.17 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 121.69 -0.631 . . . . 0.0 109.757 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.564 ' HB2' HD21 ' A' ' 97' ' ' LEU . 14.9 t -72.45 115.4 11.67 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 106' ' ' VAL . 5.3 mt -67.88 -27.65 66.86 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.124 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.4 61.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 0.0 110.389 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p -137.7 10.67 2.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.456 -0.777 . . . . 0.0 110.78 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 53.1 26.76 5.16 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.083 -1.011 . . . . 0.0 110.567 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.6 mtmt -102.12 176.67 5.12 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.58 143.0 19.46 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.29 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.38 -152.26 7.55 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.535 ' O ' HG23 ' A' ' 128' ' ' ILE . 47.1 m-85 -93.76 158.46 15.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.601 HG22 ' CD2' ' A' ' 99' ' ' PHE . 1.5 pt -155.53 115.39 2.27 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.843 -0.535 . . . . 0.0 109.778 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.76 104.32 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 122.945 0.971 . . . . 0.0 110.993 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 m -63.49 -12.37 31.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.613 -0.679 . . . . 0.0 111.426 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -68.03 -8.92 41.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.075 -1.016 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -132.68 35.94 3.57 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 134' ' ' ALA . 90.1 t -139.84 173.16 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.925 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.629 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -134.01 129.26 35.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.811 ' HA ' HG12 ' A' ' 83' ' ' VAL . 3.7 tmm_? . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.419 -0.801 . . . . 0.0 111.969 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.595 0.236 . . . . 0.0 110.998 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.706 HG12 HG13 ' A' ' 106' ' ' VAL . 56.0 mt -97.02 139.45 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.072 -1.018 . . . . 0.0 109.115 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 135' ' ' ARG . 25.5 m -128.78 179.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.295 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.3 p -131.59 126.73 58.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.496 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.591 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -68.96 119.78 13.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 134' ' ' ALA . 42.8 mt -94.01 1.34 56.26 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.071 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 60.0 m-85 -152.63 152.17 31.47 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.94 148.98 50.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.492 -0.755 . . . . 0.0 110.487 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 77.1 t80 -155.15 127.44 7.78 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.47 -0.769 . . . . 0.0 111.13 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.84 132.73 43.18 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.568 -0.708 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.122 0 O-C-N 121.456 -0.777 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.523 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tt -112.33 143.17 43.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.436 -0.79 . . . . 0.0 111.102 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -96.4 122.36 39.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.728 -0.607 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.591 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 13.7 p90 -114.03 -171.29 1.88 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.654 -0.654 . . . . 0.0 109.6 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 179.56 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.133 0.968 . . . . 0.0 111.9 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -60.76 -22.55 64.16 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.38 41.94 1.28 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.1 m-20 -90.91 165.99 13.29 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.805 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.18 128.68 51.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.529 -0.732 . . . . 0.0 109.132 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -136.96 150.47 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.767 -0.583 . . . . 0.0 109.613 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 82' ' ' ILE . 23.3 t -101.27 151.01 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 81' ' ' ILE . 99.4 t -94.58 141.46 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.022 -1.048 . . . . 0.0 110.077 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -96.78 -30.93 12.9 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.645 0.736 . . . . 0.0 109.029 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -156.36 162.2 40.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.773 -0.579 . . . . 0.0 109.729 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.72 154.26 19.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.453 -0.78 . . . . 0.0 109.896 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.8 t -147.65 -75.65 0.18 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.403 -0.811 . . . . 0.0 110.433 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.86 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 114' ' ' TRP . 2.4 tt0 -92.93 -16.04 25.63 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.94 . . . . 0.0 110.832 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 113' ' ' GLU . 85.8 m95 -132.25 107.63 8.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.452 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.423 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 31.3 m0 -100.88 155.58 17.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.292 -0.88 . . . . 0.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -97.16 111.73 23.83 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.28 168.32 14.92 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.082 0.944 . . . . 0.0 112.609 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.7 ttt180 -112.61 121.9 46.12 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.628 -0.67 . . . . 0.0 109.647 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t -74.87 110.02 8.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.912 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.28 -21.72 66.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.827 -0.546 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.88 -24.92 67.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.4 p -140.71 15.08 2.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.232 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 50.91 27.21 3.04 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.695 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 18.8 mttt -97.13 179.9 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 109.319 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -155.9 149.01 24.44 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.945 0.879 . . . . 0.0 111.791 179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -176.88 -153.98 11.41 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.548 ' O ' HG23 ' A' ' 128' ' ' ILE . 53.2 m-85 -93.49 165.03 12.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.628 -0.925 . . . . 0.0 109.391 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.2 pt -155.41 116.48 2.33 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 109.901 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -48.0 104.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.138 1.073 . . . . 0.0 111.847 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.1 m -60.12 -16.53 33.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.944 -0.473 . . . . 0.0 111.276 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.469 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 3.3 p-10 -83.91 12.11 6.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.102 -0.999 . . . . 0.0 112.06 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.469 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 3.8 m-85 -146.93 39.74 1.04 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 134' ' ' ALA . 3.8 p -146.82 168.86 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.857 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -121.16 134.04 55.21 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.277 0.561 . . . . 0.0 110.189 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.836 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.2 tpt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 112.177 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.445 0.164 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.55 HG12 HG13 ' A' ' 106' ' ' VAL . 63.5 mt -99.2 150.12 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.964 -1.085 . . . . 0.0 108.87 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 135' ' ' ARG . 33.5 m -137.13 171.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.287 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.777 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -124.49 124.14 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.52 118.42 10.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.904 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.0 mt -94.25 1.86 55.94 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.102 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.456 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 56.0 m-85 -151.54 150.83 30.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.218 -0.927 . . . . 0.0 108.726 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -70.55 144.23 51.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.527 -0.733 . . . . 0.0 110.319 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 72.5 t80 -155.54 131.89 10.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.253 -0.905 . . . . 0.0 111.531 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 0.0 OUTLIER -96.9 146.23 25.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.617 . . . . 0.0 110.364 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.804 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.451 -0.781 . . . . 0.0 110.676 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.804 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 46.8 p30 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 120.766 0.317 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 119' ' ' SER . 7.5 tp -150.63 126.32 10.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.459 -0.775 . . . . 0.0 111.264 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 2.2 m -94.68 117.82 30.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 110.171 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.1 p90 -114.57 -169.87 1.62 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.725 -0.61 . . . . 0.0 110.266 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.94 179.78 4.88 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.284 1.04 . . . . 0.0 112.422 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.6 ttmt -61.18 -22.1 64.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.54 41.32 1.29 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 171.6 9.15 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.915 -0.756 . . . . 0.0 112.026 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.5 130.26 51.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.429 -0.794 . . . . 0.0 109.52 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.29 153.39 50.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.639 . . . . 0.0 109.747 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.55 HG13 HG12 ' A' ' 82' ' ' ILE . 21.5 t -103.95 149.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 81' ' ' ILE . 58.9 t -95.57 138.02 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.164 -0.96 . . . . 0.0 109.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -96.57 -29.0 14.11 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.447 0.641 . . . . 0.0 109.469 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -155.63 149.41 25.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.777 -0.577 . . . . 0.0 109.786 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -96.19 144.59 26.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.718 . . . . 0.0 109.292 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 t -134.88 -66.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.7 -64.18 0.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -112.34 -29.86 7.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.601 -0.941 . . . . 0.0 110.047 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -125.25 103.36 7.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.709 -0.62 . . . . 0.0 109.876 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -97.31 153.78 17.84 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 0.0 110.598 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -97.97 117.29 31.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.19 167.66 15.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.189 -0.945 . . . . 0.0 112.485 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.1 ttt180 -114.96 126.33 54.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.657 -0.652 . . . . 0.0 109.416 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.681 ' HB2' HD21 ' A' ' 97' ' ' LEU . 3.8 t -79.42 118.81 21.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.83 -25.21 64.54 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.565 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p -128.05 7.11 6.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.672 -0.642 . . . . 0.0 110.897 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 119' ' ' SER . 0.3 OUTLIER 52.91 32.22 12.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.066 -1.021 . . . . 0.0 110.305 -179.122 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.8 mttm -100.78 178.86 4.57 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -154.89 137.13 14.84 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.008 0.908 . . . . 0.0 111.6 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -164.39 -147.95 5.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 128' ' ' ILE . 76.7 m-85 -94.18 164.15 13.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.622 -0.928 . . . . 0.0 110.787 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.6 pt -153.83 104.5 2.49 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.56 106.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.931 0.964 . . . . 0.0 111.774 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 m -59.46 -18.49 40.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.947 -0.47 . . . . 0.0 111.097 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -73.4 -1.26 17.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.366 -0.834 . . . . 0.0 112.596 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -142.65 46.7 1.58 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.6 p -150.09 169.72 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.607 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.904 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -120.21 122.55 41.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.828 ' HA ' HG12 ' A' ' 83' ' ' VAL . 2.6 tmm_? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.815 0.817 . . . . 0.0 112.625 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 81' ' ' ILE . 3.6 tp . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.62 HG12 HG13 ' A' ' 106' ' ' VAL . 77.4 mt -115.11 165.61 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 135' ' ' ARG . 12.0 m -143.64 171.1 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.78 129.37 58.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -71.9 119.8 16.59 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.689 -0.804 . . . . 0.0 108.898 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 134' ' ' ALA . 61.7 mt -94.12 0.05 55.6 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.895 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.9 m-85 -151.97 152.39 32.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -68.83 145.05 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.461 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 79.4 t80 -152.39 125.32 8.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.409 -0.807 . . . . 0.0 110.576 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 20.9 tp10 -94.76 134.11 37.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 110.003 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.401 -0.812 . . . . 0.0 110.719 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.419 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.1 t70 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.0 139.78 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 0.0 111.532 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.4 m -95.29 118.63 32.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.617 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.533 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 12.2 p90 -112.95 -171.7 1.91 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.0 110.048 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.93 -178.54 4.09 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.187 0.994 . . . . 0.0 112.379 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.1 ttmt -61.12 -23.06 65.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.27 41.71 1.23 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.84 167.51 12.4 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.738 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -121.04 128.27 52.5 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.469 -0.769 . . . . 0.0 109.702 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -136.97 150.39 48.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.62 HG13 HG12 ' A' ' 82' ' ' ILE . 11.3 t -95.26 152.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.454 ' CG1' HD11 ' A' ' 81' ' ' ILE . 38.4 t -94.02 134.49 31.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -94.68 -27.3 15.92 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -156.56 -169.5 3.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.69 -0.631 . . . . 0.0 110.314 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -150.98 115.06 5.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.497 -0.752 . . . . 0.0 109.961 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -127.4 -68.4 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.47 142.74 3.47 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 65.44 -69.18 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.632 -0.922 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -109.47 117.24 33.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 110.256 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.427 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 53.8 m0 -107.02 154.19 21.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.25 118.77 32.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -133.39 159.12 41.26 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.138 -0.976 . . . . 0.0 112.285 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -111.52 126.72 55.28 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.469 -0.769 . . . . 0.0 110.166 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 t -81.25 112.06 18.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 109.532 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.509 HD11 ' CG2' ' A' ' 106' ' ' VAL . 20.5 mt -65.89 -20.86 66.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.889 -0.507 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.67 73.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.9 p -129.4 11.39 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.753 -0.592 . . . . 0.0 110.658 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.69 30.14 8.37 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 27.6 mtpt -102.16 178.27 4.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.62 -0.675 . . . . 0.0 109.385 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.76 149.11 24.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.745 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.59 -150.42 7.52 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.428 ' O ' HG23 ' A' ' 128' ' ' ILE . 68.8 m-85 -93.27 162.22 14.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.745 -0.856 . . . . 0.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.2 pt -153.0 108.75 2.66 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.733 -0.604 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.51 108.11 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.027 1.014 . . . . 0.0 111.735 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.433 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 12.1 m -57.36 -15.33 6.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.776 -0.578 . . . . 0.0 111.804 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -76.7 5.54 7.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.131 -0.98 . . . . 0.0 112.808 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -151.17 38.72 0.65 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.89 -1.131 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 134' ' ' ALA . 3.3 p -146.79 168.51 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.81 141.46 46.41 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.43 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.733 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.701 0.762 . . . . 0.0 110.577 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.419 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 66.6 mt -96.93 157.43 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.869 -1.144 . . . . 0.0 109.558 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 135' ' ' ARG . 33.8 m -139.94 172.2 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.3 p -130.24 120.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB2' ' HE1' ' A' ' 105' ' ' MET . . . -62.56 118.42 7.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.792 . . . . 0.0 109.222 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 134' ' ' ALA . 69.2 mt -94.46 2.46 55.74 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.447 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.2 m-85 -153.67 152.87 31.32 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.14 -0.975 . . . . 0.0 108.831 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.35 144.29 53.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.391 -0.818 . . . . 0.0 110.447 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 48.2 t80 -155.4 127.95 7.89 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.396 -0.815 . . . . 0.0 110.793 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.87 149.35 21.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.422 -0.799 . . . . 0.0 110.771 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.781 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.499 1.998 0 O-C-N 121.467 -0.77 . . . . 0.0 109.929 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.781 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.6 p30 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 120.766 0.317 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' A' ' 119' ' ' SER . 5.9 tt -155.07 128.67 8.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.321 -0.862 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -94.79 117.02 29.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.404 -0.81 . . . . 0.0 110.494 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 128' ' ' ILE . 19.0 p90 -115.94 -170.03 1.71 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.724 -0.61 . . . . 0.0 110.501 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 179.4 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.343 1.068 . . . . 0.0 112.525 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.9 ttmt -61.08 -20.72 62.94 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 41.16 1.33 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 1.9 m-20 -91.02 170.51 9.98 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.746 -0.855 . . . . 0.0 111.693 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.87 129.28 47.92 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.513 -0.742 . . . . 0.0 109.49 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.534 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 3.1 mpp? -137.48 152.94 50.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.738 -0.601 . . . . 0.0 109.444 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.5 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 25.4 t -101.08 152.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 88.3 t -95.39 141.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.031 -1.043 . . . . 0.0 110.527 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -156.04 159.44 39.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.877 -0.515 . . . . 0.0 110.117 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -102.2 152.08 21.44 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.511 -0.743 . . . . 0.0 109.581 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -146.25 -66.95 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.142 -0.973 . . . . 0.0 111.019 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.13 -84.34 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -98.48 -20.89 16.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.591 -0.947 . . . . 0.0 110.777 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.85 107.51 9.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 109.506 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.44 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 41.6 m0 -101.26 155.06 18.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.39 -0.818 . . . . 0.0 110.886 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -100.6 111.96 24.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.749 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.09 169.71 13.11 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.241 1.02 . . . . 0.0 112.717 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.5 ttt180 -113.0 124.73 53.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.844 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.612 ' HB2' HD21 ' A' ' 97' ' ' LEU . 20.0 t -78.08 115.08 17.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.95 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.43 -23.77 66.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.847 -0.533 . . . . 0.0 110.114 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.26 -30.51 66.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.806 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.4 p -136.35 12.26 3.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.834 -0.541 . . . . 0.0 110.952 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.89 30.95 7.72 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.062 -1.024 . . . . 0.0 110.461 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.9 mttt -100.18 -179.88 4.27 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.22 137.25 14.63 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.035 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.26 6.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.543 ' O ' HG23 ' A' ' 128' ' ' ILE . 70.7 m-85 -94.24 162.85 13.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.578 -0.954 . . . . 0.0 111.317 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.6 pt -155.31 111.03 2.25 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.998 -0.439 . . . . 0.0 110.166 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -45.36 101.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.04 1.021 . . . . 0.0 112.0 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.44 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.2 m -51.89 -28.87 17.65 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -81.57 11.62 4.49 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.298 -0.876 . . . . 0.0 112.569 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -136.79 30.87 2.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.061 -1.025 . . . . 0.0 108.589 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -147.98 170.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.803 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -119.32 129.27 54.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.724 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.236 0 O-C-N 121.522 -0.736 . . . . 0.0 112.924 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 80.7 mt -111.66 166.95 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.728 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 135' ' ' ARG . 13.4 m -143.53 169.04 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.722 -0.611 . . . . 0.0 109.678 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.0 p -131.95 126.53 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.778 . . . . 0.0 108.948 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.97 118.24 10.16 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.84 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 1.029 HD11 ' HB2' ' A' ' 134' ' ' ALA . 86.9 mt -94.18 1.26 56.08 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.874 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.49 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 55.9 m-85 -152.99 151.1 29.9 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.197 -0.939 . . . . 0.0 108.652 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.05 145.99 55.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.587 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 129' ' ' PRO . 69.1 t80 -150.31 163.84 37.29 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.502 -0.749 . . . . 0.0 110.611 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.76 125.59 22.53 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.61 -0.682 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 121.456 -0.778 . . . . 0.0 111.268 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.721 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.2 t0 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' A' ' 119' ' ' SER . 40.1 tp -107.57 129.19 55.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.76 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -94.5 176.8 6.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.699 -0.625 . . . . 0.0 109.953 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.573 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 11.6 p90 -172.98 -167.48 0.42 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.494 -0.754 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -176.88 3.64 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.125 0.964 . . . . 0.0 111.539 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.0 ttmt -61.08 -22.73 64.89 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.38 44.7 1.0 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.78 166.51 13.07 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.13 116.96 25.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.45 -0.781 . . . . 0.0 110.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.415 ' HE1' ' CD2' ' A' ' 99' ' ' PHE . 68.5 mtm -129.78 146.36 51.53 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -98.54 156.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.545 -1.262 . . . . 0.0 108.71 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 81' ' ' ILE . 43.3 t -93.62 139.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.01 0.909 . . . . 0.0 109.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -94.54 -30.76 14.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -156.23 161.2 40.29 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.71 144.68 31.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 0.0 109.975 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -139.03 -77.93 0.34 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.392 -0.817 . . . . 0.0 110.318 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.28 -85.29 0.07 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -94.27 -13.2 26.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.896 . . . . 0.0 110.596 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -133.47 96.66 3.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.775 . . . . 0.0 110.163 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.421 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 31.7 m0 -94.91 146.04 24.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.243 -0.911 . . . . 0.0 109.787 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -95.21 117.06 29.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -129.57 165.77 21.05 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.039 0.923 . . . . 0.0 112.419 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.9 ttm180 -115.01 124.54 51.9 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.593 -0.692 . . . . 0.0 109.961 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.753 ' HB2' HD21 ' A' ' 97' ' ' LEU . 4.8 t -83.92 118.77 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.68 -0.638 . . . . 0.0 109.932 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.25 -20.8 62.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.398 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.24 -26.93 66.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.0 109.864 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p -137.62 10.99 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.766 -0.584 . . . . 0.0 110.606 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 53.64 30.81 11.53 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.147 -0.971 . . . . 0.0 110.755 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -104.79 174.0 6.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.526 -0.734 . . . . 0.0 109.27 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.83 146.66 22.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.694 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -176.27 -147.19 6.33 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.431 ' O ' HG23 ' A' ' 128' ' ' ILE . 36.2 m-85 -93.44 160.59 14.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.648 -0.913 . . . . 0.0 110.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.2 pt -152.14 117.57 3.05 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HG2' ' CD1' ' A' ' 89' ' ' TYR . 35.0 Cg_exo -41.33 103.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.323 1.349 . . . . 0.0 112.843 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.421 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 74.2 m -62.36 -15.1 46.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.865 -0.522 . . . . 0.0 111.008 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -86.13 13.87 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 111.522 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -152.23 40.2 0.61 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.252 -0.905 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.2 p -149.09 168.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.421 -0.799 . . . . 0.0 110.831 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 1.029 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -127.82 127.81 44.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.975 -0.453 . . . . 0.0 109.93 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.683 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.454 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 107' ' ' VAL . 4.9 tp . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 119.858 -0.115 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 7.0 mt -110.31 167.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 108.436 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 135' ' ' ARG . 3.8 m -146.17 167.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.669 . . . . 0.0 110.617 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.6 p -128.51 124.16 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.63 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.9 117.57 9.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 134' ' ' ALA . 79.8 mt -94.39 5.53 51.5 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.257 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.431 ' N ' ' HA ' ' A' ' 101' ' ' LYS . 38.9 m-85 -152.44 151.74 31.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -70.17 141.99 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 109.536 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 65.4 t80 -155.53 126.95 7.25 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.349 -0.844 . . . . 0.0 111.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -100.1 122.02 42.32 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.506 0.67 . . . . 0.0 109.895 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.66 ' HB1' ' OD2' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.508 0.671 . . . . 0.0 111.903 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.66 ' OD2' ' HB1' ' A' ' 91' ' ' ALA . 20.1 p-10 . . . . . 0 N--CA 1.501 2.125 0 CA-C-O 121.049 0.452 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 125' ' ' GLU . 7.9 tt -137.54 134.34 35.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.415 -0.803 . . . . 0.0 110.47 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -94.44 166.94 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 110.001 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.63 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 24.0 p90 -164.76 -170.78 2.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.291 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -124.37 179.88 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.328 1.061 . . . . 0.0 112.69 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HA ' ' N ' ' A' ' 87' ' ' TYR . 16.6 ttmt -60.95 -19.32 60.75 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.34 41.22 1.31 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.0 m-20 -90.9 166.06 13.26 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.686 -0.89 . . . . 0.0 111.527 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.05 111.31 15.82 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.561 -0.712 . . . . 0.0 110.112 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.9 mtm -126.01 147.41 49.55 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.1 m -95.02 157.33 3.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.073 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 83' ' ' VAL . 73.9 t -93.98 135.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.201 1.001 . . . . 0.0 110.329 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -94.98 -27.62 15.56 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.632 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -155.61 177.45 11.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.75 -0.594 . . . . 0.0 109.844 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.81 94.52 3.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -97.29 -152.87 0.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.678 -0.639 . . . . 0.0 110.084 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.33 -114.66 0.07 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -86.54 -6.87 58.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.948 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -119.0 102.81 9.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 109.669 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -98.72 157.11 16.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.421 -0.799 . . . . 0.0 110.645 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 5.9 mttt -97.51 121.72 39.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.24 161.32 32.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.351 -0.843 . . . . 0.0 111.83 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.8 ttm180 -114.97 122.35 45.98 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.545 -0.722 . . . . 0.0 109.83 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.5 t -84.48 127.33 33.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.645 -0.659 . . . . 0.0 110.456 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.88 -26.59 60.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.114 -0.366 . . . . 0.0 110.715 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.76 66.15 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.42 -0.8 . . . . 0.0 110.671 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p -128.31 9.4 6.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.688 . . . . 0.0 110.566 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.48 33.78 19.56 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -107.82 176.98 4.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.562 -0.711 . . . . 0.0 109.087 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pm0 -155.26 137.99 15.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.39 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -162.41 -149.71 5.76 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 75.9 m-85 -94.52 161.35 14.25 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 122.032 -0.687 . . . . 0.0 110.69 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.52 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -155.4 117.59 2.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -48.62 109.38 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.036 1.019 . . . . 0.0 111.73 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 m -56.96 -18.2 12.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.765 -0.584 . . . . 0.0 111.719 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 18.7 4.27 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.096 -1.003 . . . . 0.0 111.631 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -145.74 36.66 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 134' ' ' ALA . 8.9 p -154.86 169.21 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.784 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.65 132.54 39.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.062 0.458 . . . . 0.0 110.301 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.688 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.882 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 81' ' ' ILE . 1.4 tp . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 88.0 mt -123.16 159.18 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 135' ' ' ARG . 17.2 m -137.83 169.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.9 p -130.01 123.96 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.587 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.26 120.67 14.18 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.045 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 134' ' ' ALA . 85.3 mt -94.26 1.12 56.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.95 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.6 m-85 -152.48 152.53 32.06 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.49 146.23 54.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 36.7 t80 -155.15 127.68 7.91 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.35 -0.844 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -98.03 144.4 27.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.427 -0.796 . . . . 0.0 111.551 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.746 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.665 -0.647 . . . . 0.0 111.585 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.746 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 40.3 p30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.204 0.526 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 98' ' ' SER . 0.9 OUTLIER -154.35 121.89 5.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 110.106 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.521 ' N ' HD13 ' A' ' 97' ' ' LEU . 1.1 m -94.52 112.0 23.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 110.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.587 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 14.4 p90 -114.83 -169.24 1.51 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.806 -0.559 . . . . 0.0 109.959 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -178.15 4.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.062 0.934 . . . . 0.0 111.72 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -60.95 -20.56 62.43 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.01 42.51 1.13 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.7 m-20 -91.05 169.21 11.06 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.947 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.33 125.65 43.81 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.495 0.664 . . . . 0.0 109.547 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.486 ' HE3' ' HB2' ' A' ' 85' ' ' ALA . 3.2 mpp? -134.4 153.95 51.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.616 ' CG2' HD11 ' A' ' 120' ' ' LEU . 36.6 t -94.41 152.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.576 HG11 HD11 ' A' ' 81' ' ' ILE . 33.6 t -95.57 134.93 31.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.902 0.858 . . . . 0.0 110.142 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.715 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -95.64 -27.83 15.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.54 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -156.05 -168.92 2.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.596 0.712 . . . . 0.0 111.128 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -143.62 99.22 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.64 -0.662 . . . . 0.0 109.562 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 t -94.42 -71.47 0.66 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 110.697 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.88 -77.21 0.07 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -94.04 -22.7 18.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.488 -1.007 . . . . 0.0 110.298 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.423 ' HZ3' ' HH ' ' A' ' 89' ' ' TYR . 84.0 m95 -133.83 108.27 8.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.539 -0.726 . . . . 0.0 110.217 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.402 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 34.0 m0 -98.98 158.9 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -100.27 126.65 46.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.416 -0.802 . . . . 0.0 109.094 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.715 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -135.73 162.6 32.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 112.164 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.3 ttt180 -111.35 120.54 42.53 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.391 -0.818 . . . . 0.0 109.829 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.441 ' HB2' HD11 ' A' ' 97' ' ' LEU . 1.1 t -72.41 110.71 7.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.485 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.616 HD11 ' CG2' ' A' ' 106' ' ' VAL . 7.3 mt -64.96 -26.0 68.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 -29.95 70.88 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.632 -0.668 . . . . 0.0 110.097 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.0 p -129.53 8.61 5.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 110.883 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 53.66 29.25 9.07 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.135 -0.978 . . . . 0.0 109.86 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -97.48 176.24 5.94 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.74 140.59 17.18 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.765 0.793 . . . . 0.0 111.464 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.24 -150.01 6.83 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.5 ' O ' HG23 ' A' ' 128' ' ' ILE . 52.8 m-85 -93.92 165.28 12.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.905 -0.762 . . . . 0.0 110.805 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.529 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.7 pt -155.29 112.56 2.27 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 34.3 Cg_exo -42.67 102.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.109 1.206 . . . . 0.0 112.078 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.402 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 71.6 m -54.9 -20.6 9.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.906 -0.496 . . . . 0.0 111.513 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -90.26 25.32 2.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.214 -0.928 . . . . 0.0 111.63 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -154.99 32.02 0.4 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 109.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -149.02 169.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.579 -0.7 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -132.79 123.88 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.683 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 ttp180 . . . . . 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 112.455 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.916 0.389 . . . . 0.0 110.641 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.962 ' CD1' HG13 ' A' ' 106' ' ' VAL . 4.9 mm -96.65 140.1 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.064 -1.022 . . . . 0.0 108.882 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 135' ' ' ARG . 32.2 m -126.33 174.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.428 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.882 HG12 ' HB3' ' A' ' 134' ' ' ALA . 7.1 p -127.66 123.66 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.655 -0.653 . . . . 0.0 109.365 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.577 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.36 119.41 11.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 134' ' ' ALA . 64.5 mt -94.3 4.2 54.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.561 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.463 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.1 m-85 -152.63 151.5 30.68 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.031 -1.043 . . . . 0.0 109.117 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 74.6 m-20 -69.13 143.14 54.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.352 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 58.9 t80 -155.12 131.15 10.15 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.181 -0.949 . . . . 0.0 111.019 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -97.4 142.19 29.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.7 -0.625 . . . . 0.0 110.723 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.774 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.123 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.774 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 53.2 p-10 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 119' ' ' SER . 55.4 tp -151.9 129.33 11.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.312 -0.868 . . . . 0.0 111.14 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.76 116.65 28.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.686 -0.634 . . . . 0.0 110.295 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.3 p90 -113.62 -170.92 1.79 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.579 -0.7 . . . . 0.0 109.958 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -125.71 -179.77 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.032 0.92 . . . . 0.0 111.831 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.463 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.14 -23.36 65.47 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.7 40.9 1.37 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.96 171.08 9.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.049 -0.677 . . . . 0.0 111.543 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 139.55 53.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.484 -0.76 . . . . 0.0 109.781 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 71.8 mtm -142.95 154.01 43.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.79 -0.569 . . . . 0.0 110.178 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.962 HG13 ' CD1' ' A' ' 82' ' ' ILE . 22.4 t -100.77 147.89 7.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 81' ' ' ILE . 95.4 t -94.92 138.93 19.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.881 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.14 -25.69 14.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.04 155.33 32.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.749 -0.595 . . . . 0.0 110.05 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -108.7 133.16 53.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 109.916 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.8 t -132.6 -85.38 0.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.279 -0.888 . . . . 0.0 110.658 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.96 -91.76 0.08 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.88 -16.83 30.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.585 -0.95 . . . . 0.0 110.807 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -127.59 104.9 8.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.371 -0.831 . . . . 0.0 110.468 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 44.5 m0 -101.95 153.56 19.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.249 -0.907 . . . . 0.0 109.984 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -102.78 113.21 26.44 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.737 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.02 167.93 16.01 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.127 -0.983 . . . . 0.0 112.675 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HB2' HD11 ' A' ' 108' ' ' LEU . 1.1 ttt180 -115.76 124.01 49.71 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.65 -0.656 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.822 ' HB2' HD21 ' A' ' 97' ' ' LEU . 24.2 t -78.98 120.82 24.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.624 -0.673 . . . . 0.0 109.741 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mt -71.75 -21.81 61.7 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.17 73.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.4 -0.812 . . . . 0.0 109.656 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 p -130.56 9.54 5.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.726 -0.609 . . . . 0.0 110.735 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.23 31.3 13.87 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.042 -1.036 . . . . 0.0 110.641 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.5 mtpt -104.51 173.3 6.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.6 OUTLIER -154.6 140.35 18.08 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.644 179.632 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.03 -146.04 4.71 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.491 ' O ' HG23 ' A' ' 128' ' ' ILE . 72.7 m-85 -94.15 157.81 15.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 122.056 -0.673 . . . . 0.0 110.6 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.568 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.7 pt -154.0 113.59 2.53 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.794 -0.566 . . . . 0.0 109.796 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.62 97.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.277 1.146 . . . . 0.0 112.062 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 66.9 m -49.56 -24.6 2.21 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.684 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -85.71 16.4 4.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.403 -0.811 . . . . 0.0 111.755 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.71 29.15 1.93 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.2 -0.938 . . . . 0.0 109.147 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.3 p -146.69 169.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.669 0.747 . . . . 0.0 110.901 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.882 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -119.7 135.71 54.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.867 -0.52 . . . . 0.0 110.072 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.848 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.39 -0.818 . . . . 0.0 111.696 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.0 mt -107.88 157.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.902 -1.124 . . . . 0.0 109.055 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 135' ' ' ARG . 28.9 m -139.86 173.12 11.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.815 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.6 p -133.09 121.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.42 118.94 9.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.707 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' A' ' 134' ' ' ALA . 90.5 mt -94.15 0.75 55.99 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.253 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 41.0 m-85 -150.13 149.72 30.66 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.257 -0.902 . . . . 0.0 108.834 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -66.24 151.31 47.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -153.94 167.78 28.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.374 -0.829 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 94.06 2.17 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.169 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.587 -0.696 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.942 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 20.2 p-10 . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 120.989 0.423 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 119' ' ' SER . 2.3 tt -133.43 134.66 43.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 110.431 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 m -94.7 170.2 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.594 -0.691 . . . . 0.0 109.976 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.571 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 18.4 p90 -161.02 -169.14 2.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.623 -0.673 . . . . 0.0 110.638 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.98 179.22 4.73 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.259 1.028 . . . . 0.0 112.523 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -61.12 -23.02 65.21 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.36 43.62 1.08 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.3 m-20 -90.53 167.85 12.27 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.894 -0.768 . . . . 0.0 111.396 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.47 128.61 50.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.589 -0.694 . . . . 0.0 109.717 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -137.45 148.1 45.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 38.4 t -95.08 155.16 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 81' ' ' ILE . 49.4 t -95.13 140.51 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.159 -0.963 . . . . 0.0 110.634 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -97.59 -27.63 14.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -156.14 173.23 17.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.776 -0.578 . . . . 0.0 110.122 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -139.98 89.17 2.28 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.459 -0.775 . . . . 0.0 110.0 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.6 t -99.32 -68.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 110.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.86 154.59 7.27 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 65.14 -72.64 0.07 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.562 -0.963 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 39.4 m95 -108.86 126.4 53.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.94 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -106.39 141.62 37.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.521 -0.737 . . . . 0.0 110.213 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.6 114.02 25.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -130.31 164.89 23.65 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.841 0.829 . . . . 0.0 111.987 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.0 ttt180 -112.34 124.53 52.67 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.625 -0.672 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.727 ' HB2' HD21 ' A' ' 97' ' ' LEU . 6.8 t -78.88 114.39 17.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.578 . . . . 0.0 109.664 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.16 -27.7 68.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.51 . . . . 0.0 109.992 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.97 38.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.094 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -139.49 10.6 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.676 -0.64 . . . . 0.0 110.717 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 52.24 30.51 7.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.959 -1.088 . . . . 0.0 110.707 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 28.2 mttt -103.26 -178.75 3.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.4 OUTLIER -155.38 147.41 23.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.52 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -155.73 11.15 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 79.0 m-85 -94.18 157.75 15.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 122.045 -0.68 . . . . 0.0 110.348 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 127' ' ' TYR . 3.8 pt -155.0 125.58 3.41 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.641 -0.662 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.01 117.34 4.18 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 122.967 0.983 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 m -53.95 -34.43 59.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.789 -0.57 . . . . 0.0 111.989 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -71.33 -6.52 40.6 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.907 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -109.72 25.36 11.88 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.098 -1.001 . . . . 0.0 109.466 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -156.71 170.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.965 0.888 . . . . 0.0 112.175 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -124.65 127.1 46.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.844 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.8 ttp180 . . . . . 0 N--CA 1.487 1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 112.58 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.763 HD11 HG11 ' A' ' 107' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 83' ' ' VAL . 74.4 mt -119.34 164.48 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.938 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 135' ' ' ARG . 15.4 m -142.12 169.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -129.9 126.71 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.622 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -70.56 120.58 16.41 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.0 mt -94.33 3.2 55.52 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.187 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 44.9 m-85 -153.0 150.58 29.35 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 108.872 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.48 141.06 58.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 109.941 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 44.2 t80 -155.38 119.99 4.73 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.361 -0.837 . . . . 0.0 111.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.52 124.23 50.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.706 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.502 2.133 0 O-C-N 121.25 -0.906 . . . . 0.0 110.433 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.706 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 24.0 t0 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 119' ' ' SER . 37.4 tp -98.23 133.54 42.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.912 . . . . 0.0 111.734 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -94.56 162.42 13.81 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.622 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 13.6 p90 -171.53 -165.66 0.4 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.491 -0.756 . . . . 0.0 110.115 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 178.37 5.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.242 1.02 . . . . 0.0 112.247 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 16.7 ttmt -61.08 -21.49 63.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.74 40.57 1.44 Allowed Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.1 m-20 -91.0 169.55 10.79 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.852 -0.793 . . . . 0.0 112.131 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 122.04 36.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.561 -0.712 . . . . 0.0 110.116 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.7 mtm -127.69 152.85 47.19 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 120' ' ' LEU . 41.3 t -95.5 154.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.763 HG11 HD11 ' A' ' 81' ' ' ILE . 5.7 t -94.78 136.25 26.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.949 0.88 . . . . 0.0 109.699 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -96.89 -27.03 14.86 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.546 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -155.99 -174.42 4.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.706 -0.621 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -137.88 98.78 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.405 -0.809 . . . . 0.0 109.751 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 t -94.69 -77.98 0.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.51 -80.23 0.08 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -93.55 -8.66 40.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.945 . . . . 0.0 110.729 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -143.44 96.94 2.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.893 . . . . 0.0 110.076 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -95.65 157.87 15.71 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.098 -1.002 . . . . 0.0 110.781 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tttt -102.17 122.47 44.22 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.566 ' O ' HD22 ' A' ' 97' ' ' LEU . . . -132.16 159.96 37.46 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 112.37 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.0 ttt180 -113.0 124.41 52.57 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.496 -0.753 . . . . 0.0 109.937 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.701 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.1 t -81.51 119.21 23.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.622 . . . . 0.0 109.362 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.453 HD11 ' CG2' ' A' ' 106' ' ' VAL . 3.2 mt -71.15 -24.79 62.33 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.767 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.33 59.57 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.35 -0.844 . . . . 0.0 109.587 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 p -137.34 9.4 2.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.436 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.19 27.63 6.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.01 -1.056 . . . . 0.0 110.67 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 38.4 mttt -95.51 171.47 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.5 151.83 28.17 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.854 0.835 . . . . 0.0 111.849 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . 177.07 -152.89 12.67 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.92 153.36 18.83 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.865 . . . . 0.0 109.705 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.55 132.31 14.18 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.803 -0.561 . . . . 0.0 110.404 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 39.0 Cg_exo -47.87 96.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.121 1.064 . . . . 0.0 111.677 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 m -55.87 -20.5 15.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.721 -0.612 . . . . 0.0 111.379 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.65 18.36 5.56 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.327 -0.858 . . . . 0.0 111.351 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -146.75 33.33 0.93 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -146.13 168.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.936 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.718 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -131.21 120.09 22.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.712 ' HA ' HG12 ' A' ' 83' ' ' VAL . 14.6 ttp180 . . . . . 0 N--CA 1.484 1.242 0 O-C-N 121.229 -0.92 . . . . 0.0 112.029 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.585 HD11 HG11 ' A' ' 107' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 83' ' ' VAL . 74.8 mt -118.14 164.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.873 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 135' ' ' ARG . 22.4 m -142.22 173.49 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.9 p -131.49 128.07 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.012 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.957 ' HA ' HG12 ' A' ' 133' ' ' VAL . . . -70.46 116.1 10.41 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 134' ' ' ALA . 77.2 mt -94.33 3.05 55.72 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.261 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.6 m-85 -149.71 150.32 31.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.198 -0.939 . . . . 0.0 108.906 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -71.75 145.02 49.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.166 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 19.6 t80 -155.5 121.95 5.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.465 -0.772 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 20.3 mt-10 -97.15 124.42 41.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.354 -0.841 . . . . 0.0 110.752 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.82 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.575 -0.703 . . . . 0.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.82 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 1.7 p30 . . . . . 0 N--CA 1.509 2.519 0 CA-C-O 120.948 0.404 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tt -109.28 146.19 34.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.513 -0.742 . . . . 0.0 111.024 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.8 m -97.29 119.97 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.821 -0.549 . . . . 0.0 109.777 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CE2' HG22 ' A' ' 128' ' ' ILE . 20.2 p90 -114.99 -170.92 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.587 -0.696 . . . . 0.0 110.742 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.73 177.28 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.295 1.045 . . . . 0.0 112.159 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 14.7 ttmt -61.32 -20.29 62.78 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.68 1.32 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.88 170.14 10.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.902 -0.763 . . . . 0.0 111.724 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.33 123.52 41.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 110.181 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.422 ' HE1' ' CG ' ' A' ' 99' ' ' PHE . 77.4 mtm -129.58 150.43 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.514 ' CG2' HD11 ' A' ' 120' ' ' LEU . 38.0 t -96.2 153.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 81' ' ' ILE . 24.8 t -95.2 134.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.84 0.829 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -95.03 -26.36 16.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.208 0.528 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -155.43 -177.37 6.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.067 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -145.17 95.19 2.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 t -104.88 -53.99 2.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.524 -0.735 . . . . 0.0 111.003 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.81 141.99 3.8 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 64.58 -72.41 0.06 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.646 -0.914 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -106.07 117.86 35.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 0.0 110.208 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -106.78 152.38 23.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.643 . . . . 0.0 110.207 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.69 117.2 31.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.541 -0.724 . . . . 0.0 109.187 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -130.21 162.5 28.79 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.623 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 4.6 ttt180 -114.88 124.51 51.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.7 -0.625 . . . . 0.0 109.889 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 t -78.23 117.06 19.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.482 -0.761 . . . . 0.0 109.654 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 106' ' ' VAL . 13.2 mt -67.35 -26.3 66.42 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.313 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.46 66.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -136.58 9.89 3.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.588 -0.695 . . . . 0.0 110.714 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.65 27.84 4.32 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.979 -1.075 . . . . 0.0 110.414 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 47.6 mttt -101.84 179.71 4.25 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.24 151.36 28.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.412 -0.805 . . . . 0.0 111.48 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.1 -157.58 15.22 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.441 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 88.4 m-85 -94.03 151.35 19.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 122.311 -0.523 . . . . 0.0 109.703 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.479 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -154.04 130.12 5.45 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.58 -0.7 . . . . 0.0 110.575 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.69 107.51 0.75 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 109.347 -1.059 . . . . 0.0 109.347 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 m -55.34 -26.01 38.29 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.384 -0.822 . . . . 0.0 110.857 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' ND2' ' CD1' ' A' ' 132' ' ' TYR . 16.8 p-10 -71.28 -12.44 61.45 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.414 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.436 ' CD1' ' ND2' ' A' ' 131' ' ' ASN . 3.0 m-85 -100.54 9.23 42.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.957 HG12 ' HA ' ' A' ' 85' ' ' ALA . 35.2 m -138.5 -177.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 111.929 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.713 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -132.06 114.77 14.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.71 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 O-C-N 121.308 -0.87 . . . . 0.0 111.066 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.782 0.325 . . . . 0.0 110.725 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 73.7 mt -98.47 144.73 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.746 -1.221 . . . . 0.0 109.889 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.893 HG12 ' HA ' ' A' ' 135' ' ' ARG . 28.0 m -127.45 174.62 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 110.785 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.78 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.6 p -130.38 126.22 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -69.63 121.17 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 134' ' ' ALA . 64.5 mt -94.43 1.83 55.78 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.738 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.478 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.6 m-85 -152.52 151.01 30.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.257 -0.902 . . . . 0.0 108.899 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -67.12 147.88 52.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.531 -0.731 . . . . 0.0 109.927 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.484 ' CZ ' ' HG3' ' A' ' 129' ' ' PRO . 54.4 t80 -153.89 146.35 24.02 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.354 -0.841 . . . . 0.0 111.768 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 114.88 23.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.538 0.685 . . . . 0.0 110.921 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.823 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.505 2.297 0 O-C-N 121.387 -0.821 . . . . 0.0 112.09 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.823 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 55.4 p-10 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 117' ' ' ALA . 40.9 tp -138.84 125.62 20.91 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.592 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -93.98 159.74 15.03 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.289 0.566 . . . . 0.0 109.587 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.558 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.5 p90 -163.36 -170.42 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.637 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -178.17 3.93 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.164 0.983 . . . . 0.0 112.162 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -61.07 -21.32 63.55 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.98 43.3 1.04 Allowed Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.5 m-20 -90.76 171.68 9.17 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.989 -0.712 . . . . 0.0 111.877 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.87 136.03 53.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.665 -0.647 . . . . 0.0 109.764 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 76.4 mtm -143.44 154.52 43.77 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.507 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 40.8 t -101.65 150.94 5.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 81' ' ' ILE . 61.9 t -95.5 138.21 21.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 O-C-N 121.241 -0.912 . . . . 0.0 110.542 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.736 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.87 -25.84 14.49 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.39 147.72 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.648 -0.658 . . . . 0.0 110.192 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.09 145.39 28.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.297 -0.877 . . . . 0.0 109.237 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -142.29 -71.5 0.33 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.51 -77.61 0.14 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.27 -10.22 30.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -1.014 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -147.71 107.15 3.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.272 -0.893 . . . . 0.0 110.585 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -104.21 155.61 18.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 17.7 tttt -105.17 116.74 32.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.736 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.05 169.41 14.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.897 . . . . 0.0 112.54 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 1.6 ttt180 -115.3 121.67 43.59 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 121.775 -0.578 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.3 t -77.6 116.11 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.676 -0.64 . . . . 0.0 109.765 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.63 -22.41 65.33 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.052 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.93 66.78 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.676 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.7 p -138.63 9.02 2.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.892 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 53.68 29.01 8.73 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.981 -1.074 . . . . 0.0 110.597 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 52.5 mttt -103.09 174.73 5.74 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -155.22 142.57 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.931 0.872 . . . . 0.0 111.406 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -169.22 -146.31 4.98 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 56.5 m-85 -93.49 161.39 14.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 122.058 -0.672 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 127' ' ' TYR . 3.4 pt -151.52 118.87 3.28 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.736 -0.603 . . . . 0.0 109.83 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 68.5 Cg_exo -40.76 99.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.37 1.38 . . . . 0.0 112.436 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -61.02 -19.68 61.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.905 -0.497 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 24.8 p30 -87.82 17.89 4.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.32 -0.862 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.428 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 4.5 m-85 -152.06 44.49 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.052 -1.03 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.497 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -154.18 168.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 111.023 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.78 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -123.41 138.98 54.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.882 -0.511 . . . . 0.0 110.37 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.893 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 O-C-N 121.397 -0.815 . . . . 0.0 112.088 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.838 0.351 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 27.3 mt -97.55 124.91 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.056 -1.027 . . . . 0.0 109.206 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 135' ' ' ARG . 32.8 m -111.23 171.94 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.364 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.7 p -128.32 127.6 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.575 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.66 117.84 10.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.931 HD11 ' HB2' ' A' ' 134' ' ' ALA . 80.5 mt -94.54 4.26 54.08 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.297 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.423 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 27.6 m-85 -151.94 150.42 30.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -68.26 146.15 53.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 109.725 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.449 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 65.3 t80 -153.48 145.04 23.28 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.255 -0.903 . . . . 0.0 111.15 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -118.32 103.48 9.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.916 -0.49 . . . . 0.0 110.165 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HB1' ' HB2' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.103 0 O-C-N 121.46 -0.775 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.852 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 19.2 p-10 . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 121.092 0.472 . . . . 0.0 112.132 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 119' ' ' SER . 6.4 tt -148.45 130.91 15.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.699 -0.625 . . . . 0.0 110.227 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -94.8 151.57 19.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.612 -0.68 . . . . 0.0 110.157 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.575 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.5 p90 -142.43 -167.96 2.62 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.455 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -125.39 179.93 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.173 0.987 . . . . 0.0 112.119 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.0 ttmt -61.24 -20.07 62.4 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.54 41.49 1.32 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 84' ' ' VAL . 10.9 m-20 -91.06 165.04 13.73 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.744 -0.856 . . . . 0.0 112.408 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.69 54.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -138.75 153.14 48.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.469 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 20.9 t -100.83 152.61 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 81' ' ' ILE . 94.5 t -95.36 139.7 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.109 -0.995 . . . . 0.0 109.789 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -98.6 -27.18 14.13 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -156.23 159.46 38.93 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.88 105.34 13.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.216 -0.927 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 -151.96 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.4 -0.813 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.53 -107.22 0.61 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.91 -4.42 59.16 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.543 -0.975 . . . . 0.0 111.575 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 30.7 m95 -127.77 106.21 8.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.411 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 50.1 m0 -100.67 153.03 19.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 109.767 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -100.62 114.26 27.79 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.659 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.61 164.03 22.92 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.712 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -113.33 120.61 41.73 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.724 -0.61 . . . . 0.0 109.6 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.496 ' HB2' HD21 ' A' ' 97' ' ' LEU . 6.1 t -78.38 122.67 26.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.655 -0.653 . . . . 0.0 109.35 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.84 -27.88 63.19 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.934 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.45 31.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.443 -0.785 . . . . 0.0 109.85 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.8 p -137.81 10.33 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.613 . . . . 0.0 110.528 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 50.61 27.48 2.95 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.993 -1.067 . . . . 0.0 110.574 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 4.2 mttt -100.45 179.78 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.24 147.18 23.46 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.77 0.795 . . . . 0.0 111.183 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -147.03 5.52 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.453 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 75.8 m-85 -94.42 157.39 16.04 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.091 -0.652 . . . . 0.0 110.606 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.9 pt -152.15 109.59 2.83 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.652 -0.655 . . . . 0.0 109.735 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HG3' ' CH2' ' A' ' 114' ' ' TRP . 51.3 Cg_exo -50.66 110.07 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 122.958 0.978 . . . . 0.0 111.56 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 24.0 m -59.88 -17.23 35.43 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.935 -0.478 . . . . 0.0 111.249 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -84.77 12.93 6.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.276 -0.89 . . . . 0.0 111.719 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -147.02 44.27 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 0.0 108.802 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.4 p -156.25 168.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.792 0.806 . . . . 0.0 111.317 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.931 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -128.61 127.6 42.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.727 ' HA ' HG12 ' A' ' 83' ' ' VAL . 4.2 tmm_? . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 112.474 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.449 HG12 HG13 ' A' ' 106' ' ' VAL . 47.7 mt -104.29 155.91 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.915 -1.116 . . . . 0.0 109.448 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.6 m -139.01 176.5 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.836 HG12 ' HB3' ' A' ' 134' ' ' ALA . 3.9 p -134.28 122.69 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.549 -0.72 . . . . 0.0 109.414 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.42 120.36 13.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.84 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 134' ' ' ALA . 79.5 mt -94.09 1.47 56.15 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.483 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.8 m-85 -152.49 151.0 30.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.152 -0.967 . . . . 0.0 108.393 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 67.4 m-20 -66.61 148.46 51.87 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.501 -0.75 . . . . 0.0 110.339 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 46.2 t80 -155.3 131.05 9.91 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.317 -0.865 . . . . 0.0 111.31 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -100.09 137.73 38.14 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.403 -0.811 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.769 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.506 2.349 0 O-C-N 121.606 -0.684 . . . . 0.0 111.721 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.769 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 50.3 p30 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 119' ' ' SER . 61.2 tp -155.01 124.78 6.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.488 -0.758 . . . . 0.0 111.232 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.75 114.93 26.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.27 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.562 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 14.3 p90 -113.14 -168.86 1.38 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.63 -0.669 . . . . 0.0 110.057 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 1.8 tt0 -125.69 -178.33 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.352 1.073 . . . . 0.0 112.799 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.2 -23.9 65.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.95 42.42 1.19 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.52 166.84 13.0 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.649 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.17 128.75 50.47 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.691 -0.631 . . . . 0.0 109.377 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.416 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.8 mpp? -135.78 148.47 48.78 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 33.6 t -98.65 152.59 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' ILE . 58.2 t -95.05 138.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.16 -31.65 13.43 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -156.32 163.4 39.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.917 -0.49 . . . . 0.0 109.857 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.87 153.72 21.0 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.9 t -147.87 -68.62 0.24 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.03 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -99.57 -20.74 16.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.652 -0.91 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -121.43 102.33 8.19 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -99.19 150.78 21.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.932 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.4 tttt -94.75 112.73 24.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.56 166.59 18.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.257 -0.902 . . . . 0.0 112.246 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.8 ttt180 -112.75 124.93 53.69 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.479 ' HB2' HD21 ' A' ' 97' ' ' LEU . 42.2 t -77.85 115.1 17.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.455 HD11 ' CG2' ' A' ' 106' ' ' VAL . 20.5 mt -68.8 -24.93 64.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 110.625 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.69 67.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.802 . . . . 0.0 109.965 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p -135.99 9.29 3.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.605 -0.685 . . . . 0.0 110.798 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.36 30.63 12.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.045 -1.034 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 mmmm -99.68 177.73 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.262 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.44 139.0 15.96 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.83 0.824 . . . . 0.0 111.388 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -168.31 -150.71 6.74 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.54 ' O ' HG23 ' A' ' 128' ' ' ILE . 59.8 m-85 -93.89 162.73 13.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.718 -0.872 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.3 pt -155.45 111.7 2.23 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.713 -0.617 . . . . 0.0 109.866 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 O-C-N 123.038 1.02 . . . . 0.0 112.079 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.436 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 16.4 m -61.27 -17.11 51.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -76.79 1.48 17.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.208 -0.932 . . . . 0.0 112.316 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -141.84 46.82 1.66 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 134' ' ' ALA . 4.1 p -154.83 168.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.836 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -120.98 129.07 53.27 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.735 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.416 -0.803 . . . . 0.0 112.871 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 122.181 0.991 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 105' ' ' MET . 69.0 mt -128.75 150.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.616 HG12 ' CG ' ' A' ' 135' ' ' ARG . 28.4 m -128.89 175.1 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 134' ' ' ALA . 8.5 p -132.74 118.12 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.632 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -63.33 116.18 5.26 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.2 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.949 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.6 mt -94.45 1.68 55.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.126 -0.359 . . . . 0.0 111.77 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.468 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 51.3 m-85 -151.25 151.75 32.28 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.98 144.54 54.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 109.685 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 33.6 t80 -152.28 131.78 13.0 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.125 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -99.79 139.73 35.03 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.277 0.56 . . . . 0.0 111.202 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.784 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.505 2.276 0 O-C-N 121.567 -0.708 . . . . 0.0 111.24 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.784 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.9 p30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.48 HD12 ' CA ' ' A' ' 125' ' ' GLU . 6.3 tt -145.92 127.77 15.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 111.037 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -94.7 116.5 28.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.566 -0.709 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.632 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 12.1 p90 -114.35 -167.75 1.26 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.11 177.43 6.38 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.194 0.997 . . . . 0.0 111.942 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 1.3 ttmt -60.92 -18.78 58.72 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.75 38.19 1.3 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -91.03 171.77 9.03 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.802 -0.822 . . . . 0.0 111.871 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.72 136.75 54.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' HG23 ' A' ' 82' ' ' ILE . 69.6 mtm -140.33 155.64 46.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 t -98.68 152.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.486 ' HB ' HG13 ' A' ' 81' ' ' ILE . 84.8 t -94.41 133.42 35.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.934 0.873 . . . . 0.0 109.704 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -96.25 -26.99 15.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -156.4 179.63 9.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 0.0 109.291 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.57 86.26 2.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.173 -0.954 . . . . 0.0 110.389 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.0 t -96.2 -164.7 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.685 -0.634 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.11 139.79 15.06 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 66.43 -64.16 0.23 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.593 -0.946 . . . . 0.0 111.095 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -105.88 115.39 30.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -101.96 149.0 24.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.417 -0.802 . . . . 0.0 109.231 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 15.4 tttt -95.38 113.97 25.69 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.613 -0.68 . . . . 0.0 110.172 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.682 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -129.58 164.91 22.81 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.952 0.882 . . . . 0.0 112.34 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -114.03 124.32 51.85 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.473 -0.767 . . . . 0.0 110.364 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.417 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.4 t -80.09 123.08 27.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.338 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.67 -25.96 60.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.696 -0.627 . . . . 0.0 110.94 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.16 68.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.314 -0.867 . . . . 0.0 110.031 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p -127.79 7.68 6.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.832 -0.542 . . . . 0.0 110.36 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.55 31.98 13.42 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.991 -1.068 . . . . 0.0 110.128 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 35.6 mtpt -102.17 175.41 5.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.48 ' CA ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -155.62 143.24 19.61 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.669 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -168.21 -150.01 6.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 128' ' ' ILE . 66.5 m-85 -93.91 167.93 11.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.956 . . . . 0.0 109.994 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.5 pt -154.98 116.49 2.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -52.23 105.49 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 122.849 0.921 . . . . 0.0 111.594 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -19.33 7.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.715 -0.616 . . . . 0.0 111.241 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -83.88 20.08 1.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.249 -0.907 . . . . 0.0 111.746 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -154.29 39.69 0.46 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.021 -1.05 . . . . 0.0 109.288 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.2 p -154.0 170.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 111.112 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.949 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -129.36 120.57 25.8 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.616 ' CG ' HG12 ' A' ' 83' ' ' VAL . 3.5 ttm180 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 113.148 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.504 HG13 ' HB ' ' A' ' 107' ' ' VAL . 2.4 tp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 110.867 -0.049 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.607 HG12 HG13 ' A' ' 106' ' ' VAL . 82.3 mt -115.6 164.71 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 107' ' ' VAL . 18.5 m -143.18 175.72 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.428 0.632 . . . . 0.0 110.087 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 84' ' ' VAL . 8.8 p -137.14 122.33 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.574 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -63.76 119.96 10.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 109.345 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 134' ' ' ALA . 32.3 mt -94.26 3.06 55.75 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.352 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 132' ' ' TYR . 39.3 m-85 -150.67 148.99 29.26 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 0.0 108.885 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 65.7 m-20 -66.29 143.97 56.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 18.2 t80 -155.39 122.67 5.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.272 -0.892 . . . . 0.0 111.466 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.69 113.35 26.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 110.238 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.779 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.499 1.978 0 O-C-N 121.328 -0.857 . . . . 0.0 111.092 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.779 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 1.8 p30 . . . . . 0 N--CA 1.503 2.175 0 CA-C-O 121.16 0.505 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.7 149.51 27.21 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.746 0.784 . . . . 0.0 111.619 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.0 m -94.88 147.36 23.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.84 -0.537 . . . . 0.0 109.903 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.3 p90 -148.1 -165.04 2.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.447 -0.783 . . . . 0.0 110.496 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 1.1 tt0 -129.41 176.47 7.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.449 1.119 . . . . 0.0 112.889 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 17.7 ttmt -60.95 -21.06 63.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.18 41.15 1.28 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.86 167.2 12.62 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.782 -0.834 . . . . 0.0 111.63 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.46 124.77 46.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 72.0 mtm -134.82 151.52 51.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 82' ' ' ILE . 21.3 t -94.73 154.07 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.582 HG23 HG13 ' A' ' 83' ' ' VAL . 38.1 t -94.36 141.16 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 0.0 108.996 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.8 mp -101.68 -26.46 13.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -155.95 -171.33 3.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 110.692 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -147.44 105.19 3.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.475 -0.766 . . . . 0.0 110.579 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.4 t -104.76 -53.83 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.01 -70.73 0.3 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -83.24 -57.29 3.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.634 -0.921 . . . . 0.0 110.064 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 40.8 m95 -105.55 121.63 44.36 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.626 . . . . 0.0 110.576 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 130' ' ' SER . 50.9 m0 -107.04 146.39 31.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.474 -0.767 . . . . 0.0 109.751 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -96.94 120.86 38.06 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.648 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -132.96 160.69 36.36 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.187 -0.946 . . . . 0.0 112.323 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.0 ttt180 -111.74 121.46 45.17 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.586 -0.696 . . . . 0.0 109.933 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 5.1 t -75.11 115.77 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.641 -0.662 . . . . 0.0 109.427 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.9 mt -68.38 -24.95 64.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.909 -0.495 . . . . 0.0 110.209 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.74 -23.77 65.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p -138.93 10.71 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.713 . . . . 0.0 111.002 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.32 30.62 6.14 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.928 -1.108 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 7.8 mtmt -105.19 -177.05 3.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.61 156.5 35.15 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.279 -0.888 . . . . 0.0 111.776 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.81 -159.44 21.08 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.454 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 89.3 m-85 -94.25 158.33 15.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.059 -0.671 . . . . 0.0 110.33 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.542 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -154.65 123.9 3.14 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.36 121.14 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.787 0.888 . . . . 0.0 109.973 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 1.5 m -51.59 -35.86 43.16 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.459 -0.775 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -75.1 -9.23 58.35 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.924 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.489 ' HA ' ' CD1' ' A' ' 87' ' ' TYR . 3.0 m-85 -104.69 23.72 12.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.333 -0.854 . . . . 0.0 109.42 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 134' ' ' ALA . 9.8 p -159.43 170.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.848 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.636 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -137.95 135.47 36.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.515 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.7 tmm_? . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.115 -0.99 . . . . 0.0 112.265 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.435 HG12 HG13 ' A' ' 106' ' ' VAL . 65.0 mt -101.17 151.78 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.869 -1.144 . . . . 0.0 109.263 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 135' ' ' ARG . 29.6 m -135.22 177.56 6.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.096 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.932 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.4 p -128.57 121.79 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.47 118.84 11.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 134' ' ' ALA . 18.8 mt -94.11 1.35 56.15 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.489 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.487 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.7 m-85 -151.9 151.14 30.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.392 -0.817 . . . . 0.0 108.846 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -67.5 145.35 55.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.135 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 67.4 t80 -151.75 126.99 9.87 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.364 -0.835 . . . . 0.0 110.779 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -94.71 135.56 36.05 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.63 0.729 . . . . 0.0 111.963 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.759 -0.588 . . . . 0.0 110.824 179.423 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.431 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 1.8 t0 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.747 HD21 ' HB2' ' A' ' 119' ' ' SER . 32.1 tp -112.89 136.01 53.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.474 -0.766 . . . . 0.0 110.861 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 120.76 35.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.806 . . . . 0.0 110.232 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.9 p90 -115.45 -169.51 1.59 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.963 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.0 179.83 5.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.134 0.969 . . . . 0.0 112.062 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.5 ttmt -60.66 -22.04 63.44 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.84 41.3 1.23 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 1.1 m-20 -90.63 171.53 9.32 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.557 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.14 132.48 50.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.533 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.8 mpp? -139.1 150.71 46.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 82' ' ' ILE . 38.2 t -95.85 151.22 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 81' ' ' ILE . 68.6 t -94.98 137.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.117 -0.99 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.02 -30.96 13.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.742 0.782 . . . . 0.0 108.936 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -156.36 163.98 38.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.58 119.87 40.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.633 . . . . 0.0 109.514 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -109.63 -76.44 0.61 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.126 -0.984 . . . . 0.0 110.858 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.05 -85.89 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.45 -20.56 18.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -127.47 103.76 7.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 108.982 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -95.75 155.76 16.61 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.098 -1.001 . . . . 0.0 110.851 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 24.3 tttt -95.67 112.51 24.21 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.651 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -126.85 165.84 18.59 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.143 0.973 . . . . 0.0 112.798 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.3 ttt180 -112.68 130.52 56.02 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.747 ' HB2' HD21 ' A' ' 97' ' ' LEU . 29.3 t -82.96 115.29 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.183 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.5 mt -67.24 -26.35 66.53 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.24 0.543 . . . . 0.0 110.368 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.68 -29.74 66.84 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.462 -0.774 . . . . 0.0 109.813 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.7 p -133.62 10.53 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.762 -0.586 . . . . 0.0 110.476 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 119' ' ' SER . 7.8 mmm-85 51.68 28.3 4.7 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.986 -1.071 . . . . 0.0 110.898 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 10.9 mtmt -99.8 177.91 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.425 -0.797 . . . . 0.0 109.376 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -153.56 151.77 30.15 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.947 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -177.99 -150.72 8.79 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 128' ' ' ILE . 48.0 m-85 -93.58 164.76 13.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.666 -0.902 . . . . 0.0 110.207 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.3 pt -155.09 110.71 2.29 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.668 -0.645 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -45.19 99.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 O-C-N 123.008 1.004 . . . . 0.0 111.838 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -57.03 -20.68 25.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.825 -0.547 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 5.0 p-10 -74.42 -1.84 22.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.535 -0.728 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 4.8 m-85 -137.23 44.92 2.25 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.908 -1.12 . . . . 0.0 110.186 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -147.7 170.85 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.32 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.932 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -125.12 117.41 23.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.746 -0.596 . . . . 0.0 109.509 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.778 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.2 tmm_? . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.858 0.837 . . . . 0.0 112.648 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.005 0.431 . . . . 0.0 110.405 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.9 mt -97.43 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.4 m -136.46 172.55 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.748 -0.595 . . . . 0.0 109.414 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.873 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.2 p -127.63 124.41 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.148 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.556 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.68 116.12 5.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.989 HD11 ' HB2' ' A' ' 134' ' ' ALA . 93.9 mt -93.85 3.53 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.837 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 70.5 m-85 -153.57 150.29 28.52 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 100' ' ' GLN . 47.9 m-20 -66.64 150.91 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.455 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 66.0 t80 -154.38 119.78 5.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.254 -0.904 . . . . 0.0 110.896 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.38 128.75 39.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.35 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.611 -0.681 . . . . 0.0 110.704 179.611 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 3.4 t0 . . . . . 0 N--CA 1.513 2.711 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 124' ' ' LYS . 6.5 tt -109.11 137.45 46.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.975 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -94.44 122.22 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.684 -0.635 . . . . 0.0 109.599 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 8.6 p90 -117.36 -167.13 1.27 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.788 -0.57 . . . . 0.0 110.029 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HA ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -126.08 179.42 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.324 1.059 . . . . 0.0 112.695 -177.85 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.7 ttmt -61.14 -23.35 65.47 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.94 40.05 1.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 2.3 m-20 -91.27 163.91 14.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.688 -0.89 . . . . 0.0 112.065 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.22 134.95 55.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.44 ' HE1' ' CD2' ' A' ' 99' ' ' PHE . 76.2 mtm -142.45 149.3 39.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.839 -0.538 . . . . 0.0 109.6 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.597 ' CG2' HD11 ' A' ' 120' ' ' LEU . 21.3 t -97.01 150.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 81' ' ' ILE . 79.3 t -94.79 139.57 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.131 -0.981 . . . . 0.0 110.192 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.7 mp -95.72 -27.11 15.43 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 144.15 20.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -103.02 137.73 40.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -128.34 -70.73 0.67 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 157.15 -40.51 0.55 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.48 -30.37 4.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.355 -1.086 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -137.11 102.88 4.96 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.0 109.24 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -98.22 151.14 20.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.401 -0.812 . . . . 0.0 111.099 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -101.06 124.59 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -132.73 166.12 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.896 . . . . 0.0 111.883 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HB2' HD11 ' A' ' 108' ' ' LEU . 2.4 ttt180 -114.0 126.59 55.3 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.652 -0.655 . . . . 0.0 109.985 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -77.92 114.9 17.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.698 -0.626 . . . . 0.0 109.387 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.597 HD11 ' CG2' ' A' ' 106' ' ' VAL . 9.6 mt -67.56 -28.74 68.04 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.083 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.97 60.71 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -135.04 12.02 3.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.738 -0.601 . . . . 0.0 110.767 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.9 30.93 4.24 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.175 -0.953 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 97' ' ' LEU . 36.8 mtmt -100.47 177.37 5.05 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -152.2 149.48 28.79 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.966 0.889 . . . . 0.0 111.913 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.88 -152.98 9.06 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.446 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 96.6 m-85 -94.07 164.09 13.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 122.201 -0.588 . . . . 0.0 109.47 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 127' ' ' TYR . 4.2 pt -151.06 106.96 3.01 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -47.32 107.4 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.04 1.021 . . . . 0.0 111.719 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.413 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 24.0 m -60.76 -15.95 35.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.944 -0.472 . . . . 0.0 111.017 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 39.5 p30 -80.74 3.19 23.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.21 -0.931 . . . . 0.0 112.063 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 8.9 m-85 -144.92 46.96 1.34 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.142 -0.974 . . . . 0.0 109.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 134' ' ' ALA . 5.4 p -153.91 170.83 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.424 -0.797 . . . . 0.0 110.594 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.989 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -125.57 124.14 40.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.75 -0.594 . . . . 0.0 109.905 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.772 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 112.498 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.441 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 105' ' ' MET . 89.4 mt -101.39 157.87 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 109.554 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 135' ' ' ARG . 31.6 m -139.83 165.67 21.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.896 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.0 p -123.61 122.02 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 109.095 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.659 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.24 116.85 6.41 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.926 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 134' ' ' ALA . 96.6 mt -94.5 7.95 43.84 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.158 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.7 m-85 -154.81 151.16 28.31 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.226 -0.921 . . . . 0.0 108.851 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.93 141.03 56.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 39.5 t80 -155.34 125.14 6.5 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.222 -0.924 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.17 130.94 54.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 110.682 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.451 -0.781 . . . . 0.0 110.217 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.634 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.524 3.236 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.749 HD13 ' N ' ' A' ' 98' ' ' SER . 1.2 tm? -98.31 133.77 42.25 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.565 0.698 . . . . 0.0 111.481 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.749 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.5 m -94.75 142.82 27.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.659 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 20.3 p90 -152.99 -164.71 2.0 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.261 -0.899 . . . . 0.0 111.017 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.24 179.25 5.35 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.118 0.961 . . . . 0.0 111.742 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 10.3 ttmt -61.36 -18.94 61.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.69 41.22 1.38 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.93 172.01 8.89 Favored 'General case' 0 N--CA 1.505 2.325 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.815 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.63 129.5 45.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.646 -0.659 . . . . 0.0 110.199 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 82' ' ' ILE . 20.9 mtm -132.52 156.19 47.25 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 24.9 t -106.5 152.37 8.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 94.9 t -95.06 139.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.557 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp -94.84 -30.83 14.0 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.64 152.93 27.76 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -95.97 151.32 19.54 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.6 t -147.27 -83.09 0.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.394 -0.816 . . . . 0.0 110.715 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.03 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -91.32 -5.61 54.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.429 -1.042 . . . . 0.0 110.825 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -143.97 96.96 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 109.886 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.95 149.05 21.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.73 117.34 29.97 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.625 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.3 164.54 25.4 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.239 -0.913 . . . . 0.0 112.607 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.1 ttt180 -118.03 131.82 56.43 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.633 -0.667 . . . . 0.0 109.914 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -87.46 118.36 26.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.577 -0.702 . . . . 0.0 109.859 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.449 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.3 mt -67.36 -23.02 65.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.827 -0.545 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.86 -31.11 68.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.353 -0.842 . . . . 0.0 110.171 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 p -137.57 14.0 2.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.725 -0.609 . . . . 0.0 110.437 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 50.52 35.18 10.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.103 -0.998 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 45.6 mttt -102.93 173.75 6.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.7 156.51 35.03 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.737 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 174.59 -154.91 19.99 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -93.64 118.77 31.81 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.974 -0.721 . . . . 0.0 109.701 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 117' ' ' ALA . 4.3 pt -99.14 134.83 21.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.108 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' A' ' 99' ' ' PHE . 36.1 Cg_exo -57.96 95.89 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.978 0.989 . . . . 0.0 111.058 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.4 m -57.89 -18.74 24.81 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.663 -0.648 . . . . 0.0 111.412 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 14.2 p-10 -90.03 19.16 5.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.153 -0.967 . . . . 0.0 111.934 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 20.6 m-85 -155.19 52.26 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -160.52 170.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.421 -0.799 . . . . 0.0 111.396 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.896 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -120.72 126.07 49.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.789 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.243 -0.911 . . . . 0.0 112.809 -177.716 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 . . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.634 HG12 HG13 ' A' ' 106' ' ' VAL . 59.6 mt -96.23 137.42 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.778 -1.201 . . . . 0.0 108.717 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.8 m -125.34 170.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.4 p -124.59 122.93 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.6 -0.688 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.86 123.53 20.82 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 84.2 mt -94.32 -2.4 52.26 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.703 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.479 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 62.2 m-85 -151.67 151.14 31.07 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.135 -0.978 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -62.71 147.09 50.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.61 -0.681 . . . . 0.0 110.236 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.445 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 53.3 t80 -154.56 134.05 12.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.559 -0.713 . . . . 0.0 110.916 179.362 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -98.4 136.62 38.29 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.585 -0.697 . . . . 0.0 111.713 -179.204 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.834 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 121.442 -0.786 . . . . 0.0 111.22 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.834 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 32.6 p30 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.911 0.386 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 119' ' ' SER . 49.7 tp -153.25 132.34 12.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.0 116.26 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.916 -0.49 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.632 ' CE2' HG22 ' A' ' 128' ' ' ILE . 15.6 p90 -108.65 -176.27 3.0 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.324 178.299 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -176.63 3.31 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.278 1.037 . . . . 0.0 112.104 -178.221 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.3 ttmt -60.48 -27.07 67.28 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.352 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.14 43.67 1.15 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -178.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 1.3 m-20 -91.04 165.32 13.59 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.233 -179.085 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.2 131.99 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.507 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.2 mpp? -138.77 152.22 47.74 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.634 HG13 HG12 ' A' ' 82' ' ' ILE . 11.8 t -102.1 147.84 8.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 81' ' ' ILE . 71.5 t -94.94 139.22 19.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.025 -1.047 . . . . 0.0 109.976 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.41 -30.27 13.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -156.51 159.57 38.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.74 -0.6 . . . . 0.0 110.332 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.0 147.97 27.23 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.4 t -135.99 -75.07 0.44 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 170.9 -44.74 0.19 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -127.61 -40.27 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.621 -0.929 . . . . 0.0 110.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -116.7 107.97 15.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.106 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CH2' ' HB3' ' A' ' 130' ' ' SER . 35.5 m0 -98.29 151.88 20.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.819 . . . . 0.0 110.002 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -97.57 118.1 33.32 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.706 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.41 168.23 17.95 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.1 ttt180 -116.73 121.55 41.95 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.608 -0.683 . . . . 0.0 109.634 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.738 ' HB2' HD21 ' A' ' 97' ' ' LEU . 46.2 t -73.81 121.3 20.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.827 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.98 -29.35 65.31 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.14 62.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.436 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -136.87 9.39 3.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 110.795 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 51.92 30.31 7.07 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.045 -1.035 . . . . 0.0 110.706 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 14.9 mttt -101.85 176.76 5.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 2.4 pm0 -155.66 143.78 19.97 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.154 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.62 -149.83 6.36 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.549 ' O ' HG23 ' A' ' 128' ' ' ILE . 76.2 m-85 -95.22 162.42 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.755 -0.85 . . . . 0.0 110.72 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.632 HG22 ' CE2' ' A' ' 99' ' ' PHE . 3.0 pt -155.5 113.67 2.24 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.613 -0.679 . . . . 0.0 110.182 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -53.29 110.06 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.154 1.081 . . . . 0.0 111.541 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.456 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 8.8 m -59.03 -18.48 35.01 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.897 -0.502 . . . . 0.0 110.917 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -71.96 -0.79 12.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.421 -0.799 . . . . 0.0 113.094 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.53 40.61 1.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.912 -1.117 . . . . 0.0 109.863 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -150.06 169.65 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.729 . . . . 0.0 111.315 -178.404 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.748 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -122.54 137.25 54.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.217 0.532 . . . . 0.0 110.325 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.895 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 111.518 -178.821 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.703 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 90.2 mt -98.3 155.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.299 -0.96 . . . . 0.0 108.619 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 135' ' ' ARG . 29.7 m -138.41 174.6 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.367 -0.833 . . . . 0.0 110.2 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.901 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.3 p -133.89 128.15 53.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -70.79 120.28 16.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.497 -0.752 . . . . 0.0 109.145 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 134' ' ' ALA . 77.2 mt -94.28 0.39 55.59 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.284 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.3 m-85 -152.21 151.13 30.61 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.57 150.58 48.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.406 -0.809 . . . . 0.0 110.05 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 42.5 t80 -153.65 136.55 15.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.339 -0.851 . . . . 0.0 111.094 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 3.7 tt0 -101.06 142.36 32.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.794 -0.566 . . . . 0.0 111.163 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.772 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.502 2.15 0 O-C-N 121.393 -0.817 . . . . 0.0 110.535 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.772 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.0 p30 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 119' ' ' SER . 16.7 tp -151.82 128.75 10.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.2 m -95.2 105.36 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.204 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.659 ' CD2' HG22 ' A' ' 128' ' ' ILE . 16.9 p90 -103.01 -168.1 1.47 Allowed 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.774 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.32 178.87 5.36 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.408 1.099 . . . . 0.0 112.859 -177.888 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 86' ' ' LEU . 13.0 ttmt -60.92 -19.41 60.58 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.595 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 42.37 1.13 Allowed Glycine 0 C--N 1.281 -2.512 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.47 164.14 14.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.525 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.94 110.78 15.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.637 -0.664 . . . . 0.0 109.853 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.0 mtm -124.84 143.45 50.82 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -96.53 160.21 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.396 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 81' ' ' ILE . 60.9 t -94.02 138.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.982 -1.074 . . . . 0.0 110.613 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.19 -29.25 14.63 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -156.0 163.62 39.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.838 -0.539 . . . . 0.0 109.649 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -121.23 121.11 37.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.503 -0.748 . . . . 0.0 110.75 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.7 t -123.23 -60.96 1.46 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 114' ' ' TRP . . . 150.19 129.54 1.68 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 65.97 -68.01 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.549 -0.971 . . . . 0.0 110.505 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 114' ' ' TRP . . . . . 0.401 ' N ' ' O ' ' A' ' 112' ' ' GLY . 95.9 m95 -98.77 109.64 22.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.275 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 46.3 m0 -108.13 147.94 30.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.147 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.42 162.82 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.338 -0.851 . . . . 0.0 112.205 -178.121 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 7.5 tmm_? -111.1 125.48 53.81 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.495 -0.753 . . . . 0.0 109.374 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.593 ' HB2' HD21 ' A' ' 97' ' ' LEU . 31.8 t -88.14 122.81 32.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.06 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.96 -26.17 63.05 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.503 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.49 -32.87 42.27 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.438 -0.788 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 p -134.5 10.19 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.617 -0.677 . . . . 0.0 110.334 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.04 31.9 14.56 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.081 -1.012 . . . . 0.0 110.545 -179.248 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 53.8 mttt -104.37 -178.04 3.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.04 139.71 17.04 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.889 0.852 . . . . 0.0 111.349 179.14 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.44 -156.59 10.94 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 128' ' ' ILE . 53.0 m-85 -93.47 157.85 16.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.891 . . . . 0.0 110.693 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.659 HG22 ' CD2' ' A' ' 99' ' ' PHE . 1.3 pt -155.61 110.93 2.19 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.9 102.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 122.802 0.896 . . . . 0.0 110.805 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.404 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 1.1 m -62.01 -15.32 43.38 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.706 -0.621 . . . . 0.0 111.313 -178.922 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -64.66 -11.33 34.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.161 -0.962 . . . . 0.0 111.478 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.431 ' C ' HG23 ' A' ' 133' ' ' VAL . 10.7 m-85 -130.03 43.41 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 134' ' ' ALA . 61.5 t -145.76 170.81 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 -177.643 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.901 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -124.09 125.63 44.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.529 -0.732 . . . . 0.0 109.341 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 83' ' ' VAL . 9.4 ttt180 . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.423 -0.798 . . . . 0.0 112.522 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.496 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 106' ' ' VAL . 48.3 mt -95.11 139.31 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.78 -1.2 . . . . 0.0 108.504 178.098 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.6 m -126.93 166.95 22.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.444 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.2 p -121.16 128.35 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.219 178.438 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' HA2' ' A' ' 102' ' ' GLY . . . -68.78 145.76 53.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.054 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 9.6 mt -106.74 -15.84 14.64 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.851 0.751 . . . . 0.0 110.972 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 87.8 m-85 -149.01 153.99 38.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.293 -0.88 . . . . 0.0 109.559 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -56.43 149.45 16.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.703 -0.623 . . . . 0.0 111.625 -178.604 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -155.42 126.89 7.3 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.731 -0.605 . . . . 0.0 110.353 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -100.5 130.59 46.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.766 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 121.32 -0.863 . . . . 0.0 111.442 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.766 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 2.8 t0 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.611 HD13 ' N ' ' A' ' 98' ' ' SER . 0.6 OUTLIER -121.47 127.21 50.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.314 -0.866 . . . . 0.0 111.107 -178.543 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.611 ' N ' HD13 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -97.35 93.33 6.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.625 -0.672 . . . . 0.0 109.251 178.479 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 128' ' ' ILE . 31.5 p90 -97.56 -173.97 2.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.082 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -118.4 -164.89 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.67 0.747 . . . . 0.0 111.368 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 2.0 ttmt -53.9 -90.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.581 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 102' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 85' ' ' ALA . . . -93.45 65.49 1.82 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.4 m-20 -91.64 167.58 12.1 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.967 -0.725 . . . . 0.0 111.549 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.66 120.26 32.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 110.181 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.407 ' HG3' ' HA ' ' A' ' 119' ' ' SER . 2.5 mpp? -128.69 156.73 43.0 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.52 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 24.5 t -103.07 151.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 84.0 t -95.64 139.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.133 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -97.18 -30.55 12.94 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.66 0.743 . . . . 0.0 109.522 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -156.39 158.07 36.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.94 -0.475 . . . . 0.0 109.925 -178.679 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -99.6 152.07 20.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.384 -0.822 . . . . 0.0 109.588 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -146.95 -75.71 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.91 -92.72 0.08 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.85 -27.08 14.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.935 . . . . 0.0 109.611 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -110.39 107.29 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 0.0 109.401 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -100.1 148.02 25.03 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.303 -0.873 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 116' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 11.5 tttt -96.35 111.6 23.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.686 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -126.84 169.47 13.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.871 0.843 . . . . 0.0 111.856 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.5 ttt180 -114.14 123.7 50.25 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.628 -0.67 . . . . 0.0 109.693 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.407 ' HA ' ' HG3' ' A' ' 105' ' ' MET . 1.1 t -78.29 111.98 14.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.741 -0.599 . . . . 0.0 109.537 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.483 HD11 ' CG2' ' A' ' 106' ' ' VAL . 8.4 mt -65.48 -24.41 67.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.856 -0.527 . . . . 0.0 110.351 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.44 -31.24 69.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 p -133.93 16.29 3.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.566 . . . . 0.0 110.459 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.51 29.91 2.24 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.266 -0.896 . . . . 0.0 110.857 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.8 mttt -96.82 177.18 5.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.66 134.93 12.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.086 0.946 . . . . 0.0 112.023 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -166.37 -156.7 9.69 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.48 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 32.0 m-85 -93.03 160.69 14.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.746 -0.855 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.5 pt -152.98 107.66 2.66 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.835 -0.54 . . . . 0.0 109.99 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.45 100.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.263 1.138 . . . . 0.0 111.572 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.2 m -60.62 -13.69 15.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.666 -0.646 . . . . 0.0 112.288 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -65.0 -11.0 33.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.123 -0.986 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.1 45.22 2.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.897 . . . . 0.0 108.877 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 134' ' ' ALA . 98.7 t -145.07 171.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.774 -0.578 . . . . 0.0 109.719 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.817 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -133.46 124.58 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.539 -0.725 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.786 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 111.728 -178.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.834 0.349 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 106' ' ' VAL . 61.2 mt -98.71 152.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.866 HG12 ' HA ' ' A' ' 135' ' ' ARG . 27.6 m -138.41 179.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.541 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.9 p -134.61 121.29 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -60.7 115.37 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 134' ' ' ALA . 62.2 mt -94.54 10.78 33.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.447 -178.953 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CD2' ' HA ' ' A' ' 132' ' ' TYR . 33.4 m-85 -154.35 151.42 29.03 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.019 -1.051 . . . . 0.0 109.686 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.69 146.6 48.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.312 -0.867 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 52.4 t80 -153.57 169.48 23.14 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.006 -1.059 . . . . 0.0 110.988 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -151.56 99.17 2.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.694 . . . . 0.0 110.517 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.4 -0.813 . . . . 0.0 110.515 179.675 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.43 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 22.2 p30 . . . . . 0 N--CA 1.506 2.365 0 CA-C-O 120.822 0.344 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 119' ' ' SER . 1.4 tp -135.76 146.99 48.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.248 -0.907 . . . . 0.0 112.035 -177.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.0 m -96.92 167.26 11.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.808 -0.558 . . . . 0.0 110.074 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 20.8 p90 -165.32 -167.46 1.17 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.405 -0.809 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -126.19 176.55 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.042 0.925 . . . . 0.0 111.506 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.443 ' HA ' ' N ' ' A' ' 87' ' ' TYR . 15.3 ttmt -61.25 -19.18 61.4 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -177.332 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.72 41.48 1.41 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 2.5 m-20 -90.94 166.43 13.04 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.704 -0.88 . . . . 0.0 111.508 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.41 131.17 54.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.605 -0.684 . . . . 0.0 109.461 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.414 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 60.7 mtm -140.53 148.67 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG2' HD11 ' A' ' 120' ' ' LEU . 41.6 t -95.67 155.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' ILE . 69.3 t -95.73 142.5 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.159 -0.963 . . . . 0.0 110.464 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 117' ' ' ALA . 3.6 mp -95.66 -31.1 13.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -156.24 -177.45 6.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.742 -0.599 . . . . 0.0 110.472 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.45 94.8 3.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.504 -0.748 . . . . 0.0 110.306 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -94.66 -75.13 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.434 -0.791 . . . . 0.0 110.304 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.82 -98.88 0.11 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.486 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.41 -50.1 68.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.403 -1.057 . . . . 0.0 110.814 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.67 140.97 41.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.613 -0.679 . . . . 0.0 109.469 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.71 121.95 36.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.386 -0.821 . . . . 0.0 108.997 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.729 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -138.07 162.98 32.75 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.978 -179.066 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.5 ttt180 -114.57 125.89 54.29 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.555 -0.715 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.678 ' HB2' HD21 ' A' ' 97' ' ' LEU . 15.3 t -78.16 121.4 24.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 120' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.3 mt -70.52 -26.91 63.8 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.18 63.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.599 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -138.1 12.49 2.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.513 -0.742 . . . . 0.0 111.089 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 52.18 30.21 7.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.009 -1.057 . . . . 0.0 110.738 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.58 ' HB2' HD11 ' A' ' 97' ' ' LEU . 6.0 mttp -103.14 176.32 5.19 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.95 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -155.87 150.08 25.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.416 -0.803 . . . . 0.0 111.356 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 126' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' A' ' 97' ' ' LEU . . . -166.58 -140.04 2.8 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.815 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 128' ' ' ILE . 68.9 m-85 -113.34 154.24 27.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 122.03 -0.688 . . . . 0.0 110.746 -178.649 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 127' ' ' TYR . 19.4 pt -153.49 134.98 8.67 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.822 -0.549 . . . . 0.0 110.161 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 128' ' ' ILE . 6.4 Cg_exo -69.01 124.74 11.7 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 O-C-N 123.085 1.045 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.9 m -51.94 -35.31 45.41 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.519 -0.738 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -75.34 -6.91 52.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.49 -0.756 . . . . 0.0 111.701 -178.989 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' TYR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 87' ' ' TYR . 3.3 m-85 -104.78 24.02 12.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.157 -0.964 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' A' ' 83' ' ' VAL . 5.7 p -161.26 169.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.531 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.787 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -118.58 135.29 54.51 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.718 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.866 ' HA ' HG12 ' A' ' 83' ' ' VAL . 3.4 tpp180 . . . . . 0 N--CA 1.485 1.29 0 O-C-N 121.297 -0.877 . . . . 0.0 112.779 -178.436 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' ILE . . . . . 0.445 HG13 ' HB ' ' A' ' 107' ' ' VAL . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ILE . . . . . 0.64 HG23 HG12 ' A' ' 106' ' ' VAL . 86.9 mt -109.17 161.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.894 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 135' ' ' ARG . 16.3 m -138.95 167.63 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.714 0.768 . . . . 0.0 110.637 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.4 p -130.2 123.42 55.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.007 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' ALA . . . . . 0.543 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -68.9 121.57 16.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.454 -0.899 . . . . 0.0 109.361 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 134' ' ' ALA . 19.7 mt -94.04 0.03 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' TYR . . . . . 0.488 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 65.3 m-85 -151.14 151.18 31.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.242 -0.911 . . . . 0.0 109.041 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.68 145.9 54.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.517 -0.74 . . . . 0.0 110.178 -179.465 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 40.5 t80 -153.54 132.92 12.8 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.201 -0.937 . . . . 0.0 111.025 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -100.95 133.4 45.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.776 -0.577 . . . . 0.0 111.675 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.11 0 O-C-N 121.48 -0.762 . . . . 0.0 110.363 179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 96' ' ' ASP . . . . . 0.434 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 7.4 p30 . . . . . 0 N--CA 1.505 2.318 0 CA-C-O 121.085 0.469 . . . . 0.0 111.902 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 119' ' ' SER . 0.6 OUTLIER -130.07 153.61 48.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.436 -0.79 . . . . 0.0 111.493 -178.186 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m -98.93 116.38 31.03 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.418 0.628 . . . . 0.0 109.767 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 128' ' ' ILE . 16.2 p90 -104.62 -172.29 2.07 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.839 -0.538 . . . . 0.0 110.016 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.1 -178.83 4.32 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.389 1.09 . . . . 0.0 112.439 -178.048 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' LYS . . . . . 0.488 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -60.75 -22.72 64.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.28 43.15 1.08 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 m-20 -90.54 165.14 13.94 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.311 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.05 109.76 14.96 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.573 -0.705 . . . . 0.0 109.718 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' MET . . . . . 0.491 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 1.5 mpp? -126.7 147.21 49.97 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' VAL . . . . . 0.64 HG12 HG23 ' A' ' 82' ' ' ILE . 4.5 m -99.02 158.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.27 -178.945 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 81' ' ' ILE . 39.6 t -94.09 143.06 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.395 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -98.06 -28.26 13.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.501 0.667 . . . . 0.0 109.512 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -156.32 168.26 27.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.734 -0.604 . . . . 0.0 109.591 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -115.48 109.54 17.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.453 -0.78 . . . . 0.0 109.261 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -96.95 -66.68 0.89 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.284 -0.885 . . . . 0.0 110.76 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 -56.49 0.24 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -119.33 -31.28 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.944 . . . . 0.0 109.752 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -121.67 101.97 7.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -94.8 154.15 17.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.406 -0.808 . . . . 0.0 109.846 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -94.48 135.67 35.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 117' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -143.7 159.61 42.18 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.217 -177.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.5 ttm180 -112.82 122.51 47.86 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.743 0.783 . . . . 0.0 110.174 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' SER . . . . . 0.578 ' HB2' HD22 ' A' ' 97' ' ' LEU . 8.5 t -84.23 129.53 34.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.829 -0.544 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.1 -26.56 53.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.925 -0.484 . . . . 0.0 110.561 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.9 65.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 109.745 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -129.48 4.89 5.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.843 -0.535 . . . . 0.0 110.662 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.45 28.32 9.44 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.996 -1.065 . . . . 0.0 109.678 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 124' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 64.9 mttt -109.18 -173.89 2.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.603 -0.685 . . . . 0.0 109.919 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 125' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -154.87 153.88 31.83 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.337 -0.852 . . . . 0.0 111.034 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.56 -124.16 0.7 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 127' ' ' TYR . . . . . 0.482 ' O ' HG23 ' A' ' 128' ' ' ILE . 60.7 m-85 -127.82 157.4 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.73 -0.865 . . . . 0.0 109.732 -179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 128' ' ' ILE . . . . . 0.68 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.3 pt -153.08 106.24 2.63 Favored Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.429 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -47.31 113.08 0.63 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.013 1.142 . . . . 0.0 111.731 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 130' ' ' SER . . . . . 0.412 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 11.0 m -59.86 -15.4 20.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.709 -0.62 . . . . 0.0 111.849 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -75.67 1.5 14.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.91 -1.119 . . . . 0.0 111.951 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -144.97 45.09 1.35 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.926 -1.109 . . . . 0.0 110.711 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.5 p -153.28 168.84 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 110.874 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' ALA . . . . . 0.792 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -124.28 116.44 22.65 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.681 ' HA ' HG12 ' A' ' 83' ' ' VAL . 10.9 ttp180 . . . . . 0 C--N 1.311 -1.094 0 O-C-N 121.24 -0.912 . . . . 0.0 112.069 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 137' ' ' ASP . 27.6 mt-10 -72.75 -177.65 2.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.089 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -139.18 -152.74 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -127.41 43.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.968 ' CD1' HG13 ' A' ' 106' ' ' VAL . 5.8 mm -96.54 132.86 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.009 -1.057 . . . . 0.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.9 m -120.52 168.12 13.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.571 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -125.16 133.66 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -78.85 121.02 24.3 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.854 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 134' ' ' ALA . 3.7 mt -94.23 3.33 55.39 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.433 ' N ' ' HA ' ' A' ' 101' ' ' LYS . 80.6 m-85 -153.16 152.86 31.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -69.97 142.59 52.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.37 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 68.6 t80 -151.72 131.87 13.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.427 -0.795 . . . . 0.0 110.137 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 9.6 tp10 -101.9 141.01 35.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.725 . . . . 0.0 111.036 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.86 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -54.67 177.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.623 -0.673 . . . . 0.0 111.283 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 tt -174.26 35.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.702 . . . . 0.0 110.362 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.47 -164.73 0.61 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -73.29 -74.4 0.18 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 14.2 tp10 -86.02 54.58 3.19 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.86 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 44.7 p30 -93.46 175.73 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 119' ' ' SER . 62.8 tp -154.89 124.64 6.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.0 111.102 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.3 m -95.14 113.48 25.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.746 -0.596 . . . . 0.0 110.148 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.616 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.8 p90 -109.83 -173.28 2.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.965 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 179.52 4.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.188 0.994 . . . . 0.0 111.996 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' LEU . 12.1 ttmt -61.05 -20.93 63.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.4 41.2 1.31 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.3 m-20 -90.99 164.29 14.03 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.16 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.33 135.22 55.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 75.7 mtm -140.27 151.96 45.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.32 0.581 . . . . 0.0 109.647 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.968 HG13 ' CD1' ' A' ' 82' ' ' ILE . 43.2 t -101.43 147.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' ILE . 90.8 t -95.12 139.89 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.019 -1.051 . . . . 0.0 110.113 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.9 mp -97.05 -27.5 14.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -156.07 161.33 40.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.674 -0.641 . . . . 0.0 109.853 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -107.58 143.44 36.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.436 -0.79 . . . . 0.0 109.816 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -153.05 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.831 . . . . 0.0 110.388 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.09 -113.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -94.99 -16.69 22.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.668 -0.901 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -100.62 101.09 11.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.604 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.8 m0 -97.53 148.96 22.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.436 -0.79 . . . . 0.0 110.204 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -98.14 111.37 23.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.71 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.08 169.26 13.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.186 -0.946 . . . . 0.0 112.302 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -113.03 118.57 35.17 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 121.69 -0.631 . . . . 0.0 109.757 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.564 ' HB2' HD21 ' A' ' 97' ' ' LEU . 14.9 t -72.45 115.4 11.67 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 106' ' ' VAL . 5.3 mt -67.88 -27.65 66.86 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.124 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.4 61.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 0.0 110.389 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p -137.7 10.67 2.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.456 -0.777 . . . . 0.0 110.78 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 53.1 26.76 5.16 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.083 -1.011 . . . . 0.0 110.567 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.6 mtmt -102.12 176.67 5.12 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.58 143.0 19.46 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.29 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.38 -152.26 7.55 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.535 ' O ' HG23 ' A' ' 128' ' ' ILE . 47.1 m-85 -93.76 158.46 15.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.601 HG22 ' CD2' ' A' ' 99' ' ' PHE . 1.5 pt -155.53 115.39 2.27 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.843 -0.535 . . . . 0.0 109.778 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.76 104.32 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 122.945 0.971 . . . . 0.0 110.993 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 m -63.49 -12.37 31.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.613 -0.679 . . . . 0.0 111.426 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -68.03 -8.92 41.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.075 -1.016 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -132.68 35.94 3.57 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 134' ' ' ALA . 90.1 t -139.84 173.16 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.925 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.629 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -134.01 129.26 35.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.811 ' HA ' HG12 ' A' ' 83' ' ' VAL . 3.7 tmm_? -85.12 137.06 33.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.419 -0.801 . . . . 0.0 111.969 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 135' ' ' ARG . 31.4 m -151.48 170.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' CB ' ' HA ' ' A' ' 79' ' ' GLU . 3.5 p30 -94.39 24.07 4.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.855 . . . . 0.0 110.581 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 136' ' ' VAL . 1.8 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.168 0.508 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HA ' ' CB ' ' A' ' 137' ' ' ASP . 12.4 mt-10 -75.16 153.4 38.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.45 -0.781 . . . . 0.0 110.079 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -134.86 -159.66 0.98 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.427 -0.796 . . . . 0.0 109.385 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -125.02 41.58 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.998 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.706 HG12 HG13 ' A' ' 106' ' ' VAL . 56.0 mt -97.02 139.45 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.072 -1.018 . . . . 0.0 109.115 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 135' ' ' ARG . 25.5 m -128.78 179.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.295 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.3 p -131.59 126.73 58.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.496 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.591 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -68.96 119.78 13.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 134' ' ' ALA . 42.8 mt -94.01 1.34 56.26 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.071 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 60.0 m-85 -152.63 152.17 31.47 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.94 148.98 50.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.492 -0.755 . . . . 0.0 110.487 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 77.1 t80 -155.15 127.44 7.78 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.47 -0.769 . . . . 0.0 111.13 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.84 132.73 43.18 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.568 -0.708 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -54.76 155.3 4.35 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.456 -0.777 . . . . 0.0 111.018 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.45 HG23 ' C ' ' A' ' 91' ' ' ALA . 3.1 pt -154.56 43.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.79 -0.569 . . . . 0.0 109.566 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -178.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.457 -0.777 . . . . 0.0 109.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -58.24 -73.82 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.443 -0.786 . . . . 0.0 111.048 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 4.6 tp10 -89.13 45.59 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.319 -0.863 . . . . 0.0 110.437 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.523 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 0.7 OUTLIER -102.4 128.49 48.97 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.429 -0.794 . . . . 0.0 109.421 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tt -112.33 143.17 43.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.436 -0.79 . . . . 0.0 111.102 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -96.4 122.36 39.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.728 -0.607 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.591 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 13.7 p90 -114.03 -171.29 1.88 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.654 -0.654 . . . . 0.0 109.6 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 179.56 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.133 0.968 . . . . 0.0 111.9 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -60.76 -22.55 64.16 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.38 41.94 1.28 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.1 m-20 -90.91 165.99 13.29 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.805 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.18 128.68 51.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.529 -0.732 . . . . 0.0 109.132 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -136.96 150.47 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.767 -0.583 . . . . 0.0 109.613 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 82' ' ' ILE . 23.3 t -101.27 151.01 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 81' ' ' ILE . 99.4 t -94.58 141.46 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.022 -1.048 . . . . 0.0 110.077 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -96.78 -30.93 12.9 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.645 0.736 . . . . 0.0 109.029 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -156.36 162.2 40.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.773 -0.579 . . . . 0.0 109.729 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.72 154.26 19.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.453 -0.78 . . . . 0.0 109.896 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.8 t -147.65 -75.65 0.18 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.403 -0.811 . . . . 0.0 110.433 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.86 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 114' ' ' TRP . 2.4 tt0 -92.93 -16.04 25.63 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.94 . . . . 0.0 110.832 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 113' ' ' GLU . 85.8 m95 -132.25 107.63 8.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.452 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.423 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 31.3 m0 -100.88 155.58 17.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.292 -0.88 . . . . 0.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -97.16 111.73 23.83 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.28 168.32 14.92 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.082 0.944 . . . . 0.0 112.609 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.7 ttt180 -112.61 121.9 46.12 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.628 -0.67 . . . . 0.0 109.647 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t -74.87 110.02 8.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.912 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.28 -21.72 66.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.827 -0.546 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.88 -24.92 67.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.4 p -140.71 15.08 2.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.232 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 50.91 27.21 3.04 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.695 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 18.8 mttt -97.13 179.9 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 109.319 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -155.9 149.01 24.44 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.945 0.879 . . . . 0.0 111.791 179.347 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -176.88 -153.98 11.41 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.548 ' O ' HG23 ' A' ' 128' ' ' ILE . 53.2 m-85 -93.49 165.03 12.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.628 -0.925 . . . . 0.0 109.391 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.2 pt -155.41 116.48 2.33 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 109.901 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -48.0 104.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.138 1.073 . . . . 0.0 111.847 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.1 m -60.12 -16.53 33.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.944 -0.473 . . . . 0.0 111.276 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.469 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 3.3 p-10 -83.91 12.11 6.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.102 -0.999 . . . . 0.0 112.06 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.469 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 3.8 m-85 -146.93 39.74 1.04 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 134' ' ' ALA . 3.8 p -146.82 168.86 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.857 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -121.16 134.04 55.21 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.277 0.561 . . . . 0.0 110.189 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.836 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.2 tpt180 -90.91 127.74 36.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 112.177 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.06 167.09 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.44 0.638 . . . . 0.0 110.34 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.424 ' CB ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 p30 -94.39 -159.18 0.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.223 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.159 0.504 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -85.16 117.72 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.553 -0.717 . . . . 0.0 109.945 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -123.66 -158.71 0.82 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.774 . . . . 0.0 109.791 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -129.22 51.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.42 -0.8 . . . . 0.0 111.224 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.55 HG12 HG13 ' A' ' 106' ' ' VAL . 63.5 mt -99.2 150.12 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.964 -1.085 . . . . 0.0 108.87 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 135' ' ' ARG . 33.5 m -137.13 171.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.287 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.777 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -124.49 124.14 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.52 118.42 10.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.904 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.0 mt -94.25 1.86 55.94 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.102 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.456 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 56.0 m-85 -151.54 150.83 30.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.218 -0.927 . . . . 0.0 108.726 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -70.55 144.23 51.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.527 -0.733 . . . . 0.0 110.319 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 72.5 t80 -155.54 131.89 10.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.253 -0.905 . . . . 0.0 111.531 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 0.0 OUTLIER -96.9 146.23 25.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.617 . . . . 0.0 110.364 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.804 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -58.26 178.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.451 -0.781 . . . . 0.0 110.676 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 tt -172.88 36.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -173.41 -166.09 0.31 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.893 -1.129 . . . . 0.0 110.305 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -70.8 -74.8 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.326 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 3.6 tp10 -83.62 57.32 4.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.887 . . . . 0.0 109.205 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.804 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 46.8 p30 -99.66 168.6 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.732 -0.605 . . . . 0.0 110.344 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 119' ' ' SER . 7.5 tp -150.63 126.32 10.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.459 -0.775 . . . . 0.0 111.264 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 2.2 m -94.68 117.82 30.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 110.171 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.1 p90 -114.57 -169.87 1.62 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.725 -0.61 . . . . 0.0 110.266 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.94 179.78 4.88 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.284 1.04 . . . . 0.0 112.422 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.6 ttmt -61.18 -22.1 64.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.54 41.32 1.29 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 171.6 9.15 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.915 -0.756 . . . . 0.0 112.026 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.5 130.26 51.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.429 -0.794 . . . . 0.0 109.52 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.29 153.39 50.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.639 . . . . 0.0 109.747 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.55 HG13 HG12 ' A' ' 82' ' ' ILE . 21.5 t -103.95 149.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 81' ' ' ILE . 58.9 t -95.57 138.02 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.164 -0.96 . . . . 0.0 109.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -96.57 -29.0 14.11 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.447 0.641 . . . . 0.0 109.469 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -155.63 149.41 25.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.777 -0.577 . . . . 0.0 109.786 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -96.19 144.59 26.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.718 . . . . 0.0 109.292 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 t -134.88 -66.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.7 -64.18 0.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -112.34 -29.86 7.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.601 -0.941 . . . . 0.0 110.047 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -125.25 103.36 7.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.709 -0.62 . . . . 0.0 109.876 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -97.31 153.78 17.84 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 0.0 110.598 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -97.97 117.29 31.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.19 167.66 15.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.189 -0.945 . . . . 0.0 112.485 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.1 ttt180 -114.96 126.33 54.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.657 -0.652 . . . . 0.0 109.416 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.681 ' HB2' HD21 ' A' ' 97' ' ' LEU . 3.8 t -79.42 118.81 21.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.83 -25.21 64.54 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.565 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p -128.05 7.11 6.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.672 -0.642 . . . . 0.0 110.897 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 119' ' ' SER . 0.3 OUTLIER 52.91 32.22 12.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.066 -1.021 . . . . 0.0 110.305 -179.122 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.8 mttm -100.78 178.86 4.57 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -154.89 137.13 14.84 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.008 0.908 . . . . 0.0 111.6 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -164.39 -147.95 5.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 128' ' ' ILE . 76.7 m-85 -94.18 164.15 13.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.622 -0.928 . . . . 0.0 110.787 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.6 pt -153.83 104.5 2.49 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.56 106.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.931 0.964 . . . . 0.0 111.774 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 m -59.46 -18.49 40.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.947 -0.47 . . . . 0.0 111.097 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -73.4 -1.26 17.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.366 -0.834 . . . . 0.0 112.596 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -142.65 46.7 1.58 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.6 p -150.09 169.72 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.607 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.904 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -120.21 122.55 41.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.828 ' HA ' HG12 ' A' ' 83' ' ' VAL . 2.6 tmm_? -85.11 136.97 33.32 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.815 0.817 . . . . 0.0 112.625 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.3 m -139.82 132.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.422 0.629 . . . . 0.0 109.421 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.98 -24.68 11.92 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.553 -0.717 . . . . 0.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.114 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.106 0.479 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.43 119.27 30.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.466 -0.771 . . . . 0.0 110.46 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 66.9 m-20 -99.28 -152.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.457 -0.777 . . . . 0.0 109.955 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.479 HG23 ' O ' ' A' ' 81' ' ' ILE . 3.6 tp -112.22 45.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.62 HG12 HG13 ' A' ' 106' ' ' VAL . 77.4 mt -115.11 165.61 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 135' ' ' ARG . 12.0 m -143.64 171.1 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.78 129.37 58.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -71.9 119.8 16.59 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.689 -0.804 . . . . 0.0 108.898 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 134' ' ' ALA . 61.7 mt -94.12 0.05 55.6 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.895 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.9 m-85 -151.97 152.39 32.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -68.83 145.05 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.461 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 79.4 t80 -152.39 125.32 8.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.409 -0.807 . . . . 0.0 110.576 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 20.9 tp10 -94.76 134.11 37.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 110.003 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -54.13 165.9 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.401 -0.812 . . . . 0.0 110.719 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 tt -163.16 41.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.714 -0.616 . . . . 0.0 109.995 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -174.91 -175.97 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.239 -0.913 . . . . 0.0 110.138 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -63.87 -69.57 0.27 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.562 -0.712 . . . . 0.0 110.448 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 20.9 tt0 -88.98 46.81 1.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.587 -0.696 . . . . 0.0 109.812 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.419 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.1 t70 -108.96 126.4 53.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.0 139.78 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 0.0 111.532 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.4 m -95.29 118.63 32.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.617 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.533 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 12.2 p90 -112.95 -171.7 1.91 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.0 110.048 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.93 -178.54 4.09 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.187 0.994 . . . . 0.0 112.379 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.1 ttmt -61.12 -23.06 65.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.27 41.71 1.23 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.84 167.51 12.4 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.738 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -121.04 128.27 52.5 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.469 -0.769 . . . . 0.0 109.702 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -136.97 150.39 48.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.62 HG13 HG12 ' A' ' 82' ' ' ILE . 11.3 t -95.26 152.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.454 ' CG1' HD11 ' A' ' 81' ' ' ILE . 38.4 t -94.02 134.49 31.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -94.68 -27.3 15.92 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -156.56 -169.5 3.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.69 -0.631 . . . . 0.0 110.314 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -150.98 115.06 5.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.497 -0.752 . . . . 0.0 109.961 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -127.4 -68.4 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.47 142.74 3.47 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 65.44 -69.18 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.632 -0.922 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -109.47 117.24 33.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 110.256 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.427 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 53.8 m0 -107.02 154.19 21.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.25 118.77 32.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -133.39 159.12 41.26 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.138 -0.976 . . . . 0.0 112.285 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -111.52 126.72 55.28 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.469 -0.769 . . . . 0.0 110.166 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 t -81.25 112.06 18.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 109.532 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.509 HD11 ' CG2' ' A' ' 106' ' ' VAL . 20.5 mt -65.89 -20.86 66.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.889 -0.507 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.67 73.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.9 p -129.4 11.39 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.753 -0.592 . . . . 0.0 110.658 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.69 30.14 8.37 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 27.6 mtpt -102.16 178.27 4.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.62 -0.675 . . . . 0.0 109.385 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.76 149.11 24.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.745 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -173.59 -150.42 7.52 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 68.8 m-85 -93.27 162.22 14.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.745 -0.856 . . . . 0.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.2 pt -153.0 108.75 2.66 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.733 -0.604 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.51 108.11 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.027 1.014 . . . . 0.0 111.735 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.433 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 12.1 m -57.36 -15.33 6.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.776 -0.578 . . . . 0.0 111.804 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -76.7 5.54 7.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.131 -0.98 . . . . 0.0 112.808 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -151.17 38.72 0.65 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.89 -1.131 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 134' ' ' ALA . 3.3 p -146.79 168.51 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.81 141.46 46.41 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.43 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.733 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -85.08 122.53 29.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.701 0.762 . . . . 0.0 110.577 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.01 167.92 12.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 80' ' ' ASP . 22.0 p-10 -94.56 -153.77 0.39 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.538 -0.726 . . . . 0.0 110.345 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.482 -178.891 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.955 0.407 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.95 137.41 38.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' H ' ' HA ' ' A' ' 137' ' ' ASP . 3.2 m-20 -158.41 -163.26 1.25 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.502 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.524 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -114.31 54.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.58 178.73 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 136' ' ' VAL . 66.6 mt -96.93 157.43 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.869 -1.144 . . . . 0.0 109.558 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 135' ' ' ARG . 33.8 m -139.94 172.2 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.3 p -130.24 120.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB2' ' HE1' ' A' ' 105' ' ' MET . . . -62.56 118.42 7.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.792 . . . . 0.0 109.222 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 134' ' ' ALA . 69.2 mt -94.46 2.46 55.74 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.447 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.2 m-85 -153.67 152.87 31.32 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.14 -0.975 . . . . 0.0 108.831 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.35 144.29 53.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.391 -0.818 . . . . 0.0 110.447 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 48.2 t80 -155.4 127.95 7.89 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.396 -0.815 . . . . 0.0 110.793 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.87 149.35 21.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.422 -0.799 . . . . 0.0 110.771 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.781 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -59.57 170.02 1.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.467 -0.77 . . . . 0.0 109.929 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 tt -171.41 38.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 109.817 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -171.46 -168.34 0.6 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.246 -0.909 . . . . 0.0 109.851 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -74.09 -70.82 0.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.482 -0.761 . . . . 0.0 110.124 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 8.6 tp10 -86.53 54.44 3.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.885 . . . . 0.0 108.93 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.781 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.6 p30 -98.79 173.52 6.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.678 -0.638 . . . . 0.0 110.425 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' A' ' 119' ' ' SER . 5.9 tt -155.07 128.67 8.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.321 -0.862 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -94.79 117.02 29.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.404 -0.81 . . . . 0.0 110.494 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 128' ' ' ILE . 19.0 p90 -115.94 -170.03 1.71 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.724 -0.61 . . . . 0.0 110.501 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 179.4 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.343 1.068 . . . . 0.0 112.525 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.9 ttmt -61.08 -20.72 62.94 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 41.16 1.33 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 1.9 m-20 -91.02 170.51 9.98 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.746 -0.855 . . . . 0.0 111.693 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.87 129.28 47.92 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.513 -0.742 . . . . 0.0 109.49 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.534 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 3.1 mpp? -137.48 152.94 50.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.738 -0.601 . . . . 0.0 109.444 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.5 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 25.4 t -101.08 152.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 88.3 t -95.39 141.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.031 -1.043 . . . . 0.0 110.527 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -156.04 159.44 39.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.877 -0.515 . . . . 0.0 110.117 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -102.2 152.08 21.44 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.511 -0.743 . . . . 0.0 109.581 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -146.25 -66.95 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.142 -0.973 . . . . 0.0 111.019 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.13 -84.34 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -98.48 -20.89 16.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.591 -0.947 . . . . 0.0 110.777 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.85 107.51 9.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 109.506 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.44 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 41.6 m0 -101.26 155.06 18.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.39 -0.818 . . . . 0.0 110.886 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -100.6 111.96 24.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.749 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.09 169.71 13.11 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.241 1.02 . . . . 0.0 112.717 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.5 ttt180 -113.0 124.73 53.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.844 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.612 ' HB2' HD21 ' A' ' 97' ' ' LEU . 20.0 t -78.08 115.08 17.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.95 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.43 -23.77 66.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.847 -0.533 . . . . 0.0 110.114 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.26 -30.51 66.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.806 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.4 p -136.35 12.26 3.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.834 -0.541 . . . . 0.0 110.952 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.89 30.95 7.72 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.062 -1.024 . . . . 0.0 110.461 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.9 mttt -100.18 -179.88 4.27 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.22 137.25 14.63 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.035 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.26 6.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.543 ' O ' HG23 ' A' ' 128' ' ' ILE . 70.7 m-85 -94.24 162.85 13.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.578 -0.954 . . . . 0.0 111.317 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.6 pt -155.31 111.03 2.25 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.998 -0.439 . . . . 0.0 110.166 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -45.36 101.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.04 1.021 . . . . 0.0 112.0 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.44 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.2 m -51.89 -28.87 17.65 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -81.57 11.62 4.49 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.298 -0.876 . . . . 0.0 112.569 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -136.79 30.87 2.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.061 -1.025 . . . . 0.0 108.589 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -147.98 170.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.803 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -119.32 129.27 54.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.724 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -93.16 114.17 26.59 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.522 -0.736 . . . . 0.0 112.924 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 82' ' ' ILE . 28.4 m -103.19 146.37 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.418 ' HA ' ' H ' ' A' ' 80' ' ' ASP . 2.3 p30 -154.28 40.2 0.47 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.303 -0.873 . . . . 0.0 109.582 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.926 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.048 0.451 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.41 46.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.428 ' N ' ' HA ' ' A' ' 137' ' ' ASP . 9.8 m-20 -150.91 -157.59 0.83 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.541 -0.725 . . . . 0.0 110.543 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.8 OUTLIER -97.18 52.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.134 -0.979 . . . . 0.0 109.69 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 80.7 mt -111.66 166.95 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.728 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 135' ' ' ARG . 13.4 m -143.53 169.04 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.722 -0.611 . . . . 0.0 109.678 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.0 p -131.95 126.53 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.778 . . . . 0.0 108.948 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.97 118.24 10.16 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.84 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 1.029 HD11 ' HB2' ' A' ' 134' ' ' ALA . 86.9 mt -94.18 1.26 56.08 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.874 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.49 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 55.9 m-85 -152.99 151.1 29.9 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.197 -0.939 . . . . 0.0 108.652 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.05 145.99 55.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.587 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CD1' ' HG2' ' A' ' 129' ' ' PRO . 69.1 t80 -150.31 163.84 37.29 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.502 -0.749 . . . . 0.0 110.611 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.76 125.59 22.53 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.61 -0.682 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -49.95 168.42 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.456 -0.778 . . . . 0.0 111.268 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 tt -167.14 39.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.636 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -169.52 -164.99 0.47 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.731 -0.606 . . . . 0.0 109.67 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -69.38 -74.7 0.12 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 110.914 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 5.2 tp10 -89.98 50.89 1.95 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.721 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.2 t0 -100.46 128.04 46.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.485 -0.759 . . . . 0.0 109.598 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' A' ' 119' ' ' SER . 40.1 tp -107.57 129.19 55.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.76 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -94.5 176.8 6.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.699 -0.625 . . . . 0.0 109.953 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 11.6 p90 -172.98 -167.48 0.42 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.494 -0.754 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -176.88 3.64 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.125 0.964 . . . . 0.0 111.539 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.0 ttmt -61.08 -22.73 64.89 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.38 44.7 1.0 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.78 166.51 13.07 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.13 116.96 25.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.45 -0.781 . . . . 0.0 110.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.415 ' HE1' ' CD2' ' A' ' 99' ' ' PHE . 68.5 mtm -129.78 146.36 51.53 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -98.54 156.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.545 -1.262 . . . . 0.0 108.71 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 81' ' ' ILE . 43.3 t -93.62 139.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.01 0.909 . . . . 0.0 109.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -94.54 -30.76 14.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -156.23 161.2 40.29 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.71 144.68 31.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 0.0 109.975 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -139.03 -77.93 0.34 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.392 -0.817 . . . . 0.0 110.318 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.28 -85.29 0.07 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -94.27 -13.2 26.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.896 . . . . 0.0 110.596 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -133.47 96.66 3.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.775 . . . . 0.0 110.163 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.421 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 31.7 m0 -94.91 146.04 24.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.243 -0.911 . . . . 0.0 109.787 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -95.21 117.06 29.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -129.57 165.77 21.05 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.039 0.923 . . . . 0.0 112.419 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.9 ttm180 -115.01 124.54 51.9 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.593 -0.692 . . . . 0.0 109.961 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.753 ' HB2' HD21 ' A' ' 97' ' ' LEU . 4.8 t -83.92 118.77 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.68 -0.638 . . . . 0.0 109.932 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.25 -20.8 62.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.398 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.24 -26.93 66.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.0 109.864 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p -137.62 10.99 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.766 -0.584 . . . . 0.0 110.606 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 53.64 30.81 11.53 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.147 -0.971 . . . . 0.0 110.755 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -104.79 174.0 6.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.526 -0.734 . . . . 0.0 109.27 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.83 146.66 22.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.694 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -176.27 -147.19 6.33 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 36.2 m-85 -93.44 160.59 14.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.648 -0.913 . . . . 0.0 110.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.2 pt -152.14 117.57 3.05 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HG2' ' CD1' ' A' ' 89' ' ' TYR . 35.0 Cg_exo -41.33 103.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.323 1.349 . . . . 0.0 112.843 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.421 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 74.2 m -62.36 -15.1 46.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.865 -0.522 . . . . 0.0 111.008 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -86.13 13.87 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 111.522 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -152.23 40.2 0.61 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.252 -0.905 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.2 p -149.09 168.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.421 -0.799 . . . . 0.0 110.831 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 1.029 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -127.82 127.81 44.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.975 -0.453 . . . . 0.0 109.93 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.683 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -95.15 129.43 42.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.454 -178.82 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 82' ' ' ILE . 10.9 m -102.96 129.29 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.428 ' HA ' ' N ' ' A' ' 80' ' ' ASP . 2.6 p30 -155.65 -165.96 2.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.988 -0.445 . . . . 0.0 109.838 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.917 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.057 0.456 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 137' ' ' ASP . 45.5 mt-10 -88.87 125.67 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.615 -0.678 . . . . 0.0 110.534 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 59.6 m-20 -100.61 -150.57 0.39 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.407 -0.808 . . . . 0.0 109.625 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 107' ' ' VAL . 4.9 tp -120.51 41.66 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.169 -0.957 . . . . 0.0 111.082 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.662 HD13 ' C ' ' A' ' 138' ' ' SER . 7.0 mt -110.31 167.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 108.436 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 135' ' ' ARG . 3.8 m -146.17 167.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.669 . . . . 0.0 110.617 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.6 p -128.51 124.16 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.63 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.9 117.57 9.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 134' ' ' ALA . 79.8 mt -94.39 5.53 51.5 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.257 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.431 ' N ' ' HA ' ' A' ' 101' ' ' LYS . 38.9 m-85 -152.44 151.74 31.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -70.17 141.99 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 109.536 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 65.4 t80 -155.53 126.95 7.25 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.349 -0.844 . . . . 0.0 111.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -100.1 122.02 42.32 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.506 0.67 . . . . 0.0 109.895 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.66 ' HB1' ' OD2' ' A' ' 96' ' ' ASP . . . -55.91 161.98 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.508 0.671 . . . . 0.0 111.903 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.07 64.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.634 -0.666 . . . . 0.0 109.571 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.2 -157.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.94 -72.12 0.59 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.432 -0.792 . . . . 0.0 110.693 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 19.8 tp10 -74.04 -8.08 54.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.082 -1.011 . . . . 0.0 110.176 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.66 ' OD2' ' HB1' ' A' ' 91' ' ' ALA . 20.1 p-10 -48.23 156.96 0.35 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.348 -0.845 . . . . 0.0 111.505 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 125' ' ' GLU . 7.9 tt -137.54 134.34 35.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.415 -0.803 . . . . 0.0 110.47 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -94.44 166.94 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 110.001 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.63 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 24.0 p90 -164.76 -170.78 2.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.291 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -124.37 179.88 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.328 1.061 . . . . 0.0 112.69 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HA ' ' N ' ' A' ' 87' ' ' TYR . 16.6 ttmt -60.95 -19.32 60.75 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.34 41.22 1.31 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.0 m-20 -90.9 166.06 13.26 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.686 -0.89 . . . . 0.0 111.527 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.05 111.31 15.82 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.561 -0.712 . . . . 0.0 110.112 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.9 mtm -126.01 147.41 49.55 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.1 m -95.02 157.33 3.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.073 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 83' ' ' VAL . 73.9 t -93.98 135.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.201 1.001 . . . . 0.0 110.329 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -94.98 -27.62 15.56 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.632 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -155.61 177.45 11.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.75 -0.594 . . . . 0.0 109.844 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.81 94.52 3.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -97.29 -152.87 0.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.678 -0.639 . . . . 0.0 110.084 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.33 -114.66 0.07 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -86.54 -6.87 58.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.948 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -119.0 102.81 9.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 109.669 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -98.72 157.11 16.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.421 -0.799 . . . . 0.0 110.645 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 5.9 mttt -97.51 121.72 39.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.24 161.32 32.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.351 -0.843 . . . . 0.0 111.83 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.8 ttm180 -114.97 122.35 45.98 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.545 -0.722 . . . . 0.0 109.83 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.5 t -84.48 127.33 33.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.645 -0.659 . . . . 0.0 110.456 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.88 -26.59 60.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.114 -0.366 . . . . 0.0 110.715 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.76 66.15 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.42 -0.8 . . . . 0.0 110.671 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p -128.31 9.4 6.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.688 . . . . 0.0 110.566 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.48 33.78 19.56 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -107.82 176.98 4.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.562 -0.711 . . . . 0.0 109.087 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pm0 -155.26 137.99 15.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.39 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -162.41 -149.71 5.76 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 75.9 m-85 -94.52 161.35 14.25 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 122.032 -0.687 . . . . 0.0 110.69 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.52 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -155.4 117.59 2.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -48.62 109.38 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.036 1.019 . . . . 0.0 111.73 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 m -56.96 -18.2 12.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.765 -0.584 . . . . 0.0 111.719 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 18.7 4.27 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.096 -1.003 . . . . 0.0 111.631 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -145.74 36.66 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 134' ' ' ALA . 8.9 p -154.86 169.21 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.784 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.65 132.54 39.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.062 0.458 . . . . 0.0 110.301 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.688 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -75.2 119.36 19.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.882 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.08 151.96 14.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.473 ' HB3' ' HA ' ' A' ' 79' ' ' GLU . 31.0 p-10 -96.89 38.07 1.26 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.745 -0.597 . . . . 0.0 110.098 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.662 ' C ' HD13 ' A' ' 82' ' ' ILE . 3.2 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.279 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . 0.599 ' C ' HD12 ' A' ' 82' ' ' ILE . 5.3 t . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 121.336 0.588 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.713 ' N ' HD12 ' A' ' 82' ' ' ILE . 18.6 mt-10 57.13 -152.49 0.39 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.474 -0.766 . . . . 0.0 110.188 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.475 ' N ' ' HA ' ' A' ' 137' ' ' ASP . 1.6 m-20 61.63 -103.03 0.13 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.401 -0.812 . . . . 0.0 110.586 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.603 HG23 ' O ' ' A' ' 81' ' ' ILE . 1.4 tp -112.8 56.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.881 -1.137 . . . . 0.0 109.575 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 79' ' ' GLU . 88.0 mt -123.16 159.18 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 135' ' ' ARG . 17.2 m -137.83 169.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.9 p -130.01 123.96 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.587 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.26 120.67 14.18 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.045 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 134' ' ' ALA . 85.3 mt -94.26 1.12 56.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.95 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.6 m-85 -152.48 152.53 32.06 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.49 146.23 54.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 36.7 t80 -155.15 127.68 7.91 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.35 -0.844 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -98.03 144.4 27.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.427 -0.796 . . . . 0.0 111.551 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.746 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -56.78 147.23 23.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.665 -0.647 . . . . 0.0 111.585 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.61 -67.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.586 -0.696 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -59.92 -167.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.198 -0.939 . . . . 0.0 110.734 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -81.12 -48.8 11.66 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 127' ' ' TYR . 12.6 tp10 -95.76 52.99 1.38 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.746 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 40.3 p30 -92.28 -179.11 5.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.204 0.526 . . . . 0.0 111.498 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 98' ' ' SER . 0.9 OUTLIER -154.35 121.89 5.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 110.106 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.521 ' N ' HD13 ' A' ' 97' ' ' LEU . 1.1 m -94.52 112.0 23.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 110.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.587 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 14.4 p90 -114.83 -169.24 1.51 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.806 -0.559 . . . . 0.0 109.959 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -178.15 4.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.062 0.934 . . . . 0.0 111.72 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -60.95 -20.56 62.43 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.01 42.51 1.13 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.7 m-20 -91.05 169.21 11.06 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.947 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.33 125.65 43.81 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.495 0.664 . . . . 0.0 109.547 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.486 ' HE3' ' HB2' ' A' ' 85' ' ' ALA . 3.2 mpp? -134.4 153.95 51.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.616 ' CG2' HD11 ' A' ' 120' ' ' LEU . 36.6 t -94.41 152.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.576 HG11 HD11 ' A' ' 81' ' ' ILE . 33.6 t -95.57 134.93 31.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.902 0.858 . . . . 0.0 110.142 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.715 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -95.64 -27.83 15.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.54 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -156.05 -168.92 2.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.596 0.712 . . . . 0.0 111.128 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -143.62 99.22 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.64 -0.662 . . . . 0.0 109.562 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 t -94.42 -71.47 0.66 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 110.697 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.88 -77.21 0.07 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -94.04 -22.7 18.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.488 -1.007 . . . . 0.0 110.298 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.423 ' HZ3' ' HH ' ' A' ' 89' ' ' TYR . 84.0 m95 -133.83 108.27 8.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.539 -0.726 . . . . 0.0 110.217 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.402 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 34.0 m0 -98.98 158.9 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -100.27 126.65 46.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.416 -0.802 . . . . 0.0 109.094 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.715 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -135.73 162.6 32.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 112.164 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.3 ttt180 -111.35 120.54 42.53 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.391 -0.818 . . . . 0.0 109.829 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.441 ' HB2' HD11 ' A' ' 97' ' ' LEU . 1.1 t -72.41 110.71 7.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.485 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.616 HD11 ' CG2' ' A' ' 106' ' ' VAL . 7.3 mt -64.96 -26.0 68.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 -29.95 70.88 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.632 -0.668 . . . . 0.0 110.097 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.0 p -129.53 8.61 5.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 110.883 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 53.66 29.25 9.07 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.135 -0.978 . . . . 0.0 109.86 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -97.48 176.24 5.94 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.74 140.59 17.18 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.765 0.793 . . . . 0.0 111.464 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.24 -150.01 6.83 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.5 ' O ' HG23 ' A' ' 128' ' ' ILE . 52.8 m-85 -93.92 165.28 12.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.905 -0.762 . . . . 0.0 110.805 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.529 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.7 pt -155.29 112.56 2.27 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 34.3 Cg_exo -42.67 102.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.109 1.206 . . . . 0.0 112.078 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.402 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 71.6 m -54.9 -20.6 9.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.906 -0.496 . . . . 0.0 111.513 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -90.26 25.32 2.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.214 -0.928 . . . . 0.0 111.63 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -154.99 32.02 0.4 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 109.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -149.02 169.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.579 -0.7 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -132.79 123.88 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.683 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 ttp180 -91.76 126.53 36.88 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 112.455 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 79' ' ' GLU . 29.9 m -94.58 140.81 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.475 ' HA ' ' N ' ' A' ' 80' ' ' ASP . 2.9 p30 -141.51 -157.21 0.75 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.955 -0.466 . . . . 0.0 109.967 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.153 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.99 165.04 7.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.625 -0.672 . . . . 0.0 110.502 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -138.22 -162.55 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.567 -0.708 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -121.86 46.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.641 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.962 ' CD1' HG13 ' A' ' 106' ' ' VAL . 4.9 mm -96.65 140.1 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.064 -1.022 . . . . 0.0 108.882 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 135' ' ' ARG . 32.2 m -126.33 174.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.428 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.882 HG12 ' HB3' ' A' ' 134' ' ' ALA . 7.1 p -127.66 123.66 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.655 -0.653 . . . . 0.0 109.365 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.577 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.36 119.41 11.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 134' ' ' ALA . 64.5 mt -94.3 4.2 54.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.561 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.463 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.1 m-85 -152.63 151.5 30.68 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.031 -1.043 . . . . 0.0 109.117 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 74.6 m-20 -69.13 143.14 54.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.352 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 58.9 t80 -155.12 131.15 10.15 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.181 -0.949 . . . . 0.0 111.019 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -97.4 142.19 29.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.7 -0.625 . . . . 0.0 110.723 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.774 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -55.93 175.21 0.1 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.0 tt -172.23 39.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.533 -0.729 . . . . 0.0 110.278 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -173.29 -168.3 0.45 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.288 -0.882 . . . . 0.0 110.217 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -72.44 -74.25 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.398 -0.814 . . . . 0.0 109.828 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 10.7 tp10 -83.36 55.59 3.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.356 -0.84 . . . . 0.0 109.15 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.774 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 53.2 p-10 -101.36 170.97 7.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.606 . . . . 0.0 109.809 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 119' ' ' SER . 55.4 tp -151.9 129.33 11.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.312 -0.868 . . . . 0.0 111.14 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.76 116.65 28.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.686 -0.634 . . . . 0.0 110.295 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.3 p90 -113.62 -170.92 1.79 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.579 -0.7 . . . . 0.0 109.958 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -125.71 -179.77 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.032 0.92 . . . . 0.0 111.831 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.463 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.14 -23.36 65.47 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.7 40.9 1.37 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.96 171.08 9.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.049 -0.677 . . . . 0.0 111.543 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 139.55 53.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.484 -0.76 . . . . 0.0 109.781 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 71.8 mtm -142.95 154.01 43.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.79 -0.569 . . . . 0.0 110.178 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.962 HG13 ' CD1' ' A' ' 82' ' ' ILE . 22.4 t -100.77 147.89 7.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 81' ' ' ILE . 95.4 t -94.92 138.93 19.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.881 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.14 -25.69 14.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.04 155.33 32.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.749 -0.595 . . . . 0.0 110.05 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -108.7 133.16 53.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 109.916 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.8 t -132.6 -85.38 0.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.279 -0.888 . . . . 0.0 110.658 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.96 -91.76 0.08 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.88 -16.83 30.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.585 -0.95 . . . . 0.0 110.807 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -127.59 104.9 8.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.371 -0.831 . . . . 0.0 110.468 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 44.5 m0 -101.95 153.56 19.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.249 -0.907 . . . . 0.0 109.984 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -102.78 113.21 26.44 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.737 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.02 167.93 16.01 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.127 -0.983 . . . . 0.0 112.675 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HB2' HD11 ' A' ' 108' ' ' LEU . 1.1 ttt180 -115.76 124.01 49.71 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.65 -0.656 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.822 ' HB2' HD21 ' A' ' 97' ' ' LEU . 24.2 t -78.98 120.82 24.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.624 -0.673 . . . . 0.0 109.741 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mt -71.75 -21.81 61.7 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.17 73.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.4 -0.812 . . . . 0.0 109.656 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 p -130.56 9.54 5.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.726 -0.609 . . . . 0.0 110.735 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.23 31.3 13.87 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.042 -1.036 . . . . 0.0 110.641 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.5 mtpt -104.51 173.3 6.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.6 OUTLIER -154.6 140.35 18.08 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.644 179.632 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.03 -146.04 4.71 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.491 ' O ' HG23 ' A' ' 128' ' ' ILE . 72.7 m-85 -94.15 157.81 15.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 122.056 -0.673 . . . . 0.0 110.6 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.568 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.7 pt -154.0 113.59 2.53 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.794 -0.566 . . . . 0.0 109.796 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.62 97.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.277 1.146 . . . . 0.0 112.062 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 66.9 m -49.56 -24.6 2.21 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.684 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -85.71 16.4 4.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.403 -0.811 . . . . 0.0 111.755 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.71 29.15 1.93 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.2 -0.938 . . . . 0.0 109.147 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.3 p -146.69 169.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.669 0.747 . . . . 0.0 110.901 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.882 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -119.7 135.71 54.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.867 -0.52 . . . . 0.0 110.072 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.848 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -93.95 128.1 40.08 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.39 -0.818 . . . . 0.0 111.696 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.7 m -146.39 179.9 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.63 . . . . 0.0 109.985 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -94.18 -158.08 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.751 . . . . 0.0 109.852 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.286 -179.713 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.202 0.525 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.8 84.02 0.91 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.532 -0.73 . . . . 0.0 110.295 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 3.5 m-20 -161.03 -167.06 1.72 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.495 -0.753 . . . . 0.0 109.975 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -94.8 58.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.801 -1.187 . . . . 0.0 109.566 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 136' ' ' VAL . 49.0 mt -107.88 157.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.902 -1.124 . . . . 0.0 109.055 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 135' ' ' ARG . 28.9 m -139.86 173.12 11.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.815 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.6 p -133.09 121.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.42 118.94 9.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.707 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' A' ' 134' ' ' ALA . 90.5 mt -94.15 0.75 55.99 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.253 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 41.0 m-85 -150.13 149.72 30.66 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.257 -0.902 . . . . 0.0 108.834 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -66.24 151.31 47.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -153.94 167.78 28.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.374 -0.829 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 94.06 2.17 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.169 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' A' ' 96' ' ' ASP . . . -60.13 161.91 6.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.587 -0.696 . . . . 0.0 111.013 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.1 mt -130.85 -31.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.312 -0.867 . . . . 0.0 111.693 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -157.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.033 -1.042 . . . . 0.0 111.065 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -91.26 -70.72 0.67 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.354 -0.842 . . . . 0.0 111.161 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -66.12 -17.53 64.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.942 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 20.2 p-10 -42.08 146.8 0.27 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.766 -0.584 . . . . 0.0 112.074 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 119' ' ' SER . 2.3 tt -133.43 134.66 43.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 110.431 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 m -94.7 170.2 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.594 -0.691 . . . . 0.0 109.976 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.571 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 18.4 p90 -161.02 -169.14 2.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.623 -0.673 . . . . 0.0 110.638 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.98 179.22 4.73 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.259 1.028 . . . . 0.0 112.523 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -61.12 -23.02 65.21 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.36 43.62 1.08 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.3 m-20 -90.53 167.85 12.27 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.894 -0.768 . . . . 0.0 111.396 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.47 128.61 50.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.589 -0.694 . . . . 0.0 109.717 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -137.45 148.1 45.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 38.4 t -95.08 155.16 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 81' ' ' ILE . 49.4 t -95.13 140.51 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.159 -0.963 . . . . 0.0 110.634 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -97.59 -27.63 14.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -156.14 173.23 17.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.776 -0.578 . . . . 0.0 110.122 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -139.98 89.17 2.28 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.459 -0.775 . . . . 0.0 110.0 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.6 t -99.32 -68.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 110.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.86 154.59 7.27 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 65.14 -72.64 0.07 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.562 -0.963 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 39.4 m95 -108.86 126.4 53.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.94 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -106.39 141.62 37.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.521 -0.737 . . . . 0.0 110.213 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.6 114.02 25.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -130.31 164.89 23.65 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.841 0.829 . . . . 0.0 111.987 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.0 ttt180 -112.34 124.53 52.67 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.625 -0.672 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.727 ' HB2' HD21 ' A' ' 97' ' ' LEU . 6.8 t -78.88 114.39 17.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.578 . . . . 0.0 109.664 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.16 -27.7 68.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.51 . . . . 0.0 109.992 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.97 38.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.094 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -139.49 10.6 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.676 -0.64 . . . . 0.0 110.717 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 52.24 30.51 7.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.959 -1.088 . . . . 0.0 110.707 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 28.2 mttt -103.26 -178.75 3.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.4 OUTLIER -155.38 147.41 23.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.52 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -155.73 11.15 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 79.0 m-85 -94.18 157.75 15.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 122.045 -0.68 . . . . 0.0 110.348 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 127' ' ' TYR . 3.8 pt -155.0 125.58 3.41 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.641 -0.662 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.01 117.34 4.18 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 122.967 0.983 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 m -53.95 -34.43 59.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.789 -0.57 . . . . 0.0 111.989 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -71.33 -6.52 40.6 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.907 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -109.72 25.36 11.88 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.098 -1.001 . . . . 0.0 109.466 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -156.71 170.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.965 0.888 . . . . 0.0 112.175 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -124.65 127.1 46.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.844 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.8 ttp180 -91.59 118.13 30.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 112.58 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 82' ' ' ILE . 29.0 m -102.68 137.27 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.471 0.653 . . . . 0.0 109.532 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 37.2 t70 -155.8 30.52 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.865 -0.522 . . . . 0.0 110.114 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 -179.822 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.146 0.498 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 52.27 93.55 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.374 -0.829 . . . . 0.0 111.054 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -154.96 -162.56 1.39 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.54 -0.725 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.763 HD11 HG11 ' A' ' 107' ' ' VAL . 0.7 OUTLIER -95.33 58.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 83' ' ' VAL . 74.4 mt -119.34 164.48 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.938 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 135' ' ' ARG . 15.4 m -142.12 169.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -129.9 126.71 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.622 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -70.56 120.58 16.41 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.0 mt -94.33 3.2 55.52 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.187 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 44.9 m-85 -153.0 150.58 29.35 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 108.872 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.48 141.06 58.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 109.941 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 44.2 t80 -155.38 119.99 4.73 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.361 -0.837 . . . . 0.0 111.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.52 124.23 50.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.706 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -57.55 148.02 25.18 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.25 -0.906 . . . . 0.0 110.433 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.4 mt -103.0 -24.24 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.613 -0.68 . . . . 0.0 109.295 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -178.46 -169.96 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.563 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.56 -170.3 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.446 -0.783 . . . . 0.0 111.825 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 8.6 tp10 -81.88 55.99 2.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.706 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 24.0 t0 -95.66 137.2 35.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 119' ' ' SER . 37.4 tp -98.23 133.54 42.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.912 . . . . 0.0 111.734 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -94.56 162.42 13.81 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.622 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 13.6 p90 -171.53 -165.66 0.4 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.491 -0.756 . . . . 0.0 110.115 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 178.37 5.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.242 1.02 . . . . 0.0 112.247 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 16.7 ttmt -61.08 -21.49 63.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.74 40.57 1.44 Allowed Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.1 m-20 -91.0 169.55 10.79 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.852 -0.793 . . . . 0.0 112.131 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 122.04 36.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.561 -0.712 . . . . 0.0 110.116 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.7 mtm -127.69 152.85 47.19 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 120' ' ' LEU . 41.3 t -95.5 154.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.763 HG11 HD11 ' A' ' 81' ' ' ILE . 5.7 t -94.78 136.25 26.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.949 0.88 . . . . 0.0 109.699 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -96.89 -27.03 14.86 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.546 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -155.99 -174.42 4.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.706 -0.621 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -137.88 98.78 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.405 -0.809 . . . . 0.0 109.751 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 t -94.69 -77.98 0.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.51 -80.23 0.08 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -93.55 -8.66 40.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.945 . . . . 0.0 110.729 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -143.44 96.94 2.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.893 . . . . 0.0 110.076 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -95.65 157.87 15.71 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.098 -1.002 . . . . 0.0 110.781 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tttt -102.17 122.47 44.22 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.566 ' O ' HD22 ' A' ' 97' ' ' LEU . . . -132.16 159.96 37.46 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 112.37 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.0 ttt180 -113.0 124.41 52.57 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.496 -0.753 . . . . 0.0 109.937 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.701 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.1 t -81.51 119.21 23.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.622 . . . . 0.0 109.362 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.453 HD11 ' CG2' ' A' ' 106' ' ' VAL . 3.2 mt -71.15 -24.79 62.33 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.767 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.33 59.57 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.35 -0.844 . . . . 0.0 109.587 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 p -137.34 9.4 2.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.436 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.19 27.63 6.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.01 -1.056 . . . . 0.0 110.67 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 38.4 mttt -95.51 171.47 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.5 151.83 28.17 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.854 0.835 . . . . 0.0 111.849 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.412 ' HA2' ' HG3' ' A' ' 95' ' ' GLU . . . 177.07 -152.89 12.67 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 4.5 m-85 -92.92 153.36 18.83 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.865 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.55 132.31 14.18 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.803 -0.561 . . . . 0.0 110.404 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 39.0 Cg_exo -47.87 96.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.121 1.064 . . . . 0.0 111.677 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 m -55.87 -20.5 15.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.721 -0.612 . . . . 0.0 111.379 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.65 18.36 5.56 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.327 -0.858 . . . . 0.0 111.351 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -146.75 33.33 0.93 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -146.13 168.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.936 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.718 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -131.21 120.09 22.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.712 ' HA ' HG12 ' A' ' 83' ' ' VAL . 14.6 ttp180 -88.31 129.43 35.38 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.229 -0.92 . . . . 0.0 112.029 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 136' ' ' VAL . 25.9 m -98.88 130.43 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -155.54 -41.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.849 -0.532 . . . . 0.0 111.001 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.235 -179.756 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.957 0.408 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -166.36 71.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.489 -0.757 . . . . 0.0 110.486 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.494 ' N ' ' HA ' ' A' ' 137' ' ' ASP . 13.8 m-20 -149.24 -152.87 0.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.655 -0.653 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.585 HD11 HG11 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -98.23 54.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.849 -1.157 . . . . 0.0 109.397 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 83' ' ' VAL . 74.8 mt -118.14 164.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.873 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 135' ' ' ARG . 22.4 m -142.22 173.49 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.9 p -131.49 128.07 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.012 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.957 ' HA ' HG12 ' A' ' 133' ' ' VAL . . . -70.46 116.1 10.41 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 134' ' ' ALA . 77.2 mt -94.33 3.05 55.72 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.261 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.6 m-85 -149.71 150.32 31.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.198 -0.939 . . . . 0.0 108.906 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -71.75 145.02 49.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.166 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 19.6 t80 -155.5 121.95 5.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.465 -0.772 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 20.3 mt-10 -97.15 124.42 41.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.354 -0.841 . . . . 0.0 110.752 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.82 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . -60.67 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.575 -0.703 . . . . 0.0 111.323 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.1 mm -135.69 -70.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.225 -0.922 . . . . 0.0 110.679 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -175.1 53.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.084 -1.01 . . . . 0.0 110.396 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -167.32 -153.12 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.261 -0.9 . . . . 0.0 109.45 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 2.7 tp10 -54.81 -29.27 54.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.206 -0.934 . . . . 0.0 109.171 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.82 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 1.7 p30 -43.35 125.95 4.03 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 120.948 0.404 . . . . 0.0 111.239 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tt -109.28 146.19 34.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.513 -0.742 . . . . 0.0 111.024 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.8 m -97.29 119.97 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.821 -0.549 . . . . 0.0 109.777 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CE2' HG22 ' A' ' 128' ' ' ILE . 20.2 p90 -114.99 -170.92 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.587 -0.696 . . . . 0.0 110.742 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.73 177.28 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.295 1.045 . . . . 0.0 112.159 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 14.7 ttmt -61.32 -20.29 62.78 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.68 1.32 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.88 170.14 10.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.902 -0.763 . . . . 0.0 111.724 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.33 123.52 41.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 110.181 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.422 ' HE1' ' CG ' ' A' ' 99' ' ' PHE . 77.4 mtm -129.58 150.43 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.514 ' CG2' HD11 ' A' ' 120' ' ' LEU . 38.0 t -96.2 153.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 81' ' ' ILE . 24.8 t -95.2 134.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.84 0.829 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -95.03 -26.36 16.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.208 0.528 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -155.43 -177.37 6.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.067 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -145.17 95.19 2.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 t -104.88 -53.99 2.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.524 -0.735 . . . . 0.0 111.003 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.81 141.99 3.8 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 64.58 -72.41 0.06 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.646 -0.914 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -106.07 117.86 35.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 0.0 110.208 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -106.78 152.38 23.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.643 . . . . 0.0 110.207 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.69 117.2 31.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.541 -0.724 . . . . 0.0 109.187 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -130.21 162.5 28.79 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.623 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 4.6 ttt180 -114.88 124.51 51.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.7 -0.625 . . . . 0.0 109.889 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 t -78.23 117.06 19.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.482 -0.761 . . . . 0.0 109.654 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 106' ' ' VAL . 13.2 mt -67.35 -26.3 66.42 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.313 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.46 66.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -136.58 9.89 3.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.588 -0.695 . . . . 0.0 110.714 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.65 27.84 4.32 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.979 -1.075 . . . . 0.0 110.414 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 47.6 mttt -101.84 179.71 4.25 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.24 151.36 28.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.412 -0.805 . . . . 0.0 111.48 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 95' ' ' GLU . . . -173.1 -157.58 15.22 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.441 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 88.4 m-85 -94.03 151.35 19.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 122.311 -0.523 . . . . 0.0 109.703 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.479 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -154.04 130.12 5.45 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.58 -0.7 . . . . 0.0 110.575 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.69 107.51 0.75 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 109.347 -1.059 . . . . 0.0 109.347 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 m -55.34 -26.01 38.29 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.384 -0.822 . . . . 0.0 110.857 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' ND2' ' CD1' ' A' ' 132' ' ' TYR . 16.8 p-10 -71.28 -12.44 61.45 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.414 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.436 ' CD1' ' ND2' ' A' ' 131' ' ' ASN . 3.0 m-85 -100.54 9.23 42.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.957 HG12 ' HA ' ' A' ' 85' ' ' ALA . 35.2 m -138.5 -177.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 111.929 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.713 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -132.06 114.77 14.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.71 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -82.34 123.17 28.85 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.308 -0.87 . . . . 0.0 111.066 -178.197 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 136' ' ' VAL . 27.3 m -97.48 126.53 50.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.494 ' HA ' ' N ' ' A' ' 80' ' ' ASP . 7.1 p-10 -155.38 -42.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.942 -0.474 . . . . 0.0 110.677 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.239 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 137' ' ' ASP . 2.7 tt0 54.01 98.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 110.754 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -143.93 -164.01 1.79 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.572 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -121.13 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.905 . . . . 0.0 110.725 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 73.7 mt -98.47 144.73 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.746 -1.221 . . . . 0.0 109.889 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.893 HG12 ' HA ' ' A' ' 135' ' ' ARG . 28.0 m -127.45 174.62 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 110.785 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.78 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.6 p -130.38 126.22 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -69.63 121.17 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 134' ' ' ALA . 64.5 mt -94.43 1.83 55.78 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.738 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.478 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.6 m-85 -152.52 151.01 30.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.257 -0.902 . . . . 0.0 108.899 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -67.12 147.88 52.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.531 -0.731 . . . . 0.0 109.927 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.484 ' CZ ' ' HG3' ' A' ' 129' ' ' PRO . 54.4 t80 -153.89 146.35 24.02 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.354 -0.841 . . . . 0.0 111.768 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 114.88 23.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.538 0.685 . . . . 0.0 110.921 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.823 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -48.51 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.387 -0.821 . . . . 0.0 112.09 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -146.19 -58.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.617 -0.677 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.39 -173.48 0.1 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.241 -0.912 . . . . 0.0 111.929 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -64.5 -80.89 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 110.119 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 15.1 tp10 -74.62 63.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.823 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 55.4 p-10 -101.44 161.68 13.45 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 117' ' ' ALA . 40.9 tp -138.84 125.62 20.91 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.592 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -93.98 159.74 15.03 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.289 0.566 . . . . 0.0 109.587 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.558 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.5 p90 -163.36 -170.42 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.637 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -178.17 3.93 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.164 0.983 . . . . 0.0 112.162 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -61.07 -21.32 63.55 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.98 43.3 1.04 Allowed Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.5 m-20 -90.76 171.68 9.17 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.989 -0.712 . . . . 0.0 111.877 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.87 136.03 53.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.665 -0.647 . . . . 0.0 109.764 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 76.4 mtm -143.44 154.52 43.77 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.507 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 40.8 t -101.65 150.94 5.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 81' ' ' ILE . 61.9 t -95.5 138.21 21.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 O-C-N 121.241 -0.912 . . . . 0.0 110.542 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.736 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.87 -25.84 14.49 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.39 147.72 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.648 -0.658 . . . . 0.0 110.192 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.09 145.39 28.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.297 -0.877 . . . . 0.0 109.237 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -142.29 -71.5 0.33 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.51 -77.61 0.14 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.27 -10.22 30.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -1.014 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -147.71 107.15 3.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.272 -0.893 . . . . 0.0 110.585 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -104.21 155.61 18.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 17.7 tttt -105.17 116.74 32.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.736 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.05 169.41 14.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.897 . . . . 0.0 112.54 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 1.6 ttt180 -115.3 121.67 43.59 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 121.775 -0.578 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.3 t -77.6 116.11 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.676 -0.64 . . . . 0.0 109.765 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.63 -22.41 65.33 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.052 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.93 66.78 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.676 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.7 p -138.63 9.02 2.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.892 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 53.68 29.01 8.73 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.981 -1.074 . . . . 0.0 110.597 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 52.5 mttt -103.09 174.73 5.74 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -155.22 142.57 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.931 0.872 . . . . 0.0 111.406 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -169.22 -146.31 4.98 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 56.5 m-85 -93.49 161.39 14.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 122.058 -0.672 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 127' ' ' TYR . 3.4 pt -151.52 118.87 3.28 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.736 -0.603 . . . . 0.0 109.83 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 68.5 Cg_exo -40.76 99.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.37 1.38 . . . . 0.0 112.436 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -61.02 -19.68 61.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.905 -0.497 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 24.8 p30 -87.82 17.89 4.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.32 -0.862 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.428 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 4.5 m-85 -152.06 44.49 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.052 -1.03 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.497 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -154.18 168.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 111.023 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.78 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -123.41 138.98 54.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.882 -0.511 . . . . 0.0 110.37 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.893 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -101.66 120.29 40.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.397 -0.815 . . . . 0.0 112.088 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 82' ' ' ILE . 29.6 m -121.88 144.41 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 79' ' ' GLU . 3.1 p30 -106.61 47.49 0.88 Allowed 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.271 -0.893 . . . . 0.0 109.96 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.287 179.864 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.325 0.583 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.22 172.99 3.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.701 -0.624 . . . . 0.0 109.722 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -114.6 -161.58 0.78 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -115.2 42.76 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.715 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 137' ' ' ASP . 27.3 mt -97.55 124.91 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.056 -1.027 . . . . 0.0 109.206 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 135' ' ' ARG . 32.8 m -111.23 171.94 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.364 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.7 p -128.32 127.6 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.575 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.66 117.84 10.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.931 HD11 ' HB2' ' A' ' 134' ' ' ALA . 80.5 mt -94.54 4.26 54.08 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.297 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.423 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 27.6 m-85 -151.94 150.42 30.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -68.26 146.15 53.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 109.725 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.449 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 65.3 t80 -153.48 145.04 23.28 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.255 -0.903 . . . . 0.0 111.15 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -118.32 103.48 9.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.916 -0.49 . . . . 0.0 110.165 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HB1' ' HB2' ' A' ' 96' ' ' ASP . . . -56.51 155.13 7.61 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.46 -0.775 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.48 74.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.497 -0.752 . . . . 0.0 109.941 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -175.69 -155.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 -71.28 0.69 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.176 -0.952 . . . . 0.0 110.522 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 5.4 tp10 -65.0 -19.54 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -0.922 . . . . 0.0 109.453 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.852 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 19.2 p-10 -42.04 161.8 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.826 -0.546 . . . . 0.0 112.132 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 119' ' ' SER . 6.4 tt -148.45 130.91 15.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.699 -0.625 . . . . 0.0 110.227 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -94.8 151.57 19.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.612 -0.68 . . . . 0.0 110.157 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.5 p90 -142.43 -167.96 2.62 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.455 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -125.39 179.93 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.173 0.987 . . . . 0.0 112.119 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.0 ttmt -61.24 -20.07 62.4 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.54 41.49 1.32 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 84' ' ' VAL . 10.9 m-20 -91.06 165.04 13.73 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.744 -0.856 . . . . 0.0 112.408 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.1 mt-30 -120.13 130.69 54.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 178.743 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -138.75 153.14 48.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.469 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 20.9 t -100.83 152.61 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 81' ' ' ILE . 94.5 t -95.36 139.7 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.109 -0.995 . . . . 0.0 109.789 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -98.6 -27.18 14.13 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -156.23 159.46 38.93 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.88 105.34 13.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.216 -0.927 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 -151.96 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.4 -0.813 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.53 -107.22 0.61 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.91 -4.42 59.16 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.543 -0.975 . . . . 0.0 111.575 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 30.7 m95 -127.77 106.21 8.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.411 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 50.1 m0 -100.67 153.03 19.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 109.767 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -100.62 114.26 27.79 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.659 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.61 164.03 22.92 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.712 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -113.33 120.61 41.73 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.724 -0.61 . . . . 0.0 109.6 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.496 ' HB2' HD21 ' A' ' 97' ' ' LEU . 6.1 t -78.38 122.67 26.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.655 -0.653 . . . . 0.0 109.35 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.84 -27.88 63.19 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.934 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.45 31.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.443 -0.785 . . . . 0.0 109.85 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.8 p -137.81 10.33 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.613 . . . . 0.0 110.528 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 50.61 27.48 2.95 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.993 -1.067 . . . . 0.0 110.574 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 4.2 mttt -100.45 179.78 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.24 147.18 23.46 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.77 0.795 . . . . 0.0 111.183 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -171.57 -147.03 5.52 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.453 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 75.8 m-85 -94.42 157.39 16.04 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.091 -0.652 . . . . 0.0 110.606 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.9 pt -152.15 109.59 2.83 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.652 -0.655 . . . . 0.0 109.735 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HG3' ' CH2' ' A' ' 114' ' ' TRP . 51.3 Cg_exo -50.66 110.07 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 122.958 0.978 . . . . 0.0 111.56 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 24.0 m -59.88 -17.23 35.43 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.935 -0.478 . . . . 0.0 111.249 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -84.77 12.93 6.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.276 -0.89 . . . . 0.0 111.719 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -147.02 44.27 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 0.0 108.802 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.4 p -156.25 168.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.792 0.806 . . . . 0.0 111.317 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.931 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -128.61 127.6 42.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.727 ' HA ' HG12 ' A' ' 83' ' ' VAL . 4.2 tmm_? -88.23 140.03 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 112.474 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.451 HG13 ' C ' ' A' ' 135' ' ' ARG . 15.9 m -156.54 -168.66 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 82' ' ' ILE . 7.6 t70 -105.09 -24.05 12.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.811 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.169 -179.679 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.119 0.485 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.11 81.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -161.06 -165.05 1.27 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.022 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -95.42 55.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 0.0 109.446 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 136' ' ' VAL . 47.7 mt -104.29 155.91 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.915 -1.116 . . . . 0.0 109.448 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.6 m -139.01 176.5 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.836 HG12 ' HB3' ' A' ' 134' ' ' ALA . 3.9 p -134.28 122.69 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.549 -0.72 . . . . 0.0 109.414 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.42 120.36 13.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.84 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 134' ' ' ALA . 79.5 mt -94.09 1.47 56.15 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.483 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.8 m-85 -152.49 151.0 30.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.152 -0.967 . . . . 0.0 108.393 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 67.4 m-20 -66.61 148.46 51.87 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.501 -0.75 . . . . 0.0 110.339 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 46.2 t80 -155.3 131.05 9.91 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.317 -0.865 . . . . 0.0 111.31 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -100.09 137.73 38.14 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.403 -0.811 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.769 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -47.7 161.5 0.09 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.606 -0.684 . . . . 0.0 111.721 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -155.23 31.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.627 -0.671 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -173.05 -165.56 0.3 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.171 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -70.8 0.31 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.411 -0.806 . . . . 0.0 110.065 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 1.8 tt0 -86.24 50.67 2.03 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 0.0 109.4 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.769 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 50.3 p30 -93.94 176.27 6.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.779 -0.576 . . . . 0.0 110.09 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 119' ' ' SER . 61.2 tp -155.01 124.78 6.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.488 -0.758 . . . . 0.0 111.232 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.75 114.93 26.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.27 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.562 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 14.3 p90 -113.14 -168.86 1.38 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.63 -0.669 . . . . 0.0 110.057 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 1.8 tt0 -125.69 -178.33 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.352 1.073 . . . . 0.0 112.799 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.2 -23.9 65.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.95 42.42 1.19 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.52 166.84 13.0 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.649 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.17 128.75 50.47 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.691 -0.631 . . . . 0.0 109.377 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.416 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.8 mpp? -135.78 148.47 48.78 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 33.6 t -98.65 152.59 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' ILE . 58.2 t -95.05 138.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.16 -31.65 13.43 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -156.32 163.4 39.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.917 -0.49 . . . . 0.0 109.857 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.87 153.72 21.0 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.9 t -147.87 -68.62 0.24 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.03 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -99.57 -20.74 16.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.652 -0.91 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -121.43 102.33 8.19 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -99.19 150.78 21.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.932 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.4 tttt -94.75 112.73 24.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.56 166.59 18.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.257 -0.902 . . . . 0.0 112.246 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.8 ttt180 -112.75 124.93 53.69 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.479 ' HB2' HD21 ' A' ' 97' ' ' LEU . 42.2 t -77.85 115.1 17.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.455 HD11 ' CG2' ' A' ' 106' ' ' VAL . 20.5 mt -68.8 -24.93 64.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 110.625 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.69 67.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.802 . . . . 0.0 109.965 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p -135.99 9.29 3.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.605 -0.685 . . . . 0.0 110.798 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.36 30.63 12.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.045 -1.034 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 mmmm -99.68 177.73 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.262 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.44 139.0 15.96 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.83 0.824 . . . . 0.0 111.388 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -168.31 -150.71 6.74 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.54 ' O ' HG23 ' A' ' 128' ' ' ILE . 59.8 m-85 -93.89 162.73 13.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.718 -0.872 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.3 pt -155.45 111.7 2.23 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.713 -0.617 . . . . 0.0 109.866 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 O-C-N 123.038 1.02 . . . . 0.0 112.079 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.436 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 16.4 m -61.27 -17.11 51.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -76.79 1.48 17.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.208 -0.932 . . . . 0.0 112.316 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -141.84 46.82 1.66 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 134' ' ' ALA . 4.1 p -154.83 168.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.836 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -120.98 129.07 53.27 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.735 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -97.17 119.99 36.7 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.416 -0.803 . . . . 0.0 112.871 -178.072 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 82' ' ' ILE . 20.5 m -99.12 136.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -155.59 29.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.161 -179.815 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.06 49.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.5 -0.75 . . . . 0.0 109.992 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 7.4 m-20 -163.6 -171.11 2.42 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.731 -0.605 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -94.36 79.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.503 179.228 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.709 ' O ' HG22 ' A' ' 136' ' ' VAL . 69.0 mt -128.75 150.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.616 HG12 ' CG ' ' A' ' 135' ' ' ARG . 28.4 m -128.89 175.1 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 134' ' ' ALA . 8.5 p -132.74 118.12 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.632 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -63.33 116.18 5.26 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.2 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.949 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.6 mt -94.45 1.68 55.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.126 -0.359 . . . . 0.0 111.77 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.468 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 51.3 m-85 -151.25 151.75 32.28 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.98 144.54 54.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 109.685 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 33.6 t80 -152.28 131.78 13.0 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.125 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -99.79 139.73 35.03 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.277 0.56 . . . . 0.0 111.202 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.784 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -49.34 152.75 1.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.567 -0.708 . . . . 0.0 111.24 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.35 38.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.444 -0.785 . . . . 0.0 110.255 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.3 -167.76 0.35 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.21 -0.931 . . . . 0.0 110.765 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -69.0 -75.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.649 -0.657 . . . . 0.0 109.926 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 17.9 tp10 -88.33 54.39 3.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.437 -0.789 . . . . 0.0 109.473 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.784 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.9 p30 -94.09 169.21 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.48 HD12 ' CA ' ' A' ' 125' ' ' GLU . 6.3 tt -145.92 127.77 15.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 111.037 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -94.7 116.5 28.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.566 -0.709 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.632 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 12.1 p90 -114.35 -167.75 1.26 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.11 177.43 6.38 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.194 0.997 . . . . 0.0 111.942 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 1.3 ttmt -60.92 -18.78 58.72 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.75 38.19 1.3 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -91.03 171.77 9.03 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.802 -0.822 . . . . 0.0 111.871 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.72 136.75 54.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' HG23 ' A' ' 82' ' ' ILE . 69.6 mtm -140.33 155.64 46.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 t -98.68 152.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.486 ' HB ' HG13 ' A' ' 81' ' ' ILE . 84.8 t -94.41 133.42 35.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.934 0.873 . . . . 0.0 109.704 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -96.25 -26.99 15.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -156.4 179.63 9.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 0.0 109.291 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.57 86.26 2.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.173 -0.954 . . . . 0.0 110.389 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.0 t -96.2 -164.7 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.685 -0.634 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.11 139.79 15.06 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 66.43 -64.16 0.23 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.593 -0.946 . . . . 0.0 111.095 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -105.88 115.39 30.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -101.96 149.0 24.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.417 -0.802 . . . . 0.0 109.231 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 15.4 tttt -95.38 113.97 25.69 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.613 -0.68 . . . . 0.0 110.172 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.682 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -129.58 164.91 22.81 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.952 0.882 . . . . 0.0 112.34 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -114.03 124.32 51.85 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.473 -0.767 . . . . 0.0 110.364 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.417 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.4 t -80.09 123.08 27.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.338 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.67 -25.96 60.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.696 -0.627 . . . . 0.0 110.94 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.16 68.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.314 -0.867 . . . . 0.0 110.031 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p -127.79 7.68 6.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.832 -0.542 . . . . 0.0 110.36 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.55 31.98 13.42 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.991 -1.068 . . . . 0.0 110.128 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 35.6 mtpt -102.17 175.41 5.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.48 ' CA ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -155.62 143.24 19.61 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.669 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -168.21 -150.01 6.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 128' ' ' ILE . 66.5 m-85 -93.91 167.93 11.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.956 . . . . 0.0 109.994 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.5 pt -154.98 116.49 2.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -52.23 105.49 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 122.849 0.921 . . . . 0.0 111.594 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -19.33 7.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.715 -0.616 . . . . 0.0 111.241 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -83.88 20.08 1.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.249 -0.907 . . . . 0.0 111.746 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -154.29 39.69 0.46 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.021 -1.05 . . . . 0.0 109.288 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.2 p -154.0 170.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 111.112 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.949 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -129.36 120.57 25.8 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.616 ' CG ' HG12 ' A' ' 83' ' ' VAL . 3.5 ttm180 -89.12 129.76 35.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 113.148 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 82' ' ' ILE . 29.9 m -103.41 142.84 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 2.4 t0 -155.79 -154.6 0.5 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.894 -0.504 . . . . 0.0 109.652 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.026 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.149 0.499 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 48.64 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.521 -0.737 . . . . 0.0 111.331 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 39.1 m-20 -116.49 -157.68 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.504 HG13 ' HB ' ' A' ' 107' ' ' VAL . 2.4 tp -115.28 50.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 110.867 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.607 HG12 HG13 ' A' ' 106' ' ' VAL . 82.3 mt -115.6 164.71 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 107' ' ' VAL . 18.5 m -143.18 175.72 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.428 0.632 . . . . 0.0 110.087 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.469 HG13 ' O ' ' A' ' 84' ' ' VAL . 8.8 p -137.14 122.33 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.574 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -63.76 119.96 10.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 109.345 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 134' ' ' ALA . 32.3 mt -94.26 3.06 55.75 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.352 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 132' ' ' TYR . 39.3 m-85 -150.67 148.99 29.26 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 0.0 108.885 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 65.7 m-20 -66.29 143.97 56.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 18.2 t80 -155.39 122.67 5.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.272 -0.892 . . . . 0.0 111.466 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.69 113.35 26.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 110.238 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.779 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . -60.24 -161.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.328 -0.857 . . . . 0.0 111.092 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.2 mt -117.47 -57.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.915 -0.491 . . . . 0.0 110.125 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -175.83 -37.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.948 -1.095 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -154.61 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.987 -1.071 . . . . 0.0 111.182 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 4.2 tp10 -55.04 -26.22 35.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.357 -0.839 . . . . 0.0 109.7 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.779 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 1.8 p30 -45.26 121.27 2.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.798 -0.564 . . . . 0.0 110.808 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.7 149.51 27.21 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.746 0.784 . . . . 0.0 111.619 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.0 m -94.88 147.36 23.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.84 -0.537 . . . . 0.0 109.903 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.3 p90 -148.1 -165.04 2.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.447 -0.783 . . . . 0.0 110.496 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 1.1 tt0 -129.41 176.47 7.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.449 1.119 . . . . 0.0 112.889 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 17.7 ttmt -60.95 -21.06 63.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.18 41.15 1.28 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.86 167.2 12.62 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.782 -0.834 . . . . 0.0 111.63 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 3.0 mt-30 -120.46 124.77 46.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 179.099 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 72.0 mtm -134.82 151.52 51.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 82' ' ' ILE . 21.3 t -94.73 154.07 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.582 HG23 HG13 ' A' ' 83' ' ' VAL . 38.1 t -94.36 141.16 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 0.0 108.996 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.8 mp -101.68 -26.46 13.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -155.95 -171.33 3.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 110.692 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -147.44 105.19 3.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.475 -0.766 . . . . 0.0 110.579 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.4 t -104.76 -53.83 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.01 -70.73 0.3 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -83.24 -57.29 3.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.634 -0.921 . . . . 0.0 110.064 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 40.8 m95 -105.55 121.63 44.36 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.626 . . . . 0.0 110.576 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 130' ' ' SER . 50.9 m0 -107.04 146.39 31.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.474 -0.767 . . . . 0.0 109.751 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -96.94 120.86 38.06 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.648 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -132.96 160.69 36.36 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.187 -0.946 . . . . 0.0 112.323 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.0 ttt180 -111.74 121.46 45.17 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.586 -0.696 . . . . 0.0 109.933 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 5.1 t -75.11 115.77 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.641 -0.662 . . . . 0.0 109.427 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.9 mt -68.38 -24.95 64.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.909 -0.495 . . . . 0.0 110.209 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.74 -23.77 65.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p -138.93 10.71 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.713 . . . . 0.0 111.002 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.32 30.62 6.14 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.928 -1.108 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 7.8 mtmt -105.19 -177.05 3.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.61 156.5 35.15 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.279 -0.888 . . . . 0.0 111.776 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -174.81 -159.44 21.08 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.454 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 89.3 m-85 -94.25 158.33 15.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.059 -0.671 . . . . 0.0 110.33 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.542 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -154.65 123.9 3.14 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.36 121.14 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.787 0.888 . . . . 0.0 109.973 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 1.5 m -51.59 -35.86 43.16 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.459 -0.775 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -75.1 -9.23 58.35 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.924 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.489 ' HA ' ' CD1' ' A' ' 87' ' ' TYR . 3.0 m-85 -104.69 23.72 12.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.333 -0.854 . . . . 0.0 109.42 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 134' ' ' ALA . 9.8 p -159.43 170.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.848 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.636 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -137.95 135.47 36.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.515 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.7 tmm_? -81.8 138.6 35.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.115 -0.99 . . . . 0.0 112.265 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 162.06 33.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.336 0.589 . . . . 0.0 109.456 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' A' ' 80' ' ' ASP . 2.9 p30 -96.56 28.85 3.17 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.206 -179.878 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.174 0.512 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.92 68.43 0.81 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.414 -0.804 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -138.9 -165.07 1.76 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -124.15 54.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.792 . . . . 0.0 110.168 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.618 HD12 ' C ' ' A' ' 138' ' ' SER . 65.0 mt -101.17 151.78 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.869 -1.144 . . . . 0.0 109.263 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 135' ' ' ARG . 29.6 m -135.22 177.56 6.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.096 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.932 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.4 p -128.57 121.79 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.47 118.84 11.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 134' ' ' ALA . 18.8 mt -94.11 1.35 56.15 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.489 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.487 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.7 m-85 -151.9 151.14 30.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.392 -0.817 . . . . 0.0 108.846 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -67.5 145.35 55.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.135 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 67.4 t80 -151.75 126.99 9.87 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.364 -0.835 . . . . 0.0 110.779 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -94.71 135.56 36.05 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.63 0.729 . . . . 0.0 111.963 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.48 142.15 55.56 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.759 -0.588 . . . . 0.0 110.824 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.64 -54.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.666 -0.646 . . . . 0.0 109.837 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -67.51 177.3 2.0 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.57 -0.706 . . . . 0.0 111.961 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -57.81 -63.18 1.34 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.839 -0.538 . . . . 0.0 110.236 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 10.4 tp10 -92.22 47.9 1.36 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.403 -0.811 . . . . 0.0 109.708 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.431 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 1.8 t0 -99.87 137.49 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.747 HD21 ' HB2' ' A' ' 119' ' ' SER . 32.1 tp -112.89 136.01 53.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.474 -0.766 . . . . 0.0 110.861 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 120.76 35.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.806 . . . . 0.0 110.232 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.9 p90 -115.45 -169.51 1.59 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.963 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.0 179.83 5.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.134 0.969 . . . . 0.0 112.062 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.5 ttmt -60.66 -22.04 63.44 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.84 41.3 1.23 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 1.1 m-20 -90.63 171.53 9.32 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.557 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.14 132.48 50.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.533 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.8 mpp? -139.1 150.71 46.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 82' ' ' ILE . 38.2 t -95.85 151.22 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 81' ' ' ILE . 68.6 t -94.98 137.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.117 -0.99 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.02 -30.96 13.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.742 0.782 . . . . 0.0 108.936 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -156.36 163.98 38.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.58 119.87 40.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.633 . . . . 0.0 109.514 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -109.63 -76.44 0.61 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.126 -0.984 . . . . 0.0 110.858 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.05 -85.89 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.45 -20.56 18.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -127.47 103.76 7.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 108.982 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -95.75 155.76 16.61 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.098 -1.001 . . . . 0.0 110.851 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 24.3 tttt -95.67 112.51 24.21 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.651 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -126.85 165.84 18.59 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.143 0.973 . . . . 0.0 112.798 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.3 ttt180 -112.68 130.52 56.02 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.747 ' HB2' HD21 ' A' ' 97' ' ' LEU . 29.3 t -82.96 115.29 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.183 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.5 mt -67.24 -26.35 66.53 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.24 0.543 . . . . 0.0 110.368 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.68 -29.74 66.84 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.462 -0.774 . . . . 0.0 109.813 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.7 p -133.62 10.53 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.762 -0.586 . . . . 0.0 110.476 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 119' ' ' SER . 7.8 mmm-85 51.68 28.3 4.7 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.986 -1.071 . . . . 0.0 110.898 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 10.9 mtmt -99.8 177.91 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.425 -0.797 . . . . 0.0 109.376 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -153.56 151.77 30.15 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.947 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -177.99 -150.72 8.79 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 128' ' ' ILE . 48.0 m-85 -93.58 164.76 13.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.666 -0.902 . . . . 0.0 110.207 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.3 pt -155.09 110.71 2.29 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.668 -0.645 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -45.19 99.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 O-C-N 123.008 1.004 . . . . 0.0 111.838 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -57.03 -20.68 25.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.825 -0.547 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 5.0 p-10 -74.42 -1.84 22.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.535 -0.728 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 4.8 m-85 -137.23 44.92 2.25 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.908 -1.12 . . . . 0.0 110.186 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -147.7 170.85 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.32 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.932 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -125.12 117.41 23.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.746 -0.596 . . . . 0.0 109.509 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.778 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.2 tmm_? -80.07 133.98 36.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.858 0.837 . . . . 0.0 112.648 -178.106 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.79 146.11 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.75 43.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.119 -0.988 . . . . 0.0 109.622 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.618 ' C ' HD12 ' A' ' 82' ' ' ILE . 13.3 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.684 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.987 0.423 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -142.23 76.2 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.58 -164.66 1.24 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 109.564 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -129.47 47.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.79 . . . . 0.0 110.405 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 136' ' ' VAL . 41.9 mt -97.43 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.4 m -136.46 172.55 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.748 -0.595 . . . . 0.0 109.414 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.873 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.2 p -127.63 124.41 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.148 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.556 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.68 116.12 5.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.989 HD11 ' HB2' ' A' ' 134' ' ' ALA . 93.9 mt -93.85 3.53 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.837 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 70.5 m-85 -153.57 150.29 28.52 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 100' ' ' GLN . 47.9 m-20 -66.64 150.91 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.455 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 66.0 t80 -154.38 119.78 5.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.254 -0.904 . . . . 0.0 110.896 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.38 128.75 39.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.35 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.611 -0.681 . . . . 0.0 110.704 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mm -127.45 -71.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.378 -0.826 . . . . 0.0 110.11 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.06 53.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -169.31 -153.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.362 -0.836 . . . . 0.0 108.89 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 5.1 tp10 -59.28 -18.21 35.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.198 -0.939 . . . . 0.0 110.404 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 3.4 t0 -44.51 130.0 6.7 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.342 -0.849 . . . . 0.0 111.263 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 124' ' ' LYS . 6.5 tt -109.11 137.45 46.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.975 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -94.44 122.22 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.684 -0.635 . . . . 0.0 109.599 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 8.6 p90 -117.36 -167.13 1.27 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.788 -0.57 . . . . 0.0 110.029 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HA ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -126.08 179.42 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.324 1.059 . . . . 0.0 112.695 -177.85 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.7 ttmt -61.14 -23.35 65.47 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.94 40.05 1.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 2.3 m-20 -91.27 163.91 14.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.688 -0.89 . . . . 0.0 112.065 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.22 134.95 55.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.44 ' HE1' ' CD2' ' A' ' 99' ' ' PHE . 76.2 mtm -142.45 149.3 39.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.839 -0.538 . . . . 0.0 109.6 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.597 ' CG2' HD11 ' A' ' 120' ' ' LEU . 21.3 t -97.01 150.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 81' ' ' ILE . 79.3 t -94.79 139.57 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.131 -0.981 . . . . 0.0 110.192 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.7 mp -95.72 -27.11 15.43 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 144.15 20.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -103.02 137.73 40.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -128.34 -70.73 0.67 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 157.15 -40.51 0.55 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.48 -30.37 4.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.355 -1.086 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -137.11 102.88 4.96 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.0 109.24 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -98.22 151.14 20.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.401 -0.812 . . . . 0.0 111.099 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -101.06 124.59 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -132.73 166.12 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.896 . . . . 0.0 111.883 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HB2' HD11 ' A' ' 108' ' ' LEU . 2.4 ttt180 -114.0 126.59 55.3 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.652 -0.655 . . . . 0.0 109.985 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -77.92 114.9 17.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.698 -0.626 . . . . 0.0 109.387 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.597 HD11 ' CG2' ' A' ' 106' ' ' VAL . 9.6 mt -67.56 -28.74 68.04 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.083 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.97 60.71 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -135.04 12.02 3.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.738 -0.601 . . . . 0.0 110.767 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.9 30.93 4.24 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.175 -0.953 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 97' ' ' LEU . 36.8 mtmt -100.47 177.37 5.05 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -152.2 149.48 28.79 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.966 0.889 . . . . 0.0 111.913 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 95' ' ' GLU . . . -172.88 -152.98 9.06 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.446 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 96.6 m-85 -94.07 164.09 13.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 122.201 -0.588 . . . . 0.0 109.47 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 127' ' ' TYR . 4.2 pt -151.06 106.96 3.01 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -47.32 107.4 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.04 1.021 . . . . 0.0 111.719 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.413 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 24.0 m -60.76 -15.95 35.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.944 -0.472 . . . . 0.0 111.017 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 39.5 p30 -80.74 3.19 23.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.21 -0.931 . . . . 0.0 112.063 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 8.9 m-85 -144.92 46.96 1.34 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.142 -0.974 . . . . 0.0 109.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 134' ' ' ALA . 5.4 p -153.91 170.83 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.424 -0.797 . . . . 0.0 110.594 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.989 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -125.57 124.14 40.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.75 -0.594 . . . . 0.0 109.905 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.772 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -83.93 137.82 33.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 112.498 -178.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 82' ' ' ILE . 25.6 m -140.85 139.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.67 33.84 2.41 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.263 -0.898 . . . . 0.0 110.557 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.951 179.656 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.042 0.448 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -71.83 88.03 1.01 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.597 -0.689 . . . . 0.0 109.998 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 4.5 m-20 -164.39 -163.6 0.76 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.806 -0.559 . . . . 0.0 109.666 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.466 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.1 OUTLIER -96.7 52.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.689 -1.257 . . . . 0.0 108.914 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.64 ' O ' HG22 ' A' ' 136' ' ' VAL . 89.4 mt -101.39 157.87 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 109.554 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 135' ' ' ARG . 31.6 m -139.83 165.67 21.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.896 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.0 p -123.61 122.02 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 109.095 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.659 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.24 116.85 6.41 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.926 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 134' ' ' ALA . 96.6 mt -94.5 7.95 43.84 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.158 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.7 m-85 -154.81 151.16 28.31 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.226 -0.921 . . . . 0.0 108.851 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.93 141.03 56.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 39.5 t80 -155.34 125.14 6.5 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.222 -0.924 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.17 130.94 54.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 110.682 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -58.92 -167.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.451 -0.781 . . . . 0.0 110.217 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.03 -38.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.494 -0.754 . . . . 0.0 110.75 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -177.14 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.107 -0.995 . . . . 0.0 110.485 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -58.04 -168.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 110.579 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 3.4 tp10 -51.56 -30.36 20.46 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.295 -0.878 . . . . 0.0 110.416 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.634 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -14.7 124.54 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.236 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.749 HD13 ' N ' ' A' ' 98' ' ' SER . 1.2 tm? -98.31 133.77 42.25 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.565 0.698 . . . . 0.0 111.481 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.749 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.5 m -94.75 142.82 27.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.659 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 20.3 p90 -152.99 -164.71 2.0 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.261 -0.899 . . . . 0.0 111.017 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.24 179.25 5.35 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.118 0.961 . . . . 0.0 111.742 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 10.3 ttmt -61.36 -18.94 61.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.69 41.22 1.38 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.93 172.01 8.89 Favored 'General case' 0 N--CA 1.505 2.325 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.815 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.63 129.5 45.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.646 -0.659 . . . . 0.0 110.199 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 82' ' ' ILE . 20.9 mtm -132.52 156.19 47.25 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 24.9 t -106.5 152.37 8.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 94.9 t -95.06 139.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.557 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp -94.84 -30.83 14.0 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.64 152.93 27.76 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -95.97 151.32 19.54 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.6 t -147.27 -83.09 0.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.394 -0.816 . . . . 0.0 110.715 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.03 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -91.32 -5.61 54.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.429 -1.042 . . . . 0.0 110.825 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -143.97 96.96 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 109.886 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.95 149.05 21.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.73 117.34 29.97 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.625 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.3 164.54 25.4 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.239 -0.913 . . . . 0.0 112.607 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.1 ttt180 -118.03 131.82 56.43 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.633 -0.667 . . . . 0.0 109.914 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -87.46 118.36 26.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.577 -0.702 . . . . 0.0 109.859 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.449 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.3 mt -67.36 -23.02 65.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.827 -0.545 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.86 -31.11 68.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.353 -0.842 . . . . 0.0 110.171 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 p -137.57 14.0 2.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.725 -0.609 . . . . 0.0 110.437 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 50.52 35.18 10.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.103 -0.998 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 45.6 mttt -102.93 173.75 6.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.7 156.51 35.03 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.737 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 95' ' ' GLU . . . 174.59 -154.91 19.99 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -93.64 118.77 31.81 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.974 -0.721 . . . . 0.0 109.701 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 117' ' ' ALA . 4.3 pt -99.14 134.83 21.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.108 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' A' ' 99' ' ' PHE . 36.1 Cg_exo -57.96 95.89 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.978 0.989 . . . . 0.0 111.058 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.4 m -57.89 -18.74 24.81 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.663 -0.648 . . . . 0.0 111.412 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 14.2 p-10 -90.03 19.16 5.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.153 -0.967 . . . . 0.0 111.934 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 20.6 m-85 -155.19 52.26 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -160.52 170.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.421 -0.799 . . . . 0.0 111.396 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.896 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -120.72 126.07 49.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.789 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -94.79 120.96 35.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.243 -0.911 . . . . 0.0 112.809 -177.716 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 82' ' ' ILE . 28.8 m -100.24 131.19 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 26.5 t70 -155.97 -42.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.591 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.112 0.482 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.6 96.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.514 -0.742 . . . . 0.0 110.705 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -133.18 -158.2 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.733 . . . . 0.0 109.171 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.58 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -126.89 43.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.846 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.634 HG12 HG13 ' A' ' 106' ' ' VAL . 59.6 mt -96.23 137.42 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.778 -1.201 . . . . 0.0 108.717 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.8 m -125.34 170.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.4 p -124.59 122.93 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.6 -0.688 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.86 123.53 20.82 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 84.2 mt -94.32 -2.4 52.26 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.703 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.479 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 62.2 m-85 -151.67 151.14 31.07 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.135 -0.978 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -62.71 147.09 50.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.61 -0.681 . . . . 0.0 110.236 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.445 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 53.3 t80 -154.56 134.05 12.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.559 -0.713 . . . . 0.0 110.916 179.362 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -98.4 136.62 38.29 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.585 -0.697 . . . . 0.0 111.713 -179.204 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.834 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -60.58 154.46 21.06 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.442 -0.786 . . . . 0.0 111.22 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 92' ' ' ILE . 11.0 tt -171.67 58.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 110.369 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -175.57 60.9 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 51.16 -95.74 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 O-C-N 120.78 -1.2 . . . . 0.0 110.5 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 10.1 tp10 -77.35 58.06 1.6 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.54 -1.35 . . . . 0.0 108.964 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.834 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 32.6 p30 -100.84 174.24 6.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 110.268 -179.422 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 119' ' ' SER . 49.7 tp -153.25 132.34 12.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.0 116.26 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.916 -0.49 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.632 ' CE2' HG22 ' A' ' 128' ' ' ILE . 15.6 p90 -108.65 -176.27 3.0 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.324 178.299 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -176.63 3.31 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.278 1.037 . . . . 0.0 112.104 -178.221 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.3 ttmt -60.48 -27.07 67.28 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.352 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.14 43.67 1.15 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -178.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 1.3 m-20 -91.04 165.32 13.59 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.233 -179.085 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.2 131.99 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.507 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.2 mpp? -138.77 152.22 47.74 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.634 HG13 HG12 ' A' ' 82' ' ' ILE . 11.8 t -102.1 147.84 8.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 81' ' ' ILE . 71.5 t -94.94 139.22 19.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.025 -1.047 . . . . 0.0 109.976 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.41 -30.27 13.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -156.51 159.57 38.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.74 -0.6 . . . . 0.0 110.332 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.0 147.97 27.23 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.4 t -135.99 -75.07 0.44 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 170.9 -44.74 0.19 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -127.61 -40.27 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.621 -0.929 . . . . 0.0 110.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -116.7 107.97 15.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.106 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CH2' ' HB3' ' A' ' 130' ' ' SER . 35.5 m0 -98.29 151.88 20.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.819 . . . . 0.0 110.002 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -97.57 118.1 33.32 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.706 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.41 168.23 17.95 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.1 ttt180 -116.73 121.55 41.95 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.608 -0.683 . . . . 0.0 109.634 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.738 ' HB2' HD21 ' A' ' 97' ' ' LEU . 46.2 t -73.81 121.3 20.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.827 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.98 -29.35 65.31 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.14 62.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.436 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -136.87 9.39 3.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 110.795 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 51.92 30.31 7.07 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.045 -1.035 . . . . 0.0 110.706 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 14.9 mttt -101.85 176.76 5.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 2.4 pm0 -155.66 143.78 19.97 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.154 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.62 -149.83 6.36 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.549 ' O ' HG23 ' A' ' 128' ' ' ILE . 76.2 m-85 -95.22 162.42 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.755 -0.85 . . . . 0.0 110.72 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.632 HG22 ' CE2' ' A' ' 99' ' ' PHE . 3.0 pt -155.5 113.67 2.24 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.613 -0.679 . . . . 0.0 110.182 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -53.29 110.06 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.154 1.081 . . . . 0.0 111.541 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.456 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 8.8 m -59.03 -18.48 35.01 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.897 -0.502 . . . . 0.0 110.917 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -71.96 -0.79 12.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.421 -0.799 . . . . 0.0 113.094 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.53 40.61 1.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.912 -1.117 . . . . 0.0 109.863 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -150.06 169.65 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.729 . . . . 0.0 111.315 -178.404 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.748 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -122.54 137.25 54.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.217 0.532 . . . . 0.0 110.325 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.895 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -96.49 130.85 43.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 111.518 -178.821 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 82' ' ' ILE . 27.5 m -144.08 173.24 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.775 -0.578 . . . . 0.0 110.024 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.33 -159.68 0.72 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.974 179.353 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.271 -179.955 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.962 0.41 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 2.1 tt0 56.95 20.06 5.05 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.362 -0.836 . . . . 0.0 110.988 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' H ' ' HA ' ' A' ' 137' ' ' ASP . 6.4 m-20 -165.57 -162.34 0.58 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.437 -0.79 . . . . 0.0 110.105 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -97.23 53.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.783 -1.198 . . . . 0.0 109.073 178.539 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.703 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 90.2 mt -98.3 155.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.299 -0.96 . . . . 0.0 108.619 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 135' ' ' ARG . 29.7 m -138.41 174.6 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.367 -0.833 . . . . 0.0 110.2 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.901 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.3 p -133.89 128.15 53.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -70.79 120.28 16.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.497 -0.752 . . . . 0.0 109.145 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 134' ' ' ALA . 77.2 mt -94.28 0.39 55.59 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.284 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.3 m-85 -152.21 151.13 30.61 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.57 150.58 48.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.406 -0.809 . . . . 0.0 110.05 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 42.5 t80 -153.65 136.55 15.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.339 -0.851 . . . . 0.0 111.094 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 3.7 tt0 -101.06 142.36 32.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.794 -0.566 . . . . 0.0 111.163 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.772 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -55.54 171.08 0.21 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.393 -0.817 . . . . 0.0 110.535 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 tt -173.85 42.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 109.938 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.72 -166.52 0.13 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.055 -1.028 . . . . 0.0 110.164 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -73.32 -73.78 0.2 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 6.6 tp10 -85.06 52.45 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.772 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.0 p30 -94.47 171.56 8.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.603 -0.686 . . . . 0.0 109.843 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 119' ' ' SER . 16.7 tp -151.82 128.75 10.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.2 m -95.2 105.36 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.204 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.659 ' CD2' HG22 ' A' ' 128' ' ' ILE . 16.9 p90 -103.01 -168.1 1.47 Allowed 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.774 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.32 178.87 5.36 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.408 1.099 . . . . 0.0 112.859 -177.888 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 86' ' ' LEU . 13.0 ttmt -60.92 -19.41 60.58 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.595 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 42.37 1.13 Allowed Glycine 0 C--N 1.281 -2.512 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.47 164.14 14.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.525 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.94 110.78 15.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.637 -0.664 . . . . 0.0 109.853 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.0 mtm -124.84 143.45 50.82 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -96.53 160.21 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.396 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 81' ' ' ILE . 60.9 t -94.02 138.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.982 -1.074 . . . . 0.0 110.613 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.19 -29.25 14.63 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -156.0 163.62 39.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.838 -0.539 . . . . 0.0 109.649 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -121.23 121.11 37.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.503 -0.748 . . . . 0.0 110.75 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.7 t -123.23 -60.96 1.46 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 114' ' ' TRP . . . 150.19 129.54 1.68 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 65.97 -68.01 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.549 -0.971 . . . . 0.0 110.505 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 114' ' ' TRP . . . . . 0.401 ' N ' ' O ' ' A' ' 112' ' ' GLY . 95.9 m95 -98.77 109.64 22.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.275 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 46.3 m0 -108.13 147.94 30.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.147 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.42 162.82 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.338 -0.851 . . . . 0.0 112.205 -178.121 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 7.5 tmm_? -111.1 125.48 53.81 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.495 -0.753 . . . . 0.0 109.374 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.593 ' HB2' HD21 ' A' ' 97' ' ' LEU . 31.8 t -88.14 122.81 32.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.06 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.96 -26.17 63.05 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.503 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.49 -32.87 42.27 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.438 -0.788 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 p -134.5 10.19 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.617 -0.677 . . . . 0.0 110.334 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.04 31.9 14.56 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.081 -1.012 . . . . 0.0 110.545 -179.248 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 53.8 mttt -104.37 -178.04 3.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.04 139.71 17.04 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.889 0.852 . . . . 0.0 111.349 179.14 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.44 -156.59 10.94 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 128' ' ' ILE . 53.0 m-85 -93.47 157.85 16.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.891 . . . . 0.0 110.693 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.659 HG22 ' CD2' ' A' ' 99' ' ' PHE . 1.3 pt -155.61 110.93 2.19 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.9 102.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 122.802 0.896 . . . . 0.0 110.805 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.404 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 1.1 m -62.01 -15.32 43.38 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.706 -0.621 . . . . 0.0 111.313 -178.922 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -64.66 -11.33 34.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.161 -0.962 . . . . 0.0 111.478 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.431 ' C ' HG23 ' A' ' 133' ' ' VAL . 10.7 m-85 -130.03 43.41 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 134' ' ' ALA . 61.5 t -145.76 170.81 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 -177.643 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.901 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -124.09 125.63 44.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.529 -0.732 . . . . 0.0 109.341 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 83' ' ' VAL . 9.4 ttt180 -95.72 121.58 37.58 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.423 -0.798 . . . . 0.0 112.522 -178.501 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 82' ' ' ILE . 30.6 m -100.46 133.69 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.289 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 137' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 80' ' ' ASP . 24.8 t0 -155.64 -55.32 0.09 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.697 -0.627 . . . . 0.0 109.81 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.009 -179.896 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.99 0.424 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.42 -173.83 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 110.885 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -139.68 -159.92 1.01 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.659 -0.651 . . . . 0.0 109.375 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.57 ' H ' HD13 ' A' ' 81' ' ' ILE . 0.2 OUTLIER -121.57 41.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.052 -1.03 . . . . 0.0 112.12 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 106' ' ' VAL . 48.3 mt -95.11 139.31 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.78 -1.2 . . . . 0.0 108.504 178.098 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.6 m -126.93 166.95 22.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.444 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.2 p -121.16 128.35 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.219 178.438 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' HA2' ' A' ' 102' ' ' GLY . . . -68.78 145.76 53.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.054 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 9.6 mt -106.74 -15.84 14.64 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.851 0.751 . . . . 0.0 110.972 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 87.8 m-85 -149.01 153.99 38.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.293 -0.88 . . . . 0.0 109.559 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -56.43 149.45 16.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.703 -0.623 . . . . 0.0 111.625 -178.604 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -155.42 126.89 7.3 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.731 -0.605 . . . . 0.0 110.353 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -100.5 130.59 46.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.766 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -51.23 162.09 0.36 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.32 -0.863 . . . . 0.0 111.442 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' ILE . . . . . 0.425 HG23 ' C ' ' A' ' 91' ' ' ALA . 3.8 pt -153.22 32.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.789 -0.569 . . . . 0.0 109.965 179.078 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.81 -170.55 1.6 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.431 -0.793 . . . . 0.0 110.613 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -62.1 -78.15 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.769 -0.582 . . . . 0.0 111.195 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 4.2 tp10 -88.27 49.27 1.77 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.222 -0.924 . . . . 0.0 110.861 -179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.766 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 2.8 t0 -95.32 158.91 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 108.815 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.611 HD13 ' N ' ' A' ' 98' ' ' SER . 0.6 OUTLIER -121.47 127.21 50.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.314 -0.866 . . . . 0.0 111.107 -178.543 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.611 ' N ' HD13 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -97.35 93.33 6.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.625 -0.672 . . . . 0.0 109.251 178.479 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 128' ' ' ILE . 31.5 p90 -97.56 -173.97 2.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.082 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -118.4 -164.89 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.67 0.747 . . . . 0.0 111.368 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 2.0 ttmt -53.9 -90.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.581 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 102' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 85' ' ' ALA . . . -93.45 65.49 1.82 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.4 m-20 -91.64 167.58 12.1 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.967 -0.725 . . . . 0.0 111.549 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.66 120.26 32.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 110.181 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.407 ' HG3' ' HA ' ' A' ' 119' ' ' SER . 2.5 mpp? -128.69 156.73 43.0 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.52 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 24.5 t -103.07 151.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 84.0 t -95.64 139.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.133 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -97.18 -30.55 12.94 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.66 0.743 . . . . 0.0 109.522 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -156.39 158.07 36.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.94 -0.475 . . . . 0.0 109.925 -178.679 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -99.6 152.07 20.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.384 -0.822 . . . . 0.0 109.588 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -146.95 -75.71 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.91 -92.72 0.08 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.85 -27.08 14.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.935 . . . . 0.0 109.611 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -110.39 107.29 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 0.0 109.401 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -100.1 148.02 25.03 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.303 -0.873 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 116' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 11.5 tttt -96.35 111.6 23.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.686 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -126.84 169.47 13.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.871 0.843 . . . . 0.0 111.856 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.5 ttt180 -114.14 123.7 50.25 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.628 -0.67 . . . . 0.0 109.693 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.407 ' HA ' ' HG3' ' A' ' 105' ' ' MET . 1.1 t -78.29 111.98 14.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.741 -0.599 . . . . 0.0 109.537 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.483 HD11 ' CG2' ' A' ' 106' ' ' VAL . 8.4 mt -65.48 -24.41 67.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.856 -0.527 . . . . 0.0 110.351 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.44 -31.24 69.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 p -133.93 16.29 3.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.566 . . . . 0.0 110.459 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.51 29.91 2.24 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.266 -0.896 . . . . 0.0 110.857 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.8 mttt -96.82 177.18 5.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.66 134.93 12.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.086 0.946 . . . . 0.0 112.023 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -166.37 -156.7 9.69 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.48 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 32.0 m-85 -93.03 160.69 14.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.746 -0.855 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.5 pt -152.98 107.66 2.66 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.835 -0.54 . . . . 0.0 109.99 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.45 100.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.263 1.138 . . . . 0.0 111.572 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.2 m -60.62 -13.69 15.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.666 -0.646 . . . . 0.0 112.288 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -65.0 -11.0 33.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.123 -0.986 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.1 45.22 2.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.897 . . . . 0.0 108.877 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 134' ' ' ALA . 98.7 t -145.07 171.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.774 -0.578 . . . . 0.0 109.719 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.817 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -133.46 124.58 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.539 -0.725 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.786 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -79.26 136.85 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 111.728 -178.992 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG13 ' C ' ' A' ' 135' ' ' ARG . 23.0 m -153.32 172.24 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.14 0.495 . . . . 0.0 110.069 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.34 -162.36 0.94 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.384 -0.823 . . . . 0.0 110.772 -179.624 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 138' ' ' SER . . . . . 0.446 ' HA ' HD12 ' A' ' 82' ' ' ILE . 4.4 t . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.228 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.997 0.427 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -91.48 133.87 35.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.764 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -142.52 -165.01 1.94 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -121.35 52.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 110.75 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 106' ' ' VAL . 61.2 mt -98.71 152.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.866 HG12 ' HA ' ' A' ' 135' ' ' ARG . 27.6 m -138.41 179.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.541 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.9 p -134.61 121.29 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -60.7 115.37 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 134' ' ' ALA . 62.2 mt -94.54 10.78 33.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.447 -178.953 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CD2' ' HA ' ' A' ' 132' ' ' TYR . 33.4 m-85 -154.35 151.42 29.03 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.019 -1.051 . . . . 0.0 109.686 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.69 146.6 48.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.312 -0.867 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 52.4 t80 -153.57 169.48 23.14 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.006 -1.059 . . . . 0.0 110.988 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -151.56 99.17 2.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.694 . . . . 0.0 110.517 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.27 -179.09 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.4 -0.813 . . . . 0.0 110.515 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.8 mt -143.91 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.239 -0.913 . . . . 0.0 110.795 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -167.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.199 -0.938 . . . . 0.0 111.079 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -80.17 168.98 18.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.573 -0.704 . . . . 0.0 110.631 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 65.95 -59.89 0.3 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.697 -0.627 . . . . 0.0 111.352 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.43 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 22.2 p30 -41.87 154.04 0.05 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.565 -0.709 . . . . 0.0 111.746 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 119' ' ' SER . 1.4 tp -135.76 146.99 48.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.248 -0.907 . . . . 0.0 112.035 -177.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.0 m -96.92 167.26 11.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.808 -0.558 . . . . 0.0 110.074 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 20.8 p90 -165.32 -167.46 1.17 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.405 -0.809 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -126.19 176.55 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.042 0.925 . . . . 0.0 111.506 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.443 ' HA ' ' N ' ' A' ' 87' ' ' TYR . 15.3 ttmt -61.25 -19.18 61.4 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -177.332 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.72 41.48 1.41 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 2.5 m-20 -90.94 166.43 13.04 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.704 -0.88 . . . . 0.0 111.508 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.41 131.17 54.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.605 -0.684 . . . . 0.0 109.461 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.414 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 60.7 mtm -140.53 148.67 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG2' HD11 ' A' ' 120' ' ' LEU . 41.6 t -95.67 155.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' ILE . 69.3 t -95.73 142.5 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.159 -0.963 . . . . 0.0 110.464 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 117' ' ' ALA . 3.6 mp -95.66 -31.1 13.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -156.24 -177.45 6.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.742 -0.599 . . . . 0.0 110.472 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.45 94.8 3.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.504 -0.748 . . . . 0.0 110.306 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -94.66 -75.13 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.434 -0.791 . . . . 0.0 110.304 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.82 -98.88 0.11 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.486 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.41 -50.1 68.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.403 -1.057 . . . . 0.0 110.814 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.67 140.97 41.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.613 -0.679 . . . . 0.0 109.469 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.71 121.95 36.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.386 -0.821 . . . . 0.0 108.997 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.729 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -138.07 162.98 32.75 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.978 -179.066 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.5 ttt180 -114.57 125.89 54.29 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.555 -0.715 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.678 ' HB2' HD21 ' A' ' 97' ' ' LEU . 15.3 t -78.16 121.4 24.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 120' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.3 mt -70.52 -26.91 63.8 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.18 63.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.599 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -138.1 12.49 2.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.513 -0.742 . . . . 0.0 111.089 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 52.18 30.21 7.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.009 -1.057 . . . . 0.0 110.738 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.58 ' HB2' HD11 ' A' ' 97' ' ' LEU . 6.0 mttp -103.14 176.32 5.19 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.95 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -155.87 150.08 25.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.416 -0.803 . . . . 0.0 111.356 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' A' ' 97' ' ' LEU . . . -166.58 -140.04 2.8 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.815 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 128' ' ' ILE . 68.9 m-85 -113.34 154.24 27.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 122.03 -0.688 . . . . 0.0 110.746 -178.649 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 127' ' ' TYR . 19.4 pt -153.49 134.98 8.67 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.822 -0.549 . . . . 0.0 110.161 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 128' ' ' ILE . 6.4 Cg_exo -69.01 124.74 11.7 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 O-C-N 123.085 1.045 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.9 m -51.94 -35.31 45.41 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.519 -0.738 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -75.34 -6.91 52.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.49 -0.756 . . . . 0.0 111.701 -178.989 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 132' ' ' TYR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 87' ' ' TYR . 3.3 m-85 -104.78 24.02 12.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.157 -0.964 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' A' ' 83' ' ' VAL . 5.7 p -161.26 169.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.531 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.787 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -118.58 135.29 54.51 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.718 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.866 ' HA ' HG12 ' A' ' 83' ' ' VAL . 3.4 tpp180 -91.99 122.36 34.43 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.297 -0.877 . . . . 0.0 112.779 -178.436 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.06 145.46 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.596 -0.69 . . . . 0.0 110.023 178.218 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -116.59 73.05 0.84 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 121.382 -0.824 . . . . 0.0 109.674 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.383 -179.94 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.988 0.423 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -75.19 125.7 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.923 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -94.11 -169.59 2.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' ILE . . . . . 0.445 HG13 ' HB ' ' A' ' 107' ' ' VAL . 1.7 tp -137.58 44.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ILE . . . . . 0.64 HG23 HG12 ' A' ' 106' ' ' VAL . 86.9 mt -109.17 161.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.894 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 135' ' ' ARG . 16.3 m -138.95 167.63 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.714 0.768 . . . . 0.0 110.637 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.4 p -130.2 123.42 55.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.007 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' ALA . . . . . 0.543 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -68.9 121.57 16.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.454 -0.899 . . . . 0.0 109.361 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 134' ' ' ALA . 19.7 mt -94.04 0.03 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' TYR . . . . . 0.488 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 65.3 m-85 -151.14 151.18 31.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.242 -0.911 . . . . 0.0 109.041 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.68 145.9 54.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.517 -0.74 . . . . 0.0 110.178 -179.465 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 40.5 t80 -153.54 132.92 12.8 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.201 -0.937 . . . . 0.0 111.025 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -100.95 133.4 45.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.776 -0.577 . . . . 0.0 111.675 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . -57.2 -173.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.48 -0.762 . . . . 0.0 110.363 179.29 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.6 tt -167.27 26.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.407 -0.808 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.89 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.896 -1.127 . . . . 0.0 109.962 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -82.76 159.61 22.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.35 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 65.38 -57.47 0.3 Allowed 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.611 -0.681 . . . . 0.0 111.677 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 96' ' ' ASP . . . . . 0.434 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 7.4 p30 -44.19 148.45 0.43 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.134 -0.979 . . . . 0.0 111.902 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 119' ' ' SER . 0.6 OUTLIER -130.07 153.61 48.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.436 -0.79 . . . . 0.0 111.493 -178.186 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m -98.93 116.38 31.03 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.418 0.628 . . . . 0.0 109.767 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 128' ' ' ILE . 16.2 p90 -104.62 -172.29 2.07 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.839 -0.538 . . . . 0.0 110.016 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.1 -178.83 4.32 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.389 1.09 . . . . 0.0 112.439 -178.048 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' LYS . . . . . 0.488 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -60.75 -22.72 64.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.28 43.15 1.08 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 m-20 -90.54 165.14 13.94 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.311 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.05 109.76 14.96 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.573 -0.705 . . . . 0.0 109.718 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' MET . . . . . 0.491 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 1.5 mpp? -126.7 147.21 49.97 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' VAL . . . . . 0.64 HG12 HG23 ' A' ' 82' ' ' ILE . 4.5 m -99.02 158.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.27 -178.945 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 81' ' ' ILE . 39.6 t -94.09 143.06 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.395 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -98.06 -28.26 13.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.501 0.667 . . . . 0.0 109.512 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -156.32 168.26 27.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.734 -0.604 . . . . 0.0 109.591 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -115.48 109.54 17.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.453 -0.78 . . . . 0.0 109.261 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -96.95 -66.68 0.89 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.284 -0.885 . . . . 0.0 110.76 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 -56.49 0.24 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -119.33 -31.28 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.944 . . . . 0.0 109.752 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -121.67 101.97 7.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -94.8 154.15 17.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.406 -0.808 . . . . 0.0 109.846 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -94.48 135.67 35.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 117' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -143.7 159.61 42.18 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.217 -177.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.5 ttm180 -112.82 122.51 47.86 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.743 0.783 . . . . 0.0 110.174 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' SER . . . . . 0.578 ' HB2' HD22 ' A' ' 97' ' ' LEU . 8.5 t -84.23 129.53 34.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.829 -0.544 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.1 -26.56 53.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.925 -0.484 . . . . 0.0 110.561 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.9 65.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 109.745 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -129.48 4.89 5.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.843 -0.535 . . . . 0.0 110.662 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.45 28.32 9.44 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.996 -1.065 . . . . 0.0 109.678 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 64.9 mttt -109.18 -173.89 2.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.603 -0.685 . . . . 0.0 109.919 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -154.87 153.88 31.83 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.337 -0.852 . . . . 0.0 111.034 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.56 -124.16 0.7 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 127' ' ' TYR . . . . . 0.482 ' O ' HG23 ' A' ' 128' ' ' ILE . 60.7 m-85 -127.82 157.4 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.73 -0.865 . . . . 0.0 109.732 -179.235 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 128' ' ' ILE . . . . . 0.68 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.3 pt -153.08 106.24 2.63 Favored Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.429 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -47.31 113.08 0.63 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.013 1.142 . . . . 0.0 111.731 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' SER . . . . . 0.412 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 11.0 m -59.86 -15.4 20.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.709 -0.62 . . . . 0.0 111.849 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -75.67 1.5 14.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.91 -1.119 . . . . 0.0 111.951 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -144.97 45.09 1.35 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.926 -1.109 . . . . 0.0 110.711 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 133' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.5 p -153.28 168.84 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 110.874 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' ALA . . . . . 0.792 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -124.28 116.44 22.65 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.681 ' HA ' HG12 ' A' ' 83' ' ' VAL . 10.9 ttp180 -94.79 120.8 35.59 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.24 -0.912 . . . . 0.0 112.069 -178.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 136' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 82' ' ' ILE . 34.2 m -89.69 136.55 23.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.335 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -154.6 47.66 0.57 Allowed 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.723 -0.61 . . . . 0.0 109.36 -178.394 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.012 -179.954 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 CA-C-O 120.976 0.417 . . . . 0.0 110.751 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.968 ' CD1' HG13 ' A' ' 106' ' ' VAL . 5.8 mm -96.54 132.86 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.009 -1.057 . . . . 0.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.9 m -120.52 168.12 13.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.571 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -125.16 133.66 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -78.85 121.02 24.3 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.854 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 134' ' ' ALA . 3.7 mt -94.23 3.33 55.39 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.433 ' N ' ' HA ' ' A' ' 101' ' ' LYS . 80.6 m-85 -153.16 152.86 31.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -69.97 142.59 52.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.37 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.479 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 68.6 t80 -151.72 131.87 13.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.427 -0.795 . . . . 0.0 110.137 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 9.6 tp10 -101.9 141.01 35.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.725 . . . . 0.0 111.036 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.86 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.502 2.131 0 O-C-N 121.623 -0.673 . . . . 0.0 111.283 -179.724 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.86 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 44.7 p30 . . . . . 0 N--CA 1.491 1.608 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 119' ' ' SER . 62.8 tp -154.89 124.64 6.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.0 111.102 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.3 m -95.14 113.48 25.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.746 -0.596 . . . . 0.0 110.148 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.616 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.8 p90 -109.83 -173.28 2.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.965 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 179.52 4.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.188 0.994 . . . . 0.0 111.996 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' LEU . 12.1 ttmt -61.05 -20.93 63.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.4 41.2 1.31 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.3 m-20 -90.99 164.29 14.03 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.16 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.33 135.22 55.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 75.7 mtm -140.27 151.96 45.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.32 0.581 . . . . 0.0 109.647 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.968 HG13 ' CD1' ' A' ' 82' ' ' ILE . 43.2 t -101.43 147.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' ILE . 90.8 t -95.12 139.89 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.019 -1.051 . . . . 0.0 110.113 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.9 mp -97.05 -27.5 14.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -156.07 161.33 40.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.674 -0.641 . . . . 0.0 109.853 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -107.58 143.44 36.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.436 -0.79 . . . . 0.0 109.816 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -153.05 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.831 . . . . 0.0 110.388 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.09 -113.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -94.99 -16.69 22.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.668 -0.901 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -100.62 101.09 11.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.604 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.8 m0 -97.53 148.96 22.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.436 -0.79 . . . . 0.0 110.204 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -98.14 111.37 23.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.71 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.08 169.26 13.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.186 -0.946 . . . . 0.0 112.302 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -113.03 118.57 35.17 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 121.69 -0.631 . . . . 0.0 109.757 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.564 ' HB2' HD21 ' A' ' 97' ' ' LEU . 14.9 t -72.45 115.4 11.67 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 106' ' ' VAL . 5.3 mt -67.88 -27.65 66.86 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.124 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.4 61.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 0.0 110.389 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p -137.7 10.67 2.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.456 -0.777 . . . . 0.0 110.78 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 53.1 26.76 5.16 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.083 -1.011 . . . . 0.0 110.567 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.6 mtmt -102.12 176.67 5.12 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.58 143.0 19.46 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.29 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.38 -152.26 7.55 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.535 ' O ' HG23 ' A' ' 128' ' ' ILE . 47.1 m-85 -93.76 158.46 15.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.601 HG22 ' CD2' ' A' ' 99' ' ' PHE . 1.5 pt -155.53 115.39 2.27 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.843 -0.535 . . . . 0.0 109.778 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.76 104.32 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 122.945 0.971 . . . . 0.0 110.993 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 m -63.49 -12.37 31.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.613 -0.679 . . . . 0.0 111.426 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -68.03 -8.92 41.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.075 -1.016 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -132.68 35.94 3.57 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 134' ' ' ALA . 90.1 t -139.84 173.16 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.925 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.629 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -134.01 129.26 35.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.811 ' HA ' HG12 ' A' ' 83' ' ' VAL . 3.7 tmm_? . . . . . 0 N--CA 1.489 1.495 0 O-C-N 121.419 -0.801 . . . . 0.0 111.969 -179.389 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 120.595 0.236 . . . . 0.0 110.998 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.706 HG12 HG13 ' A' ' 106' ' ' VAL . 56.0 mt -97.02 139.45 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.072 -1.018 . . . . 0.0 109.115 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 135' ' ' ARG . 25.5 m -128.78 179.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.295 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.3 p -131.59 126.73 58.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.496 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.591 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -68.96 119.78 13.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 134' ' ' ALA . 42.8 mt -94.01 1.34 56.26 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.071 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 60.0 m-85 -152.63 152.17 31.47 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.94 148.98 50.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.492 -0.755 . . . . 0.0 110.487 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 77.1 t80 -155.15 127.44 7.78 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.47 -0.769 . . . . 0.0 111.13 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.84 132.73 43.18 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.568 -0.708 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.122 0 O-C-N 121.456 -0.777 . . . . 0.0 111.018 179.741 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.523 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.87 0 N-CA-C 109.421 -0.585 . . . . 0.0 109.421 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tt -112.33 143.17 43.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.436 -0.79 . . . . 0.0 111.102 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -96.4 122.36 39.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.728 -0.607 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.591 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 13.7 p90 -114.03 -171.29 1.88 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.654 -0.654 . . . . 0.0 109.6 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 179.56 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.133 0.968 . . . . 0.0 111.9 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -60.76 -22.55 64.16 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.38 41.94 1.28 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.1 m-20 -90.91 165.99 13.29 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.805 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.18 128.68 51.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.529 -0.732 . . . . 0.0 109.132 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -136.96 150.47 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.767 -0.583 . . . . 0.0 109.613 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 82' ' ' ILE . 23.3 t -101.27 151.01 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 81' ' ' ILE . 99.4 t -94.58 141.46 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.022 -1.048 . . . . 0.0 110.077 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -96.78 -30.93 12.9 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.645 0.736 . . . . 0.0 109.029 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -156.36 162.2 40.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.773 -0.579 . . . . 0.0 109.729 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.72 154.26 19.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.453 -0.78 . . . . 0.0 109.896 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.8 t -147.65 -75.65 0.18 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.403 -0.811 . . . . 0.0 110.433 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.86 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 114' ' ' TRP . 2.4 tt0 -92.93 -16.04 25.63 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.94 . . . . 0.0 110.832 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 113' ' ' GLU . 85.8 m95 -132.25 107.63 8.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.452 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.423 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 31.3 m0 -100.88 155.58 17.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.292 -0.88 . . . . 0.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -97.16 111.73 23.83 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.28 168.32 14.92 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.082 0.944 . . . . 0.0 112.609 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.7 ttt180 -112.61 121.9 46.12 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.628 -0.67 . . . . 0.0 109.647 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t -74.87 110.02 8.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.912 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.28 -21.72 66.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.827 -0.546 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.88 -24.92 67.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.4 p -140.71 15.08 2.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.232 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 50.91 27.21 3.04 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.695 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 18.8 mttt -97.13 179.9 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 109.319 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -155.9 149.01 24.44 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.945 0.879 . . . . 0.0 111.791 179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -176.88 -153.98 11.41 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.548 ' O ' HG23 ' A' ' 128' ' ' ILE . 53.2 m-85 -93.49 165.03 12.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.628 -0.925 . . . . 0.0 109.391 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.2 pt -155.41 116.48 2.33 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 109.901 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -48.0 104.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.138 1.073 . . . . 0.0 111.847 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.1 m -60.12 -16.53 33.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.944 -0.473 . . . . 0.0 111.276 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.469 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 3.3 p-10 -83.91 12.11 6.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.102 -0.999 . . . . 0.0 112.06 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.469 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 3.8 m-85 -146.93 39.74 1.04 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 134' ' ' ALA . 3.8 p -146.82 168.86 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.857 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -121.16 134.04 55.21 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.277 0.561 . . . . 0.0 110.189 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.836 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.2 tpt180 . . . . . 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 112.177 -178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 120.445 0.164 . . . . 0.0 111.224 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.55 HG12 HG13 ' A' ' 106' ' ' VAL . 63.5 mt -99.2 150.12 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.964 -1.085 . . . . 0.0 108.87 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 135' ' ' ARG . 33.5 m -137.13 171.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.287 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.777 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -124.49 124.14 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.52 118.42 10.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.904 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.0 mt -94.25 1.86 55.94 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.102 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.456 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 56.0 m-85 -151.54 150.83 30.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.218 -0.927 . . . . 0.0 108.726 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -70.55 144.23 51.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.527 -0.733 . . . . 0.0 110.319 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 72.5 t80 -155.54 131.89 10.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.253 -0.905 . . . . 0.0 111.531 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 0.0 OUTLIER -96.9 146.23 25.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.617 . . . . 0.0 110.364 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.804 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.084 0 O-C-N 121.451 -0.781 . . . . 0.0 110.676 -179.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.804 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 46.8 p30 . . . . . 0 N--CA 1.494 1.773 0 CA-C-O 120.766 0.317 . . . . 0.0 110.344 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 119' ' ' SER . 7.5 tp -150.63 126.32 10.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.459 -0.775 . . . . 0.0 111.264 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 2.2 m -94.68 117.82 30.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 110.171 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.1 p90 -114.57 -169.87 1.62 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.725 -0.61 . . . . 0.0 110.266 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.94 179.78 4.88 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.284 1.04 . . . . 0.0 112.422 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.6 ttmt -61.18 -22.1 64.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.54 41.32 1.29 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 171.6 9.15 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.915 -0.756 . . . . 0.0 112.026 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.5 130.26 51.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.429 -0.794 . . . . 0.0 109.52 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.29 153.39 50.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.639 . . . . 0.0 109.747 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.55 HG13 HG12 ' A' ' 82' ' ' ILE . 21.5 t -103.95 149.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 81' ' ' ILE . 58.9 t -95.57 138.02 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.164 -0.96 . . . . 0.0 109.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -96.57 -29.0 14.11 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.447 0.641 . . . . 0.0 109.469 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -155.63 149.41 25.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.777 -0.577 . . . . 0.0 109.786 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -96.19 144.59 26.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.718 . . . . 0.0 109.292 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 t -134.88 -66.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.7 -64.18 0.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -112.34 -29.86 7.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.601 -0.941 . . . . 0.0 110.047 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -125.25 103.36 7.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.709 -0.62 . . . . 0.0 109.876 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -97.31 153.78 17.84 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 0.0 110.598 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -97.97 117.29 31.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.19 167.66 15.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.189 -0.945 . . . . 0.0 112.485 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.1 ttt180 -114.96 126.33 54.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.657 -0.652 . . . . 0.0 109.416 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.681 ' HB2' HD21 ' A' ' 97' ' ' LEU . 3.8 t -79.42 118.81 21.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.83 -25.21 64.54 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.565 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p -128.05 7.11 6.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.672 -0.642 . . . . 0.0 110.897 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 119' ' ' SER . 0.3 OUTLIER 52.91 32.22 12.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.066 -1.021 . . . . 0.0 110.305 -179.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.8 mttm -100.78 178.86 4.57 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -154.89 137.13 14.84 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.008 0.908 . . . . 0.0 111.6 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -164.39 -147.95 5.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 128' ' ' ILE . 76.7 m-85 -94.18 164.15 13.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.622 -0.928 . . . . 0.0 110.787 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.6 pt -153.83 104.5 2.49 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.56 106.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.931 0.964 . . . . 0.0 111.774 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 m -59.46 -18.49 40.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.947 -0.47 . . . . 0.0 111.097 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -73.4 -1.26 17.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.366 -0.834 . . . . 0.0 112.596 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -142.65 46.7 1.58 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.6 p -150.09 169.72 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.607 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.904 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -120.21 122.55 41.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.828 ' HA ' HG12 ' A' ' 83' ' ' VAL . 2.6 tmm_? . . . . . 0 N--CA 1.49 1.563 0 CA-C-O 121.815 0.817 . . . . 0.0 112.625 -178.299 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 81' ' ' ILE . 3.6 tp . . . . . 0 N--CA 1.496 1.874 0 CA-C-O 119.804 -0.141 . . . . 0.0 111.197 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.62 HG12 HG13 ' A' ' 106' ' ' VAL . 77.4 mt -115.11 165.61 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 135' ' ' ARG . 12.0 m -143.64 171.1 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.78 129.37 58.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -71.9 119.8 16.59 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.689 -0.804 . . . . 0.0 108.898 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 134' ' ' ALA . 61.7 mt -94.12 0.05 55.6 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.895 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.9 m-85 -151.97 152.39 32.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -68.83 145.05 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.461 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 79.4 t80 -152.39 125.32 8.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.409 -0.807 . . . . 0.0 110.576 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 20.9 tp10 -94.76 134.11 37.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 110.003 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.499 1.983 0 O-C-N 121.401 -0.812 . . . . 0.0 110.719 -179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.419 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.1 t70 . . . . . 0 N--CA 1.496 1.866 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.0 139.78 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 0.0 111.532 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.4 m -95.29 118.63 32.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.617 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.533 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 12.2 p90 -112.95 -171.7 1.91 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.0 110.048 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.93 -178.54 4.09 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.187 0.994 . . . . 0.0 112.379 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.1 ttmt -61.12 -23.06 65.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.27 41.71 1.23 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.84 167.51 12.4 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.738 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -121.04 128.27 52.5 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.469 -0.769 . . . . 0.0 109.702 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -136.97 150.39 48.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.62 HG13 HG12 ' A' ' 82' ' ' ILE . 11.3 t -95.26 152.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.454 ' CG1' HD11 ' A' ' 81' ' ' ILE . 38.4 t -94.02 134.49 31.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -94.68 -27.3 15.92 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -156.56 -169.5 3.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.69 -0.631 . . . . 0.0 110.314 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -150.98 115.06 5.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.497 -0.752 . . . . 0.0 109.961 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -127.4 -68.4 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.47 142.74 3.47 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 65.44 -69.18 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.632 -0.922 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -109.47 117.24 33.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 110.256 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.427 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 53.8 m0 -107.02 154.19 21.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.25 118.77 32.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -133.39 159.12 41.26 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.138 -0.976 . . . . 0.0 112.285 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -111.52 126.72 55.28 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.469 -0.769 . . . . 0.0 110.166 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 t -81.25 112.06 18.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 109.532 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.509 HD11 ' CG2' ' A' ' 106' ' ' VAL . 20.5 mt -65.89 -20.86 66.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.889 -0.507 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.67 73.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.9 p -129.4 11.39 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.753 -0.592 . . . . 0.0 110.658 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.69 30.14 8.37 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 27.6 mtpt -102.16 178.27 4.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.62 -0.675 . . . . 0.0 109.385 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.76 149.11 24.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.745 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.59 -150.42 7.52 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.646 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.428 ' O ' HG23 ' A' ' 128' ' ' ILE . 68.8 m-85 -93.27 162.22 14.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.745 -0.856 . . . . 0.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.2 pt -153.0 108.75 2.66 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.733 -0.604 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.51 108.11 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.027 1.014 . . . . 0.0 111.735 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.433 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 12.1 m -57.36 -15.33 6.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.776 -0.578 . . . . 0.0 111.804 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -76.7 5.54 7.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.131 -0.98 . . . . 0.0 112.808 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -151.17 38.72 0.65 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.89 -1.131 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 134' ' ' ALA . 3.3 p -146.79 168.51 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.81 141.46 46.41 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.43 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.733 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.512 0 CA-C-O 121.701 0.762 . . . . 0.0 110.577 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.419 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.467 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 66.6 mt -96.93 157.43 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.869 -1.144 . . . . 0.0 109.558 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 135' ' ' ARG . 33.8 m -139.94 172.2 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.3 p -130.24 120.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB2' ' HE1' ' A' ' 105' ' ' MET . . . -62.56 118.42 7.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.792 . . . . 0.0 109.222 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 134' ' ' ALA . 69.2 mt -94.46 2.46 55.74 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.447 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.2 m-85 -153.67 152.87 31.32 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.14 -0.975 . . . . 0.0 108.831 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.35 144.29 53.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.391 -0.818 . . . . 0.0 110.447 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 48.2 t80 -155.4 127.95 7.89 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.396 -0.815 . . . . 0.0 110.793 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.87 149.35 21.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.422 -0.799 . . . . 0.0 110.771 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.781 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.499 1.998 0 O-C-N 121.467 -0.77 . . . . 0.0 109.929 179.444 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.781 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.6 p30 . . . . . 0 N--CA 1.497 1.908 0 CA-C-O 120.766 0.317 . . . . 0.0 110.425 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' A' ' 119' ' ' SER . 5.9 tt -155.07 128.67 8.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.321 -0.862 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -94.79 117.02 29.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.404 -0.81 . . . . 0.0 110.494 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 128' ' ' ILE . 19.0 p90 -115.94 -170.03 1.71 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.724 -0.61 . . . . 0.0 110.501 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 179.4 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.343 1.068 . . . . 0.0 112.525 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.9 ttmt -61.08 -20.72 62.94 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 41.16 1.33 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 1.9 m-20 -91.02 170.51 9.98 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.746 -0.855 . . . . 0.0 111.693 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.87 129.28 47.92 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.513 -0.742 . . . . 0.0 109.49 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.534 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 3.1 mpp? -137.48 152.94 50.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.738 -0.601 . . . . 0.0 109.444 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.5 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 25.4 t -101.08 152.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 88.3 t -95.39 141.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.031 -1.043 . . . . 0.0 110.527 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -156.04 159.44 39.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.877 -0.515 . . . . 0.0 110.117 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -102.2 152.08 21.44 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.511 -0.743 . . . . 0.0 109.581 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -146.25 -66.95 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.142 -0.973 . . . . 0.0 111.019 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.13 -84.34 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -98.48 -20.89 16.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.591 -0.947 . . . . 0.0 110.777 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.85 107.51 9.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 109.506 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.44 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 41.6 m0 -101.26 155.06 18.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.39 -0.818 . . . . 0.0 110.886 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -100.6 111.96 24.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.749 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.09 169.71 13.11 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.241 1.02 . . . . 0.0 112.717 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.5 ttt180 -113.0 124.73 53.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.844 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.612 ' HB2' HD21 ' A' ' 97' ' ' LEU . 20.0 t -78.08 115.08 17.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.95 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.43 -23.77 66.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.847 -0.533 . . . . 0.0 110.114 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.26 -30.51 66.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.806 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.4 p -136.35 12.26 3.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.834 -0.541 . . . . 0.0 110.952 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.89 30.95 7.72 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.062 -1.024 . . . . 0.0 110.461 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.9 mttt -100.18 -179.88 4.27 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.22 137.25 14.63 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.035 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.26 6.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.543 ' O ' HG23 ' A' ' 128' ' ' ILE . 70.7 m-85 -94.24 162.85 13.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.578 -0.954 . . . . 0.0 111.317 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.6 pt -155.31 111.03 2.25 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.998 -0.439 . . . . 0.0 110.166 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -45.36 101.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.04 1.021 . . . . 0.0 112.0 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.44 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.2 m -51.89 -28.87 17.65 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -81.57 11.62 4.49 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.298 -0.876 . . . . 0.0 112.569 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -136.79 30.87 2.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.061 -1.025 . . . . 0.0 108.589 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -147.98 170.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.803 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -119.32 129.27 54.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.724 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--N 1.308 -1.236 0 O-C-N 121.522 -0.736 . . . . 0.0 112.924 -177.821 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.916 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 80.7 mt -111.66 166.95 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.728 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 135' ' ' ARG . 13.4 m -143.53 169.04 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.722 -0.611 . . . . 0.0 109.678 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.0 p -131.95 126.53 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.778 . . . . 0.0 108.948 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.97 118.24 10.16 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.84 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 1.029 HD11 ' HB2' ' A' ' 134' ' ' ALA . 86.9 mt -94.18 1.26 56.08 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.874 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.49 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 55.9 m-85 -152.99 151.1 29.9 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.197 -0.939 . . . . 0.0 108.652 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.05 145.99 55.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.587 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CE1' ' HG3' ' A' ' 129' ' ' PRO . 69.1 t80 -150.31 163.84 37.29 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.502 -0.749 . . . . 0.0 110.611 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.76 125.59 22.53 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.61 -0.682 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.222 0 O-C-N 121.456 -0.778 . . . . 0.0 111.268 179.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.721 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.2 t0 . . . . . 0 N--CA 1.496 1.834 0 N-CA-C 109.598 -0.519 . . . . 0.0 109.598 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' A' ' 119' ' ' SER . 40.1 tp -107.57 129.19 55.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.76 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -94.5 176.8 6.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.699 -0.625 . . . . 0.0 109.953 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.573 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 11.6 p90 -172.98 -167.48 0.42 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.494 -0.754 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -176.88 3.64 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.125 0.964 . . . . 0.0 111.539 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.0 ttmt -61.08 -22.73 64.89 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.38 44.7 1.0 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.78 166.51 13.07 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.13 116.96 25.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.45 -0.781 . . . . 0.0 110.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.415 ' HE1' ' CD2' ' A' ' 99' ' ' PHE . 68.5 mtm -129.78 146.36 51.53 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -98.54 156.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.545 -1.262 . . . . 0.0 108.71 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 81' ' ' ILE . 43.3 t -93.62 139.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.01 0.909 . . . . 0.0 109.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -94.54 -30.76 14.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -156.23 161.2 40.29 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.71 144.68 31.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 0.0 109.975 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -139.03 -77.93 0.34 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.392 -0.817 . . . . 0.0 110.318 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.28 -85.29 0.07 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -94.27 -13.2 26.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.896 . . . . 0.0 110.596 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -133.47 96.66 3.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.775 . . . . 0.0 110.163 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.421 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 31.7 m0 -94.91 146.04 24.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.243 -0.911 . . . . 0.0 109.787 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -95.21 117.06 29.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -129.57 165.77 21.05 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.039 0.923 . . . . 0.0 112.419 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.9 ttm180 -115.01 124.54 51.9 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.593 -0.692 . . . . 0.0 109.961 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.753 ' HB2' HD21 ' A' ' 97' ' ' LEU . 4.8 t -83.92 118.77 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.68 -0.638 . . . . 0.0 109.932 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.25 -20.8 62.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.398 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.24 -26.93 66.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.0 109.864 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p -137.62 10.99 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.766 -0.584 . . . . 0.0 110.606 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 53.64 30.81 11.53 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.147 -0.971 . . . . 0.0 110.755 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -104.79 174.0 6.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.526 -0.734 . . . . 0.0 109.27 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.83 146.66 22.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.694 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -176.27 -147.19 6.33 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.431 ' O ' HG23 ' A' ' 128' ' ' ILE . 36.2 m-85 -93.44 160.59 14.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.648 -0.913 . . . . 0.0 110.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.2 pt -152.14 117.57 3.05 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HG3' ' CE1' ' A' ' 89' ' ' TYR . 35.0 Cg_exo -41.33 103.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.323 1.349 . . . . 0.0 112.843 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.421 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 74.2 m -62.36 -15.1 46.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.865 -0.522 . . . . 0.0 111.008 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -86.13 13.87 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 111.522 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -152.23 40.2 0.61 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.252 -0.905 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.2 p -149.09 168.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.421 -0.799 . . . . 0.0 110.831 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 1.029 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -127.82 127.81 44.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.975 -0.453 . . . . 0.0 109.93 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.683 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.454 -178.82 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 107' ' ' VAL . 4.9 tp . . . . . 0 N--CA 1.496 1.845 0 CA-C-O 119.858 -0.115 . . . . 0.0 111.082 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.639 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 7.0 mt -110.31 167.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 108.436 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 135' ' ' ARG . 3.8 m -146.17 167.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.669 . . . . 0.0 110.617 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.6 p -128.51 124.16 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.63 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.9 117.57 9.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 134' ' ' ALA . 79.8 mt -94.39 5.53 51.5 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.257 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.431 ' N ' ' HA ' ' A' ' 101' ' ' LYS . 38.9 m-85 -152.44 151.74 31.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -70.17 141.99 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 109.536 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 65.4 t80 -155.53 126.95 7.25 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.349 -0.844 . . . . 0.0 111.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -100.1 122.02 42.32 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.506 0.67 . . . . 0.0 109.895 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.66 ' HB1' ' OD2' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.498 1.964 0 CA-C-O 121.508 0.671 . . . . 0.0 111.903 -179.153 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.66 ' OD2' ' HB1' ' A' ' 91' ' ' ALA . 20.1 p-10 . . . . . 0 N--CA 1.501 2.125 0 CA-C-O 121.049 0.452 . . . . 0.0 111.505 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 125' ' ' GLU . 7.9 tt -137.54 134.34 35.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.415 -0.803 . . . . 0.0 110.47 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -94.44 166.94 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 110.001 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.63 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 24.0 p90 -164.76 -170.78 2.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.291 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -124.37 179.88 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.328 1.061 . . . . 0.0 112.69 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HA ' ' N ' ' A' ' 87' ' ' TYR . 16.6 ttmt -60.95 -19.32 60.75 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.34 41.22 1.31 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.0 m-20 -90.9 166.06 13.26 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.686 -0.89 . . . . 0.0 111.527 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.05 111.31 15.82 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.561 -0.712 . . . . 0.0 110.112 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.9 mtm -126.01 147.41 49.55 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.1 m -95.02 157.33 3.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.073 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 83' ' ' VAL . 73.9 t -93.98 135.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.201 1.001 . . . . 0.0 110.329 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -94.98 -27.62 15.56 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.632 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -155.61 177.45 11.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.75 -0.594 . . . . 0.0 109.844 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.81 94.52 3.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -97.29 -152.87 0.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.678 -0.639 . . . . 0.0 110.084 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.33 -114.66 0.07 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -86.54 -6.87 58.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.948 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -119.0 102.81 9.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 109.669 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -98.72 157.11 16.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.421 -0.799 . . . . 0.0 110.645 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 5.9 mttt -97.51 121.72 39.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.24 161.32 32.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.351 -0.843 . . . . 0.0 111.83 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.8 ttm180 -114.97 122.35 45.98 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.545 -0.722 . . . . 0.0 109.83 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.5 t -84.48 127.33 33.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.645 -0.659 . . . . 0.0 110.456 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.88 -26.59 60.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.114 -0.366 . . . . 0.0 110.715 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.76 66.15 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.42 -0.8 . . . . 0.0 110.671 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p -128.31 9.4 6.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.688 . . . . 0.0 110.566 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.48 33.78 19.56 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -107.82 176.98 4.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.562 -0.711 . . . . 0.0 109.087 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pm0 -155.26 137.99 15.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.39 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -162.41 -149.71 5.76 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 75.9 m-85 -94.52 161.35 14.25 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 122.032 -0.687 . . . . 0.0 110.69 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.52 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -155.4 117.59 2.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -48.62 109.38 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.036 1.019 . . . . 0.0 111.73 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 m -56.96 -18.2 12.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.765 -0.584 . . . . 0.0 111.719 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 18.7 4.27 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.096 -1.003 . . . . 0.0 111.631 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -145.74 36.66 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 134' ' ' ALA . 8.9 p -154.86 169.21 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.784 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.65 132.54 39.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.062 0.458 . . . . 0.0 110.301 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.688 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.882 -179.684 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.4 tp . . . . . 0 N--CA 1.498 1.96 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 88.0 mt -123.16 159.18 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.591 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 135' ' ' ARG . 17.2 m -137.83 169.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.9 p -130.01 123.96 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.587 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.26 120.67 14.18 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.045 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 134' ' ' ALA . 85.3 mt -94.26 1.12 56.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.95 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.6 m-85 -152.48 152.53 32.06 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.49 146.23 54.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 36.7 t80 -155.15 127.68 7.91 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.35 -0.844 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -98.03 144.4 27.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.427 -0.796 . . . . 0.0 111.551 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.746 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.08 0 O-C-N 121.665 -0.647 . . . . 0.0 111.585 -179.764 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.746 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 40.3 p30 . . . . . 0 N--CA 1.492 1.653 0 CA-C-O 121.204 0.526 . . . . 0.0 111.498 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 98' ' ' SER . 0.9 OUTLIER -154.35 121.89 5.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 110.106 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.521 ' N ' HD13 ' A' ' 97' ' ' LEU . 1.1 m -94.52 112.0 23.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 110.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.587 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 14.4 p90 -114.83 -169.24 1.51 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.806 -0.559 . . . . 0.0 109.959 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -178.15 4.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.062 0.934 . . . . 0.0 111.72 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -60.95 -20.56 62.43 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.01 42.51 1.13 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.7 m-20 -91.05 169.21 11.06 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.947 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.33 125.65 43.81 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.495 0.664 . . . . 0.0 109.547 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.486 ' HE3' ' HB2' ' A' ' 85' ' ' ALA . 3.2 mpp? -134.4 153.95 51.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.616 ' CG2' HD11 ' A' ' 120' ' ' LEU . 36.6 t -94.41 152.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.576 HG11 HD11 ' A' ' 81' ' ' ILE . 33.6 t -95.57 134.93 31.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.902 0.858 . . . . 0.0 110.142 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.715 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -95.64 -27.83 15.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.54 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -156.05 -168.92 2.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.596 0.712 . . . . 0.0 111.128 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -143.62 99.22 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.64 -0.662 . . . . 0.0 109.562 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 t -94.42 -71.47 0.66 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 110.697 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.88 -77.21 0.07 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -94.04 -22.7 18.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.488 -1.007 . . . . 0.0 110.298 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.423 ' HZ3' ' HH ' ' A' ' 89' ' ' TYR . 84.0 m95 -133.83 108.27 8.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.539 -0.726 . . . . 0.0 110.217 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.402 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 34.0 m0 -98.98 158.9 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -100.27 126.65 46.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.416 -0.802 . . . . 0.0 109.094 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.715 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -135.73 162.6 32.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 112.164 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.3 ttt180 -111.35 120.54 42.53 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.391 -0.818 . . . . 0.0 109.829 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.441 ' HB2' HD11 ' A' ' 97' ' ' LEU . 1.1 t -72.41 110.71 7.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.485 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.616 HD11 ' CG2' ' A' ' 106' ' ' VAL . 7.3 mt -64.96 -26.0 68.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 -29.95 70.88 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.632 -0.668 . . . . 0.0 110.097 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.0 p -129.53 8.61 5.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 110.883 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 53.66 29.25 9.07 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.135 -0.978 . . . . 0.0 109.86 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -97.48 176.24 5.94 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.74 140.59 17.18 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.765 0.793 . . . . 0.0 111.464 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.24 -150.01 6.83 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.5 ' O ' HG23 ' A' ' 128' ' ' ILE . 52.8 m-85 -93.92 165.28 12.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.905 -0.762 . . . . 0.0 110.805 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.529 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.7 pt -155.29 112.56 2.27 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 34.3 Cg_exo -42.67 102.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.109 1.206 . . . . 0.0 112.078 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.402 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 71.6 m -54.9 -20.6 9.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.906 -0.496 . . . . 0.0 111.513 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -90.26 25.32 2.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.214 -0.928 . . . . 0.0 111.63 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -154.99 32.02 0.4 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 109.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -149.02 169.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.579 -0.7 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -132.79 123.88 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.683 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 ttp180 . . . . . 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 112.455 -178.69 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.491 1.582 0 CA-C-O 120.916 0.389 . . . . 0.0 110.641 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.962 ' CD1' HG13 ' A' ' 106' ' ' VAL . 4.9 mm -96.65 140.1 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.064 -1.022 . . . . 0.0 108.882 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 135' ' ' ARG . 32.2 m -126.33 174.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.428 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.882 HG12 ' HB3' ' A' ' 134' ' ' ALA . 7.1 p -127.66 123.66 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.655 -0.653 . . . . 0.0 109.365 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.577 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.36 119.41 11.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 134' ' ' ALA . 64.5 mt -94.3 4.2 54.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.561 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.463 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.1 m-85 -152.63 151.5 30.68 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.031 -1.043 . . . . 0.0 109.117 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 74.6 m-20 -69.13 143.14 54.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.352 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 58.9 t80 -155.12 131.15 10.15 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.181 -0.949 . . . . 0.0 111.019 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -97.4 142.19 29.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.7 -0.625 . . . . 0.0 110.723 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.774 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.123 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 179.701 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.774 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 53.2 p-10 . . . . . 0 N--CA 1.494 1.732 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 119' ' ' SER . 55.4 tp -151.9 129.33 11.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.312 -0.868 . . . . 0.0 111.14 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.76 116.65 28.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.686 -0.634 . . . . 0.0 110.295 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.3 p90 -113.62 -170.92 1.79 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.579 -0.7 . . . . 0.0 109.958 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -125.71 -179.77 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.032 0.92 . . . . 0.0 111.831 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.463 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.14 -23.36 65.47 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.7 40.9 1.37 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.96 171.08 9.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.049 -0.677 . . . . 0.0 111.543 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 139.55 53.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.484 -0.76 . . . . 0.0 109.781 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 71.8 mtm -142.95 154.01 43.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.79 -0.569 . . . . 0.0 110.178 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.962 HG13 ' CD1' ' A' ' 82' ' ' ILE . 22.4 t -100.77 147.89 7.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 81' ' ' ILE . 95.4 t -94.92 138.93 19.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.881 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.14 -25.69 14.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.04 155.33 32.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.749 -0.595 . . . . 0.0 110.05 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -108.7 133.16 53.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 109.916 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.8 t -132.6 -85.38 0.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.279 -0.888 . . . . 0.0 110.658 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.96 -91.76 0.08 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.88 -16.83 30.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.585 -0.95 . . . . 0.0 110.807 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -127.59 104.9 8.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.371 -0.831 . . . . 0.0 110.468 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 44.5 m0 -101.95 153.56 19.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.249 -0.907 . . . . 0.0 109.984 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -102.78 113.21 26.44 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.737 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.02 167.93 16.01 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.127 -0.983 . . . . 0.0 112.675 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HB2' HD11 ' A' ' 108' ' ' LEU . 1.1 ttt180 -115.76 124.01 49.71 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.65 -0.656 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.822 ' HB2' HD21 ' A' ' 97' ' ' LEU . 24.2 t -78.98 120.82 24.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.624 -0.673 . . . . 0.0 109.741 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mt -71.75 -21.81 61.7 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.17 73.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.4 -0.812 . . . . 0.0 109.656 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 p -130.56 9.54 5.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.726 -0.609 . . . . 0.0 110.735 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.23 31.3 13.87 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.042 -1.036 . . . . 0.0 110.641 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.5 mtpt -104.51 173.3 6.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.6 OUTLIER -154.6 140.35 18.08 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.644 179.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.03 -146.04 4.71 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.491 ' O ' HG23 ' A' ' 128' ' ' ILE . 72.7 m-85 -94.15 157.81 15.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 122.056 -0.673 . . . . 0.0 110.6 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.568 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.7 pt -154.0 113.59 2.53 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.794 -0.566 . . . . 0.0 109.796 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.62 97.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.277 1.146 . . . . 0.0 112.062 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 66.9 m -49.56 -24.6 2.21 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.684 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -85.71 16.4 4.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.403 -0.811 . . . . 0.0 111.755 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.71 29.15 1.93 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.2 -0.938 . . . . 0.0 109.147 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.3 p -146.69 169.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.669 0.747 . . . . 0.0 110.901 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.882 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -119.7 135.71 54.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.867 -0.52 . . . . 0.0 110.072 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.848 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.378 0 O-C-N 121.39 -0.818 . . . . 0.0 111.696 -179.065 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.493 1.687 0 N-CA-C 109.566 -0.531 . . . . 0.0 109.566 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 49.0 mt -107.88 157.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.902 -1.124 . . . . 0.0 109.055 179.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 135' ' ' ARG . 28.9 m -139.86 173.12 11.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.815 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.6 p -133.09 121.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.42 118.94 9.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.707 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' A' ' 134' ' ' ALA . 90.5 mt -94.15 0.75 55.99 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.253 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 41.0 m-85 -150.13 149.72 30.66 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.257 -0.902 . . . . 0.0 108.834 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -66.24 151.31 47.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -153.94 167.78 28.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.374 -0.829 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 94.06 2.17 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.169 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.108 0 O-C-N 121.587 -0.696 . . . . 0.0 111.013 -179.573 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.942 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 20.2 p-10 . . . . . 0 N--CA 1.504 2.234 0 CA-C-O 120.989 0.423 . . . . 0.0 112.074 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 119' ' ' SER . 2.3 tt -133.43 134.66 43.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 110.431 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 m -94.7 170.2 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.594 -0.691 . . . . 0.0 109.976 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.571 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 18.4 p90 -161.02 -169.14 2.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.623 -0.673 . . . . 0.0 110.638 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.98 179.22 4.73 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.259 1.028 . . . . 0.0 112.523 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -61.12 -23.02 65.21 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.36 43.62 1.08 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.3 m-20 -90.53 167.85 12.27 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.894 -0.768 . . . . 0.0 111.396 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.47 128.61 50.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.589 -0.694 . . . . 0.0 109.717 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -137.45 148.1 45.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 38.4 t -95.08 155.16 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 81' ' ' ILE . 49.4 t -95.13 140.51 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.159 -0.963 . . . . 0.0 110.634 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -97.59 -27.63 14.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -156.14 173.23 17.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.776 -0.578 . . . . 0.0 110.122 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -139.98 89.17 2.28 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.459 -0.775 . . . . 0.0 110.0 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.6 t -99.32 -68.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 110.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.86 154.59 7.27 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 65.14 -72.64 0.07 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.562 -0.963 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 39.4 m95 -108.86 126.4 53.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.94 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -106.39 141.62 37.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.521 -0.737 . . . . 0.0 110.213 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.6 114.02 25.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -130.31 164.89 23.65 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.841 0.829 . . . . 0.0 111.987 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.0 ttt180 -112.34 124.53 52.67 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.625 -0.672 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.727 ' HB2' HD21 ' A' ' 97' ' ' LEU . 6.8 t -78.88 114.39 17.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.578 . . . . 0.0 109.664 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.16 -27.7 68.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.51 . . . . 0.0 109.992 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.97 38.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.094 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -139.49 10.6 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.676 -0.64 . . . . 0.0 110.717 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 52.24 30.51 7.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.959 -1.088 . . . . 0.0 110.707 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 28.2 mttt -103.26 -178.75 3.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.4 OUTLIER -155.38 147.41 23.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.52 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -155.73 11.15 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 79.0 m-85 -94.18 157.75 15.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 122.045 -0.68 . . . . 0.0 110.348 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 127' ' ' TYR . 3.8 pt -155.0 125.58 3.41 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.641 -0.662 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.01 117.34 4.18 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 122.967 0.983 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 m -53.95 -34.43 59.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.789 -0.57 . . . . 0.0 111.989 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -71.33 -6.52 40.6 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.907 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -109.72 25.36 11.88 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.098 -1.001 . . . . 0.0 109.466 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -156.71 170.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.965 0.888 . . . . 0.0 112.175 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -124.65 127.1 46.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.844 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.8 ttp180 . . . . . 0 N--CA 1.487 1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 112.58 -178.172 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.763 HD11 HG11 ' A' ' 107' ' ' VAL . 0.7 OUTLIER . . . . . 0 N--CA 1.496 1.867 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 83' ' ' VAL . 74.4 mt -119.34 164.48 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.938 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 135' ' ' ARG . 15.4 m -142.12 169.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -129.9 126.71 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.622 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -70.56 120.58 16.41 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.0 mt -94.33 3.2 55.52 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.187 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 44.9 m-85 -153.0 150.58 29.35 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 108.872 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.48 141.06 58.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 109.941 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 44.2 t80 -155.38 119.99 4.73 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.361 -0.837 . . . . 0.0 111.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.52 124.23 50.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.706 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.502 2.133 0 O-C-N 121.25 -0.906 . . . . 0.0 110.433 179.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.706 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 24.0 t0 . . . . . 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 119' ' ' SER . 37.4 tp -98.23 133.54 42.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.912 . . . . 0.0 111.734 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -94.56 162.42 13.81 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.622 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 13.6 p90 -171.53 -165.66 0.4 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.491 -0.756 . . . . 0.0 110.115 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 178.37 5.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.242 1.02 . . . . 0.0 112.247 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 16.7 ttmt -61.08 -21.49 63.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.74 40.57 1.44 Allowed Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.1 m-20 -91.0 169.55 10.79 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.852 -0.793 . . . . 0.0 112.131 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 122.04 36.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.561 -0.712 . . . . 0.0 110.116 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.7 mtm -127.69 152.85 47.19 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 120' ' ' LEU . 41.3 t -95.5 154.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.763 HG11 HD11 ' A' ' 81' ' ' ILE . 5.7 t -94.78 136.25 26.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.949 0.88 . . . . 0.0 109.699 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -96.89 -27.03 14.86 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.546 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -155.99 -174.42 4.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.706 -0.621 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -137.88 98.78 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.405 -0.809 . . . . 0.0 109.751 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 t -94.69 -77.98 0.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.51 -80.23 0.08 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -93.55 -8.66 40.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.945 . . . . 0.0 110.729 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -143.44 96.94 2.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.893 . . . . 0.0 110.076 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -95.65 157.87 15.71 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.098 -1.002 . . . . 0.0 110.781 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tttt -102.17 122.47 44.22 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.566 ' O ' HD22 ' A' ' 97' ' ' LEU . . . -132.16 159.96 37.46 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 112.37 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.0 ttt180 -113.0 124.41 52.57 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.496 -0.753 . . . . 0.0 109.937 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.701 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.1 t -81.51 119.21 23.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.622 . . . . 0.0 109.362 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.453 HD11 ' CG2' ' A' ' 106' ' ' VAL . 3.2 mt -71.15 -24.79 62.33 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.767 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.33 59.57 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.35 -0.844 . . . . 0.0 109.587 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 p -137.34 9.4 2.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.436 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.19 27.63 6.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.01 -1.056 . . . . 0.0 110.67 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 38.4 mttt -95.51 171.47 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.5 151.83 28.17 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.854 0.835 . . . . 0.0 111.849 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.4 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . 177.07 -152.89 12.67 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 4.5 m-85 -92.92 153.36 18.83 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.865 . . . . 0.0 109.705 -179.447 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.55 132.31 14.18 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.803 -0.561 . . . . 0.0 110.404 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 39.0 Cg_exo -47.87 96.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.121 1.064 . . . . 0.0 111.677 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 m -55.87 -20.5 15.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.721 -0.612 . . . . 0.0 111.379 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.65 18.36 5.56 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.327 -0.858 . . . . 0.0 111.351 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -146.75 33.33 0.93 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -146.13 168.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.936 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.718 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -131.21 120.09 22.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.712 ' HA ' HG12 ' A' ' 83' ' ' VAL . 14.6 ttp180 . . . . . 0 N--CA 1.484 1.242 0 O-C-N 121.229 -0.92 . . . . 0.0 112.029 -178.604 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.585 HD11 HG11 ' A' ' 107' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.499 2.018 0 N-CA-C 109.397 -0.594 . . . . 0.0 109.397 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 83' ' ' VAL . 74.8 mt -118.14 164.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.873 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 135' ' ' ARG . 22.4 m -142.22 173.49 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.9 p -131.49 128.07 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.012 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.957 ' HA ' HG12 ' A' ' 133' ' ' VAL . . . -70.46 116.1 10.41 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 134' ' ' ALA . 77.2 mt -94.33 3.05 55.72 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.261 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.6 m-85 -149.71 150.32 31.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.198 -0.939 . . . . 0.0 108.906 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -71.75 145.02 49.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.166 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 19.6 t80 -155.5 121.95 5.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.465 -0.772 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 20.3 mt-10 -97.15 124.42 41.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.354 -0.841 . . . . 0.0 110.752 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.82 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.197 0 O-C-N 121.575 -0.703 . . . . 0.0 111.323 -179.773 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.82 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 1.7 p30 . . . . . 0 N--CA 1.509 2.519 0 CA-C-O 120.948 0.404 . . . . 0.0 111.239 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tt -109.28 146.19 34.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.513 -0.742 . . . . 0.0 111.024 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.8 m -97.29 119.97 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.821 -0.549 . . . . 0.0 109.777 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CE2' HG22 ' A' ' 128' ' ' ILE . 20.2 p90 -114.99 -170.92 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.587 -0.696 . . . . 0.0 110.742 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.73 177.28 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.295 1.045 . . . . 0.0 112.159 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 14.7 ttmt -61.32 -20.29 62.78 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.68 1.32 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.88 170.14 10.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.902 -0.763 . . . . 0.0 111.724 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.33 123.52 41.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 110.181 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.422 ' HE1' ' CG ' ' A' ' 99' ' ' PHE . 77.4 mtm -129.58 150.43 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.514 ' CG2' HD11 ' A' ' 120' ' ' LEU . 38.0 t -96.2 153.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 81' ' ' ILE . 24.8 t -95.2 134.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.84 0.829 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -95.03 -26.36 16.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.208 0.528 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -155.43 -177.37 6.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.067 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -145.17 95.19 2.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 t -104.88 -53.99 2.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.524 -0.735 . . . . 0.0 111.003 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.81 141.99 3.8 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 64.58 -72.41 0.06 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.646 -0.914 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -106.07 117.86 35.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 0.0 110.208 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -106.78 152.38 23.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.643 . . . . 0.0 110.207 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.69 117.2 31.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.541 -0.724 . . . . 0.0 109.187 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -130.21 162.5 28.79 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.623 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 4.6 ttt180 -114.88 124.51 51.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.7 -0.625 . . . . 0.0 109.889 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 t -78.23 117.06 19.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.482 -0.761 . . . . 0.0 109.654 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 106' ' ' VAL . 13.2 mt -67.35 -26.3 66.42 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.313 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.46 66.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -136.58 9.89 3.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.588 -0.695 . . . . 0.0 110.714 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.65 27.84 4.32 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.979 -1.075 . . . . 0.0 110.414 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 47.6 mttt -101.84 179.71 4.25 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.24 151.36 28.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.412 -0.805 . . . . 0.0 111.48 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -173.1 -157.58 15.22 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.874 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.441 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 88.4 m-85 -94.03 151.35 19.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 122.311 -0.523 . . . . 0.0 109.703 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.479 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -154.04 130.12 5.45 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.58 -0.7 . . . . 0.0 110.575 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.69 107.51 0.75 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 109.347 -1.059 . . . . 0.0 109.347 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 m -55.34 -26.01 38.29 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.384 -0.822 . . . . 0.0 110.857 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.436 ' ND2' ' CD1' ' A' ' 132' ' ' TYR . 16.8 p-10 -71.28 -12.44 61.45 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.414 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.436 ' CD1' ' ND2' ' A' ' 131' ' ' ASN . 3.0 m-85 -100.54 9.23 42.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.957 HG12 ' HA ' ' A' ' 85' ' ' ALA . 35.2 m -138.5 -177.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 111.929 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.713 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -132.06 114.77 14.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.71 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.346 0 O-C-N 121.308 -0.87 . . . . 0.0 111.066 -178.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.503 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.765 0 CA-C-O 120.782 0.325 . . . . 0.0 110.725 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 73.7 mt -98.47 144.73 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.746 -1.221 . . . . 0.0 109.889 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.893 HG12 ' HA ' ' A' ' 135' ' ' ARG . 28.0 m -127.45 174.62 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 110.785 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.78 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.6 p -130.38 126.22 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -69.63 121.17 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 134' ' ' ALA . 64.5 mt -94.43 1.83 55.78 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.738 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.478 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.6 m-85 -152.52 151.01 30.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.257 -0.902 . . . . 0.0 108.899 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -67.12 147.88 52.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.531 -0.731 . . . . 0.0 109.927 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.484 ' CZ ' ' HG3' ' A' ' 129' ' ' PRO . 54.4 t80 -153.89 146.35 24.02 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.354 -0.841 . . . . 0.0 111.768 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 114.88 23.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.538 0.685 . . . . 0.0 110.921 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.823 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.505 2.297 0 O-C-N 121.387 -0.821 . . . . 0.0 112.09 -179.776 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.823 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 55.4 p-10 . . . . . 0 N--CA 1.483 1.224 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 117' ' ' ALA . 40.9 tp -138.84 125.62 20.91 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.592 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -93.98 159.74 15.03 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.289 0.566 . . . . 0.0 109.587 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.558 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.5 p90 -163.36 -170.42 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.637 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -178.17 3.93 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.164 0.983 . . . . 0.0 112.162 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -61.07 -21.32 63.55 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.98 43.3 1.04 Allowed Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.5 m-20 -90.76 171.68 9.17 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.989 -0.712 . . . . 0.0 111.877 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.87 136.03 53.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.665 -0.647 . . . . 0.0 109.764 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 76.4 mtm -143.44 154.52 43.77 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.507 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 40.8 t -101.65 150.94 5.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 81' ' ' ILE . 61.9 t -95.5 138.21 21.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 O-C-N 121.241 -0.912 . . . . 0.0 110.542 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.736 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.87 -25.84 14.49 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.39 147.72 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.648 -0.658 . . . . 0.0 110.192 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.09 145.39 28.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.297 -0.877 . . . . 0.0 109.237 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -142.29 -71.5 0.33 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.51 -77.61 0.14 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.27 -10.22 30.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -1.014 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -147.71 107.15 3.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.272 -0.893 . . . . 0.0 110.585 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -104.21 155.61 18.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 17.7 tttt -105.17 116.74 32.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.736 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.05 169.41 14.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.897 . . . . 0.0 112.54 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 1.6 ttt180 -115.3 121.67 43.59 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 121.775 -0.578 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.3 t -77.6 116.11 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.676 -0.64 . . . . 0.0 109.765 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.63 -22.41 65.33 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.052 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.93 66.78 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.676 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.7 p -138.63 9.02 2.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.892 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 53.68 29.01 8.73 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.981 -1.074 . . . . 0.0 110.597 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 52.5 mttt -103.09 174.73 5.74 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -155.22 142.57 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.931 0.872 . . . . 0.0 111.406 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -169.22 -146.31 4.98 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 56.5 m-85 -93.49 161.39 14.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 122.058 -0.672 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 127' ' ' TYR . 3.4 pt -151.52 118.87 3.28 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.736 -0.603 . . . . 0.0 109.83 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 68.5 Cg_exo -40.76 99.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.37 1.38 . . . . 0.0 112.436 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -61.02 -19.68 61.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.905 -0.497 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 24.8 p30 -87.82 17.89 4.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.32 -0.862 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.428 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 4.5 m-85 -152.06 44.49 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.052 -1.03 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.497 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -154.18 168.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 111.023 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.78 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -123.41 138.98 54.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.882 -0.511 . . . . 0.0 110.37 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.893 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.33 0 O-C-N 121.397 -0.815 . . . . 0.0 112.088 -179.064 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 120.838 0.351 . . . . 0.0 110.715 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.443 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 27.3 mt -97.55 124.91 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.056 -1.027 . . . . 0.0 109.206 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 135' ' ' ARG . 32.8 m -111.23 171.94 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.364 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.7 p -128.32 127.6 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.575 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.66 117.84 10.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.931 HD11 ' HB2' ' A' ' 134' ' ' ALA . 80.5 mt -94.54 4.26 54.08 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.297 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.423 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 27.6 m-85 -151.94 150.42 30.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -68.26 146.15 53.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 109.725 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.449 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 65.3 t80 -153.48 145.04 23.28 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.255 -0.903 . . . . 0.0 111.15 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -118.32 103.48 9.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.916 -0.49 . . . . 0.0 110.165 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HB1' ' HB2' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.103 0 O-C-N 121.46 -0.775 . . . . 0.0 110.871 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.852 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 19.2 p-10 . . . . . 0 N--CA 1.504 2.27 0 CA-C-O 121.092 0.472 . . . . 0.0 112.132 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 119' ' ' SER . 6.4 tt -148.45 130.91 15.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.699 -0.625 . . . . 0.0 110.227 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -94.8 151.57 19.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.612 -0.68 . . . . 0.0 110.157 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.575 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.5 p90 -142.43 -167.96 2.62 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.455 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -125.39 179.93 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.173 0.987 . . . . 0.0 112.119 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.0 ttmt -61.24 -20.07 62.4 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.54 41.49 1.32 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 84' ' ' VAL . 10.9 m-20 -91.06 165.04 13.73 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.744 -0.856 . . . . 0.0 112.408 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.69 54.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -138.75 153.14 48.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.469 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 20.9 t -100.83 152.61 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 81' ' ' ILE . 94.5 t -95.36 139.7 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.109 -0.995 . . . . 0.0 109.789 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -98.6 -27.18 14.13 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -156.23 159.46 38.93 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.88 105.34 13.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.216 -0.927 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 -151.96 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.4 -0.813 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.53 -107.22 0.61 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.91 -4.42 59.16 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.543 -0.975 . . . . 0.0 111.575 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 30.7 m95 -127.77 106.21 8.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.411 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 50.1 m0 -100.67 153.03 19.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 109.767 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -100.62 114.26 27.79 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.659 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.61 164.03 22.92 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.712 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -113.33 120.61 41.73 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.724 -0.61 . . . . 0.0 109.6 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.496 ' HB2' HD21 ' A' ' 97' ' ' LEU . 6.1 t -78.38 122.67 26.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.655 -0.653 . . . . 0.0 109.35 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.84 -27.88 63.19 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.934 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.45 31.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.443 -0.785 . . . . 0.0 109.85 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.8 p -137.81 10.33 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.613 . . . . 0.0 110.528 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 50.61 27.48 2.95 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.993 -1.067 . . . . 0.0 110.574 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 4.2 mttt -100.45 179.78 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.24 147.18 23.46 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.77 0.795 . . . . 0.0 111.183 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -147.03 5.52 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.453 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 75.8 m-85 -94.42 157.39 16.04 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.091 -0.652 . . . . 0.0 110.606 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.9 pt -152.15 109.59 2.83 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.652 -0.655 . . . . 0.0 109.735 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HG3' ' CH2' ' A' ' 114' ' ' TRP . 51.3 Cg_exo -50.66 110.07 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 122.958 0.978 . . . . 0.0 111.56 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 24.0 m -59.88 -17.23 35.43 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.935 -0.478 . . . . 0.0 111.249 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -84.77 12.93 6.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.276 -0.89 . . . . 0.0 111.719 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -147.02 44.27 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 0.0 108.802 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.4 p -156.25 168.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.792 0.806 . . . . 0.0 111.317 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.931 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -128.61 127.6 42.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.727 ' HA ' HG12 ' A' ' 83' ' ' VAL . 4.2 tmm_? . . . . . 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 112.474 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.595 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 . . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.449 HG12 HG13 ' A' ' 106' ' ' VAL . 47.7 mt -104.29 155.91 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.915 -1.116 . . . . 0.0 109.448 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.6 m -139.01 176.5 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.836 HG12 ' HB3' ' A' ' 134' ' ' ALA . 3.9 p -134.28 122.69 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.549 -0.72 . . . . 0.0 109.414 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.42 120.36 13.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.84 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 134' ' ' ALA . 79.5 mt -94.09 1.47 56.15 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.483 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.8 m-85 -152.49 151.0 30.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.152 -0.967 . . . . 0.0 108.393 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 67.4 m-20 -66.61 148.46 51.87 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.501 -0.75 . . . . 0.0 110.339 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.472 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 46.2 t80 -155.3 131.05 9.91 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.317 -0.865 . . . . 0.0 111.31 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -100.09 137.73 38.14 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.403 -0.811 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.769 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.506 2.349 0 O-C-N 121.606 -0.684 . . . . 0.0 111.721 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.769 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 50.3 p30 . . . . . 0 N--CA 1.495 1.794 0 N-CA-C 110.09 -0.337 . . . . 0.0 110.09 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 119' ' ' SER . 61.2 tp -155.01 124.78 6.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.488 -0.758 . . . . 0.0 111.232 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.75 114.93 26.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.27 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.562 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 14.3 p90 -113.14 -168.86 1.38 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.63 -0.669 . . . . 0.0 110.057 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 1.8 tt0 -125.69 -178.33 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.352 1.073 . . . . 0.0 112.799 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.2 -23.9 65.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.95 42.42 1.19 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.52 166.84 13.0 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.649 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.17 128.75 50.47 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.691 -0.631 . . . . 0.0 109.377 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.416 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.8 mpp? -135.78 148.47 48.78 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 33.6 t -98.65 152.59 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' ILE . 58.2 t -95.05 138.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.16 -31.65 13.43 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -156.32 163.4 39.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.917 -0.49 . . . . 0.0 109.857 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.87 153.72 21.0 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.9 t -147.87 -68.62 0.24 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.03 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -99.57 -20.74 16.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.652 -0.91 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -121.43 102.33 8.19 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -99.19 150.78 21.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.932 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.4 tttt -94.75 112.73 24.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.56 166.59 18.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.257 -0.902 . . . . 0.0 112.246 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.8 ttt180 -112.75 124.93 53.69 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.479 ' HB2' HD21 ' A' ' 97' ' ' LEU . 42.2 t -77.85 115.1 17.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.455 HD11 ' CG2' ' A' ' 106' ' ' VAL . 20.5 mt -68.8 -24.93 64.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 110.625 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.69 67.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.802 . . . . 0.0 109.965 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p -135.99 9.29 3.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.605 -0.685 . . . . 0.0 110.798 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.36 30.63 12.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.045 -1.034 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 mmmm -99.68 177.73 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.262 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.44 139.0 15.96 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.83 0.824 . . . . 0.0 111.388 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -168.31 -150.71 6.74 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.54 ' O ' HG23 ' A' ' 128' ' ' ILE . 59.8 m-85 -93.89 162.73 13.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.718 -0.872 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.3 pt -155.45 111.7 2.23 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.713 -0.617 . . . . 0.0 109.866 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 O-C-N 123.038 1.02 . . . . 0.0 112.079 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.436 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 16.4 m -61.27 -17.11 51.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -76.79 1.48 17.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.208 -0.932 . . . . 0.0 112.316 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -141.84 46.82 1.66 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 134' ' ' ALA . 4.1 p -154.83 168.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.836 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -120.98 129.07 53.27 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.735 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.453 0 O-C-N 121.416 -0.803 . . . . 0.0 112.871 -178.072 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.817 0 CA-C-O 122.181 0.991 . . . . 0.0 109.503 . . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.403 HG23 ' O ' ' A' ' 105' ' ' MET . 69.0 mt -128.75 150.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.616 HG12 ' CG ' ' A' ' 135' ' ' ARG . 28.4 m -128.89 175.1 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 134' ' ' ALA . 8.5 p -132.74 118.12 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.632 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -63.33 116.18 5.26 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.2 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.949 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.6 mt -94.45 1.68 55.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.126 -0.359 . . . . 0.0 111.77 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.468 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 51.3 m-85 -151.25 151.75 32.28 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.98 144.54 54.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 109.685 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 33.6 t80 -152.28 131.78 13.0 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.125 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -99.79 139.73 35.03 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.277 0.56 . . . . 0.0 111.202 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.784 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.505 2.276 0 O-C-N 121.567 -0.708 . . . . 0.0 111.24 179.426 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.784 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.9 p30 . . . . . 0 N--CA 1.489 1.499 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.48 HD12 ' CA ' ' A' ' 125' ' ' GLU . 6.3 tt -145.92 127.77 15.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 111.037 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -94.7 116.5 28.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.566 -0.709 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.632 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 12.1 p90 -114.35 -167.75 1.26 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.11 177.43 6.38 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.194 0.997 . . . . 0.0 111.942 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 1.3 ttmt -60.92 -18.78 58.72 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.75 38.19 1.3 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -91.03 171.77 9.03 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.802 -0.822 . . . . 0.0 111.871 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.72 136.75 54.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' HG23 ' A' ' 82' ' ' ILE . 69.6 mtm -140.33 155.64 46.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 t -98.68 152.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.486 ' HB ' HG13 ' A' ' 81' ' ' ILE . 84.8 t -94.41 133.42 35.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.934 0.873 . . . . 0.0 109.704 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -96.25 -26.99 15.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -156.4 179.63 9.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 0.0 109.291 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.57 86.26 2.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.173 -0.954 . . . . 0.0 110.389 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.0 t -96.2 -164.7 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.685 -0.634 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.11 139.79 15.06 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 66.43 -64.16 0.23 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.593 -0.946 . . . . 0.0 111.095 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -105.88 115.39 30.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -101.96 149.0 24.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.417 -0.802 . . . . 0.0 109.231 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 15.4 tttt -95.38 113.97 25.69 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.613 -0.68 . . . . 0.0 110.172 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.682 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -129.58 164.91 22.81 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.952 0.882 . . . . 0.0 112.34 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -114.03 124.32 51.85 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.473 -0.767 . . . . 0.0 110.364 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.417 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.4 t -80.09 123.08 27.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.338 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.67 -25.96 60.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.696 -0.627 . . . . 0.0 110.94 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.16 68.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.314 -0.867 . . . . 0.0 110.031 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p -127.79 7.68 6.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.832 -0.542 . . . . 0.0 110.36 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.55 31.98 13.42 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.991 -1.068 . . . . 0.0 110.128 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 35.6 mtpt -102.17 175.41 5.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.48 ' CA ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -155.62 143.24 19.61 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.669 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -168.21 -150.01 6.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 128' ' ' ILE . 66.5 m-85 -93.91 167.93 11.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.956 . . . . 0.0 109.994 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.5 pt -154.98 116.49 2.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -52.23 105.49 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 122.849 0.921 . . . . 0.0 111.594 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -19.33 7.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.715 -0.616 . . . . 0.0 111.241 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -83.88 20.08 1.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.249 -0.907 . . . . 0.0 111.746 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -154.29 39.69 0.46 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.021 -1.05 . . . . 0.0 109.288 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.2 p -154.0 170.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 111.112 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.949 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -129.36 120.57 25.8 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.616 ' CG ' HG12 ' A' ' 83' ' ' VAL . 3.5 ttm180 . . . . . 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 113.148 -177.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.504 HG13 ' HB ' ' A' ' 107' ' ' VAL . 2.4 tp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 110.867 -0.049 . . . . 0.0 110.867 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.607 HG12 HG13 ' A' ' 106' ' ' VAL . 82.3 mt -115.6 164.71 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 107' ' ' VAL . 18.5 m -143.18 175.72 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.428 0.632 . . . . 0.0 110.087 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 84' ' ' VAL . 8.8 p -137.14 122.33 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.574 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -63.76 119.96 10.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 109.345 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 134' ' ' ALA . 32.3 mt -94.26 3.06 55.75 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.352 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 132' ' ' TYR . 39.3 m-85 -150.67 148.99 29.26 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 0.0 108.885 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 65.7 m-20 -66.29 143.97 56.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 18.2 t80 -155.39 122.67 5.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.272 -0.892 . . . . 0.0 111.466 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.69 113.35 26.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 110.238 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.779 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.499 1.978 0 O-C-N 121.328 -0.857 . . . . 0.0 111.092 -179.947 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.779 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 1.8 p30 . . . . . 0 N--CA 1.503 2.175 0 CA-C-O 121.16 0.505 . . . . 0.0 110.808 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.7 149.51 27.21 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.746 0.784 . . . . 0.0 111.619 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.0 m -94.88 147.36 23.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.84 -0.537 . . . . 0.0 109.903 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.3 p90 -148.1 -165.04 2.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.447 -0.783 . . . . 0.0 110.496 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 1.1 tt0 -129.41 176.47 7.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.449 1.119 . . . . 0.0 112.889 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 17.7 ttmt -60.95 -21.06 63.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.18 41.15 1.28 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.86 167.2 12.62 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.782 -0.834 . . . . 0.0 111.63 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.46 124.77 46.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 72.0 mtm -134.82 151.52 51.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 82' ' ' ILE . 21.3 t -94.73 154.07 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.582 HG23 HG13 ' A' ' 83' ' ' VAL . 38.1 t -94.36 141.16 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 0.0 108.996 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.8 mp -101.68 -26.46 13.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -155.95 -171.33 3.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 110.692 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -147.44 105.19 3.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.475 -0.766 . . . . 0.0 110.579 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.4 t -104.76 -53.83 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.01 -70.73 0.3 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -83.24 -57.29 3.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.634 -0.921 . . . . 0.0 110.064 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 40.8 m95 -105.55 121.63 44.36 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.626 . . . . 0.0 110.576 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 130' ' ' SER . 50.9 m0 -107.04 146.39 31.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.474 -0.767 . . . . 0.0 109.751 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -96.94 120.86 38.06 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.648 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -132.96 160.69 36.36 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.187 -0.946 . . . . 0.0 112.323 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.0 ttt180 -111.74 121.46 45.17 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.586 -0.696 . . . . 0.0 109.933 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 5.1 t -75.11 115.77 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.641 -0.662 . . . . 0.0 109.427 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.9 mt -68.38 -24.95 64.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.909 -0.495 . . . . 0.0 110.209 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.74 -23.77 65.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p -138.93 10.71 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.713 . . . . 0.0 111.002 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.32 30.62 6.14 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.928 -1.108 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 7.8 mtmt -105.19 -177.05 3.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.61 156.5 35.15 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.279 -0.888 . . . . 0.0 111.776 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -174.81 -159.44 21.08 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.636 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.454 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 89.3 m-85 -94.25 158.33 15.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.059 -0.671 . . . . 0.0 110.33 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.542 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -154.65 123.9 3.14 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.36 121.14 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.787 0.888 . . . . 0.0 109.973 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 1.5 m -51.59 -35.86 43.16 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.459 -0.775 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -75.1 -9.23 58.35 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.924 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.489 ' HA ' ' CD1' ' A' ' 87' ' ' TYR . 3.0 m-85 -104.69 23.72 12.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.333 -0.854 . . . . 0.0 109.42 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 134' ' ' ALA . 9.8 p -159.43 170.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.848 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.636 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -137.95 135.47 36.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.515 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.7 tmm_? . . . . . 0 N--CA 1.495 1.814 0 O-C-N 121.115 -0.99 . . . . 0.0 112.265 -178.62 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.921 0.391 . . . . 0.0 110.168 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.435 HG12 HG13 ' A' ' 106' ' ' VAL . 65.0 mt -101.17 151.78 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.869 -1.144 . . . . 0.0 109.263 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 135' ' ' ARG . 29.6 m -135.22 177.56 6.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.096 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.932 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.4 p -128.57 121.79 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.47 118.84 11.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 134' ' ' ALA . 18.8 mt -94.11 1.35 56.15 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.489 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.487 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.7 m-85 -151.9 151.14 30.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.392 -0.817 . . . . 0.0 108.846 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -67.5 145.35 55.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.135 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 67.4 t80 -151.75 126.99 9.87 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.364 -0.835 . . . . 0.0 110.779 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -94.71 135.56 36.05 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.63 0.729 . . . . 0.0 111.963 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.499 2.006 0 O-C-N 121.759 -0.588 . . . . 0.0 110.824 179.423 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.431 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 1.8 t0 . . . . . 0 N--CA 1.493 1.702 0 N-CA-C 109.793 -0.447 . . . . 0.0 109.793 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.747 HD21 ' HB2' ' A' ' 119' ' ' SER . 32.1 tp -112.89 136.01 53.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.474 -0.766 . . . . 0.0 110.861 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 120.76 35.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.806 . . . . 0.0 110.232 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.9 p90 -115.45 -169.51 1.59 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.963 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.0 179.83 5.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.134 0.969 . . . . 0.0 112.062 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.5 ttmt -60.66 -22.04 63.44 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.84 41.3 1.23 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 1.1 m-20 -90.63 171.53 9.32 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.557 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.14 132.48 50.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.533 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.8 mpp? -139.1 150.71 46.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 82' ' ' ILE . 38.2 t -95.85 151.22 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 81' ' ' ILE . 68.6 t -94.98 137.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.117 -0.99 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.02 -30.96 13.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.742 0.782 . . . . 0.0 108.936 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -156.36 163.98 38.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.58 119.87 40.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.633 . . . . 0.0 109.514 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -109.63 -76.44 0.61 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.126 -0.984 . . . . 0.0 110.858 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.05 -85.89 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.45 -20.56 18.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -127.47 103.76 7.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 108.982 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -95.75 155.76 16.61 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.098 -1.001 . . . . 0.0 110.851 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 24.3 tttt -95.67 112.51 24.21 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.651 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -126.85 165.84 18.59 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.143 0.973 . . . . 0.0 112.798 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.3 ttt180 -112.68 130.52 56.02 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.747 ' HB2' HD21 ' A' ' 97' ' ' LEU . 29.3 t -82.96 115.29 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.183 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.5 mt -67.24 -26.35 66.53 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.24 0.543 . . . . 0.0 110.368 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.68 -29.74 66.84 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.462 -0.774 . . . . 0.0 109.813 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.7 p -133.62 10.53 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.762 -0.586 . . . . 0.0 110.476 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 119' ' ' SER . 7.8 mmm-85 51.68 28.3 4.7 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.986 -1.071 . . . . 0.0 110.898 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 10.9 mtmt -99.8 177.91 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.425 -0.797 . . . . 0.0 109.376 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -153.56 151.77 30.15 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.947 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -177.99 -150.72 8.79 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 128' ' ' ILE . 48.0 m-85 -93.58 164.76 13.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.666 -0.902 . . . . 0.0 110.207 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.3 pt -155.09 110.71 2.29 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.668 -0.645 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -45.19 99.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 O-C-N 123.008 1.004 . . . . 0.0 111.838 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -57.03 -20.68 25.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.825 -0.547 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 5.0 p-10 -74.42 -1.84 22.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.535 -0.728 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 4.8 m-85 -137.23 44.92 2.25 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.908 -1.12 . . . . 0.0 110.186 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -147.7 170.85 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.32 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.932 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -125.12 117.41 23.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.746 -0.596 . . . . 0.0 109.509 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.778 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.2 tmm_? . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.858 0.837 . . . . 0.0 112.648 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 121.005 0.431 . . . . 0.0 110.405 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . . . . . . . . . 41.9 mt -97.43 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.752 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.4 m -136.46 172.55 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.748 -0.595 . . . . 0.0 109.414 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.873 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.2 p -127.63 124.41 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.148 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.556 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.68 116.12 5.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.989 HD11 ' HB2' ' A' ' 134' ' ' ALA . 93.9 mt -93.85 3.53 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.837 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 70.5 m-85 -153.57 150.29 28.52 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 100' ' ' GLN . 47.9 m-20 -66.64 150.91 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.455 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 66.0 t80 -154.38 119.78 5.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.254 -0.904 . . . . 0.0 110.896 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.38 128.75 39.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.35 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.971 0 O-C-N 121.611 -0.681 . . . . 0.0 110.704 179.611 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 3.4 t0 . . . . . 0 N--CA 1.513 2.711 0 CA-C-O 121.029 0.443 . . . . 0.0 111.263 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 124' ' ' LYS . 6.5 tt -109.11 137.45 46.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.975 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -94.44 122.22 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.684 -0.635 . . . . 0.0 109.599 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 8.6 p90 -117.36 -167.13 1.27 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.788 -0.57 . . . . 0.0 110.029 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HA ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -126.08 179.42 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.324 1.059 . . . . 0.0 112.695 -177.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.7 ttmt -61.14 -23.35 65.47 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.94 40.05 1.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 2.3 m-20 -91.27 163.91 14.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.688 -0.89 . . . . 0.0 112.065 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.22 134.95 55.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.44 ' HE1' ' CD2' ' A' ' 99' ' ' PHE . 76.2 mtm -142.45 149.3 39.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.839 -0.538 . . . . 0.0 109.6 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.597 ' CG2' HD11 ' A' ' 120' ' ' LEU . 21.3 t -97.01 150.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 81' ' ' ILE . 79.3 t -94.79 139.57 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.131 -0.981 . . . . 0.0 110.192 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.7 mp -95.72 -27.11 15.43 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 144.15 20.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -103.02 137.73 40.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -128.34 -70.73 0.67 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 157.15 -40.51 0.55 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.48 -30.37 4.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.355 -1.086 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -137.11 102.88 4.96 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.0 109.24 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -98.22 151.14 20.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.401 -0.812 . . . . 0.0 111.099 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -101.06 124.59 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -132.73 166.12 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.896 . . . . 0.0 111.883 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HB2' HD11 ' A' ' 108' ' ' LEU . 2.4 ttt180 -114.0 126.59 55.3 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.652 -0.655 . . . . 0.0 109.985 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -77.92 114.9 17.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.698 -0.626 . . . . 0.0 109.387 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.597 HD11 ' CG2' ' A' ' 106' ' ' VAL . 9.6 mt -67.56 -28.74 68.04 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.083 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.97 60.71 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -135.04 12.02 3.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.738 -0.601 . . . . 0.0 110.767 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.9 30.93 4.24 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.175 -0.953 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 97' ' ' LEU . 36.8 mtmt -100.47 177.37 5.05 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -152.2 149.48 28.79 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.966 0.889 . . . . 0.0 111.913 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -172.88 -152.98 9.06 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.446 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 96.6 m-85 -94.07 164.09 13.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 122.201 -0.588 . . . . 0.0 109.47 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 127' ' ' TYR . 4.2 pt -151.06 106.96 3.01 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -47.32 107.4 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.04 1.021 . . . . 0.0 111.719 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.413 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 24.0 m -60.76 -15.95 35.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.944 -0.472 . . . . 0.0 111.017 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 39.5 p30 -80.74 3.19 23.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.21 -0.931 . . . . 0.0 112.063 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 8.9 m-85 -144.92 46.96 1.34 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.142 -0.974 . . . . 0.0 109.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 134' ' ' ALA . 5.4 p -153.91 170.83 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.424 -0.797 . . . . 0.0 110.594 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.989 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -125.57 124.14 40.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.75 -0.594 . . . . 0.0 109.905 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.772 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER . . . . . 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 112.498 -178.885 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.441 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.617 0 N-CA-C 108.914 -0.773 . . . . 0.0 108.914 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 105' ' ' MET . 89.4 mt -101.39 157.87 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 109.554 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 135' ' ' ARG . 31.6 m -139.83 165.67 21.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.896 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.0 p -123.61 122.02 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 109.095 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.659 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.24 116.85 6.41 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.926 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 134' ' ' ALA . 96.6 mt -94.5 7.95 43.84 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.158 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.7 m-85 -154.81 151.16 28.31 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.226 -0.921 . . . . 0.0 108.851 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.93 141.03 56.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 39.5 t80 -155.34 125.14 6.5 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.222 -0.924 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.17 130.94 54.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 110.682 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.451 -0.781 . . . . 0.0 110.217 179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.634 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER . . . . . 0 N--CA 1.524 3.236 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.749 HD13 ' N ' ' A' ' 98' ' ' SER . 1.2 tm? -98.31 133.77 42.25 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.565 0.698 . . . . 0.0 111.481 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.749 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.5 m -94.75 142.82 27.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.659 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 20.3 p90 -152.99 -164.71 2.0 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.261 -0.899 . . . . 0.0 111.017 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.24 179.25 5.35 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.118 0.961 . . . . 0.0 111.742 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 10.3 ttmt -61.36 -18.94 61.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.69 41.22 1.38 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.93 172.01 8.89 Favored 'General case' 0 N--CA 1.505 2.325 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.815 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.63 129.5 45.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.646 -0.659 . . . . 0.0 110.199 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 82' ' ' ILE . 20.9 mtm -132.52 156.19 47.25 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 24.9 t -106.5 152.37 8.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 94.9 t -95.06 139.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.557 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp -94.84 -30.83 14.0 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.64 152.93 27.76 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -95.97 151.32 19.54 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.6 t -147.27 -83.09 0.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.394 -0.816 . . . . 0.0 110.715 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.03 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -91.32 -5.61 54.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.429 -1.042 . . . . 0.0 110.825 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -143.97 96.96 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 109.886 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.95 149.05 21.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.73 117.34 29.97 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.625 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.3 164.54 25.4 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.239 -0.913 . . . . 0.0 112.607 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.1 ttt180 -118.03 131.82 56.43 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.633 -0.667 . . . . 0.0 109.914 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -87.46 118.36 26.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.577 -0.702 . . . . 0.0 109.859 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.449 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.3 mt -67.36 -23.02 65.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.827 -0.545 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.86 -31.11 68.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.353 -0.842 . . . . 0.0 110.171 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 p -137.57 14.0 2.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.725 -0.609 . . . . 0.0 110.437 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 50.52 35.18 10.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.103 -0.998 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 45.6 mttt -102.93 173.75 6.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.7 156.51 35.03 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.737 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . 174.59 -154.91 19.99 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -93.64 118.77 31.81 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.974 -0.721 . . . . 0.0 109.701 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 117' ' ' ALA . 4.3 pt -99.14 134.83 21.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.108 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' A' ' 99' ' ' PHE . 36.1 Cg_exo -57.96 95.89 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.978 0.989 . . . . 0.0 111.058 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.4 m -57.89 -18.74 24.81 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.663 -0.648 . . . . 0.0 111.412 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 14.2 p-10 -90.03 19.16 5.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.153 -0.967 . . . . 0.0 111.934 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 20.6 m-85 -155.19 52.26 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -160.52 170.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.421 -0.799 . . . . 0.0 111.396 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.896 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -120.72 126.07 49.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.789 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.488 1.431 0 O-C-N 121.243 -0.911 . . . . 0.0 112.809 -177.716 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.484 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.496 1.839 0 N-CA-C 111.846 0.313 . . . . 0.0 111.846 . . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.634 HG12 HG13 ' A' ' 106' ' ' VAL . 59.6 mt -96.23 137.42 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.778 -1.201 . . . . 0.0 108.717 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.8 m -125.34 170.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.4 p -124.59 122.93 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.6 -0.688 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.86 123.53 20.82 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 84.2 mt -94.32 -2.4 52.26 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.703 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.479 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 62.2 m-85 -151.67 151.14 31.07 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.135 -0.978 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -62.71 147.09 50.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.61 -0.681 . . . . 0.0 110.236 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.445 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 53.3 t80 -154.56 134.05 12.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.559 -0.713 . . . . 0.0 110.916 179.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -98.4 136.62 38.29 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.585 -0.697 . . . . 0.0 111.713 -179.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.834 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.223 0 O-C-N 121.442 -0.786 . . . . 0.0 111.22 179.477 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.834 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 32.6 p30 . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 120.911 0.386 . . . . 0.0 110.268 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 119' ' ' SER . 49.7 tp -153.25 132.34 12.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.0 116.26 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.916 -0.49 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.632 ' CE2' HG22 ' A' ' 128' ' ' ILE . 15.6 p90 -108.65 -176.27 3.0 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.324 178.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -176.63 3.31 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.278 1.037 . . . . 0.0 112.104 -178.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.3 ttmt -60.48 -27.07 67.28 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.14 43.67 1.15 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -178.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 1.3 m-20 -91.04 165.32 13.59 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.233 -179.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.2 131.99 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.507 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.2 mpp? -138.77 152.22 47.74 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.634 HG13 HG12 ' A' ' 82' ' ' ILE . 11.8 t -102.1 147.84 8.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 81' ' ' ILE . 71.5 t -94.94 139.22 19.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.025 -1.047 . . . . 0.0 109.976 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.41 -30.27 13.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -156.51 159.57 38.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.74 -0.6 . . . . 0.0 110.332 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.0 147.97 27.23 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.4 t -135.99 -75.07 0.44 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 170.9 -44.74 0.19 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -127.61 -40.27 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.621 -0.929 . . . . 0.0 110.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -116.7 107.97 15.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.106 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CH2' ' HB3' ' A' ' 130' ' ' SER . 35.5 m0 -98.29 151.88 20.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.819 . . . . 0.0 110.002 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -97.57 118.1 33.32 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.706 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.41 168.23 17.95 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.1 ttt180 -116.73 121.55 41.95 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.608 -0.683 . . . . 0.0 109.634 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.738 ' HB2' HD21 ' A' ' 97' ' ' LEU . 46.2 t -73.81 121.3 20.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.827 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.98 -29.35 65.31 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.14 62.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.436 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -136.87 9.39 3.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 110.795 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 51.92 30.31 7.07 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.045 -1.035 . . . . 0.0 110.706 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 14.9 mttt -101.85 176.76 5.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 2.4 pm0 -155.66 143.78 19.97 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.154 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.62 -149.83 6.36 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.549 ' O ' HG23 ' A' ' 128' ' ' ILE . 76.2 m-85 -95.22 162.42 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.755 -0.85 . . . . 0.0 110.72 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.632 HG22 ' CE2' ' A' ' 99' ' ' PHE . 3.0 pt -155.5 113.67 2.24 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.613 -0.679 . . . . 0.0 110.182 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -53.29 110.06 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.154 1.081 . . . . 0.0 111.541 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.456 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 8.8 m -59.03 -18.48 35.01 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.897 -0.502 . . . . 0.0 110.917 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -71.96 -0.79 12.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.421 -0.799 . . . . 0.0 113.094 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.53 40.61 1.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.912 -1.117 . . . . 0.0 109.863 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -150.06 169.65 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.729 . . . . 0.0 111.315 -178.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.748 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -122.54 137.25 54.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.217 0.532 . . . . 0.0 110.325 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.895 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 111.518 -178.821 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.618 0 N-CA-C 109.073 -0.714 . . . . 0.0 109.073 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.703 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 90.2 mt -98.3 155.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.299 -0.96 . . . . 0.0 108.619 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 135' ' ' ARG . 29.7 m -138.41 174.6 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.367 -0.833 . . . . 0.0 110.2 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.901 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.3 p -133.89 128.15 53.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -70.79 120.28 16.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.497 -0.752 . . . . 0.0 109.145 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 134' ' ' ALA . 77.2 mt -94.28 0.39 55.59 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.284 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.3 m-85 -152.21 151.13 30.61 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.57 150.58 48.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.406 -0.809 . . . . 0.0 110.05 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 42.5 t80 -153.65 136.55 15.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.339 -0.851 . . . . 0.0 111.094 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 3.7 tt0 -101.06 142.36 32.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.794 -0.566 . . . . 0.0 111.163 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.772 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.502 2.15 0 O-C-N 121.393 -0.817 . . . . 0.0 110.535 179.808 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.772 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.0 p30 . . . . . 0 N--CA 1.488 1.454 0 N-CA-C 109.843 -0.428 . . . . 0.0 109.843 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 119' ' ' SER . 16.7 tp -151.82 128.75 10.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.2 m -95.2 105.36 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.204 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.659 ' CD2' HG22 ' A' ' 128' ' ' ILE . 16.9 p90 -103.01 -168.1 1.47 Allowed 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.774 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.32 178.87 5.36 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.408 1.099 . . . . 0.0 112.859 -177.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 86' ' ' LEU . 13.0 ttmt -60.92 -19.41 60.58 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 42.37 1.13 Allowed Glycine 0 C--N 1.281 -2.512 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.47 164.14 14.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.525 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.94 110.78 15.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.637 -0.664 . . . . 0.0 109.853 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.0 mtm -124.84 143.45 50.82 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -96.53 160.21 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.396 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 81' ' ' ILE . 60.9 t -94.02 138.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.982 -1.074 . . . . 0.0 110.613 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.19 -29.25 14.63 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -156.0 163.62 39.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.838 -0.539 . . . . 0.0 109.649 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -121.23 121.11 37.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.503 -0.748 . . . . 0.0 110.75 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.7 t -123.23 -60.96 1.46 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 114' ' ' TRP . . . 150.19 129.54 1.68 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 65.97 -68.01 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.549 -0.971 . . . . 0.0 110.505 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . 0.401 ' N ' ' O ' ' A' ' 112' ' ' GLY . 95.9 m95 -98.77 109.64 22.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.275 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 46.3 m0 -108.13 147.94 30.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.147 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.42 162.82 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.338 -0.851 . . . . 0.0 112.205 -178.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 7.5 tmm_? -111.1 125.48 53.81 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.495 -0.753 . . . . 0.0 109.374 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.593 ' HB2' HD21 ' A' ' 97' ' ' LEU . 31.8 t -88.14 122.81 32.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.06 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.96 -26.17 63.05 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.503 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.49 -32.87 42.27 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.438 -0.788 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 p -134.5 10.19 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.617 -0.677 . . . . 0.0 110.334 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.04 31.9 14.56 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.081 -1.012 . . . . 0.0 110.545 -179.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 53.8 mttt -104.37 -178.04 3.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.04 139.71 17.04 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.889 0.852 . . . . 0.0 111.349 179.14 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.44 -156.59 10.94 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 128' ' ' ILE . 53.0 m-85 -93.47 157.85 16.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.891 . . . . 0.0 110.693 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.659 HG22 ' CD2' ' A' ' 99' ' ' PHE . 1.3 pt -155.61 110.93 2.19 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.9 102.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 122.802 0.896 . . . . 0.0 110.805 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.404 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 1.1 m -62.01 -15.32 43.38 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.706 -0.621 . . . . 0.0 111.313 -178.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -64.66 -11.33 34.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.161 -0.962 . . . . 0.0 111.478 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.431 ' C ' HG23 ' A' ' 133' ' ' VAL . 10.7 m-85 -130.03 43.41 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 134' ' ' ALA . 61.5 t -145.76 170.81 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 -177.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.901 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -124.09 125.63 44.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.529 -0.732 . . . . 0.0 109.341 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 83' ' ' VAL . 9.4 ttt180 . . . . . 0 N--CA 1.484 1.263 0 O-C-N 121.423 -0.798 . . . . 0.0 112.522 -178.501 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.496 ' CG1' ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER . . . . . 0 N--CA 1.5 2.046 0 N-CA-C 112.12 0.415 . . . . 0.0 112.12 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 106' ' ' VAL . 48.3 mt -95.11 139.31 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.78 -1.2 . . . . 0.0 108.504 178.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.6 m -126.93 166.95 22.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.444 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.2 p -121.16 128.35 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.219 178.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' HA2' ' A' ' 102' ' ' GLY . . . -68.78 145.76 53.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 9.6 mt -106.74 -15.84 14.64 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.851 0.751 . . . . 0.0 110.972 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 87.8 m-85 -149.01 153.99 38.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.293 -0.88 . . . . 0.0 109.559 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -56.43 149.45 16.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.703 -0.623 . . . . 0.0 111.625 -178.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -155.42 126.89 7.3 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.731 -0.605 . . . . 0.0 110.353 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -100.5 130.59 46.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.766 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.503 2.208 0 O-C-N 121.32 -0.863 . . . . 0.0 111.442 -179.663 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.766 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 2.8 t0 . . . . . 0 N--CA 1.493 1.722 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.611 HD13 ' N ' ' A' ' 98' ' ' SER . 0.6 OUTLIER -121.47 127.21 50.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.314 -0.866 . . . . 0.0 111.107 -178.543 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.611 ' N ' HD13 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -97.35 93.33 6.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.625 -0.672 . . . . 0.0 109.251 178.479 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 128' ' ' ILE . 31.5 p90 -97.56 -173.97 2.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.082 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -118.4 -164.89 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.67 0.747 . . . . 0.0 111.368 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 2.0 ttmt -53.9 -90.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 85' ' ' ALA . . . -93.45 65.49 1.82 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.4 m-20 -91.64 167.58 12.1 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.967 -0.725 . . . . 0.0 111.549 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.66 120.26 32.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 110.181 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.407 ' HG3' ' HA ' ' A' ' 119' ' ' SER . 2.5 mpp? -128.69 156.73 43.0 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.52 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 24.5 t -103.07 151.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 84.0 t -95.64 139.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.133 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -97.18 -30.55 12.94 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.66 0.743 . . . . 0.0 109.522 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -156.39 158.07 36.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.94 -0.475 . . . . 0.0 109.925 -178.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -99.6 152.07 20.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.384 -0.822 . . . . 0.0 109.588 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -146.95 -75.71 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.91 -92.72 0.08 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.85 -27.08 14.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.935 . . . . 0.0 109.611 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -110.39 107.29 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 0.0 109.401 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -100.1 148.02 25.03 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.303 -0.873 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 11.5 tttt -96.35 111.6 23.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.686 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -126.84 169.47 13.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.871 0.843 . . . . 0.0 111.856 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.5 ttt180 -114.14 123.7 50.25 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.628 -0.67 . . . . 0.0 109.693 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.407 ' HA ' ' HG3' ' A' ' 105' ' ' MET . 1.1 t -78.29 111.98 14.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.741 -0.599 . . . . 0.0 109.537 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.483 HD11 ' CG2' ' A' ' 106' ' ' VAL . 8.4 mt -65.48 -24.41 67.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.856 -0.527 . . . . 0.0 110.351 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.44 -31.24 69.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 p -133.93 16.29 3.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.566 . . . . 0.0 110.459 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.51 29.91 2.24 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.266 -0.896 . . . . 0.0 110.857 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.8 mttt -96.82 177.18 5.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.66 134.93 12.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.086 0.946 . . . . 0.0 112.023 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -166.37 -156.7 9.69 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.48 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 32.0 m-85 -93.03 160.69 14.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.746 -0.855 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.5 pt -152.98 107.66 2.66 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.835 -0.54 . . . . 0.0 109.99 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.45 100.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.263 1.138 . . . . 0.0 111.572 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.2 m -60.62 -13.69 15.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.666 -0.646 . . . . 0.0 112.288 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -65.0 -11.0 33.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.123 -0.986 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.1 45.22 2.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.897 . . . . 0.0 108.877 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 134' ' ' ALA . 98.7 t -145.07 171.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.774 -0.578 . . . . 0.0 109.719 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.817 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -133.46 124.58 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.539 -0.725 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.786 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 111.728 -178.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.492 1.647 0 CA-C-O 120.834 0.349 . . . . 0.0 110.75 . . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 106' ' ' VAL . 61.2 mt -98.71 152.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.866 HG12 ' HA ' ' A' ' 135' ' ' ARG . 27.6 m -138.41 179.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.541 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.734 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.9 p -134.61 121.29 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -60.7 115.37 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 134' ' ' ALA . 62.2 mt -94.54 10.78 33.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.447 -178.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CD2' ' HA ' ' A' ' 132' ' ' TYR . 33.4 m-85 -154.35 151.42 29.03 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.019 -1.051 . . . . 0.0 109.686 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.69 146.6 48.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.312 -0.867 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 52.4 t80 -153.57 169.48 23.14 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.006 -1.059 . . . . 0.0 110.988 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -151.56 99.17 2.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.694 . . . . 0.0 110.517 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.496 1.87 0 O-C-N 121.4 -0.813 . . . . 0.0 110.515 179.675 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.43 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 22.2 p30 . . . . . 0 N--CA 1.506 2.365 0 CA-C-O 120.822 0.344 . . . . 0.0 111.746 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 119' ' ' SER . 1.4 tp -135.76 146.99 48.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.248 -0.907 . . . . 0.0 112.035 -177.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.0 m -96.92 167.26 11.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.808 -0.558 . . . . 0.0 110.074 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 20.8 p90 -165.32 -167.46 1.17 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.405 -0.809 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -126.19 176.55 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.042 0.925 . . . . 0.0 111.506 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.443 ' HA ' ' N ' ' A' ' 87' ' ' TYR . 15.3 ttmt -61.25 -19.18 61.4 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -177.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.72 41.48 1.41 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 2.5 m-20 -90.94 166.43 13.04 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.704 -0.88 . . . . 0.0 111.508 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.41 131.17 54.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.605 -0.684 . . . . 0.0 109.461 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.414 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 60.7 mtm -140.53 148.67 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG2' HD11 ' A' ' 120' ' ' LEU . 41.6 t -95.67 155.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' ILE . 69.3 t -95.73 142.5 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.159 -0.963 . . . . 0.0 110.464 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 117' ' ' ALA . 3.6 mp -95.66 -31.1 13.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -156.24 -177.45 6.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.742 -0.599 . . . . 0.0 110.472 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.45 94.8 3.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.504 -0.748 . . . . 0.0 110.306 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -94.66 -75.13 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.434 -0.791 . . . . 0.0 110.304 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.82 -98.88 0.11 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.486 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.41 -50.1 68.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.403 -1.057 . . . . 0.0 110.814 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.67 140.97 41.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.613 -0.679 . . . . 0.0 109.469 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.71 121.95 36.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.386 -0.821 . . . . 0.0 108.997 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.729 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -138.07 162.98 32.75 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.978 -179.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.5 ttt180 -114.57 125.89 54.29 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.555 -0.715 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.678 ' HB2' HD21 ' A' ' 97' ' ' LEU . 15.3 t -78.16 121.4 24.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.3 mt -70.52 -26.91 63.8 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.18 63.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.599 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -138.1 12.49 2.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.513 -0.742 . . . . 0.0 111.089 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 52.18 30.21 7.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.009 -1.057 . . . . 0.0 110.738 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.58 ' HB2' HD11 ' A' ' 97' ' ' LEU . 6.0 mttp -103.14 176.32 5.19 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -155.87 150.08 25.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.416 -0.803 . . . . 0.0 111.356 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' A' ' 97' ' ' LEU . . . -166.58 -140.04 2.8 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.815 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 128' ' ' ILE . 68.9 m-85 -113.34 154.24 27.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 122.03 -0.688 . . . . 0.0 110.746 -178.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 127' ' ' TYR . 19.4 pt -153.49 134.98 8.67 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.822 -0.549 . . . . 0.0 110.161 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 128' ' ' ILE . 6.4 Cg_exo -69.01 124.74 11.7 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 O-C-N 123.085 1.045 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.9 m -51.94 -35.31 45.41 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.519 -0.738 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -75.34 -6.91 52.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.49 -0.756 . . . . 0.0 111.701 -178.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 87' ' ' TYR . 3.3 m-85 -104.78 24.02 12.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.157 -0.964 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' A' ' 83' ' ' VAL . 5.7 p -161.26 169.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.531 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.787 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -118.58 135.29 54.51 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.718 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.866 ' HA ' HG12 ' A' ' 83' ' ' VAL . 3.4 tpp180 . . . . . 0 N--CA 1.485 1.29 0 O-C-N 121.297 -0.877 . . . . 0.0 112.779 -178.436 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' ILE . . . . . 0.445 HG13 ' HB ' ' A' ' 107' ' ' VAL . 1.7 tp . . . . . 0 N--CA 1.49 1.572 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ILE . . . . . 0.64 HG23 HG12 ' A' ' 106' ' ' VAL . 86.9 mt -109.17 161.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.894 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 135' ' ' ARG . 16.3 m -138.95 167.63 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.714 0.768 . . . . 0.0 110.637 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.4 p -130.2 123.42 55.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' ALA . . . . . 0.543 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -68.9 121.57 16.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.454 -0.899 . . . . 0.0 109.361 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 134' ' ' ALA . 19.7 mt -94.04 0.03 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . 0.488 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 65.3 m-85 -151.14 151.18 31.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.242 -0.911 . . . . 0.0 109.041 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.68 145.9 54.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.517 -0.74 . . . . 0.0 110.178 -179.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 40.5 t80 -153.54 132.92 12.8 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.201 -0.937 . . . . 0.0 111.025 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -100.95 133.4 45.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.776 -0.577 . . . . 0.0 111.675 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . . . . . . 0 N--CA 1.501 2.11 0 O-C-N 121.48 -0.762 . . . . 0.0 110.363 179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' ASP . . . . . 0.434 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 7.4 p30 . . . . . 0 N--CA 1.505 2.318 0 CA-C-O 121.085 0.469 . . . . 0.0 111.902 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 119' ' ' SER . 0.6 OUTLIER -130.07 153.61 48.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.436 -0.79 . . . . 0.0 111.493 -178.186 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m -98.93 116.38 31.03 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.418 0.628 . . . . 0.0 109.767 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 128' ' ' ILE . 16.2 p90 -104.62 -172.29 2.07 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.839 -0.538 . . . . 0.0 110.016 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.1 -178.83 4.32 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.389 1.09 . . . . 0.0 112.439 -178.048 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' LYS . . . . . 0.488 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -60.75 -22.72 64.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.28 43.15 1.08 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 m-20 -90.54 165.14 13.94 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.311 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.05 109.76 14.96 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.573 -0.705 . . . . 0.0 109.718 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' MET . . . . . 0.491 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 1.5 mpp? -126.7 147.21 49.97 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' VAL . . . . . 0.64 HG12 HG23 ' A' ' 82' ' ' ILE . 4.5 m -99.02 158.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.27 -178.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 81' ' ' ILE . 39.6 t -94.09 143.06 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -98.06 -28.26 13.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.501 0.667 . . . . 0.0 109.512 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -156.32 168.26 27.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.734 -0.604 . . . . 0.0 109.591 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -115.48 109.54 17.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.453 -0.78 . . . . 0.0 109.261 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -96.95 -66.68 0.89 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.284 -0.885 . . . . 0.0 110.76 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 -56.49 0.24 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -119.33 -31.28 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.944 . . . . 0.0 109.752 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -121.67 101.97 7.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -94.8 154.15 17.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.406 -0.808 . . . . 0.0 109.846 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -94.48 135.67 35.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -143.7 159.61 42.18 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.217 -177.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.5 ttm180 -112.82 122.51 47.86 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.743 0.783 . . . . 0.0 110.174 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' SER . . . . . 0.578 ' HB2' HD22 ' A' ' 97' ' ' LEU . 8.5 t -84.23 129.53 34.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.829 -0.544 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.1 -26.56 53.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.925 -0.484 . . . . 0.0 110.561 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.9 65.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 109.745 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -129.48 4.89 5.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.843 -0.535 . . . . 0.0 110.662 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.45 28.32 9.44 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.996 -1.065 . . . . 0.0 109.678 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 124' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 64.9 mttt -109.18 -173.89 2.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.603 -0.685 . . . . 0.0 109.919 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 125' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -154.87 153.88 31.83 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.337 -0.852 . . . . 0.0 111.034 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.56 -124.16 0.7 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . 0.482 ' O ' HG23 ' A' ' 128' ' ' ILE . 60.7 m-85 -127.82 157.4 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.73 -0.865 . . . . 0.0 109.732 -179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 128' ' ' ILE . . . . . 0.68 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.3 pt -153.08 106.24 2.63 Favored Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.429 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -47.31 113.08 0.63 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.013 1.142 . . . . 0.0 111.731 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . 0.412 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 11.0 m -59.86 -15.4 20.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.709 -0.62 . . . . 0.0 111.849 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -75.67 1.5 14.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.91 -1.119 . . . . 0.0 111.951 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -144.97 45.09 1.35 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.926 -1.109 . . . . 0.0 110.711 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.5 p -153.28 168.84 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 110.874 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' ALA . . . . . 0.792 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -124.28 116.44 22.65 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.681 ' HA ' HG12 ' A' ' 83' ' ' VAL . 10.9 ttp180 . . . . . 0 C--N 1.311 -1.094 0 O-C-N 121.24 -0.912 . . . . 0.0 112.069 -178.654 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 14.9 m . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 121.064 0.459 . . . . 0.0 110.12 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.412 ' HA ' ' CB ' ' A' ' 137' ' ' ASP . 27.6 mt-10 -72.75 -177.65 2.4 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.532 -0.73 . . . . 0.0 110.089 179.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 66.0 m-20 -139.18 -152.74 0.43 Allowed 'General case' 0 N--CA 1.496 1.832 0 N-CA-C 108.809 -0.812 . . . . 0.0 108.809 179.354 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -127.41 43.64 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 121.279 -0.888 . . . . 0.0 110.751 179.34 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.968 ' CD1' HG13 ' A' ' 106' ' ' VAL . 5.8 mm -96.54 132.86 39.88 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.023 0 O-C-N 121.009 -1.057 . . . . 0.0 109.3 179.458 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.811 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.9 m -120.52 168.12 13.23 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 C-N-CA 120.031 -0.667 . . . . 0.0 110.571 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.629 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -125.16 133.66 68.83 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 179.19 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -78.85 121.02 24.3 Favored 'General case' 0 C--N 1.302 -1.481 0 C-N-CA 119.607 -0.837 . . . . 0.0 108.854 179.415 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.503 HD11 ' HB2' ' A' ' 134' ' ' ALA . 3.7 mt -94.23 3.33 55.39 Favored 'General case' 0 N--CA 1.494 1.757 0 C-N-CA 120.716 -0.394 . . . . 0.0 111.138 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.433 ' N ' ' HA ' ' A' ' 101' ' ' LYS . 80.6 m-85 -153.16 152.86 31.73 Favored 'General case' 0 N--CA 1.497 1.899 0 N-CA-C 108.584 -0.895 . . . . 0.0 108.584 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 68.4 m-20 -69.97 142.59 52.84 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.605 -0.684 . . . . 0.0 110.37 -179.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.479 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 68.6 t80 -151.72 131.87 13.55 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.427 -0.795 . . . . 0.0 110.137 179.721 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.401 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 9.6 tp10 -101.9 141.01 35.42 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.541 -0.725 . . . . 0.0 111.036 -179.705 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.86 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -54.67 177.01 0.04 OUTLIER 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.623 -0.673 . . . . 0.0 111.283 -179.724 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 4.4 tt -174.26 35.62 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.001 0 O-C-N 121.576 -0.702 . . . . 0.0 110.362 179.84 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -167.47 -164.73 0.61 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.187 -0.946 . . . . 0.0 110.195 179.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 14.4 m-70 -73.29 -74.4 0.18 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.267 -0.895 . . . . 0.0 109.996 -179.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 14.2 tp10 -86.02 54.58 3.19 Favored 'General case' 0 N--CA 1.495 1.824 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 178.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.86 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 44.7 p30 -93.46 175.73 6.64 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.564 HD21 ' HB2' ' A' ' 119' ' ' SER . 62.8 tp -154.89 124.64 6.55 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.294 -0.879 . . . . 0.0 111.102 -179.212 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.401 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.3 m -95.14 113.48 25.17 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.746 -0.596 . . . . 0.0 110.148 179.341 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.616 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.8 p90 -109.83 -173.28 2.22 Favored 'General case' 0 N--CA 1.497 1.877 0 C-N-CA 119.992 -0.683 . . . . 0.0 109.965 178.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.1 179.52 4.83 Favored 'General case' 0 N--CA 1.49 1.562 0 CA-C-O 122.188 0.994 . . . . 0.0 111.996 -178.196 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HG3' ' O ' ' A' ' 86' ' ' LEU . 12.1 ttmt -61.05 -20.93 63.14 Favored 'General case' 0 N--CA 1.497 1.913 0 N-CA-C 114.769 1.396 . . . . 0.0 114.769 -177.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.4 41.2 1.31 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.018 -1.633 . . . . 0.0 109.018 -179.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.424 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.3 m-20 -90.99 164.29 14.03 Favored 'General case' 0 N--CA 1.505 2.278 0 C-N-CA 119.657 -0.817 . . . . 0.0 112.16 -179.375 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -121.33 135.22 55.12 Favored 'General case' 0 C--N 1.304 -1.375 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 178.144 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 75.7 mtm -140.27 151.96 45.52 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.32 0.581 . . . . 0.0 109.647 -179.618 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.968 HG13 ' CD1' ' A' ' 82' ' ' ILE . 43.2 t -101.43 147.98 7.78 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.66 0 N-CA-C 106.824 -1.547 . . . . 0.0 106.824 178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' ILE . 90.8 t -95.12 139.89 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.923 0 O-C-N 121.019 -1.051 . . . . 0.0 110.113 -179.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.71 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.9 mp -97.05 -27.5 14.57 Favored 'General case' 0 C--N 1.296 -1.75 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -156.07 161.33 40.43 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.674 -0.641 . . . . 0.0 109.853 179.94 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.2 mt-10 -107.58 143.44 36.01 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.436 -0.79 . . . . 0.0 109.816 178.905 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 46.8 t -153.05 -156.75 0.73 Allowed 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.371 -0.831 . . . . 0.0 110.388 179.865 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -65.09 -113.99 0.01 OUTLIER Glycine 0 N--CA 1.494 2.561 0 N-CA-C 109.827 -1.309 . . . . 0.0 109.827 -179.746 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 21.7 mm-40 -94.99 -16.69 22.57 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.668 -0.901 . . . . 0.0 110.573 179.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 96.5 m95 -100.62 101.09 11.9 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.409 -0.807 . . . . 0.0 109.604 179.778 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.8 m0 -97.53 148.96 22.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.436 -0.79 . . . . 0.0 110.204 -179.733 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.1 tttt -98.14 111.37 23.72 Favored 'General case' 0 N--CA 1.495 1.807 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 179.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.71 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.08 169.26 13.58 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.186 -0.946 . . . . 0.0 112.302 -178.757 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.502 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -113.03 118.57 35.17 Favored 'General case' 0 C--N 1.311 -1.079 0 O-C-N 121.69 -0.631 . . . . 0.0 109.757 179.562 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.564 ' HB2' HD21 ' A' ' 97' ' ' LEU . 14.9 t -72.45 115.4 11.67 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.108 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.456 HD11 HG23 ' A' ' 106' ' ' VAL . 5.3 mt -67.88 -27.65 66.86 Favored 'General case' 0 N--CA 1.494 1.746 0 C-N-CA 120.521 -0.472 . . . . 0.0 110.124 -179.586 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.76 -24.4 61.6 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.542 -0.724 . . . . 0.0 110.389 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.4 p -137.7 10.67 2.91 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.456 -0.777 . . . . 0.0 110.78 179.66 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 24.2 mtm180 53.1 26.76 5.16 Favored 'General case' 0 N--CA 1.504 2.252 0 O-C-N 121.083 -1.011 . . . . 0.0 110.567 -179.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.459 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.6 mtmt -102.12 176.67 5.12 Favored 'General case' 0 N--CA 1.494 1.754 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 179.218 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.58 143.0 19.46 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.389 -0.924 . . . . 0.0 111.29 179.058 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.38 -152.26 7.55 Favored Glycine 0 N--CA 1.486 1.99 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.535 ' O ' HG23 ' A' ' 128' ' ' ILE . 47.1 m-85 -93.76 158.46 15.65 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.787 -0.831 . . . . 0.0 110.394 -179.474 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.601 HG22 ' CD2' ' A' ' 99' ' ' PHE . 1.5 pt -155.53 115.39 2.27 Favored Pre-proline 0 N--CA 1.496 1.875 0 O-C-N 121.843 -0.535 . . . . 0.0 109.778 179.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 35.6 Cg_exo -54.76 104.32 0.12 Allowed 'Trans proline' 0 N--CA 1.491 1.327 0 O-C-N 122.945 0.971 . . . . 0.0 110.993 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.4 m -63.49 -12.37 31.32 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.613 -0.679 . . . . 0.0 111.426 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.3 p30 -68.03 -8.92 41.71 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.075 -1.016 . . . . 0.0 111.092 179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.9 m-85 -132.68 35.94 3.57 Favored 'General case' 0 N--CA 1.498 1.942 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 179.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.494 HG12 ' N ' ' A' ' 134' ' ' ALA . 90.1 t -139.84 173.16 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.587 0 O-C-N 121.706 -0.621 . . . . 0.0 109.925 -178.521 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.629 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -134.01 129.26 35.89 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.373 -0.829 . . . . 0.0 110.356 179.909 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.811 ' HA ' HG12 ' A' ' 83' ' ' VAL . 3.7 tmm_? -85.12 137.06 33.27 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.419 -0.801 . . . . 0.0 111.969 -179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.428 HG13 ' C ' ' A' ' 135' ' ' ARG . 31.4 m -151.48 170.97 1.23 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 109.376 -0.602 . . . . 0.0 109.376 178.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.412 ' CB ' ' HA ' ' A' ' 79' ' ' GLU . 3.5 p30 -94.39 24.07 4.75 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.331 -0.855 . . . . 0.0 110.581 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.416 ' O ' HG23 ' A' ' 136' ' ' VAL . 1.8 t . . . . . 0 N--CA 1.494 1.749 0 CA-C-O 117.981 -1.009 . . . . 0.0 110.095 -179.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.0 m . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 121.168 0.508 . . . . 0.0 110.201 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.424 ' HA ' ' CB ' ' A' ' 137' ' ' ASP . 12.4 mt-10 -75.16 153.4 38.21 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.45 -0.781 . . . . 0.0 110.079 179.917 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -134.86 -159.66 0.98 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.427 -0.796 . . . . 0.0 109.385 179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.506 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -125.02 41.58 0.78 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.694 0 C-N-CA 119.386 -0.926 . . . . 0.0 110.998 179.52 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.706 HG12 HG13 ' A' ' 106' ' ' VAL . 56.0 mt -97.02 139.45 19.55 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.838 0 O-C-N 121.072 -1.018 . . . . 0.0 109.115 178.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.836 HG12 ' HA ' ' A' ' 135' ' ' ARG . 25.5 m -128.78 179.29 4.07 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 C-N-CA 119.596 -0.842 . . . . 0.0 110.295 -179.736 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.857 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.3 p -131.59 126.73 58.33 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.475 0 C-N-CA 120.182 -0.607 . . . . 0.0 109.496 179.086 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.591 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -68.96 119.78 13.8 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 179.303 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.699 HD11 ' HB2' ' A' ' 134' ' ' ALA . 42.8 mt -94.01 1.34 56.26 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 120.514 -0.475 . . . . 0.0 111.071 -179.34 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.442 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 60.0 m-85 -152.63 152.17 31.47 Favored 'General case' 0 N--CA 1.498 1.943 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 179.396 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -67.94 148.98 50.35 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.492 -0.755 . . . . 0.0 110.487 -179.032 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.45 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 77.1 t80 -155.15 127.44 7.78 Favored 'General case' 0 N--CA 1.502 2.135 0 O-C-N 121.47 -0.769 . . . . 0.0 111.13 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 38.7 mt-10 -97.84 132.73 43.18 Favored 'General case' 0 N--CA 1.501 2.088 0 O-C-N 121.568 -0.708 . . . . 0.0 110.931 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.523 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -54.76 155.3 4.35 Favored 'General case' 0 N--CA 1.501 2.122 0 O-C-N 121.456 -0.777 . . . . 0.0 111.018 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.45 HG23 ' C ' ' A' ' 91' ' ' ALA . 3.1 pt -154.56 43.4 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 121.79 -0.569 . . . . 0.0 109.566 179.427 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -172.83 -178.2 1.81 Allowed 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.457 -0.777 . . . . 0.0 109.95 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 52.3 m80 -58.24 -73.82 0.07 Allowed 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.443 -0.786 . . . . 0.0 111.048 -179.319 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.45 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 4.6 tp10 -89.13 45.59 1.3 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.319 -0.863 . . . . 0.0 110.437 -179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.523 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 0.7 OUTLIER -102.4 128.49 48.97 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.429 -0.794 . . . . 0.0 109.421 179.391 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 5.1 tt -112.33 143.17 43.87 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.436 -0.79 . . . . 0.0 111.102 -179.171 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.6 m -96.4 122.36 39.21 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.728 -0.607 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.591 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 13.7 p90 -114.03 -171.29 1.88 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 121.654 -0.654 . . . . 0.0 109.6 178.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.56 179.56 4.72 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 122.133 0.968 . . . . 0.0 111.9 -178.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.442 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -60.76 -22.55 64.16 Favored 'General case' 0 N--CA 1.502 2.136 0 N-CA-C 115.334 1.605 . . . . 0.0 115.334 -177.051 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.38 41.94 1.28 Allowed Glycine 0 N--CA 1.496 2.684 0 N-CA-C 108.871 -1.692 . . . . 0.0 108.871 -178.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.436 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.1 m-20 -90.91 165.99 13.29 Favored 'General case' 0 N--CA 1.506 2.339 0 C-N-CA 119.834 -0.747 . . . . 0.0 111.805 -179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -122.18 128.68 51.5 Favored 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.529 -0.732 . . . . 0.0 109.132 178.726 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -136.96 150.47 48.18 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.767 -0.583 . . . . 0.0 109.613 -179.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.706 HG13 HG12 ' A' ' 82' ' ' ILE . 23.3 t -101.27 151.01 5.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.592 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 179.244 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.506 HG23 ' O ' ' A' ' 81' ' ' ILE . 99.4 t -94.58 141.46 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.797 0 O-C-N 121.022 -1.048 . . . . 0.0 110.077 -179.727 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.684 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -96.78 -30.93 12.9 Favored 'General case' 0 C--N 1.298 -1.672 0 CA-C-O 121.645 0.736 . . . . 0.0 109.029 179.809 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.9 mt-10 -156.36 162.2 40.08 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.773 -0.579 . . . . 0.0 109.729 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -101.72 154.26 19.05 Favored 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.453 -0.78 . . . . 0.0 109.896 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 20.8 t -147.65 -75.65 0.18 Allowed 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.403 -0.811 . . . . 0.0 110.433 179.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 179.86 -92.19 0.08 OUTLIER Glycine 0 N--CA 1.494 2.502 0 N-CA-C 109.922 -1.271 . . . . 0.0 109.922 -179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . 0.432 ' HB3' ' CD1' ' A' ' 114' ' ' TRP . 2.4 tt0 -92.93 -16.04 25.63 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.602 -0.94 . . . . 0.0 110.832 -179.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.432 ' CD1' ' HB3' ' A' ' 113' ' ' GLU . 85.8 m95 -132.25 107.63 8.7 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.342 -0.849 . . . . 0.0 109.452 -179.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.423 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 31.3 m0 -100.88 155.58 17.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.292 -0.88 . . . . 0.0 111.052 -179.161 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 17.8 tttt -97.16 111.73 23.83 Favored 'General case' 0 N--CA 1.499 2.021 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 178.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.684 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.28 168.32 14.92 Favored 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 122.082 0.944 . . . . 0.0 112.609 -178.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.538 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.7 ttt180 -112.61 121.9 46.12 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 121.628 -0.67 . . . . 0.0 109.647 179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.5 t -74.87 110.02 8.82 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.632 -0.667 . . . . 0.0 109.912 179.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 35.8 mt -64.28 -21.72 66.7 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.827 -0.546 . . . . 0.0 110.279 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.88 -24.92 67.24 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 121.422 -0.799 . . . . 0.0 109.751 179.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 61.4 p -140.71 15.08 2.33 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.56 -0.713 . . . . 0.0 110.232 179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 28.7 mtt180 50.91 27.21 3.04 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.113 -0.992 . . . . 0.0 110.695 -179.349 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.494 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 18.8 mttt -97.13 179.9 4.76 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.58 -0.7 . . . . 0.0 109.319 179.655 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.538 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.3 OUTLIER -155.9 149.01 24.44 Favored 'General case' 0 N--CA 1.502 2.129 0 CA-C-O 121.945 0.879 . . . . 0.0 111.791 179.347 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.402 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -176.88 -153.98 11.41 Favored Glycine 0 N--CA 1.487 2.094 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.548 ' O ' HG23 ' A' ' 128' ' ' ILE . 53.2 m-85 -93.49 165.03 12.96 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.628 -0.925 . . . . 0.0 109.391 179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.548 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.2 pt -155.41 116.48 2.33 Favored Pre-proline 0 N--CA 1.496 1.829 0 O-C-N 121.73 -0.606 . . . . 0.0 109.901 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 49.3 Cg_exo -48.0 104.14 0.07 OUTLIER 'Trans proline' 0 N--CA 1.49 1.273 0 O-C-N 123.138 1.073 . . . . 0.0 111.847 -179.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.423 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.1 m -60.12 -16.53 33.0 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.944 -0.473 . . . . 0.0 111.276 179.79 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.469 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 3.3 p-10 -83.91 12.11 6.67 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.102 -0.999 . . . . 0.0 112.06 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.469 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 3.8 m-85 -146.93 39.74 1.04 Allowed 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.015 -1.053 . . . . 0.0 109.372 178.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 134' ' ' ALA . 3.8 p -146.82 168.86 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.628 0.728 . . . . 0.0 110.911 -178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.857 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -121.16 134.04 55.21 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 121.277 0.561 . . . . 0.0 110.189 179.775 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.836 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.2 tpt180 -90.91 127.74 36.5 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.375 -0.828 . . . . 0.0 112.177 -178.813 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.6 m -142.06 167.09 15.98 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 CA-C-O 121.44 0.638 . . . . 0.0 110.34 178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.424 ' CB ' ' HA ' ' A' ' 79' ' ' GLU . 2.9 p30 -94.39 -159.18 0.68 Allowed 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.228 -0.92 . . . . 0.0 110.124 179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.6 t . . . . . 0 N--CA 1.493 1.7 0 CA-C-O 117.932 -1.033 . . . . 0.0 110.223 -179.919 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 121.159 0.504 . . . . 0.0 110.368 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 41.4 tt0 -85.16 117.72 24.28 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.553 -0.717 . . . . 0.0 109.945 179.772 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 27.8 m-20 -123.66 -158.71 0.82 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.462 -0.774 . . . . 0.0 109.791 -179.596 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.495 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -129.22 51.07 0.43 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.641 0 O-C-N 121.42 -0.8 . . . . 0.0 111.224 179.553 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.55 HG12 HG13 ' A' ' 106' ' ' VAL . 63.5 mt -99.2 150.12 5.26 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.936 0 O-C-N 120.964 -1.085 . . . . 0.0 108.87 178.49 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.828 HG12 ' HA ' ' A' ' 135' ' ' ARG . 33.5 m -137.13 171.32 16.56 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.506 0 C-N-CA 120.106 -0.637 . . . . 0.0 110.287 -179.458 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.777 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -124.49 124.14 67.68 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 178.555 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.506 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.52 118.42 10.1 Favored 'General case' 0 N--CA 1.487 1.419 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 179.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.904 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.0 mt -94.25 1.86 55.94 Favored 'General case' 0 N--CA 1.492 1.664 0 C-N-CA 120.494 -0.482 . . . . 0.0 111.102 -179.488 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.456 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 56.0 m-85 -151.54 150.83 30.8 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.218 -0.927 . . . . 0.0 108.726 179.481 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.5 m-20 -70.55 144.23 51.35 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.527 -0.733 . . . . 0.0 110.319 -178.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 72.5 t80 -155.54 131.89 10.26 Favored 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.253 -0.905 . . . . 0.0 111.531 179.742 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.41 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 0.0 OUTLIER -96.9 146.23 25.14 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.713 -0.617 . . . . 0.0 110.364 179.456 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.804 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -58.26 178.4 0.1 Allowed 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.451 -0.781 . . . . 0.0 110.676 -179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.3 tt -172.88 36.94 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.992 0 O-C-N 121.377 -0.827 . . . . 0.0 110.635 -179.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -173.41 -166.09 0.31 Allowed 'General case' 0 N--CA 1.506 2.346 0 O-C-N 120.893 -1.129 . . . . 0.0 110.305 179.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 75.7 m80 -70.8 -74.8 0.14 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.223 -0.923 . . . . 0.0 110.326 -179.324 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.436 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 3.6 tp10 -83.62 57.32 4.01 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.28 -0.887 . . . . 0.0 109.205 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.804 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 46.8 p30 -99.66 168.6 9.83 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.732 -0.605 . . . . 0.0 110.344 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.681 HD21 ' HB2' ' A' ' 119' ' ' SER . 7.5 tp -150.63 126.32 10.28 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.459 -0.775 . . . . 0.0 111.264 -179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.41 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 2.2 m -94.68 117.82 30.73 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.626 -0.671 . . . . 0.0 110.171 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.506 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.1 p90 -114.57 -169.87 1.62 Allowed 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.725 -0.61 . . . . 0.0 110.266 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -124.94 179.78 4.88 Favored 'General case' 0 N--CA 1.493 1.722 0 CA-C-O 122.284 1.04 . . . . 0.0 112.422 -178.311 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.456 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.6 ttmt -61.18 -22.1 64.41 Favored 'General case' 0 N--CA 1.501 2.075 0 N-CA-C 115.222 1.564 . . . . 0.0 115.222 -177.527 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.54 41.32 1.29 Allowed Glycine 0 N--CA 1.498 2.777 0 N-CA-C 109.22 -1.552 . . . . 0.0 109.22 -178.953 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -91.07 171.6 9.15 Favored 'General case' 0 N--CA 1.504 2.264 0 O-C-N 121.915 -0.756 . . . . 0.0 112.026 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -125.5 130.26 51.41 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.429 -0.794 . . . . 0.0 109.52 178.699 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 78.2 mtm -137.29 153.39 50.32 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.678 -0.639 . . . . 0.0 109.747 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.55 HG13 HG12 ' A' ' 82' ' ' ILE . 21.5 t -103.95 149.96 7.46 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 N-CA-C 107.834 -1.173 . . . . 0.0 107.834 179.179 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 81' ' ' ILE . 58.9 t -95.57 138.02 22.24 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.967 0 O-C-N 121.164 -0.96 . . . . 0.0 109.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.676 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -96.57 -29.0 14.11 Favored 'General case' 0 C--N 1.299 -1.607 0 CA-C-O 121.447 0.641 . . . . 0.0 109.469 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -155.63 149.41 25.26 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.777 -0.577 . . . . 0.0 109.786 179.671 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 1.7 tm-20 -96.19 144.59 26.27 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.552 -0.718 . . . . 0.0 109.292 179.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 9.1 t -134.88 -66.94 0.57 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.479 -0.763 . . . . 0.0 110.358 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 164.7 -64.18 0.23 Allowed Glycine 0 N--CA 1.495 2.582 0 N-CA-C 110.053 -1.219 . . . . 0.0 110.053 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 mp0 -112.34 -29.86 7.38 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.601 -0.941 . . . . 0.0 110.047 -179.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 74.3 m95 -125.25 103.36 7.91 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.709 -0.62 . . . . 0.0 109.876 -179.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 42.6 m0 -97.31 153.78 17.84 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.367 -0.833 . . . . 0.0 110.598 -179.576 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 0.0 OUTLIER -97.97 117.29 31.98 Favored 'General case' 0 N--CA 1.497 1.919 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 178.468 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.676 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.19 167.66 15.75 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.189 -0.945 . . . . 0.0 112.485 -178.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.512 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.1 ttt180 -114.96 126.33 54.65 Favored 'General case' 0 N--CA 1.481 1.077 0 O-C-N 121.657 -0.652 . . . . 0.0 109.416 179.571 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.681 ' HB2' HD21 ' A' ' 97' ' ' LEU . 3.8 t -79.42 118.81 21.64 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.569 -0.707 . . . . 0.0 109.564 179.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 19.0 mt -68.83 -25.21 64.54 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 120.592 -0.443 . . . . 0.0 110.565 -179.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.2 -32.79 73.48 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.546 -0.721 . . . . 0.0 110.018 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 30.3 p -128.05 7.11 6.02 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.672 -0.642 . . . . 0.0 110.897 179.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.405 ' N ' ' O ' ' A' ' 119' ' ' SER . 0.3 OUTLIER 52.91 32.22 12.19 Favored 'General case' 0 N--CA 1.504 2.241 0 O-C-N 121.066 -1.021 . . . . 0.0 110.305 -179.122 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.512 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.8 mttm -100.78 178.86 4.57 Favored 'General case' 0 N--CA 1.496 1.826 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 179.287 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.465 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -154.89 137.13 14.84 Favored 'General case' 0 N--CA 1.5 2.069 0 CA-C-O 122.008 0.908 . . . . 0.0 111.6 179.427 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.413 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -164.39 -147.95 5.27 Favored Glycine 0 N--CA 1.485 1.939 0 N-CA-C 109.049 -1.62 . . . . 0.0 109.049 179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.494 ' O ' HG23 ' A' ' 128' ' ' ILE . 76.7 m-85 -94.18 164.15 13.17 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.622 -0.928 . . . . 0.0 110.787 -179.728 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.494 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.6 pt -153.83 104.5 2.49 Favored Pre-proline 0 N--CA 1.496 1.828 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 178.913 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.6 Cg_exo -48.56 106.14 0.1 Allowed 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.931 0.964 . . . . 0.0 111.774 -179.263 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 14.3 m -59.46 -18.49 40.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.947 -0.47 . . . . 0.0 111.097 179.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.7 p30 -73.4 -1.26 17.52 Favored 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.366 -0.834 . . . . 0.0 112.596 -178.436 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -142.65 46.7 1.58 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 121.025 -1.047 . . . . 0.0 110.34 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.6 p -150.09 169.72 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 121.516 -0.74 . . . . 0.0 110.607 -179.522 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.904 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -120.21 122.55 41.2 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 109.525 -0.546 . . . . 0.0 109.525 179.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.828 ' HA ' HG12 ' A' ' 83' ' ' VAL . 2.6 tmm_? -85.11 136.97 33.32 Favored 'General case' 0 N--CA 1.49 1.563 0 CA-C-O 121.815 0.817 . . . . 0.0 112.625 -178.299 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 9.3 m -139.82 132.21 34.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 CA-C-O 121.422 0.629 . . . . 0.0 109.421 178.135 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -106.98 -24.68 11.92 Favored 'General case' 0 C--N 1.306 -1.298 0 O-C-N 121.553 -0.717 . . . . 0.0 109.756 -179.644 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 5.6 t . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 118.055 -0.974 . . . . 0.0 110.114 179.844 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 66.4 m . . . . . 0 N--CA 1.493 1.719 0 CA-C-O 121.106 0.479 . . . . 0.0 110.311 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 14.8 tt0 -90.43 119.27 30.57 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.466 -0.771 . . . . 0.0 110.46 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.463 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 66.9 m-20 -99.28 -152.6 0.42 Allowed 'General case' 0 N--CA 1.5 2.061 0 O-C-N 121.457 -0.777 . . . . 0.0 109.955 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.479 ' O ' HG23 ' A' ' 81' ' ' ILE . 3.6 tp -112.22 45.18 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 O-C-N 121.186 -0.946 . . . . 0.0 111.197 -179.026 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.62 HG12 HG13 ' A' ' 106' ' ' VAL . 77.4 mt -115.11 165.61 10.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.06 -1.025 . . . . 0.0 108.796 178.444 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.733 HG12 ' HA ' ' A' ' 135' ' ' ARG . 12.0 m -143.64 171.1 8.73 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 N-CA-C 109.217 -0.66 . . . . 0.0 109.217 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 4.1 p -132.78 129.37 58.18 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.364 0 N-CA-C 108.702 -0.851 . . . . 0.0 108.702 178.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.533 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -71.9 119.8 16.59 Favored 'General case' 0 C--N 1.301 -1.509 0 C-N-CA 119.689 -0.804 . . . . 0.0 108.898 179.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.686 HD11 ' HB2' ' A' ' 134' ' ' ALA . 61.7 mt -94.12 0.05 55.6 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.895 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.9 m-85 -151.97 152.39 32.42 Favored 'General case' 0 N--CA 1.497 1.918 0 N-CA-C 108.549 -0.908 . . . . 0.0 108.549 179.617 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 54.1 m-20 -68.83 145.05 54.07 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.628 -0.67 . . . . 0.0 110.736 -178.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.461 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 79.4 t80 -152.39 125.32 8.5 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.409 -0.807 . . . . 0.0 110.576 179.544 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.415 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 20.9 tp10 -94.76 134.11 37.72 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.489 -0.757 . . . . 0.0 110.003 179.404 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.419 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -54.13 165.9 0.45 Allowed 'General case' 0 N--CA 1.499 1.983 0 O-C-N 121.401 -0.812 . . . . 0.0 110.719 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.7 tt -163.16 41.04 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 121.714 -0.616 . . . . 0.0 109.995 -179.515 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -174.91 -175.97 0.93 Allowed 'General case' 0 N--CA 1.499 1.981 0 O-C-N 121.239 -0.913 . . . . 0.0 110.138 179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 22.1 m80 -63.87 -69.57 0.27 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.562 -0.712 . . . . 0.0 110.448 -179.565 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 20.9 tt0 -88.98 46.81 1.42 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.587 -0.696 . . . . 0.0 109.812 179.852 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.419 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.1 t70 -108.96 126.4 53.05 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.371 -0.83 . . . . 0.0 109.562 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 7.3 tt -109.0 139.78 43.4 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.409 -0.807 . . . . 0.0 111.532 -178.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.4 m -95.29 118.63 32.38 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.675 -0.641 . . . . 0.0 110.617 179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.533 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 12.2 p90 -112.95 -171.7 1.91 Allowed 'General case' 0 N--CA 1.502 2.141 0 O-C-N 121.57 -0.706 . . . . 0.0 110.048 178.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -123.93 -178.54 4.09 Favored 'General case' 0 N--CA 1.499 2.0 0 CA-C-O 122.187 0.994 . . . . 0.0 112.379 -178.121 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.1 ttmt -61.12 -23.06 65.23 Favored 'General case' 0 N--CA 1.501 2.097 0 N-CA-C 115.139 1.533 . . . . 0.0 115.139 -177.71 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.27 41.71 1.23 Allowed Glycine 0 N--CA 1.497 2.734 0 N-CA-C 109.048 -1.621 . . . . 0.0 109.048 -178.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.2 m-20 -90.84 167.51 12.4 Favored 'General case' 0 N--CA 1.505 2.287 0 C-N-CA 119.83 -0.748 . . . . 0.0 111.738 -179.282 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -121.04 128.27 52.5 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.469 -0.769 . . . . 0.0 109.702 178.292 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -136.97 150.39 48.12 Favored 'General case' 0 C--N 1.298 -1.656 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 179.431 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.62 HG13 HG12 ' A' ' 82' ' ' ILE . 11.3 t -95.26 152.61 3.66 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.612 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.454 ' CG1' HD11 ' A' ' 81' ' ' ILE . 38.4 t -94.02 134.49 31.44 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.783 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 179.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.602 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -94.68 -27.3 15.92 Favored 'General case' 0 C--N 1.298 -1.67 0 N-CA-C 109.403 -0.591 . . . . 0.0 109.403 -179.721 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -156.56 -169.5 3.03 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.69 -0.631 . . . . 0.0 110.314 179.906 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -150.98 115.06 5.02 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.497 -0.752 . . . . 0.0 109.961 178.529 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -127.4 -68.4 0.79 Allowed 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.646 -0.659 . . . . 0.0 110.011 -179.782 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 160.47 142.74 3.47 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 109.825 -1.31 . . . . 0.0 109.825 179.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 65.44 -69.18 0.11 Allowed 'General case' 0 N--CA 1.506 2.352 0 O-C-N 121.632 -0.922 . . . . 0.0 110.954 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 92.1 m95 -109.47 117.24 33.49 Favored 'General case' 0 N--CA 1.491 1.608 0 O-C-N 121.411 -0.806 . . . . 0.0 110.256 -179.472 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.427 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 53.8 m0 -107.02 154.19 21.48 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.356 -0.84 . . . . 0.0 109.815 179.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -95.25 118.77 32.61 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.754 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.602 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -133.39 159.12 41.26 Favored 'General case' 0 N--CA 1.5 2.063 0 O-C-N 121.138 -0.976 . . . . 0.0 112.285 -178.772 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.481 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.8 ttt180 -111.52 126.72 55.28 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.469 -0.769 . . . . 0.0 110.166 179.476 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 9.4 t -81.25 112.06 18.23 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.516 -0.74 . . . . 0.0 109.532 179.08 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.509 HD11 ' CG2' ' A' ' 106' ' ' VAL . 20.5 mt -65.89 -20.86 66.37 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.889 -0.507 . . . . 0.0 110.913 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.72 -32.67 73.82 Favored 'General case' 0 N--CA 1.494 1.761 0 O-C-N 121.265 -0.897 . . . . 0.0 109.538 179.544 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 31.9 p -129.4 11.39 5.84 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.753 -0.592 . . . . 0.0 110.658 179.436 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER 52.69 30.14 8.37 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.138 -0.976 . . . . 0.0 110.405 -179.73 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.454 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 27.6 mtpt -102.16 178.27 4.65 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.62 -0.675 . . . . 0.0 109.385 179.626 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.481 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.76 149.11 24.75 Favored 'General case' 0 N--CA 1.5 2.054 0 C-N-CA 119.702 -0.799 . . . . 0.0 111.745 179.946 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.418 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -173.59 -150.42 7.52 Favored Glycine 0 N--CA 1.485 1.958 0 N-CA-C 109.703 -1.359 . . . . 0.0 109.703 179.646 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.443 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 68.8 m-85 -93.27 162.22 14.09 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.745 -0.856 . . . . 0.0 109.931 179.916 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.428 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.2 pt -153.0 108.75 2.66 Favored Pre-proline 0 N--CA 1.493 1.676 0 O-C-N 121.733 -0.604 . . . . 0.0 109.382 179.36 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -50.51 108.11 0.2 Allowed 'Trans proline' 0 N--CA 1.49 1.295 0 O-C-N 123.027 1.014 . . . . 0.0 111.735 -178.911 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.433 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 12.1 m -57.36 -15.33 6.2 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.776 -0.578 . . . . 0.0 111.804 179.812 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 42.5 p30 -76.7 5.54 7.44 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.131 -0.98 . . . . 0.0 112.808 -178.418 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -151.17 38.72 0.65 Allowed 'General case' 0 N--CA 1.503 2.19 0 O-C-N 120.89 -1.131 . . . . 0.0 110.661 179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.475 HG22 ' N ' ' A' ' 134' ' ' ALA . 3.3 p -146.79 168.51 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.029 0 O-C-N 121.441 -0.787 . . . . 0.0 109.938 -179.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.686 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.81 141.46 46.41 Favored 'General case' 0 N--CA 1.498 1.933 0 C-N-CA 120.27 -0.572 . . . . 0.0 110.43 179.512 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.733 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -85.08 122.53 29.43 Favored 'General case' 0 N--CA 1.489 1.512 0 CA-C-O 121.701 0.762 . . . . 0.0 110.577 -179.771 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 29.0 m -120.01 167.92 12.9 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.549 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.463 ' HA ' ' HB2' ' A' ' 80' ' ' ASP . 22.0 p-10 -94.56 -153.77 0.39 Allowed 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.538 -0.726 . . . . 0.0 110.345 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 48.4 t . . . . . 0 N--CA 1.491 1.621 0 CA-C-O 117.914 -1.041 . . . . 0.0 110.482 -178.891 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 58.0 m . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 120.955 0.407 . . . . 0.0 110.192 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.95 137.41 38.31 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.41 -0.806 . . . . 0.0 109.686 179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.418 ' H ' ' HA ' ' A' ' 137' ' ' ASP . 3.2 m-20 -158.41 -163.26 1.25 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 119.351 -0.94 . . . . 0.0 110.502 -179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.524 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -114.31 54.57 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.216 -0.928 . . . . 0.0 109.58 178.73 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.559 ' O ' HG22 ' A' ' 136' ' ' VAL . 66.6 mt -96.93 157.43 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.672 0 O-C-N 120.869 -1.144 . . . . 0.0 109.558 179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.724 HG12 ' HA ' ' A' ' 135' ' ' ARG . 33.8 m -139.94 172.2 12.66 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 109.582 -0.525 . . . . 0.0 109.582 179.911 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.803 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.3 p -130.24 120.68 49.62 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 178.503 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.534 ' HB2' ' HE1' ' A' ' 105' ' ' MET . . . -62.56 118.42 7.56 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.432 -0.792 . . . . 0.0 109.222 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.733 HD11 ' HB2' ' A' ' 134' ' ' ALA . 69.2 mt -94.46 2.46 55.74 Favored 'General case' 0 N--CA 1.489 1.502 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.151 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.447 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 64.2 m-85 -153.67 152.87 31.32 Favored 'General case' 0 N--CA 1.502 2.165 0 O-C-N 121.14 -0.975 . . . . 0.0 108.831 179.271 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -69.35 144.29 53.5 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.391 -0.818 . . . . 0.0 110.447 -179.591 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.494 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 48.2 t80 -155.4 127.95 7.89 Favored 'General case' 0 N--CA 1.505 2.316 0 O-C-N 121.396 -0.815 . . . . 0.0 110.793 179.536 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.87 149.35 21.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.422 -0.799 . . . . 0.0 110.771 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.781 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -59.57 170.02 1.16 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.467 -0.77 . . . . 0.0 109.929 179.444 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 3.1 tt -171.41 38.46 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.946 0 O-C-N 121.587 -0.696 . . . . 0.0 109.817 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -171.46 -168.34 0.6 Allowed 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.246 -0.909 . . . . 0.0 109.851 -179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.4 t-80 -74.09 -70.82 0.37 Allowed 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.482 -0.761 . . . . 0.0 110.124 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.441 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 8.6 tp10 -86.53 54.44 3.16 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.285 -0.885 . . . . 0.0 108.93 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.781 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.6 p30 -98.79 173.52 6.84 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.678 -0.638 . . . . 0.0 110.425 -179.119 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.612 HD21 ' HB2' ' A' ' 119' ' ' SER . 5.9 tt -155.07 128.67 8.54 Favored 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.321 -0.862 . . . . 0.0 110.917 -179.951 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 2.5 m -94.79 117.02 29.46 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.404 -0.81 . . . . 0.0 110.494 179.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.569 ' CE2' HG22 ' A' ' 128' ' ' ILE . 19.0 p90 -115.94 -170.03 1.71 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.724 -0.61 . . . . 0.0 110.501 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.58 179.4 5.16 Favored 'General case' 0 N--CA 1.495 1.824 0 CA-C-O 122.343 1.068 . . . . 0.0 112.525 -178.181 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.447 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.9 ttmt -61.08 -20.72 62.94 Favored 'General case' 0 N--CA 1.503 2.18 0 N-CA-C 115.485 1.661 . . . . 0.0 115.485 -177.66 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.03 41.16 1.33 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 109.249 -1.54 . . . . 0.0 109.249 -178.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.429 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 1.9 m-20 -91.02 170.51 9.98 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.746 -0.855 . . . . 0.0 111.693 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.87 129.28 47.92 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 121.513 -0.742 . . . . 0.0 109.49 178.632 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.534 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 3.1 mpp? -137.48 152.94 50.08 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.738 -0.601 . . . . 0.0 109.444 179.735 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.5 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 25.4 t -101.08 152.49 5.08 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.443 0 N-CA-C 107.707 -1.22 . . . . 0.0 107.707 179.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.419 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 88.3 t -95.39 141.15 15.62 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.941 0 O-C-N 121.031 -1.043 . . . . 0.0 110.527 -179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.749 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -98.8 -27.89 13.73 Favored 'General case' 0 C--N 1.294 -1.813 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 178.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 31.7 mt-10 -156.04 159.44 39.13 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.877 -0.515 . . . . 0.0 110.117 -179.663 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 32.3 mt-10 -102.2 152.08 21.44 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.511 -0.743 . . . . 0.0 109.581 178.834 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -146.25 -66.95 0.29 Allowed 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.142 -0.973 . . . . 0.0 111.019 -179.549 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.13 -84.34 0.1 Allowed Glycine 0 N--CA 1.492 2.393 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 15.5 mm-40 -98.48 -20.89 16.83 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.591 -0.947 . . . . 0.0 110.777 179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 86.0 m95 -127.85 107.51 9.93 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 121.48 -0.762 . . . . 0.0 109.506 179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.44 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 41.6 m0 -101.26 155.06 18.25 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.39 -0.818 . . . . 0.0 110.886 -179.35 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.8 tttt -100.6 111.96 24.28 Favored 'General case' 0 N--CA 1.496 1.873 0 N-CA-C 108.623 -0.88 . . . . 0.0 108.623 178.62 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.749 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.09 169.71 13.11 Favored 'General case' 0 N--CA 1.498 1.952 0 CA-C-O 122.241 1.02 . . . . 0.0 112.717 -178.24 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.5 ttt180 -113.0 124.73 53.31 Favored 'General case' 0 C--N 1.309 -1.192 0 CA-C-N 115.947 -0.57 . . . . 0.0 109.844 179.972 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.612 ' HB2' HD21 ' A' ' 97' ' ' LEU . 20.0 t -78.08 115.08 17.55 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.625 -0.672 . . . . 0.0 109.95 179.598 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 14.9 mt -66.43 -23.77 66.34 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.847 -0.533 . . . . 0.0 110.114 179.803 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.26 -30.51 66.63 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.269 -0.895 . . . . 0.0 109.806 179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 33.4 p -136.35 12.26 3.26 Favored 'General case' 0 N--CA 1.494 1.749 0 O-C-N 121.834 -0.541 . . . . 0.0 110.952 179.829 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER 51.89 30.95 7.72 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 121.062 -1.024 . . . . 0.0 110.461 -179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.515 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.9 mttt -100.18 -179.88 4.27 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 108.912 -0.773 . . . . 0.0 108.912 179.262 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.22 137.25 14.63 Favored 'General case' 0 N--CA 1.502 2.162 0 C-N-CA 119.579 -0.848 . . . . 0.0 112.035 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -164.59 -150.26 6.09 Favored Glycine 0 N--CA 1.488 2.144 0 N-CA-C 109.522 -1.431 . . . . 0.0 109.522 179.147 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.543 ' O ' HG23 ' A' ' 128' ' ' ILE . 70.7 m-85 -94.24 162.85 13.68 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.578 -0.954 . . . . 0.0 111.317 -179.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.569 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.6 pt -155.31 111.03 2.25 Favored Pre-proline 0 N--CA 1.496 1.872 0 O-C-N 121.998 -0.439 . . . . 0.0 110.166 179.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_exo -45.36 101.08 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.04 1.021 . . . . 0.0 112.0 -179.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.44 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 50.2 m -51.89 -28.87 17.65 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-N 116.082 -0.508 . . . . 0.0 112.202 -179.808 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 19.2 p-10 -81.57 11.62 4.49 Favored 'General case' 0 N--CA 1.502 2.164 0 O-C-N 121.298 -0.876 . . . . 0.0 112.569 -178.512 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 30.2 m-85 -136.79 30.87 2.79 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.061 -1.025 . . . . 0.0 108.589 178.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.489 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -147.98 170.18 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 O-C-N 121.551 -0.718 . . . . 0.0 110.516 -178.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.803 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -119.32 129.27 54.79 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 178.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.724 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -93.16 114.17 26.59 Favored 'General case' 0 C--N 1.308 -1.236 0 O-C-N 121.522 -0.736 . . . . 0.0 112.924 -177.821 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.559 HG22 ' O ' ' A' ' 82' ' ' ILE . 28.4 m -103.19 146.37 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.788 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 177.133 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.418 ' HA ' ' H ' ' A' ' 80' ' ' ASP . 2.3 p30 -154.28 40.2 0.47 Allowed 'General case' 0 C--N 1.31 -1.124 0 O-C-N 121.303 -0.873 . . . . 0.0 109.582 -178.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.9 t . . . . . 0 N--CA 1.491 1.589 0 CA-C-O 117.948 -1.025 . . . . 0.0 109.926 -179.849 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.3 m . . . . . 0 N--CA 1.492 1.65 0 CA-C-O 121.048 0.451 . . . . 0.0 110.204 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 7.9 pt-20 -157.41 46.12 0.38 Allowed 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.569 -0.707 . . . . 0.0 109.915 179.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.428 ' N ' ' HA ' ' A' ' 137' ' ' ASP . 9.8 m-20 -150.91 -157.59 0.83 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.541 -0.725 . . . . 0.0 110.543 -179.44 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.447 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.8 OUTLIER -97.18 52.91 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.916 0 O-C-N 121.134 -0.979 . . . . 0.0 109.69 179.847 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.618 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 80.7 mt -111.66 166.95 5.64 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.091 0 C-N-CA 119.072 -1.051 . . . . 0.0 110.728 -178.958 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 135' ' ' ARG . 13.4 m -143.53 169.04 11.57 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.996 0 O-C-N 121.722 -0.611 . . . . 0.0 109.678 179.013 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.625 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.0 p -131.95 126.53 56.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.62 0 O-C-N 121.456 -0.778 . . . . 0.0 108.948 178.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.573 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.97 118.24 10.16 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.614 -0.834 . . . . 0.0 108.84 179.432 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 1.029 HD11 ' HB2' ' A' ' 134' ' ' ALA . 86.9 mt -94.18 1.26 56.08 Favored 'General case' 0 N--CA 1.493 1.703 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.874 -179.592 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.49 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 55.9 m-85 -152.99 151.1 29.9 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.197 -0.939 . . . . 0.0 108.652 179.409 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.5 m-20 -65.05 145.99 55.59 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 121.495 -0.753 . . . . 0.0 110.587 -179.008 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.442 ' CE1' ' HG3' ' A' ' 129' ' ' PRO . 69.1 t80 -150.31 163.84 37.29 Favored 'General case' 0 N--CA 1.503 2.193 0 O-C-N 121.502 -0.749 . . . . 0.0 110.611 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 34.5 tt0 -137.76 125.59 22.53 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.61 -0.682 . . . . 0.0 110.761 -179.657 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.721 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -49.95 168.42 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.222 0 O-C-N 121.456 -0.778 . . . . 0.0 111.268 179.638 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 tt -167.14 39.06 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.683 -0.636 . . . . 0.0 110.079 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -169.52 -164.99 0.47 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.731 -0.606 . . . . 0.0 109.67 179.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 73.2 m80 -69.38 -74.7 0.12 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.382 -0.824 . . . . 0.0 110.914 -179.402 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.432 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 5.2 tp10 -89.98 50.89 1.95 Allowed 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.514 -0.742 . . . . 0.0 110.253 -179.684 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.721 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.2 t0 -100.46 128.04 46.64 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.485 -0.759 . . . . 0.0 109.598 179.566 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.753 HD21 ' HB2' ' A' ' 119' ' ' SER . 40.1 tp -107.57 129.19 55.01 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.636 -0.665 . . . . 0.0 110.76 -178.731 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.3 m -94.5 176.8 6.15 Favored 'General case' 0 N--CA 1.489 1.525 0 O-C-N 121.699 -0.625 . . . . 0.0 109.953 179.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.573 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 11.6 p90 -172.98 -167.48 0.42 Allowed 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.494 -0.754 . . . . 0.0 110.512 179.736 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.53 -176.88 3.64 Favored 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.125 0.964 . . . . 0.0 111.539 -178.632 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.49 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.0 ttmt -61.08 -22.73 64.89 Favored 'General case' 0 N--CA 1.498 1.957 0 N-CA-C 115.023 1.49 . . . . 0.0 115.023 -177.653 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.38 44.7 1.0 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 109.231 -1.548 . . . . 0.0 109.231 -178.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 3.0 m-20 -90.78 166.51 13.07 Favored 'General case' 0 N--CA 1.506 2.336 0 C-N-CA 119.602 -0.839 . . . . 0.0 110.797 179.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.4 mt-30 -122.13 116.96 25.13 Favored 'General case' 0 C--N 1.308 -1.226 0 O-C-N 121.45 -0.781 . . . . 0.0 110.382 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.415 ' HE1' ' CD2' ' A' ' 99' ' ' PHE . 68.5 mtm -129.78 146.36 51.53 Favored 'General case' 0 C--N 1.3 -1.57 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 178.78 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.618 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -98.54 156.21 3.74 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 C-N-CA 118.545 -1.262 . . . . 0.0 108.71 179.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.447 ' HB ' HG13 ' A' ' 81' ' ' ILE . 43.3 t -93.62 139.68 17.82 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 CA-C-O 122.01 0.909 . . . . 0.0 109.767 -179.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.652 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -94.54 -30.76 14.23 Favored 'General case' 0 C--N 1.296 -1.718 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 179.827 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.7 mt-10 -156.23 161.2 40.29 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 109.24 -0.652 . . . . 0.0 109.24 179.437 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -103.71 144.68 31.14 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.42 -0.8 . . . . 0.0 109.975 179.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -139.03 -77.93 0.34 Allowed 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.392 -0.817 . . . . 0.0 110.318 -179.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.28 -85.29 0.07 OUTLIER Glycine 0 N--CA 1.494 2.505 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 25.4 mm-40 -94.27 -13.2 26.76 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.677 -0.896 . . . . 0.0 110.596 179.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 34.0 m95 -133.47 96.66 3.76 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.461 -0.775 . . . . 0.0 110.163 -179.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.421 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 31.7 m0 -94.91 146.04 24.5 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.243 -0.911 . . . . 0.0 109.787 179.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.409 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 0.9 OUTLIER -95.21 117.06 29.6 Favored 'General case' 0 N--CA 1.493 1.701 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.961 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.652 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -129.57 165.77 21.05 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 122.039 0.923 . . . . 0.0 112.419 -178.835 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.467 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.9 ttm180 -115.01 124.54 51.9 Favored 'General case' 0 N--CA 1.484 1.245 0 O-C-N 121.593 -0.692 . . . . 0.0 109.961 179.704 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.753 ' HB2' HD21 ' A' ' 97' ' ' LEU . 4.8 t -83.92 118.77 24.21 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.68 -0.638 . . . . 0.0 109.932 179.722 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 5.1 mt -71.25 -20.8 62.19 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.398 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.24 -26.93 66.8 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.499 -0.75 . . . . 0.0 109.864 179.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 19.5 p -137.62 10.99 2.94 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.766 -0.584 . . . . 0.0 110.606 179.238 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 5.6 mtt-85 53.64 30.81 11.53 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.147 -0.971 . . . . 0.0 110.755 -179.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 14.9 mtpt -104.79 174.0 6.06 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.526 -0.734 . . . . 0.0 109.27 179.034 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.467 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.9 OUTLIER -155.83 146.66 22.17 Favored 'General case' 0 N--CA 1.494 1.727 0 C-N-CA 119.54 -0.864 . . . . 0.0 111.694 179.559 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.409 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -176.27 -147.19 6.33 Favored Glycine 0 N--CA 1.485 1.945 0 N-CA-C 109.332 -1.507 . . . . 0.0 109.332 179.603 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.432 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 36.2 m-85 -93.44 160.59 14.74 Favored 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.648 -0.913 . . . . 0.0 110.061 -179.808 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.431 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.2 pt -152.14 117.57 3.05 Favored Pre-proline 0 N--CA 1.494 1.737 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 179.332 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HG3' ' CE1' ' A' ' 89' ' ' TYR . 35.0 Cg_exo -41.33 103.67 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.473 0 C-N-CA 121.323 1.349 . . . . 0.0 112.843 -178.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.421 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 74.2 m -62.36 -15.1 46.5 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.865 -0.522 . . . . 0.0 111.008 179.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 31.1 p30 -86.13 13.87 7.18 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 121.22 -0.925 . . . . 0.0 111.522 -179.505 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -152.23 40.2 0.61 Allowed 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.252 -0.905 . . . . 0.0 109.868 179.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.468 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.2 p -149.09 168.02 3.05 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.421 -0.799 . . . . 0.0 110.831 -179.363 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 1.029 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -127.82 127.81 44.15 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 121.975 -0.453 . . . . 0.0 109.93 179.83 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.683 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -95.15 129.43 42.25 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.272 -0.893 . . . . 0.0 111.454 -178.82 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.452 HG23 ' HB ' ' A' ' 82' ' ' ILE . 10.9 m -102.96 129.29 54.89 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.428 ' HA ' ' N ' ' A' ' 80' ' ' ASP . 2.6 p30 -155.65 -165.96 2.11 Favored 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.988 -0.445 . . . . 0.0 109.838 -179.267 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.7 t . . . . . 0 N--CA 1.493 1.715 0 CA-C-O 117.983 -1.008 . . . . 0.0 110.127 179.917 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.9 p . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.057 0.456 . . . . 0.0 110.222 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.473 ' HA ' ' HB3' ' A' ' 137' ' ' ASP . 45.5 mt-10 -88.87 125.67 35.03 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.615 -0.678 . . . . 0.0 110.534 -179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.467 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 59.6 m-20 -100.61 -150.57 0.39 Allowed 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.407 -0.808 . . . . 0.0 109.625 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.426 HG13 ' HB ' ' A' ' 107' ' ' VAL . 4.9 tp -120.51 41.66 0.69 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 121.169 -0.957 . . . . 0.0 111.082 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.662 HD13 ' C ' ' A' ' 138' ' ' SER . 7.0 mt -110.31 167.01 4.9 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 120.983 -1.073 . . . . 0.0 108.436 178.676 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.688 HG12 ' HA ' ' A' ' 135' ' ' ARG . 3.8 m -146.17 167.56 7.58 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 121.629 -0.669 . . . . 0.0 110.617 179.792 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.52 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.6 p -128.51 124.16 61.2 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 N-CA-C 109.02 -0.733 . . . . 0.0 109.02 178.069 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.63 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.9 117.57 9.18 Favored 'General case' 0 C--N 1.303 -1.42 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.685 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.685 HD11 ' HB2' ' A' ' 134' ' ' ALA . 79.8 mt -94.39 5.53 51.5 Favored 'General case' 0 N--CA 1.491 1.623 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.257 -179.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.431 ' N ' ' HA ' ' A' ' 101' ' ' LYS . 38.9 m-85 -152.44 151.74 31.14 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.235 -0.916 . . . . 0.0 109.048 179.179 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 46.5 m-20 -70.17 141.99 52.54 Favored 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.415 -0.803 . . . . 0.0 109.536 -179.602 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.508 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 65.4 t80 -155.53 126.95 7.25 Favored 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.349 -0.844 . . . . 0.0 111.565 -179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 16.6 tp10 -100.1 122.02 42.32 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.506 0.67 . . . . 0.0 109.895 178.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.66 ' HB1' ' OD2' ' A' ' 96' ' ' ASP . . . -55.91 161.98 2.03 Favored 'General case' 0 N--CA 1.498 1.964 0 CA-C-O 121.508 0.671 . . . . 0.0 111.903 -179.153 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 33.9 mt -148.07 64.99 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.634 -0.666 . . . . 0.0 109.571 179.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -177.2 -157.54 0.04 OUTLIER 'General case' 0 N--CA 1.503 2.206 0 O-C-N 121.091 -1.006 . . . . 0.0 110.152 179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -90.94 -72.12 0.59 Allowed 'General case' 0 N--CA 1.5 2.072 0 O-C-N 121.432 -0.792 . . . . 0.0 110.693 -179.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 19.8 tp10 -74.04 -8.08 54.81 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.082 -1.011 . . . . 0.0 110.176 179.512 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.66 ' OD2' ' HB1' ' A' ' 91' ' ' ALA . 20.1 p-10 -48.23 156.96 0.35 Allowed 'General case' 0 N--CA 1.501 2.125 0 O-C-N 121.348 -0.845 . . . . 0.0 111.505 -179.915 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.441 HD13 ' HA ' ' A' ' 125' ' ' GLU . 7.9 tt -137.54 134.34 35.55 Favored 'General case' 0 N--CA 1.497 1.891 0 O-C-N 121.415 -0.803 . . . . 0.0 110.47 -179.877 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.8 m -94.44 166.94 11.81 Favored 'General case' 0 N--CA 1.492 1.651 0 O-C-N 121.529 -0.732 . . . . 0.0 110.001 179.408 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.63 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 24.0 p90 -164.76 -170.78 2.08 Favored 'General case' 0 N--CA 1.493 1.693 0 C-N-CA 120.265 -0.574 . . . . 0.0 110.291 179.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 9.2 mt-30 -124.37 179.88 4.74 Favored 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.328 1.061 . . . . 0.0 112.69 -178.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.431 ' HA ' ' N ' ' A' ' 87' ' ' TYR . 16.6 ttmt -60.95 -19.32 60.75 Favored 'General case' 0 N--CA 1.501 2.111 0 N-CA-C 115.292 1.589 . . . . 0.0 115.292 -177.407 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.34 41.22 1.31 Allowed Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.397 -1.481 . . . . 0.0 109.397 -178.811 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.458 ' O ' HG23 ' A' ' 84' ' ' VAL . 7.0 m-20 -90.9 166.06 13.26 Favored 'General case' 0 N--CA 1.506 2.362 0 O-C-N 121.686 -0.89 . . . . 0.0 111.527 -179.811 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.6 mt-30 -124.05 111.31 15.82 Favored 'General case' 0 N--CA 1.484 1.251 0 O-C-N 121.561 -0.712 . . . . 0.0 110.112 179.166 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 53.9 mtm -126.01 147.41 49.55 Favored 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.626 -1.62 . . . . 0.0 106.626 178.416 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.639 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.1 m -95.02 157.33 3.08 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.416 0 C-N-CA 118.262 -1.375 . . . . 0.0 109.073 -179.376 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.522 HG23 HG22 ' A' ' 83' ' ' VAL . 73.9 t -93.98 135.87 27.16 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 CA-C-O 122.201 1.001 . . . . 0.0 110.329 -178.789 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.635 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.2 mp -94.98 -27.62 15.56 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-N 115.755 -0.657 . . . . 0.0 109.632 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -155.61 177.45 11.37 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.75 -0.594 . . . . 0.0 109.844 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mm-40 -127.81 94.52 3.97 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.524 -0.735 . . . . 0.0 110.451 179.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 3.3 t -97.29 -152.87 0.4 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.678 -0.639 . . . . 0.0 110.084 179.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -73.33 -114.66 0.07 OUTLIER Glycine 0 N--CA 1.493 2.476 0 N-CA-C 109.731 -1.348 . . . . 0.0 109.731 -179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 9.1 tt0 -86.54 -6.87 58.77 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.948 . . . . 0.0 111.179 -179.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 93.1 m95 -119.0 102.81 9.03 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.144 -0.973 . . . . 0.0 109.669 -179.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 53.6 m0 -98.72 157.11 16.48 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.421 -0.799 . . . . 0.0 110.645 -179.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.413 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 5.9 mttt -97.51 121.72 39.74 Favored 'General case' 0 N--CA 1.495 1.803 0 N-CA-C 109.097 -0.705 . . . . 0.0 109.097 178.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.635 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.24 161.32 32.51 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.351 -0.843 . . . . 0.0 111.83 -179.057 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.487 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.8 ttm180 -114.97 122.35 45.98 Favored 'General case' 0 N--CA 1.483 1.185 0 O-C-N 121.545 -0.722 . . . . 0.0 109.83 179.781 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 22.5 t -84.48 127.33 33.97 Favored 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.645 -0.659 . . . . 0.0 110.456 -179.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 8.8 mt -73.88 -26.59 60.63 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 122.114 -0.366 . . . . 0.0 110.715 -179.986 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.59 -35.76 66.15 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.42 -0.8 . . . . 0.0 110.671 -179.457 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 38.4 p -128.31 9.4 6.13 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.6 -0.688 . . . . 0.0 110.566 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 54.48 33.78 19.56 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.164 -0.96 . . . . 0.0 110.483 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . . . . . . . . . 21.7 mttt -107.82 176.98 4.95 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.562 -0.711 . . . . 0.0 109.087 179.443 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.487 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pm0 -155.26 137.99 15.23 Favored 'General case' 0 N--CA 1.495 1.784 0 C-N-CA 119.601 -0.84 . . . . 0.0 111.39 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.42 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -162.41 -149.71 5.76 Favored Glycine 0 N--CA 1.484 1.887 0 N-CA-C 110.167 -1.173 . . . . 0.0 110.167 179.978 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 75.9 m-85 -94.52 161.35 14.25 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 122.032 -0.687 . . . . 0.0 110.69 -179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.52 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -155.4 117.59 2.37 Favored Pre-proline 0 N--CA 1.496 1.837 0 N-CA-C 109.573 -0.529 . . . . 0.0 109.573 179.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_exo -48.62 109.38 0.25 Allowed 'Trans proline' 0 N--CA 1.494 1.533 0 O-C-N 123.036 1.019 . . . . 0.0 111.73 -179.258 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 12.0 m -56.96 -18.2 12.61 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.765 -0.584 . . . . 0.0 111.719 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 9.1 p-10 -88.37 18.7 4.27 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.096 -1.003 . . . . 0.0 111.631 -179.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -145.74 36.66 1.06 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.276 -0.89 . . . . 0.0 108.869 178.657 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.485 HG22 ' N ' ' A' ' 134' ' ' ALA . 8.9 p -154.86 169.21 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.602 0 C-N-CA 119.559 -0.856 . . . . 0.0 111.784 -178.174 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.685 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -134.65 132.54 39.07 Favored 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.062 0.458 . . . . 0.0 110.301 179.749 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.688 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -75.2 119.36 19.22 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.321 -0.862 . . . . 0.0 110.882 -179.684 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.6 m -113.08 151.96 14.88 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.537 0 CA-C-O 121.405 0.621 . . . . 0.0 110.11 178.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.473 ' HB3' ' HA ' ' A' ' 79' ' ' GLU . 31.0 p-10 -96.89 38.07 1.26 Allowed 'General case' 0 N--CA 1.484 1.265 0 O-C-N 121.745 -0.597 . . . . 0.0 110.098 179.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.662 ' C ' HD13 ' A' ' 82' ' ' ILE . 3.2 t . . . . . 0 N--CA 1.494 1.73 0 CA-C-O 117.933 -1.032 . . . . 0.0 110.279 -179.477 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . 0.599 ' C ' HD12 ' A' ' 82' ' ' ILE . 5.3 t . . . . . 0 N--CA 1.497 1.906 0 CA-C-O 121.336 0.588 . . . . 0.0 110.34 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.713 ' N ' HD12 ' A' ' 82' ' ' ILE . 18.6 mt-10 57.13 -152.49 0.39 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 121.474 -0.766 . . . . 0.0 110.188 179.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.475 ' N ' ' HA ' ' A' ' 137' ' ' ASP . 1.6 m-20 61.63 -103.03 0.13 Allowed 'General case' 0 N--CA 1.504 2.267 0 O-C-N 121.401 -0.812 . . . . 0.0 110.586 -179.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.603 ' O ' HG23 ' A' ' 81' ' ' ILE . 1.4 tp -112.8 56.03 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 120.881 -1.137 . . . . 0.0 109.575 -179.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.713 HD12 ' N ' ' A' ' 79' ' ' GLU . 88.0 mt -123.16 159.18 27.54 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 O-C-N 121.255 -0.903 . . . . 0.0 109.147 179.591 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.683 HG12 ' HA ' ' A' ' 135' ' ' ARG . 17.2 m -137.83 169.51 18.74 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.607 -0.683 . . . . 0.0 110.697 179.806 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.512 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.9 p -130.01 123.96 57.42 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.316 0 N-CA-C 108.652 -0.87 . . . . 0.0 108.652 178.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.587 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.26 120.67 14.18 Favored 'General case' 0 C--N 1.302 -1.462 0 C-N-CA 119.509 -0.876 . . . . 0.0 109.045 179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.765 HD11 ' HB2' ' A' ' 134' ' ' ALA . 85.3 mt -94.26 1.12 56.0 Favored 'General case' 0 N--CA 1.495 1.809 0 C-N-CA 120.907 -0.317 . . . . 0.0 110.95 -179.771 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.6 m-85 -152.48 152.53 32.06 Favored 'General case' 0 N--CA 1.497 1.883 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 179.416 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 72.4 m-20 -67.49 146.23 54.17 Favored 'General case' 0 N--CA 1.495 1.802 0 O-C-N 121.521 -0.737 . . . . 0.0 110.362 -179.387 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.453 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 36.7 t80 -155.15 127.68 7.91 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.35 -0.844 . . . . 0.0 110.475 179.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -98.03 144.4 27.58 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.427 -0.796 . . . . 0.0 111.551 -179.359 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.746 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -56.78 147.23 23.65 Favored 'General case' 0 N--CA 1.501 2.08 0 O-C-N 121.665 -0.647 . . . . 0.0 111.585 -179.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 88.0 mt -136.61 -67.83 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 121.586 -0.696 . . . . 0.0 110.193 179.514 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -59.92 -167.53 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.342 0 O-C-N 121.198 -0.939 . . . . 0.0 110.734 -179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -81.12 -48.8 11.66 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.148 -0.97 . . . . 0.0 110.588 -179.703 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.43 ' HB3' ' CZ ' ' A' ' 127' ' ' TYR . 12.6 tp10 -95.76 52.99 1.38 Allowed 'General case' 0 N--CA 1.496 1.868 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 178.086 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.746 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 40.3 p30 -92.28 -179.11 5.14 Favored 'General case' 0 N--CA 1.492 1.653 0 CA-C-O 121.204 0.526 . . . . 0.0 111.498 -178.369 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.521 HD13 ' N ' ' A' ' 98' ' ' SER . 0.9 OUTLIER -154.35 121.89 5.8 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.654 -0.654 . . . . 0.0 110.106 -179.241 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.521 ' N ' HD13 ' A' ' 97' ' ' LEU . 1.1 m -94.52 112.0 23.76 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.502 -0.749 . . . . 0.0 110.55 179.621 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.587 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 14.4 p90 -114.83 -169.24 1.51 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.806 -0.559 . . . . 0.0 109.959 178.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -126.23 -178.15 4.22 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 122.062 0.934 . . . . 0.0 111.72 -178.519 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.449 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -60.95 -20.56 62.43 Favored 'General case' 0 N--CA 1.501 2.096 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -177.314 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.01 42.51 1.13 Allowed Glycine 0 N--CA 1.497 2.72 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 -178.801 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.437 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.7 m-20 -91.05 169.21 11.06 Favored 'General case' 0 N--CA 1.508 2.465 0 C-N-CA 119.577 -0.849 . . . . 0.0 111.947 -179.471 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.33 125.65 43.81 Favored 'General case' 0 N--CA 1.486 1.344 0 CA-C-O 121.495 0.664 . . . . 0.0 109.547 178.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.486 ' HE3' ' HB2' ' A' ' 85' ' ' ALA . 3.2 mpp? -134.4 153.95 51.63 Favored 'General case' 0 C--N 1.301 -1.53 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.616 ' CG2' HD11 ' A' ' 120' ' ' LEU . 36.6 t -94.41 152.05 3.67 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 179.33 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.576 HG11 HD11 ' A' ' 81' ' ' ILE . 33.6 t -95.57 134.93 31.25 Favored 'Isoleucine or valine' 0 C--N 1.29 -1.997 0 CA-C-O 121.902 0.858 . . . . 0.0 110.142 -179.489 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.715 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -95.64 -27.83 15.12 Favored 'General case' 0 C--N 1.298 -1.671 0 CA-C-N 115.967 -0.56 . . . . 0.0 109.54 179.531 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 15.9 mt-10 -156.05 -168.92 2.9 Favored 'General case' 0 N--CA 1.496 1.841 0 CA-C-O 121.596 0.712 . . . . 0.0 111.128 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -143.62 99.22 3.38 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.64 -0.662 . . . . 0.0 109.562 179.394 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 2.4 t -94.42 -71.47 0.66 Allowed 'General case' 0 N--CA 1.496 1.828 0 O-C-N 121.422 -0.799 . . . . 0.0 110.697 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.88 -77.21 0.07 OUTLIER Glycine 0 N--CA 1.495 2.604 0 N-CA-C 110.205 -1.158 . . . . 0.0 110.205 -179.811 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.9 mt-10 -94.04 -22.7 18.36 Favored 'General case' 0 N--CA 1.495 1.788 0 O-C-N 121.488 -1.007 . . . . 0.0 110.298 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.423 ' HZ3' ' HH ' ' A' ' 89' ' ' TYR . 84.0 m95 -133.83 108.27 8.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.539 -0.726 . . . . 0.0 110.217 -179.553 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.402 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 34.0 m0 -98.98 158.9 15.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 121.312 -0.867 . . . . 0.0 110.135 179.762 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 3.2 tttt -100.27 126.65 46.6 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.416 -0.802 . . . . 0.0 109.094 178.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.715 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -135.73 162.6 32.31 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.278 -0.889 . . . . 0.0 112.164 -179.246 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.482 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.3 ttt180 -111.35 120.54 42.53 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 121.391 -0.818 . . . . 0.0 109.829 179.427 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.441 ' HB2' HD11 ' A' ' 97' ' ' LEU . 1.1 t -72.41 110.71 7.01 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.646 -0.659 . . . . 0.0 109.485 179.208 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.616 HD11 ' CG2' ' A' ' 106' ' ' VAL . 7.3 mt -64.96 -26.0 68.11 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.861 -0.524 . . . . 0.0 110.563 -179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -62.43 -29.95 70.88 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 121.632 -0.668 . . . . 0.0 110.097 -179.834 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 29.0 p -129.53 8.61 5.43 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.455 -0.778 . . . . 0.0 110.883 179.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.4 mtm180 53.66 29.25 9.07 Favored 'General case' 0 N--CA 1.502 2.166 0 O-C-N 121.135 -0.978 . . . . 0.0 109.86 -178.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.482 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -97.48 176.24 5.94 Favored 'General case' 0 N--CA 1.495 1.8 0 N-CA-C 109.186 -0.672 . . . . 0.0 109.186 179.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.48 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.74 140.59 17.18 Favored 'General case' 0 N--CA 1.5 2.057 0 CA-C-O 121.765 0.793 . . . . 0.0 111.464 179.372 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.24 -150.01 6.83 Favored Glycine 0 N--CA 1.484 1.882 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 179.558 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.5 ' O ' HG23 ' A' ' 128' ' ' ILE . 52.8 m-85 -93.92 165.28 12.74 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.905 -0.762 . . . . 0.0 110.805 -179.215 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.529 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.7 pt -155.29 112.56 2.27 Favored Pre-proline 0 N--CA 1.496 1.831 0 N-CA-C 109.627 -0.509 . . . . 0.0 109.627 179.244 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.44 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 34.3 Cg_exo -42.67 102.31 0.04 OUTLIER 'Trans proline' 0 N--CA 1.493 1.487 0 C-N-CA 121.109 1.206 . . . . 0.0 112.078 -179.469 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.402 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 71.6 m -54.9 -20.6 9.21 Favored 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.906 -0.496 . . . . 0.0 111.513 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -90.26 25.32 2.24 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.214 -0.928 . . . . 0.0 111.63 -179.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 12.5 m-85 -154.99 32.02 0.4 Allowed 'General case' 0 N--CA 1.502 2.129 0 O-C-N 121.306 -0.871 . . . . 0.0 109.269 178.515 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.503 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -149.02 169.49 2.59 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.567 0 O-C-N 121.579 -0.7 . . . . 0.0 110.651 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.765 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -132.79 123.88 26.99 Favored 'General case' 0 N--CA 1.499 1.989 0 C-N-CA 120.533 -0.467 . . . . 0.0 109.916 179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.683 ' HA ' HG12 ' A' ' 83' ' ' VAL . 18.6 ttp180 -91.76 126.53 36.88 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.255 -0.903 . . . . 0.0 112.455 -178.69 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.467 HG23 ' HA ' ' A' ' 79' ' ' GLU . 29.9 m -94.58 140.81 16.0 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 177.012 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.475 ' HA ' ' N ' ' A' ' 80' ' ' ASP . 2.9 p30 -141.51 -157.21 0.75 Allowed 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.955 -0.466 . . . . 0.0 109.967 -178.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 4.7 t . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.153 -179.963 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 78.3 p . . . . . 0 N--CA 1.492 1.625 0 CA-C-O 121.085 0.469 . . . . 0.0 110.363 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.7 pt-20 -62.99 165.04 7.35 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.625 -0.672 . . . . 0.0 110.502 -179.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -138.22 -162.55 1.32 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.567 -0.708 . . . . 0.0 109.625 179.799 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.497 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -121.86 46.05 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.582 0 C-N-CA 119.652 -0.819 . . . . 0.0 110.641 179.427 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.962 ' CD1' HG13 ' A' ' 106' ' ' VAL . 4.9 mm -96.65 140.1 18.06 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.067 0 O-C-N 121.064 -1.022 . . . . 0.0 108.882 179.157 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.848 HG12 ' HA ' ' A' ' 135' ' ' ARG . 32.2 m -126.33 174.13 10.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 C-N-CA 120.039 -0.665 . . . . 0.0 110.428 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.882 HG12 ' HB3' ' A' ' 134' ' ' ALA . 7.1 p -127.66 123.66 61.72 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.511 0 O-C-N 121.655 -0.653 . . . . 0.0 109.365 178.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.577 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -66.36 119.41 11.53 Favored 'General case' 0 N--CA 1.49 1.567 0 N-CA-C 108.837 -0.801 . . . . 0.0 108.837 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.719 HD11 ' HB2' ' A' ' 134' ' ' ALA . 64.5 mt -94.3 4.2 54.2 Favored 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 120.678 -0.409 . . . . 0.0 111.561 -179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.463 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.1 m-85 -152.63 151.5 30.68 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.031 -1.043 . . . . 0.0 109.117 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.414 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 74.6 m-20 -69.13 143.14 54.21 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.479 -0.763 . . . . 0.0 109.352 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.469 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 58.9 t80 -155.12 131.15 10.15 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.181 -0.949 . . . . 0.0 111.019 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 31.7 tt0 -97.4 142.19 29.57 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.7 -0.625 . . . . 0.0 110.723 179.947 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.774 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -55.93 175.21 0.1 Allowed 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.401 -0.812 . . . . 0.0 110.385 179.701 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.0 tt -172.23 39.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 121.533 -0.729 . . . . 0.0 110.278 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -173.29 -168.3 0.45 Allowed 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.288 -0.882 . . . . 0.0 110.217 179.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 84.5 m-70 -72.44 -74.25 0.17 Allowed 'General case' 0 N--CA 1.499 2.008 0 O-C-N 121.398 -0.814 . . . . 0.0 109.828 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.423 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 10.7 tp10 -83.36 55.59 3.23 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.356 -0.84 . . . . 0.0 109.15 178.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.774 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 53.2 p-10 -101.36 170.97 7.87 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.73 -0.606 . . . . 0.0 109.809 -179.722 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.822 HD21 ' HB2' ' A' ' 119' ' ' SER . 55.4 tp -151.9 129.33 11.36 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.312 -0.868 . . . . 0.0 111.14 -179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -94.76 116.65 28.99 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.686 -0.634 . . . . 0.0 110.295 179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.577 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.3 p90 -113.62 -170.92 1.79 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 121.579 -0.7 . . . . 0.0 109.958 178.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 0.5 OUTLIER -125.71 -179.77 4.81 Favored 'General case' 0 N--CA 1.497 1.881 0 CA-C-O 122.032 0.92 . . . . 0.0 111.831 -178.596 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.463 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.14 -23.36 65.47 Favored 'General case' 0 N--CA 1.503 2.207 0 N-CA-C 115.315 1.598 . . . . 0.0 115.315 -177.24 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.7 40.9 1.37 Allowed Glycine 0 N--CA 1.497 2.712 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 -178.666 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.439 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.96 171.08 9.53 Favored 'General case' 0 N--CA 1.502 2.145 0 O-C-N 122.049 -0.677 . . . . 0.0 111.543 -179.415 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -124.84 139.55 53.73 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.484 -0.76 . . . . 0.0 109.781 179.062 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.407 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 71.8 mtm -142.95 154.01 43.61 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.79 -0.569 . . . . 0.0 110.178 -179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.962 HG13 ' CD1' ' A' ' 82' ' ' ILE . 22.4 t -100.77 147.89 7.49 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 N-CA-C 106.614 -1.624 . . . . 0.0 106.614 178.397 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.497 HG23 ' O ' ' A' ' 81' ' ' ILE . 95.4 t -94.92 138.93 19.66 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.918 0 C-N-CA 118.919 -1.112 . . . . 0.0 109.881 179.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.737 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.14 -25.69 14.83 Favored 'General case' 0 C--N 1.297 -1.7 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.04 155.33 32.48 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.749 -0.595 . . . . 0.0 110.05 -179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 22.3 mt-10 -108.7 133.16 53.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.555 -0.716 . . . . 0.0 109.916 179.381 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 30.8 t -132.6 -85.38 0.47 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.279 -0.888 . . . . 0.0 110.658 -179.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -166.96 -91.76 0.08 OUTLIER Glycine 0 N--CA 1.494 2.508 0 N-CA-C 109.7 -1.36 . . . . 0.0 109.7 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -88.88 -16.83 30.95 Favored 'General case' 0 N--CA 1.497 1.893 0 O-C-N 121.585 -0.95 . . . . 0.0 110.807 179.706 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 31.5 m95 -127.59 104.9 8.13 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.371 -0.831 . . . . 0.0 110.468 -179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.428 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 44.5 m0 -101.95 153.56 19.76 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.249 -0.907 . . . . 0.0 109.984 179.401 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -102.78 113.21 26.44 Favored 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 108.979 -0.749 . . . . 0.0 108.979 179.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.737 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.02 167.93 16.01 Favored 'General case' 0 N--CA 1.499 1.979 0 O-C-N 121.127 -0.983 . . . . 0.0 112.675 -178.544 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.544 ' HB2' HD11 ' A' ' 108' ' ' LEU . 1.1 ttt180 -115.76 124.01 49.71 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.65 -0.656 . . . . 0.0 109.673 179.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.822 ' HB2' HD21 ' A' ' 97' ' ' LEU . 24.2 t -78.98 120.82 24.12 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.624 -0.673 . . . . 0.0 109.741 179.414 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 4.0 mt -71.75 -21.81 61.7 Favored 'General case' 0 N--CA 1.496 1.853 0 C-N-CA 120.554 -0.458 . . . . 0.0 110.461 -179.844 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.73 -33.17 73.57 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.4 -0.812 . . . . 0.0 109.656 179.828 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 11.5 p -130.56 9.54 5.08 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.726 -0.609 . . . . 0.0 110.735 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 54.23 31.3 13.87 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 121.042 -1.036 . . . . 0.0 110.641 179.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 26.5 mtpt -104.51 173.3 6.36 Favored 'General case' 0 N--CA 1.494 1.76 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 178.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.475 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.6 OUTLIER -154.6 140.35 18.08 Favored 'General case' 0 N--CA 1.496 1.873 0 C-N-CA 119.421 -0.912 . . . . 0.0 111.644 179.632 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.03 -146.04 4.71 Favored Glycine 0 N--CA 1.484 1.893 0 N-CA-C 110.086 -1.206 . . . . 0.0 110.086 179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.491 ' O ' HG23 ' A' ' 128' ' ' ILE . 72.7 m-85 -94.15 157.81 15.9 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 122.056 -0.673 . . . . 0.0 110.6 -179.232 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.568 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.7 pt -154.0 113.59 2.53 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.794 -0.566 . . . . 0.0 109.796 179.404 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 78.4 Cg_exo -44.62 97.93 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.589 0 O-C-N 123.277 1.146 . . . . 0.0 112.062 -179.445 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.428 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 66.9 m -49.56 -24.6 2.21 Favored 'General case' 0 N--CA 1.502 2.166 0 CA-C-N 116.156 -0.474 . . . . 0.0 111.684 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.1 p-10 -85.71 16.4 4.01 Favored 'General case' 0 N--CA 1.5 2.045 0 O-C-N 121.403 -0.811 . . . . 0.0 111.755 -179.308 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -140.71 29.15 1.93 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.2 -0.938 . . . . 0.0 109.147 178.644 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.495 HG22 ' N ' ' A' ' 134' ' ' ALA . 6.3 p -146.69 169.73 4.91 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 CA-C-O 121.669 0.747 . . . . 0.0 110.901 -178.303 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.882 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -119.7 135.71 54.72 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.867 -0.52 . . . . 0.0 110.072 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.848 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -93.95 128.1 40.08 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.39 -0.818 . . . . 0.0 111.696 -179.065 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 18.7 m -146.39 179.9 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.691 -0.63 . . . . 0.0 109.985 178.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 34.9 m-20 -94.18 -158.08 0.6 Allowed 'General case' 0 N--CA 1.49 1.533 0 O-C-N 121.499 -0.751 . . . . 0.0 109.852 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.1 t . . . . . 0 N--CA 1.493 1.69 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.286 -179.713 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 74.0 m . . . . . 0 N--CA 1.491 1.619 0 CA-C-O 121.202 0.525 . . . . 0.0 110.165 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -71.8 84.02 0.91 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 121.532 -0.73 . . . . 0.0 110.295 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.447 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 3.5 m-20 -161.03 -167.06 1.72 Allowed 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.495 -0.753 . . . . 0.0 109.975 179.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.454 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -94.8 58.9 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.687 0 O-C-N 120.801 -1.187 . . . . 0.0 109.566 179.129 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.628 ' O ' HG22 ' A' ' 136' ' ' VAL . 49.0 mt -107.88 157.89 7.94 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.902 -1.124 . . . . 0.0 109.055 179.233 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.844 HG12 ' HA ' ' A' ' 135' ' ' ARG . 28.9 m -139.86 173.12 11.36 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 120.184 -0.606 . . . . 0.0 109.815 179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.702 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.6 p -133.09 121.65 43.99 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.571 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.42 118.94 9.46 Favored 'General case' 0 N--CA 1.489 1.523 0 C-N-CA 119.573 -0.851 . . . . 0.0 108.707 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.841 HD11 ' HB2' ' A' ' 134' ' ' ALA . 90.5 mt -94.15 0.75 55.99 Favored 'General case' 0 N--CA 1.491 1.602 0 C-N-CA 120.568 -0.453 . . . . 0.0 111.253 -179.049 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.453 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 41.0 m-85 -150.13 149.72 30.66 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.257 -0.902 . . . . 0.0 108.834 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 45.4 m-20 -66.24 151.31 47.29 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.545 -0.722 . . . . 0.0 110.042 -179.109 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -153.94 167.78 28.59 Favored 'General case' 0 N--CA 1.499 2.021 0 O-C-N 121.374 -0.829 . . . . 0.0 110.58 179.644 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -149.28 94.06 2.17 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.628 -0.67 . . . . 0.0 110.169 -179.374 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.942 ' HB1' ' HB2' ' A' ' 96' ' ' ASP . . . -60.13 161.91 6.41 Favored 'General case' 0 N--CA 1.501 2.108 0 O-C-N 121.587 -0.696 . . . . 0.0 111.013 -179.573 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 66.1 mt -130.85 -31.19 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.507 2.41 0 O-C-N 121.312 -0.867 . . . . 0.0 111.693 -179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -61.65 -157.58 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.033 -1.042 . . . . 0.0 111.065 -179.021 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -91.26 -70.72 0.67 Allowed 'General case' 0 N--CA 1.501 2.121 0 O-C-N 121.354 -0.842 . . . . 0.0 111.161 -178.91 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -66.12 -17.53 64.77 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.153 -0.967 . . . . 0.0 109.629 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.942 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 20.2 p-10 -42.08 146.8 0.27 Allowed 'General case' 0 N--CA 1.504 2.234 0 O-C-N 121.766 -0.584 . . . . 0.0 112.074 179.564 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 119' ' ' SER . 2.3 tt -133.43 134.66 43.88 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.428 -0.795 . . . . 0.0 110.431 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 8.4 m -94.7 170.2 9.62 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.594 -0.691 . . . . 0.0 109.976 179.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.571 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 18.4 p90 -161.02 -169.14 2.26 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 121.623 -0.673 . . . . 0.0 110.638 179.762 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.98 179.22 4.73 Favored 'General case' 0 N--CA 1.495 1.79 0 CA-C-O 122.259 1.028 . . . . 0.0 112.523 -178.026 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -61.12 -23.02 65.21 Favored 'General case' 0 N--CA 1.502 2.161 0 N-CA-C 114.696 1.369 . . . . 0.0 114.696 -177.868 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.36 43.62 1.08 Allowed Glycine 0 N--CA 1.495 2.58 0 N-CA-C 109.123 -1.591 . . . . 0.0 109.123 -178.755 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.401 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.3 m-20 -90.53 167.85 12.27 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 121.894 -0.768 . . . . 0.0 111.396 -179.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -123.47 128.61 50.05 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 121.589 -0.694 . . . . 0.0 109.717 179.015 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.1 mpp? -137.45 148.1 45.84 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 109.042 -0.725 . . . . 0.0 109.042 179.675 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.419 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 38.4 t -95.08 155.16 3.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.039 -1.097 . . . . 0.0 108.039 179.675 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 81' ' ' ILE . 49.4 t -95.13 140.51 16.71 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 O-C-N 121.159 -0.963 . . . . 0.0 110.634 -179.279 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.704 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.4 mp -97.59 -27.63 14.31 Favored 'General case' 0 C--N 1.299 -1.628 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 179.068 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -156.14 173.23 17.13 Favored 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.776 -0.578 . . . . 0.0 110.122 -179.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 12.2 mt-10 -139.98 89.17 2.28 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.459 -0.775 . . . . 0.0 110.0 178.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 26.6 t -99.32 -68.83 0.79 Allowed 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.523 -0.736 . . . . 0.0 110.311 179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 158.86 154.59 7.27 Favored Glycine 0 N--CA 1.494 2.525 0 N-CA-C 109.387 -1.485 . . . . 0.0 109.387 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.4 tt0 65.14 -72.64 0.07 Allowed 'General case' 0 N--CA 1.505 2.305 0 O-C-N 121.562 -0.963 . . . . 0.0 110.363 -179.913 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.446 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 39.4 m95 -108.86 126.4 53.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.306 -0.871 . . . . 0.0 109.94 179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 51.6 m0 -106.39 141.62 37.41 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.521 -0.737 . . . . 0.0 110.213 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 5.9 tttp -97.6 114.02 25.86 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.612 -0.68 . . . . 0.0 109.215 179.276 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.704 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -130.31 164.89 23.65 Favored 'General case' 0 N--CA 1.496 1.865 0 CA-C-O 121.841 0.829 . . . . 0.0 111.987 -178.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.5 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.0 ttt180 -112.34 124.53 52.67 Favored 'General case' 0 C--N 1.311 -1.097 0 O-C-N 121.625 -0.672 . . . . 0.0 109.682 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.727 ' HB2' HD21 ' A' ' 97' ' ' LEU . 6.8 t -78.88 114.39 17.78 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.776 -0.578 . . . . 0.0 109.664 179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 37.2 mt -65.16 -27.7 68.89 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.885 -0.51 . . . . 0.0 109.992 -179.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -55.37 -25.97 38.49 Favored 'General case' 0 N--CA 1.499 1.984 0 O-C-N 121.43 -0.794 . . . . 0.0 110.094 179.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.5 p -139.49 10.6 2.5 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.676 -0.64 . . . . 0.0 110.717 179.36 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.4 mtm-85 52.24 30.51 7.96 Favored 'General case' 0 N--CA 1.503 2.213 0 O-C-N 120.959 -1.088 . . . . 0.0 110.707 -179.797 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.5 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 28.2 mttt -103.26 -178.75 3.75 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.982 -0.748 . . . . 0.0 108.982 179.176 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.4 OUTLIER -155.38 147.41 23.5 Favored 'General case' 0 N--CA 1.502 2.144 0 C-N-CA 119.695 -0.802 . . . . 0.0 111.52 179.801 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -171.57 -155.73 11.15 Favored Glycine 0 N--CA 1.486 2.03 0 N-CA-C 110.372 -1.091 . . . . 0.0 110.372 179.699 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.513 ' O ' HG23 ' A' ' 128' ' ' ILE . 79.0 m-85 -94.18 157.75 15.92 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 122.045 -0.68 . . . . 0.0 110.348 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.513 HG23 ' O ' ' A' ' 127' ' ' TYR . 3.8 pt -155.0 125.58 3.41 Favored Pre-proline 0 N--CA 1.502 2.16 0 O-C-N 121.641 -0.662 . . . . 0.0 110.793 -179.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_exo -62.01 117.34 4.18 Favored 'Trans proline' 0 N--CA 1.491 1.372 0 O-C-N 122.967 0.983 . . . . 0.0 110.618 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 5.2 m -53.95 -34.43 59.66 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 121.789 -0.57 . . . . 0.0 111.989 -179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 15.0 p-10 -71.33 -6.52 40.6 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.19 -0.944 . . . . 0.0 111.907 -178.509 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -109.72 25.36 11.88 Favored 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.098 -1.001 . . . . 0.0 109.466 178.912 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -156.71 170.65 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 CA-C-O 121.965 0.888 . . . . 0.0 112.175 -176.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.841 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -124.65 127.1 46.81 Favored 'General case' 0 N--CA 1.496 1.837 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 178.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.844 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.8 ttp180 -91.59 118.13 30.34 Favored 'General case' 0 N--CA 1.487 1.418 0 O-C-N 121.31 -0.869 . . . . 0.0 112.58 -178.172 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.628 HG22 ' O ' ' A' ' 82' ' ' ILE . 29.0 m -102.68 137.27 31.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.853 0 CA-C-O 121.471 0.653 . . . . 0.0 109.532 178.01 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.447 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 37.2 t70 -155.8 30.52 0.36 Allowed 'General case' 0 N--CA 1.486 1.369 0 O-C-N 121.865 -0.522 . . . . 0.0 110.114 -179.042 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 6.5 t . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 117.982 -1.008 . . . . 0.0 110.299 -179.822 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 40.4 m . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 121.146 0.498 . . . . 0.0 110.401 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 1.3 mp0 52.27 93.55 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.374 -0.829 . . . . 0.0 111.054 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -154.96 -162.56 1.39 Allowed 'General case' 0 N--CA 1.501 2.105 0 O-C-N 121.54 -0.725 . . . . 0.0 110.333 -179.889 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.763 HD11 HG11 ' A' ' 107' ' ' VAL . 0.7 OUTLIER -95.33 58.59 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 178.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.429 HG22 ' N ' ' A' ' 83' ' ' VAL . 74.4 mt -119.34 164.48 15.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 C-N-CA 119.195 -1.002 . . . . 0.0 109.938 -179.002 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.712 HG12 ' HA ' ' A' ' 135' ' ' ARG . 15.4 m -142.12 169.84 12.97 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.725 0 CA-C-O 121.356 0.598 . . . . 0.0 110.107 179.965 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.6 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.3 p -129.9 126.71 62.8 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.622 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -70.56 120.58 16.41 Favored 'General case' 0 C--N 1.302 -1.458 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.734 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.718 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.0 mt -94.33 3.2 55.52 Favored 'General case' 0 N--CA 1.493 1.725 0 C-N-CA 120.664 -0.414 . . . . 0.0 111.187 -179.402 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.445 ' CE2' ' HB2' ' A' ' 86' ' ' LEU . 44.9 m-85 -153.0 150.58 29.35 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.337 -0.852 . . . . 0.0 108.872 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 -66.48 141.06 58.03 Favored 'General case' 0 N--CA 1.497 1.892 0 O-C-N 121.478 -0.764 . . . . 0.0 109.941 -179.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.482 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 44.2 t80 -155.38 119.99 4.73 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 121.361 -0.837 . . . . 0.0 111.32 179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 2.0 tt0 -109.52 124.23 50.75 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.498 -0.751 . . . . 0.0 110.609 179.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.706 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -57.55 148.02 25.18 Favored 'General case' 0 N--CA 1.502 2.133 0 O-C-N 121.25 -0.906 . . . . 0.0 110.433 179.738 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.4 mt -103.0 -24.24 4.11 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 O-C-N 121.613 -0.68 . . . . 0.0 109.295 179.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 23.3 p80 -178.46 -169.96 0.2 Allowed 'General case' 0 N--CA 1.5 2.043 0 O-C-N 121.415 -0.803 . . . . 0.0 109.563 179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER 51.56 -170.3 0.03 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.446 -0.783 . . . . 0.0 111.825 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 8.6 tp10 -81.88 55.99 2.94 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.533 -0.73 . . . . 0.0 109.49 179.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.706 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 24.0 t0 -95.66 137.2 35.05 Favored 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.421 -0.955 . . . . 0.0 108.421 179.559 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.701 HD21 ' HB2' ' A' ' 119' ' ' SER . 37.4 tp -98.23 133.54 42.51 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.24 -0.912 . . . . 0.0 111.734 -178.312 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 16.4 m -94.56 162.42 13.81 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 108.952 -0.759 . . . . 0.0 108.952 178.47 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.622 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 13.6 p90 -171.53 -165.66 0.4 Allowed 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.491 -0.756 . . . . 0.0 110.115 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -126.21 178.37 5.85 Favored 'General case' 0 N--CA 1.493 1.717 0 CA-C-O 122.242 1.02 . . . . 0.0 112.247 -178.128 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 16.7 ttmt -61.08 -21.49 63.72 Favored 'General case' 0 N--CA 1.5 2.07 0 N-CA-C 115.111 1.523 . . . . 0.0 115.111 -177.425 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.74 40.57 1.44 Allowed Glycine 0 N--CA 1.498 2.781 0 N-CA-C 108.872 -1.691 . . . . 0.0 108.872 -178.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.409 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.1 m-20 -91.0 169.55 10.79 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 121.852 -0.793 . . . . 0.0 112.131 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.12 122.04 36.78 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.561 -0.712 . . . . 0.0 110.116 178.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 58.7 mtm -127.69 152.85 47.19 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 179.304 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.453 ' CG2' HD11 ' A' ' 120' ' ' LEU . 41.3 t -95.5 154.81 3.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.465 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 179.422 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.763 HG11 HD11 ' A' ' 81' ' ' ILE . 5.7 t -94.78 136.25 26.51 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.805 0 CA-C-O 121.949 0.88 . . . . 0.0 109.699 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.538 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.3 mp -96.89 -27.03 14.86 Favored 'General case' 0 C--N 1.298 -1.64 0 CA-C-O 121.427 0.632 . . . . 0.0 109.546 179.717 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 17.3 mt-10 -155.99 -174.42 4.94 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.706 -0.621 . . . . 0.0 109.898 -179.461 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 11.1 tm-20 -137.88 98.78 3.74 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.405 -0.809 . . . . 0.0 109.751 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.1 t -94.69 -77.98 0.45 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.563 -0.711 . . . . 0.0 110.483 -179.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 174.51 -80.23 0.08 OUTLIER Glycine 0 N--CA 1.496 2.682 0 N-CA-C 109.295 -1.522 . . . . 0.0 109.295 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 7.3 pm0 -93.55 -8.66 40.68 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.594 -0.945 . . . . 0.0 110.729 179.271 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 47.7 m95 -143.44 96.94 2.99 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.272 -0.893 . . . . 0.0 110.076 -179.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 15.8 m0 -95.65 157.87 15.71 Favored 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.098 -1.002 . . . . 0.0 110.781 -179.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.4 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.3 tttt -102.17 122.47 44.22 Favored 'General case' 0 N--CA 1.498 1.97 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 178.437 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.566 ' O ' HD22 ' A' ' 97' ' ' LEU . . . -132.16 159.96 37.46 Favored 'General case' 0 N--CA 1.5 2.028 0 O-C-N 121.083 -1.011 . . . . 0.0 112.37 -178.901 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.44 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 3.0 ttt180 -113.0 124.41 52.57 Favored 'General case' 0 N--CA 1.487 1.385 0 O-C-N 121.496 -0.753 . . . . 0.0 109.937 179.545 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.701 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.1 t -81.51 119.21 23.45 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.706 -0.622 . . . . 0.0 109.362 178.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.453 HD11 ' CG2' ' A' ' 106' ' ' VAL . 3.2 mt -71.15 -24.79 62.33 Favored 'General case' 0 N--CA 1.496 1.846 0 C-N-CA 120.557 -0.457 . . . . 0.0 110.767 -179.405 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.79 -27.33 59.57 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 121.35 -0.844 . . . . 0.0 109.587 179.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 6.4 p -137.34 9.4 2.94 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.677 -0.639 . . . . 0.0 110.436 179.052 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER 53.19 27.63 6.19 Favored 'General case' 0 N--CA 1.503 2.203 0 O-C-N 121.01 -1.056 . . . . 0.0 110.67 -179.597 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.44 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 38.4 mttt -95.51 171.47 8.67 Favored 'General case' 0 N--CA 1.494 1.766 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 178.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.5 151.83 28.17 Favored 'General case' 0 N--CA 1.498 1.925 0 CA-C-O 121.854 0.835 . . . . 0.0 111.849 -179.849 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.412 ' HA2' ' HG3' ' A' ' 95' ' ' GLU . . . 177.07 -152.89 12.67 Favored Glycine 0 N--CA 1.483 1.778 0 N-CA-C 108.897 -1.681 . . . . 0.0 108.897 179.551 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.428 ' CD2' ' O ' ' A' ' 95' ' ' GLU . 4.5 m-85 -92.92 153.36 18.83 Favored 'General case' 0 N--CA 1.502 2.126 0 O-C-N 121.73 -0.865 . . . . 0.0 109.705 -179.447 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . . . . . . . . . 1.1 pt -140.55 132.31 14.18 Favored Pre-proline 0 N--CA 1.496 1.847 0 O-C-N 121.803 -0.561 . . . . 0.0 110.404 -179.559 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 39.0 Cg_exo -47.87 96.67 0.03 OUTLIER 'Trans proline' 0 N--CA 1.493 1.459 0 O-C-N 123.121 1.064 . . . . 0.0 111.677 -179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.7 m -55.87 -20.5 15.83 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.721 -0.612 . . . . 0.0 111.379 179.866 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 7.5 p-10 -89.65 18.36 5.56 Favored 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.327 -0.858 . . . . 0.0 111.351 -179.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -146.75 33.33 0.93 Allowed 'General case' 0 N--CA 1.5 2.049 0 O-C-N 121.293 -0.879 . . . . 0.0 109.521 179.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.492 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.6 p -146.13 168.04 7.25 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 O-C-N 121.344 -0.847 . . . . 0.0 110.936 -179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.718 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -131.21 120.09 22.77 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 109.473 -0.565 . . . . 0.0 109.473 179.419 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.712 ' HA ' HG12 ' A' ' 83' ' ' VAL . 14.6 ttp180 -88.31 129.43 35.38 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 121.229 -0.92 . . . . 0.0 112.029 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 136' ' ' VAL . 25.9 m -98.88 130.43 47.76 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.37 0 N-CA-C 108.008 -1.108 . . . . 0.0 108.008 177.101 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -155.54 -41.28 0.08 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.849 -0.532 . . . . 0.0 111.001 -178.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 9.0 t . . . . . 0 N--CA 1.496 1.857 0 CA-C-O 117.968 -1.015 . . . . 0.0 110.235 -179.756 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 3.1 p . . . . . 0 N--CA 1.493 1.707 0 CA-C-O 120.957 0.408 . . . . 0.0 110.229 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -166.36 71.91 0.14 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.489 -0.757 . . . . 0.0 110.486 179.808 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.494 ' N ' ' HA ' ' A' ' 137' ' ' ASP . 13.8 m-20 -149.24 -152.87 0.46 Allowed 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.655 -0.653 . . . . 0.0 109.597 179.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.585 HD11 HG11 ' A' ' 107' ' ' VAL . 0.4 OUTLIER -98.23 54.9 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.018 0 O-C-N 120.849 -1.157 . . . . 0.0 109.397 179.656 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.462 HG22 ' N ' ' A' ' 83' ' ' VAL . 74.8 mt -118.14 164.49 14.37 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 C-N-CA 118.897 -1.121 . . . . 0.0 110.873 -179.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.71 HG12 ' HA ' ' A' ' 135' ' ' ARG . 22.4 m -142.22 173.49 7.39 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 179.537 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.713 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.9 p -131.49 128.07 60.49 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 O-C-N 121.494 -0.754 . . . . 0.0 109.012 177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.957 ' HA ' HG12 ' A' ' 133' ' ' VAL . . . -70.46 116.1 10.41 Favored 'General case' 0 C--N 1.305 -1.363 0 N-CA-C 108.934 -0.765 . . . . 0.0 108.934 179.822 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.463 HD11 ' HB2' ' A' ' 134' ' ' ALA . 77.2 mt -94.33 3.05 55.72 Favored 'General case' 0 N--CA 1.491 1.618 0 C-N-CA 120.434 -0.507 . . . . 0.0 111.261 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.451 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.6 m-85 -149.71 150.32 31.92 Favored 'General case' 0 N--CA 1.502 2.156 0 O-C-N 121.198 -0.939 . . . . 0.0 108.906 178.527 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -71.75 145.02 49.03 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 121.501 -0.749 . . . . 0.0 110.166 -179.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.468 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 19.6 t80 -155.5 121.95 5.24 Favored 'General case' 0 N--CA 1.502 2.147 0 O-C-N 121.465 -0.772 . . . . 0.0 111.007 -179.629 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.414 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 20.3 mt-10 -97.15 124.42 41.19 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.354 -0.841 . . . . 0.0 110.752 179.824 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.82 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . -60.67 -151.44 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.197 0 O-C-N 121.575 -0.703 . . . . 0.0 111.323 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 39.1 mm -135.69 -70.8 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.003 0 O-C-N 121.225 -0.922 . . . . 0.0 110.679 -179.447 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -175.1 53.45 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.084 -1.01 . . . . 0.0 110.396 -179.759 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.1 t60 -167.32 -153.12 0.14 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.261 -0.9 . . . . 0.0 109.45 179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.42 ' HB3' ' CE2' ' A' ' 127' ' ' TYR . 2.7 tp10 -54.81 -29.27 54.25 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.206 -0.934 . . . . 0.0 109.171 179.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.82 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 1.7 p30 -43.35 125.95 4.03 Favored 'General case' 0 N--CA 1.509 2.519 0 CA-C-O 120.948 0.404 . . . . 0.0 111.239 179.021 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 4.9 tt -109.28 146.19 34.69 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.513 -0.742 . . . . 0.0 111.024 -178.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.414 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.8 m -97.29 119.97 36.8 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.821 -0.549 . . . . 0.0 109.777 179.089 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.479 ' CE2' HG22 ' A' ' 128' ' ' ILE . 20.2 p90 -114.99 -170.92 1.84 Allowed 'General case' 0 N--CA 1.501 2.107 0 O-C-N 121.587 -0.696 . . . . 0.0 110.742 179.563 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -125.73 177.28 6.36 Favored 'General case' 0 N--CA 1.493 1.682 0 CA-C-O 122.295 1.045 . . . . 0.0 112.159 -178.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.453 ' O ' ' HA ' ' A' ' 86' ' ' LEU . 14.7 ttmt -61.32 -20.29 62.78 Favored 'General case' 0 N--CA 1.501 2.114 0 N-CA-C 114.847 1.425 . . . . 0.0 114.847 -177.891 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.72 39.68 1.32 Allowed Glycine 0 N--CA 1.499 2.848 0 N-CA-C 109.407 -1.477 . . . . 0.0 109.407 -178.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.88 170.14 10.33 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.902 -0.763 . . . . 0.0 111.724 -179.479 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -122.33 123.52 41.58 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.358 -0.839 . . . . 0.0 110.181 178.852 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.422 ' HE1' ' CG ' ' A' ' 99' ' ' PHE . 77.4 mtm -129.58 150.43 50.92 Favored 'General case' 0 N--CA 1.492 1.669 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 179.329 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.514 ' CG2' HD11 ' A' ' 120' ' ' LEU . 38.0 t -96.2 153.02 3.72 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.325 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.585 HG11 HD11 ' A' ' 81' ' ' ILE . 24.8 t -95.2 134.15 33.63 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.897 0 CA-C-O 121.84 0.829 . . . . 0.0 109.385 179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -95.03 -26.36 16.1 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.208 0.528 . . . . 0.0 109.719 179.747 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -155.43 -177.37 6.5 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.814 -0.554 . . . . 0.0 110.067 -179.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -145.17 95.19 2.64 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.601 -0.687 . . . . 0.0 109.781 179.326 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 5.9 t -104.88 -53.99 2.58 Favored 'General case' 0 N--CA 1.495 1.806 0 O-C-N 121.524 -0.735 . . . . 0.0 111.003 -179.215 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 144.81 141.99 3.8 Favored Glycine 0 N--CA 1.497 2.742 0 N-CA-C 109.576 -1.41 . . . . 0.0 109.576 -179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 64.58 -72.41 0.06 Allowed 'General case' 0 N--CA 1.505 2.301 0 O-C-N 121.646 -0.914 . . . . 0.0 110.303 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 37.3 m95 -106.07 117.86 35.12 Favored 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.353 -0.842 . . . . 0.0 110.208 179.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.1 m0 -106.78 152.38 23.92 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.672 -0.643 . . . . 0.0 110.207 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -97.69 117.2 31.45 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.541 -0.724 . . . . 0.0 109.187 179.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.661 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -130.21 162.5 28.79 Favored 'General case' 0 N--CA 1.5 2.065 0 C-N-CA 119.508 -0.877 . . . . 0.0 112.623 -178.764 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.539 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 4.6 ttt180 -114.88 124.51 51.9 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 121.7 -0.625 . . . . 0.0 109.889 179.572 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 3.1 t -78.23 117.06 19.14 Favored 'General case' 0 N--CA 1.488 1.46 0 O-C-N 121.482 -0.761 . . . . 0.0 109.654 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.514 HD11 ' CG2' ' A' ' 106' ' ' VAL . 13.2 mt -67.35 -26.3 66.42 Favored 'General case' 0 N--CA 1.495 1.807 0 C-N-CA 120.459 -0.496 . . . . 0.0 110.313 -179.688 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.41 -24.46 66.53 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.586 -0.696 . . . . 0.0 110.209 179.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.2 p -136.58 9.89 3.15 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.588 -0.695 . . . . 0.0 110.714 179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 51.65 27.84 4.32 Favored 'General case' 0 N--CA 1.505 2.278 0 O-C-N 120.979 -1.075 . . . . 0.0 110.414 -179.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.479 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 47.6 mttt -101.84 179.71 4.25 Favored 'General case' 0 N--CA 1.494 1.733 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.539 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.24 151.36 28.0 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 121.412 -0.805 . . . . 0.0 111.48 -179.917 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 95' ' ' GLU . . . -173.1 -157.58 15.22 Favored Glycine 0 N--CA 1.482 1.755 0 C-N-CA 120.051 -1.071 . . . . 0.0 110.874 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.441 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 88.4 m-85 -94.03 151.35 19.58 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 122.311 -0.523 . . . . 0.0 109.703 -179.477 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.479 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -154.04 130.12 5.45 Favored Pre-proline 0 N--CA 1.496 1.866 0 O-C-N 121.58 -0.7 . . . . 0.0 110.575 179.95 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_exo -63.69 107.51 0.75 Allowed 'Trans proline' 0 N--CA 1.486 1.042 0 N-CA-C 109.347 -1.059 . . . . 0.0 109.347 179.252 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.3 m -55.34 -26.01 38.29 Favored 'General case' 0 N--CA 1.501 2.106 0 O-C-N 121.384 -0.822 . . . . 0.0 110.857 -179.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.436 ' ND2' ' CD1' ' A' ' 132' ' ' TYR . 16.8 p-10 -71.28 -12.44 61.45 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.478 -0.764 . . . . 0.0 110.414 179.862 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.436 ' CD1' ' ND2' ' A' ' 131' ' ' ASN . 3.0 m-85 -100.54 9.23 42.82 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.375 -0.828 . . . . 0.0 110.663 179.509 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.957 HG12 ' HA ' ' A' ' 85' ' ' ALA . 35.2 m -138.5 -177.25 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 121.073 -1.017 . . . . 0.0 111.929 -177.936 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.713 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -132.06 114.77 14.96 Favored 'General case' 0 C--N 1.302 -1.459 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 177.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.71 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -82.34 123.17 28.85 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 121.308 -0.87 . . . . 0.0 111.066 -178.197 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.415 ' H ' HG22 ' A' ' 136' ' ' VAL . 27.3 m -97.48 126.53 50.33 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 177.277 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.494 ' HA ' ' N ' ' A' ' 80' ' ' ASP . 7.1 p-10 -155.38 -42.3 0.08 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.942 -0.474 . . . . 0.0 110.677 -178.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 27.2 t . . . . . 0 N--CA 1.493 1.711 0 CA-C-O 118.026 -0.988 . . . . 0.0 110.239 -179.994 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 12.5 m . . . . . 0 N--CA 1.49 1.544 0 CA-C-O 121.259 0.552 . . . . 0.0 110.246 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.419 ' HA ' ' HB2' ' A' ' 137' ' ' ASP . 2.7 tt0 54.01 98.48 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.018 0 O-C-N 121.417 -0.802 . . . . 0.0 110.754 -179.819 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -143.93 -164.01 1.79 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.519 -0.738 . . . . 0.0 109.06 179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.572 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -121.13 54.51 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.251 -0.905 . . . . 0.0 110.725 179.292 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.46 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 73.7 mt -98.47 144.73 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 120.746 -1.221 . . . . 0.0 109.889 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.893 HG12 ' HA ' ' A' ' 135' ' ' ARG . 28.0 m -127.45 174.62 10.81 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.631 0 O-C-N 121.709 -0.619 . . . . 0.0 110.785 -179.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.78 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.6 p -130.38 126.22 60.77 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.488 0 O-C-N 121.58 -0.7 . . . . 0.0 109.125 178.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.558 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -69.63 121.17 16.59 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.63 HD11 ' HB2' ' A' ' 134' ' ' ALA . 64.5 mt -94.43 1.83 55.78 Favored 'General case' 0 N--CA 1.493 1.675 0 C-N-CA 120.716 -0.393 . . . . 0.0 110.738 -179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.478 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.6 m-85 -152.52 151.01 30.19 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.257 -0.902 . . . . 0.0 108.899 179.804 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -67.12 147.88 52.57 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.531 -0.731 . . . . 0.0 109.927 -179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.484 ' CZ ' ' HG3' ' A' ' 129' ' ' PRO . 54.4 t80 -153.89 146.35 24.02 Favored 'General case' 0 N--CA 1.504 2.236 0 O-C-N 121.354 -0.841 . . . . 0.0 111.768 179.81 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -118.41 114.88 23.58 Favored 'General case' 0 N--CA 1.501 2.08 0 CA-C-O 121.538 0.685 . . . . 0.0 110.921 179.853 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.823 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -48.51 167.94 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.297 0 O-C-N 121.387 -0.821 . . . . 0.0 112.09 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 31.1 mm -146.19 -58.85 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.079 0 O-C-N 121.617 -0.677 . . . . 0.0 110.159 179.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.8 m-70 -64.39 -173.48 0.1 Allowed 'General case' 0 N--CA 1.507 2.385 0 O-C-N 121.241 -0.912 . . . . 0.0 111.929 -178.285 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 1.9 m80 -64.5 -80.89 0.03 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.513 -0.742 . . . . 0.0 110.119 -179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.416 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 15.1 tp10 -74.62 63.46 1.12 Allowed 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 108.348 -0.982 . . . . 0.0 108.348 178.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.823 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 55.4 p-10 -101.44 161.68 13.45 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 -179.801 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.483 HD22 ' O ' ' A' ' 117' ' ' ALA . 40.9 tp -138.84 125.62 20.91 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 119.341 -0.943 . . . . 0.0 111.592 -179.108 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -93.98 159.74 15.03 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-O 121.289 0.566 . . . . 0.0 109.587 179.085 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.558 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.5 p90 -163.36 -170.42 2.26 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.709 -0.619 . . . . 0.0 109.637 179.121 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.51 -178.17 3.93 Favored 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.164 0.983 . . . . 0.0 112.162 -177.956 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.478 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 7.6 ttmt -61.07 -21.32 63.55 Favored 'General case' 0 N--CA 1.498 1.975 0 N-CA-C 115.137 1.532 . . . . 0.0 115.137 -177.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.98 43.3 1.04 Allowed Glycine 0 N--CA 1.496 2.698 0 N-CA-C 109.006 -1.638 . . . . 0.0 109.006 -178.733 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.417 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 2.5 m-20 -90.76 171.68 9.17 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 121.989 -0.712 . . . . 0.0 111.877 -179.488 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -124.87 136.03 53.43 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.665 -0.647 . . . . 0.0 109.764 178.735 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 76.4 mtm -143.44 154.52 43.77 Favored 'General case' 0 N--CA 1.494 1.727 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.507 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 40.8 t -101.65 150.94 5.79 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.146 -1.057 . . . . 0.0 108.146 179.416 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.503 HG23 ' O ' ' A' ' 81' ' ' ILE . 61.9 t -95.5 138.21 21.72 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.808 0 O-C-N 121.241 -0.912 . . . . 0.0 110.542 -179.408 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.736 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.3 mp -98.87 -25.84 14.49 Favored 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.792 -0.818 . . . . 0.0 108.792 178.814 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.8 mt-10 -156.39 147.72 22.42 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.648 -0.658 . . . . 0.0 110.192 179.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 6.8 mt-10 -101.09 145.39 28.81 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.297 -0.877 . . . . 0.0 109.237 178.758 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 45.1 t -142.29 -71.5 0.33 Allowed 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.223 -0.923 . . . . 0.0 110.766 -179.786 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 165.51 -77.61 0.14 Allowed Glycine 0 N--CA 1.494 2.531 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 -179.98 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -95.27 -10.22 30.9 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 121.477 -1.014 . . . . 0.0 110.862 -179.809 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 77.2 m95 -147.71 107.15 3.91 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 121.272 -0.893 . . . . 0.0 110.585 -179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 17.5 m0 -104.21 155.61 18.58 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.452 -0.78 . . . . 0.0 110.433 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.421 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 17.7 tttt -105.17 116.74 32.46 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.736 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.05 169.41 14.08 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.264 -0.897 . . . . 0.0 112.54 -178.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.52 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 1.6 ttt180 -115.3 121.67 43.59 Favored 'General case' 0 C--N 1.314 -0.974 0 O-C-N 121.775 -0.578 . . . . 0.0 109.609 179.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 25.3 t -77.6 116.11 17.9 Favored 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.676 -0.64 . . . . 0.0 109.765 179.454 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 23.2 mt -67.63 -22.41 65.33 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 120.32 -0.552 . . . . 0.0 110.052 179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -61.31 -24.93 66.78 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.388 -0.82 . . . . 0.0 109.676 179.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 32.7 p -138.63 9.02 2.63 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.485 -0.76 . . . . 0.0 110.892 179.478 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.6 mtt-85 53.68 29.01 8.73 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 120.981 -1.074 . . . . 0.0 110.597 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.52 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 52.5 mttt -103.09 174.73 5.74 Favored 'General case' 0 N--CA 1.493 1.719 0 N-CA-C 108.827 -0.805 . . . . 0.0 108.827 179.263 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.444 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.8 OUTLIER -155.22 142.57 19.49 Favored 'General case' 0 N--CA 1.493 1.687 0 CA-C-O 121.931 0.872 . . . . 0.0 111.406 179.413 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.421 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -169.22 -146.31 4.98 Favored Glycine 0 N--CA 1.481 1.679 0 N-CA-C 108.778 -1.729 . . . . 0.0 108.778 179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.474 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 56.5 m-85 -93.49 161.39 14.39 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 122.058 -0.672 . . . . 0.0 109.827 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.43 HG23 ' O ' ' A' ' 127' ' ' TYR . 3.4 pt -151.52 118.87 3.28 Favored Pre-proline 0 N--CA 1.495 1.801 0 O-C-N 121.736 -0.603 . . . . 0.0 109.83 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.484 ' HG3' ' CZ ' ' A' ' 89' ' ' TYR . 68.5 Cg_exo -40.76 99.65 0.03 OUTLIER 'Trans proline' 0 N--CA 1.495 1.575 0 C-N-CA 121.37 1.38 . . . . 0.0 112.436 -179.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -61.02 -19.68 61.63 Favored 'General case' 0 N--CA 1.495 1.797 0 O-C-N 121.905 -0.497 . . . . 0.0 111.057 179.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.428 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 24.8 p30 -87.82 17.89 4.49 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.32 -0.862 . . . . 0.0 111.651 -179.599 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.428 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 4.5 m-85 -152.06 44.49 0.73 Allowed 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.052 -1.03 . . . . 0.0 109.826 178.687 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.497 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -154.18 168.9 0.94 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.464 -0.773 . . . . 0.0 111.023 -179.548 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.78 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -123.41 138.98 54.48 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.882 -0.511 . . . . 0.0 110.37 179.8 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.893 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -101.66 120.29 40.1 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 121.397 -0.815 . . . . 0.0 112.088 -179.064 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.45 HG22 ' O ' ' A' ' 82' ' ' ILE . 29.6 m -121.88 144.41 31.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 N-CA-C 109.135 -0.691 . . . . 0.0 109.135 177.688 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.419 ' HB2' ' HA ' ' A' ' 79' ' ' GLU . 3.1 p30 -106.61 47.49 0.88 Allowed 'General case' 0 C--N 1.309 -1.163 0 O-C-N 121.271 -0.893 . . . . 0.0 109.96 -179.404 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.1 t . . . . . 0 N--CA 1.494 1.728 0 CA-C-O 118.086 -0.959 . . . . 0.0 110.287 179.864 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 60.0 p . . . . . 0 N--CA 1.493 1.685 0 CA-C-O 121.325 0.583 . . . . 0.0 110.189 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -66.22 172.99 3.41 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.701 -0.624 . . . . 0.0 109.722 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 77.7 m-20 -114.6 -161.58 0.78 Allowed 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.329 -0.857 . . . . 0.0 109.489 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.469 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -115.2 42.76 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 C-N-CA 119.433 -0.907 . . . . 0.0 110.715 179.888 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.776 HD12 ' O ' ' A' ' 137' ' ' ASP . 27.3 mt -97.55 124.91 50.75 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.045 0 O-C-N 121.056 -1.027 . . . . 0.0 109.206 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.727 HG12 ' HA ' ' A' ' 135' ' ' ARG . 32.8 m -111.23 171.94 2.93 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.599 0 C-N-CA 120.006 -0.678 . . . . 0.0 110.364 -179.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.691 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.7 p -128.32 127.6 67.48 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.509 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.575 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.66 117.84 10.13 Favored 'General case' 0 C--N 1.3 -1.547 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 179.721 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.931 HD11 ' HB2' ' A' ' 134' ' ' ALA . 80.5 mt -94.54 4.26 54.08 Favored 'General case' 0 N--CA 1.495 1.795 0 C-N-CA 120.692 -0.403 . . . . 0.0 111.297 -179.591 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.423 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 27.6 m-85 -151.94 150.42 30.01 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 34.6 m-20 -68.26 146.15 53.6 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.392 -0.817 . . . . 0.0 109.725 -179.329 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.449 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 65.3 t80 -153.48 145.04 23.28 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.255 -0.903 . . . . 0.0 111.15 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 70.0 mt-10 -118.32 103.48 9.85 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.916 -0.49 . . . . 0.0 110.165 179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.852 ' HB1' ' HB2' ' A' ' 96' ' ' ASP . . . -56.51 155.13 7.61 Favored 'General case' 0 N--CA 1.501 2.103 0 O-C-N 121.46 -0.775 . . . . 0.0 110.871 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 86.4 mt -137.48 74.11 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.119 0 O-C-N 121.497 -0.752 . . . . 0.0 109.941 179.901 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -175.69 -155.55 0.05 OUTLIER 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.252 -0.905 . . . . 0.0 109.577 179.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -97.18 -71.28 0.69 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.176 -0.952 . . . . 0.0 110.522 -179.615 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 5.4 tp10 -65.0 -19.54 66.05 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.224 -0.922 . . . . 0.0 109.453 179.008 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.852 ' HB2' ' HB1' ' A' ' 91' ' ' ALA . 19.2 p-10 -42.04 161.8 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.27 0 O-C-N 121.826 -0.546 . . . . 0.0 112.132 179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.496 HD21 ' HB2' ' A' ' 119' ' ' SER . 6.4 tt -148.45 130.91 15.73 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.699 -0.625 . . . . 0.0 110.227 -179.485 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 17.0 m -94.8 151.57 19.13 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 121.612 -0.68 . . . . 0.0 110.157 -179.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.575 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 16.5 p90 -142.43 -167.96 2.62 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.041 -0.663 . . . . 0.0 110.455 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 63.6 mt-30 -125.39 179.93 4.89 Favored 'General case' 0 N--CA 1.495 1.799 0 CA-C-O 122.173 0.987 . . . . 0.0 112.119 -178.426 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.423 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 11.0 ttmt -61.24 -20.07 62.4 Favored 'General case' 0 N--CA 1.5 2.064 0 N-CA-C 114.609 1.337 . . . . 0.0 114.609 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.54 41.49 1.32 Allowed Glycine 0 N--CA 1.494 2.566 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 -178.784 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.425 ' O ' HG23 ' A' ' 84' ' ' VAL . 10.9 m-20 -91.06 165.04 13.73 Favored 'General case' 0 N--CA 1.513 2.693 0 O-C-N 121.744 -0.856 . . . . 0.0 112.408 -179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -120.13 130.69 54.74 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.571 -0.706 . . . . 0.0 110.125 178.743 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 2.0 mpp? -138.75 153.14 48.44 Favored 'General case' 0 C--N 1.303 -1.456 0 N-CA-C 109.259 -0.645 . . . . 0.0 109.259 179.639 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.469 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 20.9 t -100.83 152.61 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.477 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 179.3 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 81' ' ' ILE . 94.5 t -95.36 139.7 18.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.743 0 O-C-N 121.109 -0.995 . . . . 0.0 109.789 179.671 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.659 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.5 mp -98.6 -27.18 14.13 Favored 'General case' 0 C--N 1.295 -1.787 0 N-CA-C 108.76 -0.83 . . . . 0.0 108.76 179.155 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 24.8 mt-10 -156.23 159.46 38.93 Favored 'General case' 0 N--CA 1.492 1.664 0 N-CA-C 108.99 -0.745 . . . . 0.0 108.99 179.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.3 mt-10 -111.88 105.34 13.77 Favored 'General case' 0 N--CA 1.504 2.265 0 O-C-N 121.216 -0.927 . . . . 0.0 110.197 179.438 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 1.1 t -108.24 -151.96 0.48 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.4 -0.813 . . . . 0.0 111.11 -179.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -84.53 -107.22 0.61 Allowed Glycine 0 N--CA 1.495 2.576 0 N-CA-C 110.89 -0.884 . . . . 0.0 110.89 -178.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 4.8 pt-20 -85.91 -4.42 59.16 Favored 'General case' 0 N--CA 1.499 1.999 0 O-C-N 121.543 -0.975 . . . . 0.0 111.575 -179.169 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.453 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 30.7 m95 -127.77 106.21 8.97 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.25 -0.906 . . . . 0.0 110.228 -179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.411 ' CD2' ' OG ' ' A' ' 130' ' ' SER . 50.1 m0 -100.67 153.03 19.76 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.46 -0.775 . . . . 0.0 109.767 179.51 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.7 tttp -100.62 114.26 27.79 Favored 'General case' 0 N--CA 1.498 1.948 0 N-CA-C 108.713 -0.847 . . . . 0.0 108.713 179.305 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.659 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.61 164.03 22.92 Favored 'General case' 0 N--CA 1.498 1.966 0 C-N-CA 119.323 -0.951 . . . . 0.0 112.712 -178.662 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.498 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -113.33 120.61 41.73 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 121.724 -0.61 . . . . 0.0 109.6 179.287 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.496 ' HB2' HD21 ' A' ' 97' ' ' LEU . 6.1 t -78.38 122.67 26.08 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.655 -0.653 . . . . 0.0 109.35 179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 9.6 mt -71.84 -27.88 63.19 Favored 'General case' 0 N--CA 1.492 1.653 0 C-N-CA 120.454 -0.498 . . . . 0.0 109.934 -179.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -54.49 -26.45 31.52 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.443 -0.785 . . . . 0.0 109.85 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 35.8 p -137.81 10.33 2.87 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.72 -0.613 . . . . 0.0 110.528 179.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 40.4 mtt180 50.61 27.48 2.95 Favored 'General case' 0 N--CA 1.507 2.392 0 O-C-N 120.993 -1.067 . . . . 0.0 110.574 -179.79 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.489 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 4.2 mttt -100.45 179.78 4.34 Favored 'General case' 0 N--CA 1.491 1.615 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 179.429 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.498 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.24 147.18 23.46 Favored 'General case' 0 N--CA 1.499 1.99 0 CA-C-O 121.77 0.795 . . . . 0.0 111.183 179.6 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -171.57 -147.03 5.52 Favored Glycine 0 N--CA 1.483 1.83 0 N-CA-C 110.256 -1.138 . . . . 0.0 110.256 -179.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.453 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 75.8 m-85 -94.42 157.39 16.04 Favored 'General case' 0 C--N 1.303 -1.443 0 O-C-N 122.091 -0.652 . . . . 0.0 110.606 -179.413 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.407 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.9 pt -152.15 109.59 2.83 Favored Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.652 -0.655 . . . . 0.0 109.735 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.442 ' HG3' ' CH2' ' A' ' 114' ' ' TRP . 51.3 Cg_exo -50.66 110.07 0.36 Allowed 'Trans proline' 0 N--CA 1.492 1.41 0 O-C-N 122.958 0.978 . . . . 0.0 111.56 -179.34 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.411 ' OG ' ' CD2' ' A' ' 115' ' ' TRP . 24.0 m -59.88 -17.23 35.43 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.935 -0.478 . . . . 0.0 111.249 179.787 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.2 p-10 -84.77 12.93 6.39 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 121.276 -0.89 . . . . 0.0 111.719 -179.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.0 m-85 -147.02 44.27 1.16 Allowed 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.035 -1.041 . . . . 0.0 108.802 178.309 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.462 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.4 p -156.25 168.55 0.75 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.792 0.806 . . . . 0.0 111.317 -178.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.931 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -128.61 127.6 42.56 Favored 'General case' 0 N--CA 1.496 1.853 0 CA-C-O 121.178 0.514 . . . . 0.0 109.999 179.775 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.727 ' HA ' HG12 ' A' ' 83' ' ' VAL . 4.2 tmm_? -88.23 140.03 29.89 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.228 -0.92 . . . . 0.0 112.474 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.451 HG13 ' C ' ' A' ' 135' ' ' ARG . 15.9 m -156.54 -168.66 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 CA-C-O 121.204 0.526 . . . . 0.0 109.993 179.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.776 ' O ' HD12 ' A' ' 82' ' ' ILE . 7.6 t70 -105.09 -24.05 12.84 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.578 -0.701 . . . . 0.0 109.811 178.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 7.0 t . . . . . 0 N--CA 1.491 1.615 0 CA-C-O 118.0 -1.0 . . . . 0.0 110.169 -179.679 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 61.4 p . . . . . 0 N--CA 1.492 1.626 0 CA-C-O 121.119 0.485 . . . . 0.0 110.282 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 3.5 tt0 -69.11 81.03 0.33 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.606 -0.684 . . . . 0.0 110.261 -179.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -161.06 -165.05 1.27 Allowed 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.579 -0.701 . . . . 0.0 110.022 -179.88 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.432 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -95.42 55.35 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 120.999 -1.063 . . . . 0.0 109.446 179.038 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.638 ' O ' HG22 ' A' ' 136' ' ' VAL . 47.7 mt -104.29 155.91 5.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.927 0 O-C-N 120.915 -1.116 . . . . 0.0 109.448 179.699 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.735 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.6 m -139.01 176.5 6.14 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.45 0 C-N-CA 120.133 -0.627 . . . . 0.0 110.272 -179.986 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.836 HG12 ' HB3' ' A' ' 134' ' ' ALA . 3.9 p -134.28 122.69 41.29 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 O-C-N 121.549 -0.72 . . . . 0.0 109.414 178.536 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.562 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.42 120.36 13.77 Favored 'General case' 0 N--CA 1.487 1.408 0 C-N-CA 119.67 -0.812 . . . . 0.0 108.84 179.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.56 HD11 ' HB2' ' A' ' 134' ' ' ALA . 79.5 mt -94.09 1.47 56.15 Favored 'General case' 0 N--CA 1.493 1.709 0 C-N-CA 120.555 -0.458 . . . . 0.0 111.115 -179.437 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.483 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 61.8 m-85 -152.49 151.0 30.2 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.152 -0.967 . . . . 0.0 108.393 179.337 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.403 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 67.4 m-20 -66.61 148.46 51.87 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.501 -0.75 . . . . 0.0 110.339 -178.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.472 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 46.2 t80 -155.3 131.05 9.91 Favored 'General case' 0 N--CA 1.506 2.361 0 O-C-N 121.317 -0.865 . . . . 0.0 111.31 179.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -100.09 137.73 38.14 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.403 -0.811 . . . . 0.0 111.53 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.769 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -47.7 161.5 0.09 Allowed 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.606 -0.684 . . . . 0.0 111.721 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.679 ' N ' HD13 ' A' ' 92' ' ' ILE . 0.2 OUTLIER -155.23 31.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.501 2.081 0 O-C-N 121.627 -0.671 . . . . 0.0 110.92 179.971 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -173.05 -165.56 0.3 Allowed 'General case' 0 N--CA 1.507 2.42 0 O-C-N 120.829 -1.169 . . . . 0.0 111.171 179.848 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -71.88 -70.8 0.31 Allowed 'General case' 0 N--CA 1.5 2.075 0 O-C-N 121.411 -0.806 . . . . 0.0 110.065 -179.499 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.425 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 1.8 tt0 -86.24 50.67 2.03 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.424 -0.798 . . . . 0.0 109.4 179.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.769 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 50.3 p30 -93.94 176.27 6.4 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.779 -0.576 . . . . 0.0 110.09 -179.745 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.479 HD21 ' HB2' ' A' ' 119' ' ' SER . 61.2 tp -155.01 124.78 6.53 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.488 -0.758 . . . . 0.0 111.232 -179.193 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -94.75 114.93 26.9 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.543 -0.723 . . . . 0.0 110.27 179.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.562 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 14.3 p90 -113.14 -168.86 1.38 Allowed 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.63 -0.669 . . . . 0.0 110.057 179.127 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.403 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 1.8 tt0 -125.69 -178.33 4.22 Favored 'General case' 0 N--CA 1.492 1.642 0 CA-C-O 122.352 1.073 . . . . 0.0 112.799 -178.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.483 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 12.3 ttmt -61.2 -23.9 65.94 Favored 'General case' 0 N--CA 1.5 2.026 0 N-CA-C 115.002 1.482 . . . . 0.0 115.002 -177.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -140.95 42.42 1.19 Allowed Glycine 0 N--CA 1.493 2.452 0 N-CA-C 108.608 -1.797 . . . . 0.0 108.608 -178.757 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -90.52 166.84 13.0 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 119.939 -0.704 . . . . 0.0 111.649 -179.257 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -123.17 128.75 50.47 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 121.691 -0.631 . . . . 0.0 109.377 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.416 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.8 mpp? -135.78 148.47 48.78 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.457 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 33.6 t -98.65 152.59 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 179.45 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.432 HG23 ' O ' ' A' ' 81' ' ' ILE . 58.2 t -95.05 138.88 19.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.773 0 O-C-N 121.199 -0.938 . . . . 0.0 110.367 -179.549 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.665 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.16 -31.65 13.43 Favored 'General case' 0 C--N 1.297 -1.695 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -156.32 163.4 39.56 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.917 -0.49 . . . . 0.0 109.857 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 10.1 tt0 -104.87 153.72 21.0 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.475 -0.766 . . . . 0.0 109.457 178.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 28.9 t -147.87 -68.62 0.24 Allowed 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.298 -0.877 . . . . 0.0 110.549 179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 175.03 -88.47 0.08 OUTLIER Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.612 -1.395 . . . . 0.0 109.612 -179.74 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -99.57 -20.74 16.21 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.652 -0.91 . . . . 0.0 110.229 179.48 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 80.0 m95 -121.43 102.33 8.19 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.398 -0.814 . . . . 0.0 109.316 179.687 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 50.2 m0 -99.19 150.78 21.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.319 -0.863 . . . . 0.0 110.932 -179.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.412 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 1.4 tttt -94.75 112.73 24.45 Favored 'General case' 0 N--CA 1.494 1.73 0 N-CA-C 108.655 -0.869 . . . . 0.0 108.655 179.118 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.665 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -128.56 166.59 18.54 Favored 'General case' 0 N--CA 1.499 1.986 0 O-C-N 121.257 -0.902 . . . . 0.0 112.246 -178.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.499 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.8 ttt180 -112.75 124.93 53.69 Favored 'General case' 0 N--CA 1.481 1.095 0 O-C-N 121.676 -0.64 . . . . 0.0 110.278 -179.701 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.479 ' HB2' HD21 ' A' ' 97' ' ' LEU . 42.2 t -77.85 115.1 17.34 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 178.909 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.455 HD11 ' CG2' ' A' ' 106' ' ' VAL . 20.5 mt -68.8 -24.93 64.46 Favored 'General case' 0 N--CA 1.497 1.913 0 O-C-N 121.858 -0.526 . . . . 0.0 110.625 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.51 -26.69 67.03 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.418 -0.802 . . . . 0.0 109.965 179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 26.5 p -135.99 9.29 3.28 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.605 -0.685 . . . . 0.0 110.798 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER 54.36 30.63 12.97 Favored 'General case' 0 N--CA 1.504 2.251 0 O-C-N 121.045 -1.034 . . . . 0.0 110.561 -179.839 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 mmmm -99.68 177.73 5.06 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.563 -0.711 . . . . 0.0 109.262 179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.47 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.44 139.0 15.96 Favored 'General case' 0 N--CA 1.5 2.03 0 CA-C-O 121.83 0.824 . . . . 0.0 111.388 179.47 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.412 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -168.31 -150.71 6.74 Favored Glycine 0 N--CA 1.485 1.946 0 N-CA-C 109.279 -1.528 . . . . 0.0 109.279 179.52 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.54 ' O ' HG23 ' A' ' 128' ' ' ILE . 59.8 m-85 -93.89 162.73 13.79 Favored 'General case' 0 N--CA 1.496 1.873 0 O-C-N 121.718 -0.872 . . . . 0.0 110.663 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.54 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.3 pt -155.45 111.7 2.23 Favored Pre-proline 0 N--CA 1.496 1.871 0 O-C-N 121.713 -0.617 . . . . 0.0 109.866 179.373 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -49.09 108.01 0.17 Allowed 'Trans proline' 0 N--CA 1.493 1.469 0 O-C-N 123.038 1.02 . . . . 0.0 112.079 -179.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.436 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 16.4 m -61.27 -17.11 51.85 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.742 -0.599 . . . . 0.0 111.397 179.581 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.9 p30 -76.79 1.48 17.22 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.208 -0.932 . . . . 0.0 112.316 -178.562 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -141.84 46.82 1.66 Allowed 'General case' 0 N--CA 1.502 2.155 0 O-C-N 121.06 -1.025 . . . . 0.0 109.751 179.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.469 HG22 ' N ' ' A' ' 134' ' ' ALA . 4.1 p -154.83 168.81 0.85 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.803 0 CA-C-O 121.622 0.725 . . . . 0.0 110.873 -178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.836 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -120.98 129.07 53.27 Favored 'General case' 0 N--CA 1.499 2.011 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 179.093 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.735 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -97.17 119.99 36.7 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.416 -0.803 . . . . 0.0 112.871 -178.072 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.638 HG22 ' O ' ' A' ' 82' ' ' ILE . 20.5 m -99.12 136.66 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 N-CA-C 109.05 -0.722 . . . . 0.0 109.05 177.243 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 7.6 p30 -155.59 29.87 0.38 Allowed 'General case' 0 N--CA 1.491 1.601 0 CA-C-O 121.07 0.462 . . . . 0.0 110.179 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.495 1.779 0 CA-C-O 118.007 -0.997 . . . . 0.0 110.161 -179.815 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.8 p . . . . . 0 N--CA 1.493 1.699 0 CA-C-O 121.12 0.486 . . . . 0.0 110.225 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 11.3 pt-20 -164.06 49.33 0.13 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.5 -0.75 . . . . 0.0 109.992 179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.427 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 7.4 m-20 -163.6 -171.11 2.42 Favored 'General case' 0 N--CA 1.5 2.055 0 O-C-N 121.731 -0.605 . . . . 0.0 109.557 179.637 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.486 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.2 OUTLIER -94.36 79.71 1.26 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.817 0 C-N-CA 118.66 -1.216 . . . . 0.0 109.503 179.228 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.709 ' O ' HG22 ' A' ' 136' ' ' VAL . 69.0 mt -128.75 150.91 34.83 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.082 0 N-CA-C 108.077 -1.083 . . . . 0.0 108.077 179.266 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.616 HG12 ' CG ' ' A' ' 135' ' ' ARG . 28.4 m -128.89 175.1 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.597 0 O-C-N 121.338 -0.851 . . . . 0.0 110.06 179.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.714 HG12 ' HB3' ' A' ' 134' ' ' ALA . 8.5 p -132.74 118.12 32.96 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 177.948 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.632 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -63.33 116.18 5.26 Favored 'General case' 0 C--N 1.3 -1.571 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.2 -179.695 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.949 HD11 ' HB2' ' A' ' 134' ' ' ALA . 95.6 mt -94.45 1.68 55.77 Favored 'General case' 0 N--CA 1.495 1.824 0 O-C-N 122.126 -0.359 . . . . 0.0 111.77 -178.805 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.468 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 51.3 m-85 -151.25 151.75 32.28 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 62.5 m-20 -68.98 144.54 54.09 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.328 -0.857 . . . . 0.0 109.685 -179.072 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.46 ' HB2' ' CE1' ' A' ' 99' ' ' PHE . 33.6 t80 -152.28 131.78 13.0 Favored 'General case' 0 N--CA 1.5 2.036 0 C-N-CA 119.487 -0.885 . . . . 0.0 111.125 179.627 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 80.8 mm-40 -99.79 139.73 35.03 Favored 'General case' 0 N--CA 1.493 1.679 0 CA-C-O 121.277 0.56 . . . . 0.0 111.202 -179.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.784 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -49.34 152.75 1.18 Allowed 'General case' 0 N--CA 1.505 2.276 0 O-C-N 121.567 -0.708 . . . . 0.0 111.24 179.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 2.1 pt -153.35 38.81 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.129 0 O-C-N 121.444 -0.785 . . . . 0.0 110.255 179.181 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -174.3 -167.76 0.35 Allowed 'General case' 0 N--CA 1.504 2.274 0 O-C-N 121.21 -0.931 . . . . 0.0 110.765 179.528 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 47.7 m80 -69.0 -75.5 0.11 Allowed 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.649 -0.657 . . . . 0.0 109.926 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 17.9 tp10 -88.33 54.39 3.05 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.437 -0.789 . . . . 0.0 109.473 179.386 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.784 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.9 p30 -94.09 169.21 10.42 Favored 'General case' 0 N--CA 1.489 1.499 0 N-CA-C 109.147 -0.686 . . . . 0.0 109.147 179.474 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.48 HD12 ' CA ' ' A' ' 125' ' ' GLU . 6.3 tt -145.92 127.77 15.39 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.356 -0.84 . . . . 0.0 111.037 -179.486 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.4 m -94.7 116.5 28.82 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.566 -0.709 . . . . 0.0 110.153 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.632 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 12.1 p90 -114.35 -167.75 1.26 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.835 -0.541 . . . . 0.0 110.21 179.524 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -126.11 177.43 6.38 Favored 'General case' 0 N--CA 1.494 1.743 0 CA-C-O 122.194 0.997 . . . . 0.0 111.942 -178.127 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.468 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 1.3 ttmt -60.92 -18.78 58.72 Favored 'General case' 0 N--CA 1.501 2.12 0 N-CA-C 115.589 1.699 . . . . 0.0 115.589 -177.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -144.75 38.19 1.3 Allowed Glycine 0 N--CA 1.499 2.85 0 N-CA-C 109.796 -1.321 . . . . 0.0 109.796 -178.334 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.42 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.0 OUTLIER -91.03 171.77 9.03 Favored 'General case' 0 N--CA 1.507 2.389 0 O-C-N 121.802 -0.822 . . . . 0.0 111.871 -179.377 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -124.72 136.75 54.15 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.441 -0.787 . . . . 0.0 109.552 178.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.403 ' O ' HG23 ' A' ' 82' ' ' ILE . 69.6 mtm -140.33 155.64 46.73 Favored 'General case' 0 N--CA 1.493 1.676 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . . . . . . . . . 29.0 t -98.68 152.23 4.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.644 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.486 ' HB ' HG13 ' A' ' 81' ' ' ILE . 84.8 t -94.41 133.42 35.43 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.964 0 CA-C-O 121.934 0.873 . . . . 0.0 109.704 -179.927 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.682 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.6 mp -96.25 -26.99 15.21 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 108.771 -0.826 . . . . 0.0 108.771 179.135 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 10.9 mt-10 -156.4 179.63 9.07 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.612 -0.68 . . . . 0.0 109.291 179.476 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -130.57 86.26 2.36 Favored 'General case' 0 N--CA 1.497 1.88 0 O-C-N 121.173 -0.954 . . . . 0.0 110.389 179.32 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 44.0 t -96.2 -164.7 1.18 Allowed 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.685 -0.634 . . . . 0.0 110.106 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -107.11 139.79 15.06 Favored Glycine 0 N--CA 1.495 2.587 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.498 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.4 tm-20 66.43 -64.16 0.23 Allowed 'General case' 0 N--CA 1.508 2.442 0 O-C-N 121.593 -0.946 . . . . 0.0 111.095 179.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 95.0 m95 -105.88 115.39 30.15 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.345 -0.847 . . . . 0.0 110.464 -179.332 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -101.96 149.0 24.68 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.417 -0.802 . . . . 0.0 109.231 178.906 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.407 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 15.4 tttt -95.38 113.97 25.69 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.613 -0.68 . . . . 0.0 110.172 -179.965 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.682 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -129.58 164.91 22.81 Favored 'General case' 0 N--CA 1.498 1.931 0 CA-C-O 121.952 0.882 . . . . 0.0 112.34 -179.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.7 ttt180 -114.03 124.32 51.85 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 121.473 -0.767 . . . . 0.0 110.364 179.731 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.417 ' HB2' HD21 ' A' ' 97' ' ' LEU . 2.4 t -80.09 123.08 27.56 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.61 -0.681 . . . . 0.0 109.338 178.854 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 6.1 mt -73.67 -25.96 60.51 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.696 -0.627 . . . . 0.0 110.94 -179.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.21 -34.16 68.25 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 121.314 -0.867 . . . . 0.0 110.031 -179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 24.9 p -127.79 7.68 6.22 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.832 -0.542 . . . . 0.0 110.36 179.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 53.55 31.98 13.42 Favored 'General case' 0 N--CA 1.504 2.24 0 O-C-N 120.991 -1.068 . . . . 0.0 110.128 -179.048 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.446 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 35.6 mtpt -102.17 175.41 5.53 Favored 'General case' 0 N--CA 1.495 1.792 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.193 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.48 ' CA ' HD12 ' A' ' 97' ' ' LEU . 1.0 OUTLIER -155.62 143.24 19.61 Favored 'General case' 0 N--CA 1.495 1.82 0 C-N-CA 119.429 -0.908 . . . . 0.0 111.669 179.403 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.407 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -168.21 -150.01 6.4 Favored Glycine 0 N--CA 1.487 2.057 0 N-CA-C 108.752 -1.739 . . . . 0.0 108.752 179.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.509 ' O ' HG23 ' A' ' 128' ' ' ILE . 66.5 m-85 -93.91 167.93 11.3 Favored 'General case' 0 N--CA 1.496 1.872 0 O-C-N 121.575 -0.956 . . . . 0.0 109.994 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.509 HG23 ' O ' ' A' ' 127' ' ' TYR . 1.5 pt -154.98 116.49 2.41 Favored Pre-proline 0 N--CA 1.495 1.787 0 N-CA-C 109.235 -0.654 . . . . 0.0 109.235 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 39.6 Cg_exo -52.23 105.49 0.12 Allowed 'Trans proline' 0 N--CA 1.49 1.306 0 O-C-N 122.849 0.921 . . . . 0.0 111.594 -178.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.4 m -55.19 -19.33 7.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.715 -0.616 . . . . 0.0 111.241 179.529 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 5.7 p-10 -83.88 20.08 1.58 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 121.249 -0.907 . . . . 0.0 111.746 -179.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -154.29 39.69 0.46 Allowed 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.021 -1.05 . . . . 0.0 109.288 178.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.501 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.2 p -154.0 170.06 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.329 -0.857 . . . . 0.0 111.112 -178.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.949 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -129.36 120.57 25.8 Favored 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 179.291 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.616 ' CG ' HG12 ' A' ' 83' ' ' VAL . 3.5 ttm180 -89.12 129.76 35.67 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.417 -0.802 . . . . 0.0 113.148 -177.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.709 HG22 ' O ' ' A' ' 82' ' ' ILE . 29.9 m -103.41 142.84 16.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 177.154 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.427 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 2.4 t0 -155.79 -154.6 0.5 Allowed 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.894 -0.504 . . . . 0.0 109.652 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 23.1 t . . . . . 0 N--CA 1.492 1.668 0 CA-C-O 118.122 -0.942 . . . . 0.0 110.026 179.638 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.492 1.64 0 CA-C-O 121.149 0.499 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 4.1 mt-10 48.64 88.15 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.046 0 O-C-N 121.521 -0.737 . . . . 0.0 111.331 179.564 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.441 ' HB2' ' HA ' ' A' ' 137' ' ' ASP . 39.1 m-20 -116.49 -157.68 0.66 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.577 -0.702 . . . . 0.0 109.711 179.695 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.504 HG13 ' HB ' ' A' ' 107' ' ' VAL . 2.4 tp -115.28 50.1 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.368 -0.833 . . . . 0.0 110.867 -179.408 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.607 HG12 HG13 ' A' ' 106' ' ' VAL . 82.3 mt -115.6 164.71 11.72 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.837 0 O-C-N 121.153 -0.967 . . . . 0.0 109.264 178.784 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.582 HG13 HG23 ' A' ' 107' ' ' VAL . 18.5 m -143.18 175.72 3.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.748 0 CA-C-O 121.428 0.632 . . . . 0.0 110.087 179.399 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.469 ' O ' HG13 ' A' ' 84' ' ' VAL . 8.8 p -137.14 122.33 25.44 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.598 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 178.801 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.574 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -63.76 119.96 10.95 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.122 -0.986 . . . . 0.0 109.345 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.636 HD11 ' HB2' ' A' ' 134' ' ' ALA . 32.3 mt -94.26 3.06 55.75 Favored 'General case' 0 N--CA 1.493 1.717 0 C-N-CA 120.723 -0.391 . . . . 0.0 111.352 -179.603 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.489 ' CD1' ' HA ' ' A' ' 132' ' ' TYR . 39.3 m-85 -150.67 148.99 29.26 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.28 -0.887 . . . . 0.0 108.885 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.418 ' HA ' ' HA ' ' A' ' 100' ' ' GLN . 65.7 m-20 -66.29 143.97 56.87 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.365 -0.834 . . . . 0.0 109.724 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.462 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 18.2 t80 -155.39 122.67 5.52 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.272 -0.892 . . . . 0.0 111.466 -179.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -105.69 113.35 26.86 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.689 -0.632 . . . . 0.0 110.238 179.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.779 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . -60.24 -161.9 0.01 OUTLIER 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.328 -0.857 . . . . 0.0 111.092 -179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 52.2 mt -117.47 -57.38 3.62 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.75 0 O-C-N 121.915 -0.491 . . . . 0.0 110.125 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 1.3 t60 -175.83 -37.24 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.311 0 O-C-N 120.948 -1.095 . . . . 0.0 111.386 179.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -68.43 -154.61 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.352 0 O-C-N 120.987 -1.071 . . . . 0.0 111.182 -179.055 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.405 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 4.2 tp10 -55.04 -26.22 35.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.357 -0.839 . . . . 0.0 109.7 179.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.779 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 1.8 p30 -45.26 121.27 2.83 Favored 'General case' 0 N--CA 1.503 2.175 0 O-C-N 121.798 -0.564 . . . . 0.0 110.808 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . . . . . . . . . 6.5 tt -106.7 149.51 27.21 Favored 'General case' 0 N--CA 1.494 1.762 0 CA-C-O 121.746 0.784 . . . . 0.0 111.619 -178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 45.0 m -94.88 147.36 23.44 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.84 -0.537 . . . . 0.0 109.903 179.344 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.574 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.3 p90 -148.1 -165.04 2.16 Favored 'General case' 0 N--CA 1.501 2.098 0 O-C-N 121.447 -0.783 . . . . 0.0 110.496 178.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 88' ' ' ASP . 1.1 tt0 -129.41 176.47 7.93 Favored 'General case' 0 N--CA 1.495 1.801 0 CA-C-O 122.449 1.119 . . . . 0.0 112.889 -177.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.469 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 17.7 ttmt -60.95 -21.06 63.1 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 114.419 1.266 . . . . 0.0 114.419 -178.282 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.18 41.15 1.28 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.054 -1.618 . . . . 0.0 109.054 -178.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.459 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.86 167.2 12.62 Favored 'General case' 0 N--CA 1.507 2.394 0 O-C-N 121.782 -0.834 . . . . 0.0 111.63 -179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.46 124.77 46.26 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.522 -0.736 . . . . 0.0 109.878 179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.405 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 72.0 mtm -134.82 151.52 51.0 Favored 'General case' 0 C--N 1.299 -1.597 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 179.537 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.607 HG13 HG12 ' A' ' 82' ' ' ILE . 21.3 t -94.73 154.07 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.582 HG23 HG13 ' A' ' 83' ' ' VAL . 38.1 t -94.36 141.16 15.35 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.727 0 O-C-N 121.325 -0.859 . . . . 0.0 108.996 179.458 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.648 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.8 mp -101.68 -26.46 13.5 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 109.36 -0.607 . . . . 0.0 109.36 179.285 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 -155.95 -171.33 3.7 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.679 -0.638 . . . . 0.0 110.692 -179.152 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -147.44 105.19 3.7 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.475 -0.766 . . . . 0.0 110.579 179.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.4 t -104.76 -53.83 2.62 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.57 -0.706 . . . . 0.0 110.738 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 151.01 -70.73 0.3 Allowed Glycine 0 N--CA 1.494 2.513 0 N-CA-C 109.886 -1.285 . . . . 0.0 109.886 -179.84 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -83.24 -57.29 3.33 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.634 -0.921 . . . . 0.0 110.064 -179.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.454 ' CE3' ' HB3' ' A' ' 127' ' ' TYR . 40.8 m95 -105.55 121.63 44.36 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.698 -0.626 . . . . 0.0 110.576 -179.551 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 130' ' ' SER . 50.9 m0 -107.04 146.39 31.22 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.474 -0.767 . . . . 0.0 109.751 179.316 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 7.0 mttt -96.94 120.86 38.06 Favored 'General case' 0 N--CA 1.499 1.987 0 N-CA-C 108.752 -0.833 . . . . 0.0 108.752 179.238 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.648 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -132.96 160.69 36.36 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.187 -0.946 . . . . 0.0 112.323 -178.774 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.519 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 3.0 ttt180 -111.74 121.46 45.17 Favored 'General case' 0 N--CA 1.482 1.167 0 O-C-N 121.586 -0.696 . . . . 0.0 109.933 179.519 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.405 ' HA ' ' HG2' ' A' ' 105' ' ' MET . 5.1 t -75.11 115.77 15.11 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.641 -0.662 . . . . 0.0 109.427 179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.492 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.9 mt -68.38 -24.95 64.84 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.909 -0.495 . . . . 0.0 110.209 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -60.74 -23.77 65.21 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.535 -0.728 . . . . 0.0 109.9 179.301 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 18.8 p -138.93 10.71 2.62 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.56 -0.713 . . . . 0.0 111.002 179.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 51.32 30.62 6.14 Favored 'General case' 0 N--CA 1.506 2.347 0 O-C-N 120.928 -1.108 . . . . 0.0 110.344 -179.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.487 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 7.8 mtmt -105.19 -177.05 3.25 Favored 'General case' 0 N--CA 1.494 1.741 0 N-CA-C 108.72 -0.845 . . . . 0.0 108.72 178.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.519 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.1 OUTLIER -155.61 156.5 35.15 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.279 -0.888 . . . . 0.0 111.776 179.329 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.405 ' CA ' ' O ' ' A' ' 95' ' ' GLU . . . -174.81 -159.44 21.08 Favored Glycine 0 N--CA 1.485 1.926 0 N-CA-C 110.355 -1.098 . . . . 0.0 110.355 179.636 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.454 ' HB3' ' CE3' ' A' ' 114' ' ' TRP . 89.3 m-85 -94.25 158.33 15.64 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 122.059 -0.671 . . . . 0.0 110.33 -179.28 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.542 HG22 ' CE2' ' A' ' 99' ' ' PHE . 1.0 OUTLIER -154.65 123.9 3.14 Favored Pre-proline 0 N--CA 1.493 1.677 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 179.796 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_exo -59.36 121.14 9.41 Favored 'Trans proline' 0 N--CA 1.49 1.27 0 O-C-N 122.787 0.888 . . . . 0.0 109.973 -179.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 115' ' ' TRP . 1.5 m -51.59 -35.86 43.16 Favored 'General case' 0 N--CA 1.505 2.277 0 O-C-N 121.459 -0.775 . . . . 0.0 111.127 -179.544 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 16.6 p-10 -75.1 -9.23 58.35 Favored 'General case' 0 N--CA 1.497 1.925 0 C-N-CA 120.305 -0.558 . . . . 0.0 110.924 -179.103 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.489 ' HA ' ' CD1' ' A' ' 87' ' ' TYR . 3.0 m-85 -104.69 23.72 12.93 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.333 -0.854 . . . . 0.0 109.42 178.597 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.488 HG22 ' N ' ' A' ' 134' ' ' ALA . 9.8 p -159.43 170.52 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.543 0 C-N-CA 119.515 -0.874 . . . . 0.0 111.848 -177.373 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.636 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -137.95 135.47 36.07 Favored 'General case' 0 N--CA 1.496 1.867 0 N-CA-C 109.567 -0.531 . . . . 0.0 109.567 179.348 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.515 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.7 tmm_? -81.8 138.6 35.1 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.115 -0.99 . . . . 0.0 112.265 -178.62 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 31.5 m -137.53 162.06 33.15 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.353 0 CA-C-O 121.336 0.589 . . . . 0.0 109.456 178.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.441 ' HA ' ' HB2' ' A' ' 80' ' ' ASP . 2.9 p30 -96.56 28.85 3.17 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.767 -0.583 . . . . 0.0 110.092 179.377 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 10.8 t . . . . . 0 N--CA 1.492 1.652 0 CA-C-O 117.945 -1.026 . . . . 0.0 110.206 -179.878 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.9 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 121.174 0.512 . . . . 0.0 110.247 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 51.92 68.43 0.81 Allowed 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.414 -0.804 . . . . 0.0 110.849 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 75.7 m-20 -138.9 -165.07 1.76 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 109.487 -0.56 . . . . 0.0 109.487 -179.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.436 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -124.15 54.15 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.434 -0.792 . . . . 0.0 110.168 178.873 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.618 HD12 ' C ' ' A' ' 138' ' ' SER . 65.0 mt -101.17 151.78 5.32 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.869 -1.144 . . . . 0.0 109.263 179.444 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.778 HG12 ' HA ' ' A' ' 135' ' ' ARG . 29.6 m -135.22 177.56 6.57 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 C-N-CA 119.425 -0.91 . . . . 0.0 111.096 -178.8 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.932 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.4 p -128.57 121.79 55.9 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.479 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 177.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.605 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.47 118.84 11.34 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.269 -1.012 . . . . 0.0 108.269 179.602 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.448 HD11 ' HB2' ' A' ' 134' ' ' ALA . 18.8 mt -94.11 1.35 56.15 Favored 'General case' 0 N--CA 1.494 1.758 0 C-N-CA 120.408 -0.517 . . . . 0.0 111.489 -178.522 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.487 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 73.7 m-85 -151.9 151.14 30.87 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.392 -0.817 . . . . 0.0 108.846 179.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 53.3 m-20 -67.5 145.35 55.04 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.462 -0.774 . . . . 0.0 110.135 -179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.461 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 67.4 t80 -151.75 126.99 9.87 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.364 -0.835 . . . . 0.0 110.779 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -94.71 135.56 36.05 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-O 121.63 0.729 . . . . 0.0 111.963 -179.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -60.48 142.15 55.56 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 121.759 -0.588 . . . . 0.0 110.824 179.423 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 78.9 mt -131.64 -54.78 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.666 -0.646 . . . . 0.0 109.837 179.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 10.0 m-70 -67.51 177.3 2.0 Favored 'General case' 0 N--CA 1.504 2.254 0 O-C-N 121.57 -0.706 . . . . 0.0 111.961 -179.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 2.0 m80 -57.81 -63.18 1.34 Allowed 'General case' 0 N--CA 1.498 1.943 0 O-C-N 121.839 -0.538 . . . . 0.0 110.236 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.402 ' O ' ' CA ' ' A' ' 126' ' ' GLY . 10.4 tp10 -92.22 47.9 1.36 Allowed 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.403 -0.811 . . . . 0.0 109.708 179.299 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.431 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 1.8 t0 -99.87 137.49 38.26 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.352 -0.842 . . . . 0.0 109.793 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.747 HD21 ' HB2' ' A' ' 119' ' ' SER . 32.1 tp -112.89 136.01 53.01 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 121.474 -0.766 . . . . 0.0 110.861 -179.045 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.5 m -94.64 120.76 35.38 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.411 -0.806 . . . . 0.0 110.232 179.586 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.605 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 17.9 p90 -115.45 -169.51 1.59 Allowed 'General case' 0 N--CA 1.497 1.905 0 C-N-CA 120.368 -0.533 . . . . 0.0 109.963 179.08 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -126.0 179.83 5.04 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.134 0.969 . . . . 0.0 112.062 -178.679 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.487 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.5 ttmt -60.66 -22.04 63.44 Favored 'General case' 0 N--CA 1.501 2.088 0 N-CA-C 115.625 1.713 . . . . 0.0 115.625 -176.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -141.84 41.3 1.23 Allowed Glycine 0 N--CA 1.499 2.843 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.412 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 1.1 m-20 -90.63 171.53 9.32 Favored 'General case' 0 N--CA 1.501 2.115 0 C-N-CA 119.925 -0.71 . . . . 0.0 111.557 -179.125 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -127.14 132.48 50.54 Favored 'General case' 0 N--CA 1.489 1.483 0 N-CA-C 109.108 -0.701 . . . . 0.0 109.108 178.395 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.533 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.8 mpp? -139.1 150.71 46.01 Favored 'General case' 0 N--CA 1.489 1.516 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 -179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.435 HG13 HG12 ' A' ' 82' ' ' ILE . 38.2 t -95.85 151.22 4.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 179.553 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.436 HG23 ' O ' ' A' ' 81' ' ' ILE . 68.6 t -94.98 137.62 22.88 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.849 0 O-C-N 121.117 -0.99 . . . . 0.0 109.313 179.719 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.651 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.02 -30.96 13.83 Favored 'General case' 0 C--N 1.295 -1.765 0 CA-C-O 121.742 0.782 . . . . 0.0 108.936 -179.779 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 18.1 mt-10 -156.36 163.98 38.84 Favored 'General case' 0 N--CA 1.487 1.414 0 N-CA-C 109.455 -0.572 . . . . 0.0 109.455 -179.911 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -107.58 119.87 40.63 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.688 -0.633 . . . . 0.0 109.514 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 10.8 t -109.63 -76.44 0.61 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.126 -0.984 . . . . 0.0 110.858 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.05 -85.89 0.06 OUTLIER Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.158 -1.577 . . . . 0.0 109.158 179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -96.45 -20.56 18.33 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.545 -0.974 . . . . 0.0 110.023 179.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 75.0 m95 -127.47 103.76 7.53 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.497 -0.752 . . . . 0.0 108.982 -179.864 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 46.1 m0 -95.75 155.76 16.61 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.098 -1.001 . . . . 0.0 110.851 -179.02 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.448 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 24.3 tttt -95.67 112.51 24.21 Favored 'General case' 0 N--CA 1.494 1.759 0 N-CA-C 108.527 -0.916 . . . . 0.0 108.527 178.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.651 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -126.85 165.84 18.59 Favored 'General case' 0 N--CA 1.499 2.018 0 CA-C-O 122.143 0.973 . . . . 0.0 112.798 -178.143 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.504 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 7.3 ttt180 -112.68 130.52 56.02 Favored 'General case' 0 N--CA 1.48 1.046 0 O-C-N 121.722 -0.611 . . . . 0.0 109.981 179.844 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.747 ' HB2' HD21 ' A' ' 97' ' ' LEU . 29.3 t -82.96 115.29 21.75 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.534 -0.729 . . . . 0.0 109.183 178.935 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 29.5 mt -67.24 -26.35 66.53 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.24 0.543 . . . . 0.0 110.368 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.68 -29.74 66.84 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.462 -0.774 . . . . 0.0 109.813 179.382 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 73.7 p -133.62 10.53 4.02 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 121.762 -0.586 . . . . 0.0 110.476 178.8 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . 0.431 ' N ' ' O ' ' A' ' 119' ' ' SER . 7.8 mmm-85 51.68 28.3 4.7 Favored 'General case' 0 N--CA 1.505 2.284 0 O-C-N 120.986 -1.071 . . . . 0.0 110.898 -179.606 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.499 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 10.9 mtmt -99.8 177.91 4.98 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.425 -0.797 . . . . 0.0 109.376 179.812 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.504 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -153.56 151.77 30.15 Favored 'General case' 0 N--CA 1.502 2.169 0 C-N-CA 119.405 -0.918 . . . . 0.0 111.947 -179.928 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.448 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -177.99 -150.72 8.79 Favored Glycine 0 N--CA 1.487 2.07 0 N-CA-C 109.101 -1.6 . . . . 0.0 109.101 179.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.516 ' O ' HG23 ' A' ' 128' ' ' ILE . 48.0 m-85 -93.58 164.76 13.04 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.666 -0.902 . . . . 0.0 110.207 179.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.516 HG23 ' O ' ' A' ' 127' ' ' TYR . 2.3 pt -155.09 110.71 2.29 Favored Pre-proline 0 N--CA 1.5 2.059 0 O-C-N 121.668 -0.645 . . . . 0.0 109.981 -179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_exo -45.19 99.94 0.04 OUTLIER 'Trans proline' 0 N--CA 1.494 1.509 0 O-C-N 123.008 1.004 . . . . 0.0 111.838 179.823 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 53.2 m -57.03 -20.68 25.79 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.825 -0.547 . . . . 0.0 110.986 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 5.0 p-10 -74.42 -1.84 22.84 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.535 -0.728 . . . . 0.0 112.114 -179.193 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 4.8 m-85 -137.23 44.92 2.25 Favored 'General case' 0 N--CA 1.507 2.397 0 O-C-N 120.908 -1.12 . . . . 0.0 110.186 178.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.514 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -147.7 170.85 3.21 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 O-C-N 121.618 -0.676 . . . . 0.0 110.32 -179.524 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.932 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -125.12 117.41 23.86 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.746 -0.596 . . . . 0.0 109.509 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.778 ' HA ' HG12 ' A' ' 83' ' ' VAL . 1.2 tmm_? -80.07 133.98 36.16 Favored 'General case' 0 N--CA 1.493 1.685 0 CA-C-O 121.858 0.837 . . . . 0.0 112.648 -178.106 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 21.1 m -139.79 146.11 25.66 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 CA-C-O 121.286 0.565 . . . . 0.0 109.572 178.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.1 m-20 -94.75 43.75 1.1 Allowed 'General case' 0 C--N 1.306 -1.291 0 O-C-N 121.119 -0.988 . . . . 0.0 109.622 179.968 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.618 ' C ' HD12 ' A' ' 82' ' ' ILE . 13.3 t . . . . . 0 N--CA 1.492 1.641 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.684 -179.281 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 1.4 m . . . . . 0 N--CA 1.491 1.616 0 CA-C-O 120.987 0.423 . . . . 0.0 109.916 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.1 tt0 -142.23 76.2 1.53 Allowed 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.553 -0.717 . . . . 0.0 110.438 179.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -123.58 -164.66 1.24 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.38 -0.825 . . . . 0.0 109.564 179.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.502 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.2 OUTLIER -129.47 47.86 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 121.435 -0.79 . . . . 0.0 110.405 179.697 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.448 ' O ' HG22 ' A' ' 136' ' ' VAL . 41.9 mt -97.43 150.45 4.6 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 O-C-N 120.908 -1.12 . . . . 0.0 109.756 -179.752 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.772 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.4 m -136.46 172.55 15.11 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 O-C-N 121.748 -0.595 . . . . 0.0 109.414 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.873 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.2 p -127.63 124.41 63.34 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 119.669 -0.812 . . . . 0.0 110.148 178.875 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.556 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.68 116.12 5.93 Favored 'General case' 0 C--N 1.304 -1.37 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 178.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.989 HD11 ' HB2' ' A' ' 134' ' ' ALA . 93.9 mt -93.85 3.53 55.27 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 120.338 -0.545 . . . . 0.0 110.837 -179.119 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.437 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 70.5 m-85 -153.57 150.29 28.52 Favored 'General case' 0 N--CA 1.494 1.761 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 179.332 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.41 ' OD1' ' HA ' ' A' ' 100' ' ' GLN . 47.9 m-20 -66.64 150.91 48.36 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.448 -0.783 . . . . 0.0 109.455 -179.37 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' HB3' ' CE1' ' A' ' 99' ' ' PHE . 66.0 t80 -154.38 119.78 5.1 Favored 'General case' 0 N--CA 1.503 2.181 0 O-C-N 121.254 -0.904 . . . . 0.0 110.896 179.823 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 9.5 tt0 -93.38 128.75 39.56 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.585 -0.697 . . . . 0.0 111.35 -179.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.88 -165.35 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.971 0 O-C-N 121.611 -0.681 . . . . 0.0 110.704 179.611 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 47.2 mm -127.45 -71.03 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.378 -0.826 . . . . 0.0 110.11 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 2.7 t60 -174.06 53.47 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.195 0 O-C-N 121.235 -0.916 . . . . 0.0 110.561 -179.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -169.31 -153.7 0.11 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.362 -0.836 . . . . 0.0 108.89 179.08 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.44 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 5.1 tp10 -59.28 -18.21 35.45 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.198 -0.939 . . . . 0.0 110.404 179.995 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.446 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 3.4 t0 -44.51 130.0 6.7 Favored 'General case' 0 N--CA 1.513 2.711 0 O-C-N 121.342 -0.849 . . . . 0.0 111.263 179.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.561 HD11 ' HB2' ' A' ' 124' ' ' LYS . 6.5 tt -109.11 137.45 46.99 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.44 -0.787 . . . . 0.0 110.975 -178.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.9 m -94.44 122.22 36.78 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.684 -0.635 . . . . 0.0 109.599 179.333 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.556 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 8.6 p90 -117.36 -167.13 1.27 Allowed 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.788 -0.57 . . . . 0.0 110.029 179.609 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . 0.41 ' HA ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -126.08 179.42 5.25 Favored 'General case' 0 N--CA 1.49 1.572 0 CA-C-O 122.324 1.059 . . . . 0.0 112.695 -177.85 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.437 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 14.7 ttmt -61.14 -23.35 65.47 Favored 'General case' 0 N--CA 1.499 1.98 0 N-CA-C 114.625 1.342 . . . . 0.0 114.625 -177.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -135.94 40.05 1.58 Allowed Glycine 0 N--CA 1.497 2.705 0 N-CA-C 109.174 -1.57 . . . . 0.0 109.174 -178.861 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.423 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 2.3 m-20 -91.27 163.91 14.06 Favored 'General case' 0 N--CA 1.505 2.29 0 O-C-N 121.688 -0.89 . . . . 0.0 112.065 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -121.22 134.95 55.21 Favored 'General case' 0 N--CA 1.488 1.433 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 178.412 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.44 ' HE1' ' CD2' ' A' ' 99' ' ' PHE . 76.2 mtm -142.45 149.3 39.08 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.839 -0.538 . . . . 0.0 109.6 -179.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.597 ' CG2' HD11 ' A' ' 120' ' ' LEU . 21.3 t -97.01 150.86 4.31 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 179.118 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 81' ' ' ILE . 79.3 t -94.79 139.57 18.38 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.835 0 O-C-N 121.131 -0.981 . . . . 0.0 110.192 -179.419 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.609 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.7 mp -95.72 -27.11 15.43 Favored 'General case' 0 C--N 1.297 -1.679 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 179.807 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.2 mt-10 -155.61 144.15 20.32 Favored 'General case' 0 N--CA 1.489 1.517 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 179.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.9 mm-40 -103.02 137.73 40.82 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.44 -0.787 . . . . 0.0 110.151 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 38.8 t -128.34 -70.73 0.67 Allowed 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.441 -0.787 . . . . 0.0 110.107 179.858 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 157.15 -40.51 0.55 Allowed Glycine 0 N--CA 1.493 2.482 0 N-CA-C 110.161 -1.175 . . . . 0.0 110.161 179.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -119.48 -30.37 4.88 Favored 'General case' 0 N--CA 1.502 2.127 0 O-C-N 121.355 -1.086 . . . . 0.0 111.119 -179.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 36.3 m95 -137.11 102.88 4.96 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 121.404 -0.81 . . . . 0.0 109.24 -179.892 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 11.4 m0 -98.22 151.14 20.76 Favored 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.401 -0.812 . . . . 0.0 111.099 -178.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 11.7 mtpt -101.06 124.59 47.01 Favored 'General case' 0 N--CA 1.495 1.821 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 177.906 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.609 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -132.73 166.12 22.95 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 121.266 -0.896 . . . . 0.0 111.883 -179.085 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.515 ' HB2' HD11 ' A' ' 108' ' ' LEU . 2.4 ttt180 -114.0 126.59 55.3 Favored 'General case' 0 C--N 1.31 -1.145 0 O-C-N 121.652 -0.655 . . . . 0.0 109.985 -179.738 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 8.5 t -77.92 114.9 17.23 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.698 -0.626 . . . . 0.0 109.387 179.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.597 HD11 ' CG2' ' A' ' 106' ' ' VAL . 9.6 mt -67.56 -28.74 68.04 Favored 'General case' 0 N--CA 1.493 1.696 0 C-N-CA 120.226 -0.589 . . . . 0.0 110.083 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -56.35 -28.97 60.71 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.44 -0.787 . . . . 0.0 110.308 179.632 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 37.9 p -135.04 12.02 3.6 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.738 -0.601 . . . . 0.0 110.767 179.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 49.9 30.93 4.24 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.175 -0.953 . . . . 0.0 110.97 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.561 ' HB2' HD11 ' A' ' 97' ' ' LEU . 36.8 mtmt -100.47 177.37 5.05 Favored 'General case' 0 N--CA 1.495 1.808 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 179.294 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.494 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.2 OUTLIER -152.2 149.48 28.79 Favored 'General case' 0 N--CA 1.501 2.077 0 CA-C-O 121.966 0.889 . . . . 0.0 111.913 179.42 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.44 ' HA3' ' O ' ' A' ' 95' ' ' GLU . . . -172.88 -152.98 9.06 Favored Glycine 0 N--CA 1.481 1.685 0 N-CA-C 109.704 -1.359 . . . . 0.0 109.704 179.879 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.446 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 96.6 m-85 -94.07 164.09 13.21 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 122.201 -0.588 . . . . 0.0 109.47 179.373 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.435 HG23 ' O ' ' A' ' 127' ' ' TYR . 4.2 pt -151.06 106.96 3.01 Favored Pre-proline 0 N--CA 1.488 1.454 0 N-CA-C 109.191 -0.67 . . . . 0.0 109.191 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_exo -47.32 107.4 0.13 Allowed 'Trans proline' 0 N--CA 1.49 1.287 0 O-C-N 123.04 1.021 . . . . 0.0 111.719 -178.742 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.413 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 24.0 m -60.76 -15.95 35.03 Favored 'General case' 0 N--CA 1.495 1.795 0 O-C-N 121.944 -0.472 . . . . 0.0 111.017 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.401 ' OD1' ' CD2' ' A' ' 132' ' ' TYR . 39.5 p30 -80.74 3.19 23.09 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.21 -0.931 . . . . 0.0 112.063 -179.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.401 ' CD2' ' OD1' ' A' ' 131' ' ' ASN . 8.9 m-85 -144.92 46.96 1.34 Allowed 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.142 -0.974 . . . . 0.0 109.731 -179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.505 HG22 ' N ' ' A' ' 134' ' ' ALA . 5.4 p -153.91 170.83 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.784 0 O-C-N 121.424 -0.797 . . . . 0.0 110.594 -178.847 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.989 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -125.57 124.14 40.61 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.75 -0.594 . . . . 0.0 109.905 179.739 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.772 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.8 OUTLIER -83.93 137.82 33.45 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.425 -0.797 . . . . 0.0 112.498 -178.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.448 HG22 ' O ' ' A' ' 82' ' ' ILE . 25.6 m -140.85 139.95 33.64 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 178.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -99.67 33.84 2.41 Favored 'General case' 0 C--N 1.311 -1.104 0 O-C-N 121.263 -0.898 . . . . 0.0 110.557 -179.19 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 11.4 t . . . . . 0 N--CA 1.494 1.769 0 CA-C-O 118.017 -0.992 . . . . 0.0 109.951 179.656 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 6.9 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 121.042 0.448 . . . . 0.0 110.035 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 15.0 tt0 -71.83 88.03 1.01 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.597 -0.689 . . . . 0.0 109.998 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.441 ' O ' ' HA ' ' A' ' 137' ' ' ASP . 4.5 m-20 -164.39 -163.6 0.76 Allowed 'General case' 0 N--CA 1.503 2.182 0 O-C-N 121.806 -0.559 . . . . 0.0 109.666 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.466 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.1 OUTLIER -96.7 52.46 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.689 -1.257 . . . . 0.0 108.914 178.453 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.64 ' O ' HG22 ' A' ' 136' ' ' VAL . 89.4 mt -101.39 157.87 4.28 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.052 -1.03 . . . . 0.0 109.554 -179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.789 HG12 ' HA ' ' A' ' 135' ' ' ARG . 31.6 m -139.83 165.67 21.74 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 N-CA-C 109.557 -0.534 . . . . 0.0 109.557 179.477 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.896 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.0 p -123.61 122.02 63.91 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 121.356 -0.84 . . . . 0.0 109.095 178.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.659 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -64.24 116.85 6.41 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 119.764 -0.774 . . . . 0.0 108.926 179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.874 HD11 ' HB2' ' A' ' 134' ' ' ALA . 96.6 mt -94.5 7.95 43.84 Favored 'General case' 0 N--CA 1.494 1.735 0 C-N-CA 120.533 -0.467 . . . . 0.0 111.158 -179.284 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.433 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 49.7 m-85 -154.81 151.16 28.31 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.226 -0.921 . . . . 0.0 108.851 179.398 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.93 141.03 56.46 Favored 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.534 -0.729 . . . . 0.0 109.909 -179.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.503 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 39.5 t80 -155.34 125.14 6.5 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.222 -0.924 . . . . 0.0 111.159 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -107.17 130.94 54.65 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.485 -0.759 . . . . 0.0 110.682 179.555 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.634 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -58.92 -167.45 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.451 -0.781 . . . . 0.0 110.217 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 25.6 pt -135.03 -38.84 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.494 -0.754 . . . . 0.0 110.75 179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 8.5 t-80 -177.14 -54.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.107 -0.995 . . . . 0.0 110.485 179.681 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 38.1 m80 -58.04 -168.85 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.481 -0.762 . . . . 0.0 110.579 -179.322 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.442 ' O ' ' HA3' ' A' ' 126' ' ' GLY . 3.4 tp10 -51.56 -30.36 20.46 Favored 'General case' 0 N--CA 1.503 2.217 0 O-C-N 121.295 -0.878 . . . . 0.0 110.416 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.634 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 1.0 OUTLIER -14.7 124.54 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.236 0 N-CA-C 113.269 0.84 . . . . 0.0 113.269 179.755 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.749 HD13 ' N ' ' A' ' 98' ' ' SER . 1.2 tm? -98.31 133.77 42.25 Favored 'General case' 0 N--CA 1.496 1.826 0 CA-C-O 121.565 0.698 . . . . 0.0 111.481 -177.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.749 ' N ' HD13 ' A' ' 97' ' ' LEU . 8.5 m -94.75 142.82 27.01 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 108.806 -0.813 . . . . 0.0 108.806 178.25 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.659 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 20.3 p90 -152.99 -164.71 2.0 Allowed 'General case' 0 N--CA 1.5 2.039 0 O-C-N 121.261 -0.899 . . . . 0.0 111.017 -179.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -126.24 179.25 5.35 Favored 'General case' 0 N--CA 1.491 1.614 0 CA-C-O 122.118 0.961 . . . . 0.0 111.742 -178.044 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.433 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 10.3 ttmt -61.36 -18.94 61.09 Favored 'General case' 0 N--CA 1.501 2.082 0 N-CA-C 114.941 1.459 . . . . 0.0 114.941 -177.764 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -138.69 41.22 1.38 Allowed Glycine 0 N--CA 1.496 2.644 0 N-CA-C 109.444 -1.462 . . . . 0.0 109.444 -178.627 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -90.93 172.01 8.89 Favored 'General case' 0 N--CA 1.505 2.325 0 C-N-CA 119.525 -0.87 . . . . 0.0 111.815 -179.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -128.63 129.5 45.96 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.646 -0.659 . . . . 0.0 110.199 179.467 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.428 ' O ' HG23 ' A' ' 82' ' ' ILE . 20.9 mtm -132.52 156.19 47.25 Favored 'General case' 0 N--CA 1.491 1.579 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 179.153 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.494 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 24.9 t -106.5 152.37 8.13 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.756 0 N-CA-C 107.563 -1.273 . . . . 0.0 107.563 179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.441 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 94.9 t -95.06 139.16 19.24 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.85 0 C-N-CA 119.339 -0.945 . . . . 0.0 109.557 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.625 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.9 mp -94.84 -30.83 14.0 Favored 'General case' 0 C--N 1.293 -1.859 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 179.053 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 20.4 mt-10 -156.64 152.93 27.76 Favored 'General case' 0 N--CA 1.49 1.531 0 N-CA-C 109.304 -0.628 . . . . 0.0 109.304 179.342 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.5 mt-10 -95.97 151.32 19.54 Favored 'General case' 0 N--CA 1.501 2.086 0 O-C-N 121.269 -0.895 . . . . 0.0 110.004 179.485 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 12.6 t -147.27 -83.09 0.12 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.394 -0.816 . . . . 0.0 110.715 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -178.03 -90.5 0.08 OUTLIER Glycine 0 N--CA 1.496 2.642 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -179.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -91.32 -5.61 54.36 Favored 'General case' 0 N--CA 1.496 1.847 0 O-C-N 121.429 -1.042 . . . . 0.0 110.825 179.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 38.5 m95 -143.97 96.96 2.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.304 -0.873 . . . . 0.0 109.886 -179.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 9.6 m0 -94.95 149.05 21.66 Favored 'General case' 0 N--CA 1.499 2.014 0 O-C-N 121.353 -0.842 . . . . 0.0 109.844 -179.774 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.73 117.34 29.97 Favored 'General case' 0 N--CA 1.494 1.772 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.625 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.3 164.54 25.4 Favored 'General case' 0 N--CA 1.501 2.092 0 O-C-N 121.239 -0.913 . . . . 0.0 112.607 -178.208 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.501 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.1 ttt180 -118.03 131.82 56.43 Favored 'General case' 0 N--CA 1.48 1.052 0 O-C-N 121.633 -0.667 . . . . 0.0 109.914 179.613 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . . . . . . . . . 1.2 t -87.46 118.36 26.86 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.577 -0.702 . . . . 0.0 109.859 179.34 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.449 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.3 mt -67.36 -23.02 65.56 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.827 -0.545 . . . . 0.0 110.579 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.86 -31.11 68.24 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.353 -0.842 . . . . 0.0 110.171 -179.77 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.7 p -137.57 14.0 2.96 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.725 -0.609 . . . . 0.0 110.437 179.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 4.9 mtt-85 50.52 35.18 10.74 Favored 'General case' 0 N--CA 1.502 2.142 0 O-C-N 121.103 -0.998 . . . . 0.0 111.229 -179.806 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.501 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 45.6 mttt -102.93 173.75 6.17 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.49 -0.756 . . . . 0.0 108.962 179.069 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.437 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.1 pp20? -155.7 156.51 35.03 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 119.842 -0.743 . . . . 0.0 111.737 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.442 ' HA3' ' O ' ' A' ' 95' ' ' GLU . . . 174.59 -154.91 19.99 Favored Glycine 0 N--CA 1.486 2.011 0 N-CA-C 109.848 -1.301 . . . . 0.0 109.848 179.471 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 6.8 m-85 -93.64 118.77 31.81 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.974 -0.721 . . . . 0.0 109.701 -179.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.499 HG21 ' HB3' ' A' ' 117' ' ' ALA . 4.3 pt -99.14 134.83 21.05 Favored Pre-proline 0 N--CA 1.491 1.589 0 C-N-CA 120.092 -0.643 . . . . 0.0 110.108 179.432 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.427 ' HD2' ' CE2' ' A' ' 99' ' ' PHE . 36.1 Cg_exo -57.96 95.89 0.07 OUTLIER 'Trans proline' 0 N--CA 1.489 1.262 0 O-C-N 122.978 0.989 . . . . 0.0 111.058 -179.714 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 73.4 m -57.89 -18.74 24.81 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.663 -0.648 . . . . 0.0 111.412 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . 0.47 ' ND2' ' CD2' ' A' ' 132' ' ' TYR . 14.2 p-10 -90.03 19.16 5.12 Favored 'General case' 0 N--CA 1.499 1.996 0 O-C-N 121.153 -0.967 . . . . 0.0 111.934 -178.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.47 ' CD2' ' ND2' ' A' ' 131' ' ' ASN . 20.6 m-85 -155.19 52.26 0.61 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.258 -0.901 . . . . 0.0 109.459 178.653 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.498 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.7 p -160.52 170.4 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.607 0 O-C-N 121.421 -0.799 . . . . 0.0 111.396 -178.561 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.896 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -120.72 126.07 49.25 Favored 'General case' 0 N--CA 1.497 1.89 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 178.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.789 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.2 OUTLIER -94.79 120.96 35.87 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.243 -0.911 . . . . 0.0 112.809 -177.716 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.64 HG22 ' O ' ' A' ' 82' ' ' ILE . 28.8 m -100.24 131.19 48.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 177.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.441 ' HA ' ' O ' ' A' ' 80' ' ' ASP . 26.5 t70 -155.97 -42.39 0.08 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.579 -0.7 . . . . 0.0 110.613 -179.042 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 34.2 t . . . . . 0 N--CA 1.494 1.752 0 CA-C-O 118.034 -0.984 . . . . 0.0 110.192 -179.591 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.49 1.533 0 CA-C-O 121.112 0.482 . . . . 0.0 109.742 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER 54.6 96.26 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.062 0 O-C-N 121.514 -0.742 . . . . 0.0 110.705 -179.769 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -133.18 -158.2 0.87 Allowed 'General case' 0 N--CA 1.498 1.94 0 O-C-N 121.526 -0.733 . . . . 0.0 109.171 179.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.58 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -126.89 43.73 0.67 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.839 0 C-N-CA 119.13 -1.028 . . . . 0.0 111.846 179.392 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.634 HG12 HG13 ' A' ' 106' ' ' VAL . 59.6 mt -96.23 137.42 24.22 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.917 0 O-C-N 120.778 -1.201 . . . . 0.0 108.717 177.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.895 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.8 m -125.34 170.31 15.59 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.572 -0.705 . . . . 0.0 110.773 -179.025 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.748 HG12 ' HB3' ' A' ' 134' ' ' ALA . 4.4 p -124.59 122.93 64.95 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.518 0 O-C-N 121.6 -0.688 . . . . 0.0 109.625 179.178 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.616 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -67.86 123.53 20.82 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 179.522 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.423 ' O ' ' HG3' ' A' ' 101' ' ' LYS . 84.2 mt -94.32 -2.4 52.26 Favored 'General case' 0 N--CA 1.495 1.793 0 C-N-CA 120.578 -0.449 . . . . 0.0 111.703 -178.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.479 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 62.2 m-85 -151.67 151.14 31.07 Favored 'General case' 0 N--CA 1.502 2.159 0 O-C-N 121.135 -0.978 . . . . 0.0 109.016 179.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 27.4 m-20 -62.71 147.09 50.68 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.61 -0.681 . . . . 0.0 110.236 -179.194 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.445 ' CB ' ' CE1' ' A' ' 99' ' ' PHE . 53.3 t80 -154.56 134.05 12.69 Favored 'General case' 0 N--CA 1.504 2.248 0 O-C-N 121.559 -0.713 . . . . 0.0 110.916 179.362 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 35.9 tt0 -98.4 136.62 38.29 Favored 'General case' 0 N--CA 1.502 2.136 0 O-C-N 121.585 -0.697 . . . . 0.0 111.713 -179.204 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.834 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -60.58 154.46 21.06 Favored 'General case' 0 N--CA 1.503 2.223 0 O-C-N 121.442 -0.786 . . . . 0.0 111.22 179.477 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.476 HG23 ' O ' ' A' ' 92' ' ' ILE . 11.0 tt -171.67 58.47 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.465 -0.772 . . . . 0.0 110.369 179.183 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 3.6 t60 -175.57 60.9 0.02 OUTLIER 'General case' 0 N--CA 1.507 2.396 0 O-C-N 121.158 -0.964 . . . . 0.0 111.135 -179.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 50.9 m-70 51.16 -95.74 0.04 OUTLIER 'General case' 0 N--CA 1.508 2.434 0 O-C-N 120.78 -1.2 . . . . 0.0 110.5 179.866 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.426 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 10.1 tp10 -77.35 58.06 1.6 Allowed 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.54 -1.35 . . . . 0.0 108.964 178.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.834 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 32.6 p30 -100.84 174.24 6.13 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.59 -0.694 . . . . 0.0 110.268 -179.422 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.738 HD21 ' HB2' ' A' ' 119' ' ' SER . 49.7 tp -153.25 132.34 12.61 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.501 -0.75 . . . . 0.0 110.831 -179.671 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -95.0 116.26 28.46 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.916 -0.49 . . . . 0.0 110.782 -179.844 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.632 ' CE2' HG22 ' A' ' 128' ' ' ILE . 15.6 p90 -108.65 -176.27 3.0 Favored 'General case' 0 N--CA 1.498 1.931 0 C-N-CA 120.07 -0.652 . . . . 0.0 109.324 178.299 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -121.02 -176.63 3.31 Favored 'General case' 0 N--CA 1.493 1.704 0 CA-C-O 122.278 1.037 . . . . 0.0 112.104 -178.221 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.479 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 9.3 ttmt -60.48 -27.07 67.28 Favored 'General case' 0 N--CA 1.502 2.142 0 N-CA-C 115.076 1.51 . . . . 0.0 115.076 -177.352 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -139.14 43.67 1.15 Allowed Glycine 0 N--CA 1.497 2.73 0 N-CA-C 108.616 -1.794 . . . . 0.0 108.616 -178.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.422 ' O ' ' HA ' ' A' ' 84' ' ' VAL . 1.3 m-20 -91.04 165.32 13.59 Favored 'General case' 0 N--CA 1.501 2.101 0 C-N-CA 119.81 -0.756 . . . . 0.0 112.233 -179.085 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -120.2 131.99 55.19 Favored 'General case' 0 N--CA 1.487 1.423 0 N-CA-C 109.242 -0.651 . . . . 0.0 109.242 178.225 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.507 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 2.2 mpp? -138.77 152.22 47.74 Favored 'General case' 0 N--CA 1.489 1.521 0 N-CA-C 109.476 -0.565 . . . . 0.0 109.476 -179.501 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.634 HG13 HG12 ' A' ' 82' ' ' ILE . 11.8 t -102.1 147.84 8.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 N-CA-C 107.875 -1.157 . . . . 0.0 107.875 179.385 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.484 HG23 ' O ' ' A' ' 81' ' ' ILE . 71.5 t -94.94 139.22 19.08 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.891 0 O-C-N 121.025 -1.047 . . . . 0.0 109.976 -179.65 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.706 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -95.41 -30.27 13.98 Favored 'General case' 0 C--N 1.298 -1.669 0 N-CA-C 109.209 -0.663 . . . . 0.0 109.209 -179.986 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.3 mt-10 -156.51 159.57 38.71 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.74 -0.6 . . . . 0.0 110.332 -179.701 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -105.0 147.97 27.23 Favored 'General case' 0 N--CA 1.5 2.073 0 O-C-N 121.377 -0.827 . . . . 0.0 110.38 179.433 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 27.4 t -135.99 -75.07 0.44 Allowed 'General case' 0 N--CA 1.498 1.966 0 O-C-N 121.287 -0.883 . . . . 0.0 110.672 179.645 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 170.9 -44.74 0.19 Allowed Glycine 0 N--CA 1.496 2.694 0 N-CA-C 109.68 -1.368 . . . . 0.0 109.68 -179.867 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 5.6 mt-10 -127.61 -40.27 1.77 Allowed 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.621 -0.929 . . . . 0.0 110.38 -179.916 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.9 m95 -116.7 107.97 15.32 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.544 -0.723 . . . . 0.0 109.106 179.436 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CH2' ' HB3' ' A' ' 130' ' ' SER . 35.5 m0 -98.29 151.88 20.02 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.39 -0.819 . . . . 0.0 110.002 -179.656 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -97.57 118.1 33.32 Favored 'General case' 0 N--CA 1.501 2.109 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 178.807 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.706 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -131.41 168.23 17.95 Favored 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.223 -0.923 . . . . 0.0 112.513 -178.327 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.513 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 2.1 ttt180 -116.73 121.55 41.95 Favored 'General case' 0 C--N 1.311 -1.067 0 O-C-N 121.608 -0.683 . . . . 0.0 109.634 179.315 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.738 ' HB2' HD21 ' A' ' 97' ' ' LEU . 46.2 t -73.81 121.3 20.66 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.611 -0.681 . . . . 0.0 109.827 179.526 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 20.4 mt -70.98 -29.35 65.31 Favored 'General case' 0 N--CA 1.498 1.935 0 CA-C-O 121.142 0.496 . . . . 0.0 110.27 -179.869 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.11 -26.14 62.24 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.633 -0.667 . . . . 0.0 110.436 -179.891 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 27.6 p -136.87 9.39 3.06 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.61 -0.681 . . . . 0.0 110.795 179.35 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 42.4 mtt180 51.92 30.31 7.07 Favored 'General case' 0 N--CA 1.504 2.229 0 O-C-N 121.045 -1.035 . . . . 0.0 110.706 -179.595 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.503 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 14.9 mttt -101.85 176.76 5.11 Favored 'General case' 0 N--CA 1.496 1.831 0 N-CA-C 108.35 -0.982 . . . . 0.0 108.35 179.092 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.513 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 2.4 pm0 -155.66 143.78 19.97 Favored 'General case' 0 N--CA 1.494 1.742 0 C-N-CA 119.101 -1.04 . . . . 0.0 112.154 179.812 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -168.62 -149.83 6.36 Favored Glycine 0 N--CA 1.488 2.114 0 N-CA-C 109.353 -1.499 . . . . 0.0 109.353 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.549 ' O ' HG23 ' A' ' 128' ' ' ILE . 76.2 m-85 -95.22 162.42 13.7 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.755 -0.85 . . . . 0.0 110.72 -179.586 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.632 HG22 ' CE2' ' A' ' 99' ' ' PHE . 3.0 pt -155.5 113.67 2.24 Favored Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 121.613 -0.679 . . . . 0.0 110.182 178.939 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.5 Cg_exo -53.29 110.06 0.44 Allowed 'Trans proline' 0 N--CA 1.489 1.259 0 O-C-N 123.154 1.081 . . . . 0.0 111.541 -179.736 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.456 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 8.8 m -59.03 -18.48 35.01 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.897 -0.502 . . . . 0.0 110.917 179.091 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 30.6 p30 -71.96 -0.79 12.37 Favored 'General case' 0 N--CA 1.499 2.022 0 O-C-N 121.421 -0.799 . . . . 0.0 113.094 -178.013 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -141.53 40.61 1.73 Allowed 'General case' 0 N--CA 1.501 2.11 0 O-C-N 120.912 -1.117 . . . . 0.0 109.863 179.791 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.484 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.3 p -150.06 169.65 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.701 0 O-C-N 121.533 -0.729 . . . . 0.0 111.315 -178.404 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.748 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -122.54 137.25 54.95 Favored 'General case' 0 N--CA 1.5 2.068 0 CA-C-O 121.217 0.532 . . . . 0.0 110.325 179.587 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.895 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.5 OUTLIER -96.49 130.85 43.57 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 121.31 -0.869 . . . . 0.0 111.518 -178.821 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.433 HG22 ' O ' ' A' ' 82' ' ' ILE . 27.5 m -144.08 173.24 5.24 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 121.775 -0.578 . . . . 0.0 110.024 179.205 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -94.33 -159.68 0.72 Allowed 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.458 -0.776 . . . . 0.0 109.974 179.353 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 44.6 t . . . . . 0 N--CA 1.493 1.724 0 CA-C-O 118.053 -0.975 . . . . 0.0 110.271 -179.955 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.495 1.81 0 CA-C-O 120.962 0.41 . . . . 0.0 109.945 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 137' ' ' ASP . 2.1 tt0 56.95 20.06 5.05 Favored 'General case' 0 N--CA 1.502 2.132 0 O-C-N 121.362 -0.836 . . . . 0.0 110.988 179.664 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . 0.436 ' H ' ' HA ' ' A' ' 137' ' ' ASP . 6.4 m-20 -165.57 -162.34 0.58 Allowed 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.437 -0.79 . . . . 0.0 110.105 -179.473 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.412 HG13 ' HB ' ' A' ' 107' ' ' VAL . 0.1 OUTLIER -97.23 53.59 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.618 0 O-C-N 120.783 -1.198 . . . . 0.0 109.073 178.539 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.703 ' HA ' ' HA ' ' A' ' 106' ' ' VAL . 90.2 mt -98.3 155.09 3.82 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.736 0 C-N-CA 119.299 -0.96 . . . . 0.0 108.619 179.729 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.773 HG12 ' HA ' ' A' ' 135' ' ' ARG . 29.7 m -138.41 174.6 10.05 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 O-C-N 121.367 -0.833 . . . . 0.0 110.2 179.634 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.901 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.3 p -133.89 128.15 53.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.278 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 178.629 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.52 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -70.79 120.28 16.15 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.497 -0.752 . . . . 0.0 109.145 179.719 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.683 HD11 ' HB2' ' A' ' 134' ' ' ALA . 77.2 mt -94.28 0.39 55.59 Favored 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 120.856 -0.338 . . . . 0.0 111.284 -179.457 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.435 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 66.3 m-85 -152.21 151.13 30.61 Favored 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 108.079 -1.082 . . . . 0.0 108.079 179.092 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 74.8 m-20 -65.57 150.58 48.18 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.406 -0.809 . . . . 0.0 110.05 -178.728 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.463 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 42.5 t80 -153.65 136.55 15.41 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 121.339 -0.851 . . . . 0.0 111.094 179.209 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . 0.459 ' HA ' ' HB3' ' A' ' 98' ' ' SER . 3.7 tt0 -101.06 142.36 32.63 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.794 -0.566 . . . . 0.0 111.163 -179.363 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.772 ' HB1' ' CG ' ' A' ' 96' ' ' ASP . . . -55.54 171.08 0.21 Allowed 'General case' 0 N--CA 1.502 2.15 0 O-C-N 121.393 -0.817 . . . . 0.0 110.535 179.808 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 1.9 tt -173.85 42.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.82 0 O-C-N 121.493 -0.755 . . . . 0.0 109.938 -179.948 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -177.72 -166.52 0.13 Allowed 'General case' 0 N--CA 1.503 2.22 0 O-C-N 121.055 -1.028 . . . . 0.0 110.164 179.691 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 12.9 m-70 -73.32 -73.78 0.2 Allowed 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.297 -0.877 . . . . 0.0 110.207 -179.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.439 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 6.6 tp10 -85.06 52.45 2.44 Favored 'General case' 0 N--CA 1.492 1.656 0 N-CA-C 108.796 -0.816 . . . . 0.0 108.796 178.883 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.772 ' CG ' ' HB1' ' A' ' 91' ' ' ALA . 54.0 p30 -94.47 171.56 8.73 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.603 -0.686 . . . . 0.0 109.843 -179.453 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.593 HD21 ' HB2' ' A' ' 119' ' ' SER . 16.7 tp -151.82 128.75 10.99 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.481 -0.762 . . . . 0.0 111.149 -179.996 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.459 ' HB3' ' HA ' ' A' ' 90' ' ' GLU . 1.2 m -95.2 105.36 17.29 Favored 'General case' 0 N--CA 1.491 1.578 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 178.204 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.659 ' CD2' HG22 ' A' ' 128' ' ' ILE . 16.9 p90 -103.01 -168.1 1.47 Allowed 'General case' 0 N--CA 1.501 2.102 0 C-N-CA 120.404 -0.518 . . . . 0.0 110.774 -179.734 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.32 178.87 5.36 Favored 'General case' 0 N--CA 1.496 1.833 0 CA-C-O 122.408 1.099 . . . . 0.0 112.859 -177.888 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.445 ' HG3' ' O ' ' A' ' 86' ' ' LEU . 13.0 ttmt -60.92 -19.41 60.58 Favored 'General case' 0 N--CA 1.503 2.189 0 N-CA-C 114.95 1.463 . . . . 0.0 114.95 -177.595 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.34 42.37 1.13 Allowed Glycine 0 C--N 1.281 -2.512 0 N-CA-C 108.837 -1.705 . . . . 0.0 108.837 -178.527 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.2 m-20 -90.47 164.14 14.38 Favored 'General case' 0 N--CA 1.505 2.324 0 C-N-CA 119.489 -0.884 . . . . 0.0 111.525 -179.538 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 2.1 mt-30 -122.94 110.78 15.82 Favored 'General case' 0 C--N 1.304 -1.378 0 O-C-N 121.637 -0.664 . . . . 0.0 109.853 179.391 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . . . . . . . . . 59.0 mtm -124.84 143.45 50.82 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.703 ' HA ' ' HA ' ' A' ' 82' ' ' ILE . 3.2 m -96.53 160.21 2.9 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 C-N-CA 119.064 -1.054 . . . . 0.0 108.396 -179.771 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.412 ' HB ' HG13 ' A' ' 81' ' ' ILE . 60.9 t -94.02 138.38 20.64 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.966 0 O-C-N 120.982 -1.074 . . . . 0.0 110.613 -179.354 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.674 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.0 mp -95.19 -29.25 14.63 Favored 'General case' 0 C--N 1.299 -1.619 0 N-CA-C 108.79 -0.819 . . . . 0.0 108.79 178.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 4.6 mt-10 -156.0 163.62 39.49 Favored 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.838 -0.539 . . . . 0.0 109.649 179.756 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 24.4 tt0 -121.23 121.11 37.04 Favored 'General case' 0 N--CA 1.498 1.945 0 O-C-N 121.503 -0.748 . . . . 0.0 110.75 179.078 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 6.7 t -123.23 -60.96 1.46 Allowed 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.46 -0.775 . . . . 0.0 110.485 179.78 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.401 ' O ' ' N ' ' A' ' 114' ' ' TRP . . . 150.19 129.54 1.68 Allowed Glycine 0 N--CA 1.495 2.632 0 N-CA-C 109.324 -1.51 . . . . 0.0 109.324 -179.59 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 18.2 tp10 65.97 -68.01 0.13 Allowed 'General case' 0 N--CA 1.507 2.386 0 O-C-N 121.549 -0.971 . . . . 0.0 110.505 -179.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . 0.401 ' N ' ' O ' ' A' ' 112' ' ' GLY . 95.9 m95 -98.77 109.64 22.36 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.281 -0.887 . . . . 0.0 110.275 -179.891 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . 0.404 ' CG ' ' OG ' ' A' ' 130' ' ' SER . 46.3 m0 -108.13 147.94 30.55 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.471 -0.768 . . . . 0.0 110.147 -179.71 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 4.6 tttt -96.38 113.77 25.38 Favored 'General case' 0 N--CA 1.499 1.991 0 N-CA-C 108.593 -0.891 . . . . 0.0 108.593 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.674 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -127.42 162.82 25.43 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.338 -0.851 . . . . 0.0 112.205 -178.121 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.465 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 7.5 tmm_? -111.1 125.48 53.81 Favored 'General case' 0 N--CA 1.484 1.27 0 O-C-N 121.495 -0.753 . . . . 0.0 109.374 179.805 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.593 ' HB2' HD21 ' A' ' 97' ' ' LEU . 31.8 t -88.14 122.81 32.14 Favored 'General case' 0 N--CA 1.492 1.627 0 C-N-CA 120.102 -0.639 . . . . 0.0 110.06 -179.872 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.1 mt -70.96 -26.17 63.05 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 120.265 -0.574 . . . . 0.0 109.503 179.644 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -52.49 -32.87 42.27 Favored 'General case' 0 N--CA 1.502 2.173 0 O-C-N 121.438 -0.788 . . . . 0.0 110.297 179.38 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 7.2 p -134.5 10.19 3.72 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.617 -0.677 . . . . 0.0 110.334 178.83 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 54.04 31.9 14.56 Favored 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.081 -1.012 . . . . 0.0 110.545 -179.248 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.465 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 53.8 mttt -104.37 -178.04 3.54 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.511 -0.743 . . . . 0.0 110.194 179.843 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.439 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.04 139.71 17.04 Favored 'General case' 0 N--CA 1.497 1.888 0 CA-C-O 121.889 0.852 . . . . 0.0 111.349 179.14 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -169.44 -156.59 10.94 Favored Glycine 0 N--CA 1.485 1.963 0 N-CA-C 109.741 -1.344 . . . . 0.0 109.741 179.271 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.495 ' O ' HG23 ' A' ' 128' ' ' ILE . 53.0 m-85 -93.47 157.85 16.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.686 -0.891 . . . . 0.0 110.693 -178.965 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.659 HG22 ' CD2' ' A' ' 99' ' ' PHE . 1.3 pt -155.61 110.93 2.19 Favored Pre-proline 0 N--CA 1.493 1.72 0 N-CA-C 109.659 -0.497 . . . . 0.0 109.659 179.03 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 50.9 Cg_exo -48.9 102.98 0.05 OUTLIER 'Trans proline' 0 N--CA 1.494 1.504 0 O-C-N 122.802 0.896 . . . . 0.0 110.805 179.74 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.404 ' OG ' ' CG ' ' A' ' 115' ' ' TRP . 1.1 m -62.01 -15.32 43.38 Favored 'General case' 0 N--CA 1.5 2.056 0 O-C-N 121.706 -0.621 . . . . 0.0 111.313 -178.922 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 43.7 p30 -64.66 -11.33 34.35 Favored 'General case' 0 N--CA 1.5 2.057 0 O-C-N 121.161 -0.962 . . . . 0.0 111.478 -179.936 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.431 ' C ' HG23 ' A' ' 133' ' ' VAL . 10.7 m-85 -130.03 43.41 3.13 Favored 'General case' 0 N--CA 1.499 1.997 0 O-C-N 121.192 -0.943 . . . . 0.0 108.982 179.517 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.451 HG12 ' N ' ' A' ' 134' ' ' ALA . 61.5 t -145.76 170.81 5.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 O-C-N 121.587 -0.696 . . . . 0.0 110.581 -177.643 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.901 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -124.09 125.63 44.83 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.529 -0.732 . . . . 0.0 109.341 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.773 ' HA ' HG12 ' A' ' 83' ' ' VAL . 9.4 ttt180 -95.72 121.58 37.58 Favored 'General case' 0 N--CA 1.484 1.263 0 O-C-N 121.423 -0.798 . . . . 0.0 112.522 -178.501 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.561 HG22 ' O ' ' A' ' 82' ' ' ILE . 30.6 m -100.46 133.69 42.71 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.642 0 N-CA-C 108.772 -0.825 . . . . 0.0 108.772 177.289 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . 0.436 ' HA ' ' H ' ' A' ' 80' ' ' ASP . 24.8 t0 -155.64 -55.32 0.09 Allowed 'General case' 0 N--CA 1.484 1.264 0 O-C-N 121.697 -0.627 . . . . 0.0 109.81 -179.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 36.1 t . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.009 -179.896 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.491 1.624 0 CA-C-O 120.99 0.424 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 5.4 pt-20 -61.42 -173.83 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.033 0 O-C-N 121.527 -0.733 . . . . 0.0 110.885 -179.547 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 59.8 m-20 -139.68 -159.92 1.01 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.659 -0.651 . . . . 0.0 109.375 -179.632 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.57 HD13 ' H ' ' A' ' 81' ' ' ILE . 0.2 OUTLIER -121.57 41.59 0.73 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.046 0 O-C-N 121.052 -1.03 . . . . 0.0 112.12 179.766 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.495 HG12 HG13 ' A' ' 106' ' ' VAL . 48.3 mt -95.11 139.31 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.832 0 O-C-N 120.78 -1.2 . . . . 0.0 108.504 178.098 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.786 HG12 ' HA ' ' A' ' 135' ' ' ARG . 34.6 m -126.93 166.95 22.52 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 C-N-CA 120.001 -0.68 . . . . 0.0 110.444 -178.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.817 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.2 p -121.16 128.35 76.0 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.53 0 C-N-CA 119.955 -0.698 . . . . 0.0 109.219 178.438 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.526 ' O ' ' HA2' ' A' ' 102' ' ' GLY . . . -68.78 145.76 53.5 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 178.054 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.446 ' HB3' ' CE2' ' A' ' 87' ' ' TYR . 9.6 mt -106.74 -15.84 14.64 Favored 'General case' 0 N--CA 1.497 1.918 0 CA-C-N 118.851 0.751 . . . . 0.0 110.972 -179.95 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.486 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 87.8 m-85 -149.01 153.99 38.69 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 121.293 -0.88 . . . . 0.0 109.559 179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 64.8 m-20 -56.43 149.45 16.91 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.703 -0.623 . . . . 0.0 111.625 -178.604 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 75.9 t80 -155.42 126.89 7.3 Favored 'General case' 0 N--CA 1.503 2.215 0 O-C-N 121.731 -0.605 . . . . 0.0 110.353 178.881 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 18.5 tp10 -100.5 130.59 46.6 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.343 -0.848 . . . . 0.0 110.527 179.953 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.766 ' HB1' ' HB3' ' A' ' 96' ' ' ASP . . . -51.23 162.09 0.36 Allowed 'General case' 0 N--CA 1.503 2.208 0 O-C-N 121.32 -0.863 . . . . 0.0 111.442 -179.663 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . 0.425 HG23 ' C ' ' A' ' 91' ' ' ALA . 3.8 pt -153.22 32.71 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 O-C-N 121.789 -0.569 . . . . 0.0 109.965 179.078 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -166.81 -170.55 1.6 Allowed 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.431 -0.793 . . . . 0.0 110.613 179.453 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 97.5 m-70 -62.1 -78.15 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.769 -0.582 . . . . 0.0 111.195 -179.102 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.414 ' O ' ' CD2' ' A' ' 127' ' ' TYR . 4.2 tp10 -88.27 49.27 1.77 Allowed 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.222 -0.924 . . . . 0.0 110.861 -179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.766 ' HB3' ' HB1' ' A' ' 91' ' ' ALA . 2.8 t0 -95.32 158.91 15.25 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.337 -0.852 . . . . 0.0 108.815 178.908 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.611 HD13 ' N ' ' A' ' 98' ' ' SER . 0.6 OUTLIER -121.47 127.21 50.84 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 121.314 -0.866 . . . . 0.0 111.107 -178.543 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.611 ' N ' HD13 ' A' ' 97' ' ' LEU . 0.9 OUTLIER -97.35 93.33 6.44 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.625 -0.672 . . . . 0.0 109.251 178.479 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.67 ' CE2' HG22 ' A' ' 128' ' ' ILE . 31.5 p90 -97.56 -173.97 2.78 Favored 'General case' 0 N--CA 1.497 1.878 0 C-N-CA 120.037 -0.665 . . . . 0.0 110.082 179.675 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 2.8 mt-30 -118.4 -164.89 1.06 Allowed 'General case' 0 N--CA 1.492 1.672 0 CA-C-O 121.67 0.747 . . . . 0.0 111.368 -178.17 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.486 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 2.0 ttmt -53.9 -90.95 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 N-CA-C 112.88 0.696 . . . . 0.0 112.88 -178.581 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 85' ' ' ALA . . . -93.45 65.49 1.82 Allowed Glycine 0 N--CA 1.5 2.92 0 N-CA-C 109.569 -1.413 . . . . 0.0 109.569 -178.565 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.472 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.4 m-20 -91.64 167.58 12.1 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.967 -0.725 . . . . 0.0 111.549 -179.623 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -123.66 120.26 32.22 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 121.403 -0.81 . . . . 0.0 110.181 178.678 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.407 ' HG3' ' HA ' ' A' ' 119' ' ' SER . 2.5 mpp? -128.69 156.73 43.0 Favored 'General case' 0 N--CA 1.491 1.599 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.52 ' O ' ' HB1' ' A' ' 117' ' ' ALA . 24.5 t -103.07 151.05 6.34 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 N-CA-C 107.572 -1.27 . . . . 0.0 107.572 179.25 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.496 ' HB ' ' CG1' ' A' ' 81' ' ' ILE . 84.0 t -95.64 139.44 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.0 0 O-C-N 120.922 -1.111 . . . . 0.0 110.133 -179.955 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.686 HD12 ' HA ' ' A' ' 117' ' ' ALA . 5.1 mp -97.18 -30.55 12.94 Favored 'General case' 0 C--N 1.298 -1.646 0 CA-C-O 121.66 0.743 . . . . 0.0 109.522 179.637 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 5.3 mt-10 -156.39 158.07 36.72 Favored 'General case' 0 N--CA 1.489 1.524 0 O-C-N 121.94 -0.475 . . . . 0.0 109.925 -178.679 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 14.8 mt-10 -99.6 152.07 20.46 Favored 'General case' 0 N--CA 1.5 2.068 0 O-C-N 121.384 -0.822 . . . . 0.0 109.588 178.872 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 4.1 t -146.95 -75.71 0.19 Allowed 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.228 -0.92 . . . . 0.0 111.261 -179.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -174.91 -92.72 0.08 OUTLIER Glycine 0 N--CA 1.494 2.521 0 N-CA-C 109.215 -1.554 . . . . 0.0 109.215 -179.228 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -96.85 -27.08 14.86 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.61 -0.935 . . . . 0.0 109.611 179.109 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.7 m95 -110.39 107.29 16.94 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.65 -0.656 . . . . 0.0 109.401 179.516 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 54.4 m0 -100.1 148.02 25.03 Favored 'General case' 0 N--CA 1.497 1.9 0 O-C-N 121.303 -0.873 . . . . 0.0 110.159 -179.984 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . 0.422 ' HA ' ' O ' ' A' ' 126' ' ' GLY . 11.5 tttt -96.35 111.6 23.63 Favored 'General case' 0 N--CA 1.494 1.752 0 N-CA-C 108.458 -0.941 . . . . 0.0 108.458 178.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.686 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -126.84 169.47 13.2 Favored 'General case' 0 N--CA 1.496 1.837 0 CA-C-O 121.871 0.843 . . . . 0.0 111.856 -178.483 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.488 ' HA ' ' O ' ' A' ' 124' ' ' LYS . 2.5 ttt180 -114.14 123.7 50.25 Favored 'General case' 0 C--N 1.312 -1.049 0 O-C-N 121.628 -0.67 . . . . 0.0 109.693 179.682 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.407 ' HA ' ' HG3' ' A' ' 105' ' ' MET . 1.1 t -78.29 111.98 14.82 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.741 -0.599 . . . . 0.0 109.537 179.336 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.483 HD11 ' CG2' ' A' ' 106' ' ' VAL . 8.4 mt -65.48 -24.41 67.15 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.856 -0.527 . . . . 0.0 110.351 -179.65 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -59.44 -31.24 69.11 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.4 -0.813 . . . . 0.0 109.754 179.769 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 25.2 p -133.93 16.29 3.88 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 121.795 -0.566 . . . . 0.0 110.459 179.057 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 48.51 29.91 2.24 Favored 'General case' 0 N--CA 1.507 2.379 0 O-C-N 121.266 -0.896 . . . . 0.0 110.857 -179.311 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.488 ' O ' ' HA ' ' A' ' 118' ' ' ARG . 16.8 mttt -96.82 177.18 5.72 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.654 -0.654 . . . . 0.0 109.479 179.883 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.442 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -155.66 134.93 12.28 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.086 0.946 . . . . 0.0 112.023 179.445 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.422 ' O ' ' HA ' ' A' ' 116' ' ' LYS . . . -166.37 -156.7 9.69 Favored Glycine 0 N--CA 1.487 2.068 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 179.071 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.48 ' H ' ' HA ' ' A' ' 96' ' ' ASP . 32.0 m-85 -93.03 160.69 14.76 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.746 -0.855 . . . . 0.0 109.637 -179.846 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.67 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.5 pt -152.98 107.66 2.66 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.835 -0.54 . . . . 0.0 109.99 179.779 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_exo -44.45 100.18 0.04 OUTLIER 'Trans proline' 0 N--CA 1.495 1.586 0 O-C-N 123.263 1.138 . . . . 0.0 111.572 179.938 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 6.2 m -60.62 -13.69 15.94 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.666 -0.646 . . . . 0.0 112.288 -178.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 28.3 p30 -65.0 -11.0 33.95 Favored 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.123 -0.986 . . . . 0.0 110.941 179.779 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -132.1 45.22 2.8 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.264 -0.897 . . . . 0.0 108.877 178.949 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.495 HG12 ' N ' ' A' ' 134' ' ' ALA . 98.7 t -145.07 171.4 5.72 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.46 0 O-C-N 121.774 -0.578 . . . . 0.0 109.719 -178.695 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.817 ' HB3' HG12 ' A' ' 84' ' ' VAL . . . -133.46 124.58 27.31 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.539 -0.725 . . . . 0.0 109.87 179.552 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.786 ' HA ' HG12 ' A' ' 83' ' ' VAL . 0.0 OUTLIER -79.26 136.85 37.16 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.41 -0.806 . . . . 0.0 111.728 -178.992 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.464 HG13 ' C ' ' A' ' 135' ' ' ARG . 23.0 m -153.32 172.24 0.77 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 CA-C-O 121.14 0.495 . . . . 0.0 110.069 179.308 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 9.5 p-10 -94.34 -162.36 0.94 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.384 -0.823 . . . . 0.0 110.772 -179.624 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . 0.446 ' HA ' HD12 ' A' ' 82' ' ' ILE . 4.4 t . . . . . 0 N--CA 1.497 1.915 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.228 -179.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 120.997 0.427 . . . . 0.0 110.323 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -91.48 133.87 35.13 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.477 -0.764 . . . . 0.0 110.331 179.931 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 12.1 m-20 -142.52 -165.01 1.94 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.435 -0.791 . . . . 0.0 109.844 -179.718 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.482 ' O ' HG23 ' A' ' 107' ' ' VAL . 0.1 OUTLIER -121.35 52.77 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.4 -0.812 . . . . 0.0 110.75 179.387 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.518 HG12 HG22 ' A' ' 106' ' ' VAL . 61.2 mt -98.71 152.93 4.21 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 120.854 -1.154 . . . . 0.0 109.578 179.193 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.866 HG12 ' HA ' ' A' ' 135' ' ' ARG . 27.6 m -138.41 179.89 2.98 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.479 0 C-N-CA 120.154 -0.618 . . . . 0.0 109.541 179.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.734 HG12 ' HB3' ' A' ' 134' ' ' ALA . 5.9 p -134.61 121.29 35.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.393 -0.817 . . . . 0.0 110.042 179.327 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.482 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -60.7 115.37 3.59 Favored 'General case' 0 N--CA 1.492 1.652 0 N-CA-C 108.892 -0.781 . . . . 0.0 108.892 179.898 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.787 HD11 ' HB2' ' A' ' 134' ' ' ALA . 62.2 mt -94.54 10.78 33.3 Favored 'General case' 0 N--CA 1.491 1.587 0 C-N-CA 120.593 -0.443 . . . . 0.0 111.447 -178.953 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.449 ' CD2' ' HA ' ' A' ' 132' ' ' TYR . 33.4 m-85 -154.35 151.42 29.03 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 121.019 -1.051 . . . . 0.0 109.686 179.222 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 21.5 m-20 -71.69 146.6 48.11 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.312 -0.867 . . . . 0.0 109.656 179.776 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.447 ' CB ' ' CZ ' ' A' ' 99' ' ' PHE . 52.4 t80 -153.57 169.48 23.14 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 121.006 -1.059 . . . . 0.0 110.988 -179.634 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 20.0 mt-10 -151.56 99.17 2.59 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.589 -0.694 . . . . 0.0 110.517 -179.652 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . . . . . . . . . . . -59.27 -179.09 0.07 Allowed 'General case' 0 N--CA 1.496 1.87 0 O-C-N 121.4 -0.813 . . . . 0.0 110.515 179.675 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 54.8 mt -143.91 -69.81 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.209 0 O-C-N 121.239 -0.913 . . . . 0.0 110.795 -179.485 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.9 OUTLIER -57.78 -167.22 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.199 -0.938 . . . . 0.0 111.079 -179.397 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 8.0 m80 -80.17 168.98 18.43 Favored 'General case' 0 N--CA 1.502 2.163 0 O-C-N 121.573 -0.704 . . . . 0.0 110.631 -179.909 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 10.9 tt0 65.95 -59.89 0.3 Allowed 'General case' 0 N--CA 1.51 2.543 0 O-C-N 121.697 -0.627 . . . . 0.0 111.352 -179.975 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.43 ' HA ' ' H ' ' A' ' 127' ' ' TYR . 22.2 p30 -41.87 154.04 0.05 Allowed 'General case' 0 N--CA 1.506 2.365 0 O-C-N 121.565 -0.709 . . . . 0.0 111.746 -179.056 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.678 HD21 ' HB2' ' A' ' 119' ' ' SER . 1.4 tp -135.76 146.99 48.21 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.248 -0.907 . . . . 0.0 112.035 -177.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 14.0 m -96.92 167.26 11.19 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.808 -0.558 . . . . 0.0 110.074 179.081 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.482 ' CD1' ' HB1' ' A' ' 85' ' ' ALA . 20.8 p90 -165.32 -167.46 1.17 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.405 -0.809 . . . . 0.0 110.787 179.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -126.19 176.55 6.98 Favored 'General case' 0 N--CA 1.496 1.844 0 CA-C-O 122.042 0.925 . . . . 0.0 111.506 -178.891 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.443 ' HA ' ' N ' ' A' ' 87' ' ' TYR . 15.3 ttmt -61.25 -19.18 61.4 Favored 'General case' 0 N--CA 1.502 2.174 0 N-CA-C 115.235 1.569 . . . . 0.0 115.235 -177.332 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -136.72 41.48 1.41 Allowed Glycine 0 N--CA 1.496 2.696 0 N-CA-C 109.48 -1.448 . . . . 0.0 109.48 -178.69 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.441 ' HB2' ' HB3' ' A' ' 85' ' ' ALA . 2.5 m-20 -90.94 166.43 13.04 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.704 -0.88 . . . . 0.0 111.508 -179.845 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -121.41 131.17 54.02 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.605 -0.684 . . . . 0.0 109.461 178.851 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.414 ' HG2' ' HA ' ' A' ' 119' ' ' SER . 60.7 mtm -140.53 148.67 41.39 Favored 'General case' 0 N--CA 1.49 1.536 0 N-CA-C 109.302 -0.629 . . . . 0.0 109.302 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.537 ' CG2' HD11 ' A' ' 120' ' ' LEU . 41.6 t -95.67 155.44 3.36 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.427 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 179.527 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 81' ' ' ILE . 69.3 t -95.73 142.5 13.64 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 121.159 -0.963 . . . . 0.0 110.464 -179.468 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.729 HD12 ' HA ' ' A' ' 117' ' ' ALA . 3.6 mp -95.66 -31.1 13.42 Favored 'General case' 0 C--N 1.301 -1.537 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.323 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 13.2 mt-10 -156.24 -177.45 6.59 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.742 -0.599 . . . . 0.0 110.472 -179.893 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 3.8 mt-10 -135.45 94.8 3.15 Favored 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.504 -0.748 . . . . 0.0 110.306 179.478 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 13.4 t -94.66 -75.13 0.52 Allowed 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.434 -0.791 . . . . 0.0 110.304 -179.906 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -176.82 -98.88 0.11 Allowed Glycine 0 N--CA 1.496 2.662 0 C-N-CA 119.902 -1.142 . . . . 0.0 110.486 -179.813 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -64.41 -50.1 68.95 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.403 -1.057 . . . . 0.0 110.814 -178.91 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 42.2 m95 -102.18 127.02 49.3 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.41 -0.806 . . . . 0.0 110.273 -179.713 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 45.3 m0 -108.67 140.97 41.32 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.613 -0.679 . . . . 0.0 109.469 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -94.71 121.95 36.82 Favored 'General case' 0 N--CA 1.5 2.031 0 O-C-N 121.386 -0.821 . . . . 0.0 108.997 179.414 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.729 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -138.07 162.98 32.75 Favored 'General case' 0 N--CA 1.504 2.227 0 C-N-CA 119.222 -0.991 . . . . 0.0 112.978 -179.066 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.517 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 1.5 ttt180 -114.57 125.89 54.29 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 121.555 -0.715 . . . . 0.0 110.185 179.812 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.678 ' HB2' HD21 ' A' ' 97' ' ' LEU . 15.3 t -78.16 121.4 24.29 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.591 -0.693 . . . . 0.0 109.437 178.973 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . 0.537 HD11 ' CG2' ' A' ' 106' ' ' VAL . 5.3 mt -70.52 -26.91 63.8 Favored 'General case' 0 N--CA 1.494 1.765 0 C-N-CA 120.287 -0.565 . . . . 0.0 110.51 -179.859 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -57.95 -27.18 63.16 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.558 -0.714 . . . . 0.0 110.599 179.929 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 36.1 p -138.1 12.49 2.85 Favored 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.513 -0.742 . . . . 0.0 111.089 179.823 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 52.18 30.21 7.47 Favored 'General case' 0 N--CA 1.505 2.321 0 O-C-N 121.009 -1.057 . . . . 0.0 110.738 -179.65 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.58 ' HB2' HD11 ' A' ' 97' ' ' LEU . 6.0 mttp -103.14 176.32 5.19 Favored 'General case' 0 N--CA 1.496 1.862 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 178.95 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.517 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 1.0 OUTLIER -155.87 150.08 25.61 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 121.416 -0.803 . . . . 0.0 111.356 179.837 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . 0.429 ' HA3' ' N ' ' A' ' 97' ' ' LEU . . . -166.58 -140.04 2.8 Favored Glycine 0 N--CA 1.486 2.026 0 C-N-CA 120.093 -1.051 . . . . 0.0 110.815 179.754 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.441 ' O ' HG23 ' A' ' 128' ' ' ILE . 68.9 m-85 -113.34 154.24 27.19 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 122.03 -0.688 . . . . 0.0 110.746 -178.649 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.441 HG23 ' O ' ' A' ' 127' ' ' TYR . 19.4 pt -153.49 134.98 8.67 Favored Pre-proline 0 N--CA 1.495 1.779 0 O-C-N 121.822 -0.549 . . . . 0.0 110.161 178.885 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . 0.417 ' HD3' ' HA ' ' A' ' 128' ' ' ILE . 6.4 Cg_exo -69.01 124.74 11.7 Favored 'Trans proline' 0 N--CA 1.485 1.004 0 O-C-N 123.085 1.045 . . . . 0.0 109.918 179.911 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 2.9 m -51.94 -35.31 45.41 Favored 'General case' 0 N--CA 1.503 2.184 0 O-C-N 121.519 -0.738 . . . . 0.0 111.167 -179.907 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 17.9 p-10 -75.34 -6.91 52.36 Favored 'General case' 0 N--CA 1.5 2.03 0 O-C-N 121.49 -0.756 . . . . 0.0 111.701 -178.989 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . 0.449 ' HA ' ' CD2' ' A' ' 87' ' ' TYR . 3.3 m-85 -104.78 24.02 12.5 Favored 'General case' 0 N--CA 1.499 1.985 0 O-C-N 121.157 -0.964 . . . . 0.0 110.015 179.398 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.471 HG22 ' HB ' ' A' ' 83' ' ' VAL . 5.7 p -161.26 169.53 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 C-N-CA 119.533 -0.867 . . . . 0.0 111.531 -177.485 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.787 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -118.58 135.29 54.51 Favored 'General case' 0 N--CA 1.499 1.98 0 CA-C-N 116.099 -0.5 . . . . 0.0 109.718 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.866 ' HA ' HG12 ' A' ' 83' ' ' VAL . 3.4 tpp180 -91.99 122.36 34.43 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 121.297 -0.877 . . . . 0.0 112.779 -178.436 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 17.1 m -129.06 145.46 35.74 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.776 0 O-C-N 121.596 -0.69 . . . . 0.0 110.023 178.218 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 54.1 p-10 -116.59 73.05 0.84 Allowed 'General case' 0 C--N 1.31 -1.15 0 O-C-N 121.382 -0.824 . . . . 0.0 109.674 -179.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 3.2 t . . . . . 0 N--CA 1.495 1.799 0 CA-C-O 117.985 -1.007 . . . . 0.0 110.383 -179.94 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 2.6 m . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 120.988 0.423 . . . . 0.0 109.884 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -75.19 125.7 29.5 Favored 'General case' 0 N--CA 1.489 1.509 0 C-N-CA 119.949 -0.7 . . . . 0.0 109.923 -179.851 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' ASP . . . . . . . . . . . . . 45.7 m-20 -94.11 -169.59 2.11 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.534 -0.729 . . . . 0.0 110.43 -179.697 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' ILE . . . . . 0.445 HG13 ' HB ' ' A' ' 107' ' ' VAL . 1.7 tp -137.58 44.91 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.572 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 179.991 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ILE . . . . . 0.64 HG23 HG12 ' A' ' 106' ' ' VAL . 86.9 mt -109.17 161.72 7.34 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 C-N-CA 119.234 -0.986 . . . . 0.0 109.894 -179.52 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.681 HG12 ' HA ' ' A' ' 135' ' ' ARG . 16.3 m -138.95 167.63 20.37 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 CA-C-O 121.714 0.768 . . . . 0.0 110.637 179.548 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.689 HG12 ' HB3' ' A' ' 134' ' ' ALA . 6.4 p -130.2 123.42 55.88 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.384 0 N-CA-C 108.15 -1.055 . . . . 0.0 108.15 178.007 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' ALA . . . . . 0.543 ' HB1' ' CD1' ' A' ' 99' ' ' PHE . . . -68.9 121.57 16.85 Favored 'General case' 0 N--CA 1.487 1.402 0 C-N-CA 119.454 -0.899 . . . . 0.0 109.361 -179.518 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . 0.792 HD11 ' HB2' ' A' ' 134' ' ' ALA . 19.7 mt -94.04 0.03 55.72 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.704 -179.859 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . 0.488 ' CA ' ' HA ' ' A' ' 101' ' ' LYS . 65.3 m-85 -151.14 151.18 31.57 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 121.242 -0.911 . . . . 0.0 109.041 179.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 73.3 m-20 -67.68 145.9 54.33 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.517 -0.74 . . . . 0.0 110.178 -179.465 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.471 ' HB3' ' CZ ' ' A' ' 99' ' ' PHE . 40.5 t80 -153.54 132.92 12.8 Favored 'General case' 0 N--CA 1.504 2.275 0 O-C-N 121.201 -0.937 . . . . 0.0 111.025 179.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' GLU . . . . . . . . . . . . . 13.4 mt-10 -100.95 133.4 45.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.776 -0.577 . . . . 0.0 111.675 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ALA . . . . . 0.434 ' HB1' ' OD1' ' A' ' 96' ' ' ASP . . . -57.2 -173.42 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.11 0 O-C-N 121.48 -0.762 . . . . 0.0 110.363 179.29 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' ILE . . . . . . . . . . . . . 7.6 tt -167.27 26.59 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.965 0 O-C-N 121.407 -0.808 . . . . 0.0 111.266 -179.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER 176.89 -158.37 0.02 OUTLIER 'General case' 0 N--CA 1.513 2.678 0 O-C-N 120.896 -1.127 . . . . 0.0 109.962 179.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' HIS . . . . . . . . . . . . . 61.3 m80 -82.76 159.61 22.48 Favored 'General case' 0 N--CA 1.503 2.202 0 O-C-N 121.141 -0.975 . . . . 0.0 110.35 -179.907 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . . . . . . . . . 48.4 tt0 65.38 -57.47 0.3 Allowed 'General case' 0 N--CA 1.511 2.584 0 O-C-N 121.611 -0.681 . . . . 0.0 111.677 179.659 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' ASP . . . . . 0.434 ' OD1' ' HB1' ' A' ' 91' ' ' ALA . 7.4 p30 -44.19 148.45 0.43 Allowed 'General case' 0 N--CA 1.505 2.318 0 O-C-N 121.134 -0.979 . . . . 0.0 111.902 -179.125 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LEU . . . . . 0.578 HD22 ' HB2' ' A' ' 119' ' ' SER . 0.6 OUTLIER -130.07 153.61 48.29 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.436 -0.79 . . . . 0.0 111.493 -178.186 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 3.5 m -98.93 116.38 31.03 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.418 0.628 . . . . 0.0 109.767 178.67 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PHE . . . . . 0.68 ' CE2' HG22 ' A' ' 128' ' ' ILE . 16.2 p90 -104.62 -172.29 2.07 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.839 -0.538 . . . . 0.0 110.016 179.573 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -125.1 -178.83 4.32 Favored 'General case' 0 N--CA 1.491 1.58 0 CA-C-O 122.389 1.09 . . . . 0.0 112.439 -178.048 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' LYS . . . . . 0.488 ' HA ' ' CA ' ' A' ' 87' ' ' TYR . 13.6 ttmt -60.75 -22.72 64.34 Favored 'General case' 0 N--CA 1.5 2.037 0 N-CA-C 115.312 1.597 . . . . 0.0 115.312 -177.403 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' GLY . . . . . . . . . . . . . . . -142.28 43.15 1.08 Allowed Glycine 0 N--CA 1.493 2.484 0 N-CA-C 108.51 -1.836 . . . . 0.0 108.51 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 84' ' ' VAL . 1.5 m-20 -90.54 165.14 13.94 Favored 'General case' 0 N--CA 1.502 2.15 0 C-N-CA 119.716 -0.794 . . . . 0.0 111.311 -179.311 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLN . . . . . . . . . . . . . 1.9 mt-30 -122.05 109.76 14.96 Favored 'General case' 0 C--N 1.308 -1.23 0 O-C-N 121.573 -0.705 . . . . 0.0 109.718 179.224 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' MET . . . . . 0.491 ' HE1' ' HB2' ' A' ' 85' ' ' ALA . 1.5 mpp? -126.7 147.21 49.97 Favored 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 179.209 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' VAL . . . . . 0.64 HG12 HG23 ' A' ' 82' ' ' ILE . 4.5 m -99.02 158.46 3.57 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.47 0 C-N-CA 118.746 -1.182 . . . . 0.0 109.27 -178.945 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' VAL . . . . . 0.445 ' HB ' HG13 ' A' ' 81' ' ' ILE . 39.6 t -94.09 143.06 12.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.645 0 O-C-N 121.048 -1.033 . . . . 0.0 109.884 -179.395 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.699 HD12 ' HA ' ' A' ' 117' ' ' ALA . 4.2 mp -98.06 -28.26 13.84 Favored 'General case' 0 C--N 1.299 -1.619 0 CA-C-O 121.501 0.667 . . . . 0.0 109.512 179.937 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' GLU . . . . . . . . . . . . . 6.3 mt-10 -156.32 168.26 27.87 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.734 -0.604 . . . . 0.0 109.591 179.966 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' GLU . . . . . . . . . . . . . 18.5 mt-10 -115.48 109.54 17.98 Favored 'General case' 0 N--CA 1.496 1.858 0 O-C-N 121.453 -0.78 . . . . 0.0 109.261 178.82 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' SER . . . . . . . . . . . . . 47.8 t -96.95 -66.68 0.89 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.284 -0.885 . . . . 0.0 110.76 -179.344 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 166.34 -56.49 0.24 Allowed Glycine 0 N--CA 1.496 2.677 0 N-CA-C 109.551 -1.419 . . . . 0.0 109.551 -179.955 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' GLU . . . . . . . . . . . . . 19.6 mt-10 -119.33 -31.28 4.69 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.594 -0.944 . . . . 0.0 109.752 179.548 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' TRP . . . . . . . . . . . . . 79.0 m95 -121.67 101.97 7.93 Favored 'General case' 0 N--CA 1.487 1.416 0 N-CA-C 108.889 -0.782 . . . . 0.0 108.889 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' TRP . . . . . . . . . . . . . 52.0 m0 -94.8 154.15 17.4 Favored 'General case' 0 N--CA 1.495 1.786 0 O-C-N 121.406 -0.808 . . . . 0.0 109.846 -179.29 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' LYS . . . . . . . . . . . . . 1.3 mtpm? -94.48 135.67 35.64 Favored 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 178.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' ALA . . . . . 0.699 ' HA ' HD12 ' A' ' 108' ' ' LEU . . . -143.7 159.61 42.18 Favored 'General case' 0 N--CA 1.5 2.042 0 C-N-CA 118.694 -1.202 . . . . 0.0 113.217 -177.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' ARG . . . . . 0.509 ' HA ' ' HA ' ' A' ' 125' ' ' GLU . 8.5 ttm180 -112.82 122.51 47.86 Favored 'General case' 0 N--CA 1.483 1.192 0 CA-C-O 121.743 0.783 . . . . 0.0 110.174 179.658 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' SER . . . . . 0.578 ' HB2' HD22 ' A' ' 97' ' ' LEU . 8.5 t -84.23 129.53 34.88 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.829 -0.544 . . . . 0.0 110.675 -179.798 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' LEU . . . . . . . . . . . . . 7.4 mt -77.1 -26.56 53.45 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 121.925 -0.484 . . . . 0.0 110.561 179.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ALA . . . . . . . . . . . . . . . -58.44 -28.9 65.7 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 121.422 -0.799 . . . . 0.0 109.745 -179.789 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 17.6 p -129.48 4.89 5.13 Favored 'General case' 0 N--CA 1.487 1.412 0 O-C-N 121.843 -0.535 . . . . 0.0 110.662 179.341 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 54.45 28.32 9.44 Favored 'General case' 0 N--CA 1.504 2.263 0 O-C-N 120.996 -1.065 . . . . 0.0 109.678 -179.264 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' LYS . . . . . 0.43 ' O ' ' HG2' ' A' ' 118' ' ' ARG . 64.9 mttt -109.18 -173.89 2.37 Favored 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.603 -0.685 . . . . 0.0 109.919 -179.653 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.509 ' HA ' ' HA ' ' A' ' 118' ' ' ARG . 0.0 OUTLIER -154.87 153.88 31.83 Favored 'General case' 0 N--CA 1.502 2.131 0 O-C-N 121.337 -0.852 . . . . 0.0 111.034 179.837 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' GLY . . . . . . . . . . . . . . . -167.56 -124.16 0.7 Allowed Glycine 0 N--CA 1.489 2.22 0 N-CA-C 110.586 -1.006 . . . . 0.0 110.586 -179.781 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . 0.482 ' O ' HG23 ' A' ' 128' ' ' ILE . 60.7 m-85 -127.82 157.4 40.53 Favored 'General case' 0 N--CA 1.488 1.434 0 O-C-N 121.73 -0.865 . . . . 0.0 109.732 -179.235 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' ILE . . . . . 0.68 HG22 ' CE2' ' A' ' 99' ' ' PHE . 2.3 pt -153.08 106.24 2.63 Favored Pre-proline 0 N--CA 1.493 1.694 0 C-N-CA 120.23 -0.588 . . . . 0.0 110.429 179.391 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_exo -47.31 113.08 0.63 Allowed 'Trans proline' 0 N--CA 1.495 1.571 0 C-N-CA 121.013 1.142 . . . . 0.0 111.731 -179.324 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . 0.412 ' HA ' ' CG1' ' A' ' 133' ' ' VAL . 11.0 m -59.86 -15.4 20.84 Favored 'General case' 0 N--CA 1.498 1.959 0 O-C-N 121.709 -0.62 . . . . 0.0 111.849 -179.716 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' ASN . . . . . . . . . . . . . 29.1 p30 -75.67 1.5 14.39 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.91 -1.119 . . . . 0.0 111.951 -179.236 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -144.97 45.09 1.35 Allowed 'General case' 0 N--CA 1.504 2.264 0 O-C-N 120.926 -1.109 . . . . 0.0 110.711 179.479 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 134' ' ' ALA . 7.5 p -153.28 168.84 1.08 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.787 0 O-C-N 121.231 -0.918 . . . . 0.0 110.874 -179.634 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' ALA . . . . . 0.792 ' HB2' HD11 ' A' ' 86' ' ' LEU . . . -124.28 116.44 22.65 Favored 'General case' 0 N--CA 1.498 1.972 0 N-CA-C 109.141 -0.688 . . . . 0.0 109.141 179.407 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.681 ' HA ' HG12 ' A' ' 83' ' ' VAL . 10.9 ttp180 -94.79 120.8 35.59 Favored 'General case' 0 C--N 1.311 -1.094 0 O-C-N 121.24 -0.912 . . . . 0.0 112.069 -178.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . 0.465 HG22 ' O ' ' A' ' 82' ' ' ILE . 34.2 m -89.69 136.55 23.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.457 0 N-CA-C 108.209 -1.034 . . . . 0.0 108.209 177.335 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 137' ' ' ASP . . . . . . . . . . . . . 4.2 p30 -154.6 47.66 0.57 Allowed 'General case' 0 C--N 1.308 -1.231 0 O-C-N 121.723 -0.61 . . . . 0.0 109.36 -178.394 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 138' ' ' SER . . . . . . . . . . . . . 29.5 t . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 118.096 -0.954 . . . . 0.0 110.012 -179.954 . . . . . . . . 0 0 . 1 stop_ save_